Application de la chimie radicalaire par Xanthates: Synthèse des composés hétéroaromatiques by Liu, Zhibo
Application de la chimie radicalaire par Xanthates:
Synthe`se des compose´s he´te´roaromatiques
Zhibo Liu
To cite this version:
Zhibo Liu. Application de la chimie radicalaire par Xanthates: Synthe`se des compose´s
he´te´roaromatiques. Chimie organique. Ecole Polytechnique X, 2014. Franc¸ais. <pastel-
00980912>
HAL Id: pastel-00980912
https://pastel.archives-ouvertes.fr/pastel-00980912
Submitted on 19 Apr 2014
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
   
                 
 
THESIS 
 
submitted for the award of the degree of 
DOCTOR OF PHILOSOPHY 
 
In the field of 
ORGANIC CHEMISTRY 
 
by 
Zhibo LIU 
 
Application of the Radical Chemistry of Xanthates to 
the Synthesis of Novel Heteroaromatic Compounds 
 
 
 
Presented on 20 January 2014 to a committee composed of: 
 
Valérie Alezra      Referee 
Stellios Arseniyadis     Referee 
Aziz Fadli      Examiner 
Fabien Gagosz     Examiner 
Isabelle Gillaizeau     President 
Samir Z. ZARD     Director of thesis 

 3 
ACKNOWLEDGEMENTS 
 
I highly appreciate Prof. Samir Z. Zard. He is my supervisor in research who enlightens 
my study in organic chemistry in his most inspiring way. He is my director in the 
laboratory who is a model with integrity and diligent for everyone. A Chinese old saying 
says that: day as a teacher, father for life. He is like a father who shares life wisdom with 
me. I have gone through many difficult periods in the past years. He is also my most 
respected friends who always gave me support and encouragement. I want to say that it is 
my great honor to be a student of him. And it is very fortunate for me to follow him in 
my thesis study.  
 
I would like to express my great appreciation to the members of the committee, Dr. 
Valérie Alezra, Dr. Stellios Arseniyadis, Dr. Aziz Fadli, Dr. Fabien Gagosz, and Dr. 
Isabelle Gillauizeau. Thank you all for .your time and your efforts. 
 
I would also like to thank Dr. Béatrice Sire. She is very kind and generous. I benefit a lot 
from her helps in my daily work in the laboratory and moreover her rich research 
experiences shared with me.  
 
I eq.ually appreciate Dr. Fabien Gagosz and Dr. Yvan Six. Their kindness, humorous and 
generous personalities make them the best colleagues at work.  
 
My special thanks to Brigitte and Lélia, for their all kinds of help and meaningful advices 
during my daily life.  
 
I would like to thank all my friends in Lab-4, Remi, Mehdi, Raphaël, Laurent, Julien, 
Ling, Pierre, Xiaoxiang and Mario. We shared many happy memories in the past four 
years. They always gave me supports and valuable suggestions. Talking with them 
everyday is instructive and pleasant.  
 
 4 
I also want to thank all other DCSO students from different laboratories: Bill, Fernando, 
Manu, Nina, Vicky and Cheng in Lab-1; Fred, Rama, Laurent, Guillaume, My, Raphael, 
Qing and Colombe from Lab-2; Diego, Alice, Marie-Gabrielle, Nahid, Christina, 
Songzhe, Shiguang, Kelvin, Ewelinas in Lab-3; Igor, Yann, Benoît, Alex, Ziping, 
Guilhem and Liangliang from Lab-5. They are all kind and smart persons who are ready 
for help. 
 
Last but not least, I would like to express my deep gratitude to my family: my parents, for 
their support throughout all of my studies; my virtuous wife, who always gives me the 
great support whenever I need during the past ten years; and my lovely son, you are the 
biggest source of my strength forever! 
  5 
CONTENTS 
 
Abbreviations                   9 
 
Avant-propos                 11 
 
General Introduction               15 
 
Chapter 1 General Introduction to Radical Chemistry         19 
 
Introduction                 21 
 
ĉ. Geometry, stability and reactivity of radicals           23 
1. Geometry of radical                23 
2. Radical stability and reactivity              24 
 
Ċ. Sources of radicals               27 
1. Common sources for radicals              27 
2. Half-life of radicals                29 
 
ċ. How do radicals react?               30 
 
Č. Radical chain processes               32 
1. The mechanism of a radical chain process             32 
2. Applications based on the radical chain process            34 
 
Conclusion                  38 
 
Chapter 2 The Radical Chemistry of Xanthates           39 
 
Introduction                 41 
 
ĉ. The Barton-McCombie deoxygenation: mechanism, applications 
                   42 
 6 
Ċ. A discovery during a mechanism study            44 
 
ċ. Degenerative transfer of xanthates             46 
1. Mechanism                 47 
2. Preparation of the xanthates              49 
3. Synthetic potential of the degenerative transfer of xanthates          53 
 
Conclusion                  65 
 
Chapter 3 Radical Synthesis of 5-Arylpiperid-2-ones          67 
 
Introduction                 69 
 
ĉ. Synthesis of 5-substituted piperidin-2-ones           70 
1. Oxidation and reduction               70 
2. Intramolecular C-N bond formations             72 
3. Intramolecular C-C bond formations             74 
4. Intermolecular processes               76 
 
Ċ. Desulfonylative radical ring closure onto aromatics: synthesis of 
benzazepin-2-ones and 5-arylpiperidin-2-ones            78 
1. Investigation of arylpiperidin-2-one synthesis            78 
a. Initial strategy to synthesize arylpiperidin-2-ones          78 
b. An improved synthetic strategy involving a mesylate as the protecting 
group                 82 
2. Results and optimizations               84 
a. Unexpected loss of mesyl group during the radical cyclization         84 
b. Optimization of the ring closure by dilution and addition of base      88 
c. Rearrangement leading to 5-arylpiperidin-2-ones          93 
d. Generalization of the synthesis of benzazepin-2-ones          95 
 
Conclusion                  97 
  7 
Chapter 4 Radical Synthesis of 7-Azaindolines and 7-
Azaindoles                 99 
 
Introduction               101 
 
ĉ. Synthesis of 7-azaindole derivatives           103 
1. Pyrrolo annulation into preformed pyridine rings         105 
2. Pyridine ring formation based on substituted pyrrole derivatives       112 
3. Oxidation of the corresponding 7-azaindolines          114 
 
Ċ. Synthesis of 7-azaindoles and 7-azaindolines by an uncommon 
radical ipso-substitution of a C-F bond           117 
1. Discovery of an unexpected radical ipso-substitution-demethylation       117 
2. Clarification of the mechanism            120 
a. With pyrrolidyl substituted precursors          120 
b. With piperidyl substituted precursors          124 
3. Further investigations of the scope            127 
a. Discovery of another product: 7-azaindole         127 
b. A more complete view of the mechanism          129 
c. Clarification of two previous results          131 
d. Further rationalization            133 
4. Diversity and perspectives             135 
a. Further examples             135 
b. Optimization of the reaction selectivity          138 
c. Preliminary study towards the synthesis of piperidopyridine       141 
 
Conclusion                143 
 
Chapter 5 Radical Synthesis of Pyrimidine Derivatives       145 
 
Introduction               147 
 
ĉ. Synthesis of bicyclic aza-pyrimidine derivatives         149 
 8 
1. Five-membered ring fused bicyclic aza-pyrimidines         149 
2. Six-membered ring fused bicyclic aza-pyrimidines         150 
3. Seven-membered ring fused bicyclic aza-pyrimidines         156 
 
Ċ. Synthesis of bicyclic aza-pyrimidines using xanthates        160 
1. Investigation of the “carbamate puzzle”           160 
a. An unusual radical addition to the heteroaromatic nitrogen       160 
b. Identification of the minor N-cyclized product         163 
c. Further investigations of the regioselectivity with various protecting 
groups              167 
d. Preliminary evidence for an enhanced intramolecular H-bonding   170 
e. Preliminary study in evaluating the mechanistic hypothesis       174 
2. Synthesis of bicyclic aza-pyrimidines and related derivatives        177 
a. Synthesis of 5,7-diazaindolines without protecting groups       177 
b. Approach to unprotected bicyclic aza-pyrimidine derivatives       181 
c. Parallel study of the substrates based on pyridine ring        184 
d. C-C bond formation via intermolecular radical addition to aromatic 
ring               189 
3. Expansion of the reaction scope            191 
a. Synthesis of 7,7-disubstituted piperido[2,3-d]pyrimidines       191 
b. Alternative strategy for preparing pyrimidoazepines        194 
c. Functionalization of the bicyclic aza-pyrimidine derivatives       200 
4. Synthesis of bicyclic aza-pyrimidones via C-N bond formation        205 
a. Preliminary approach toward tricyclic aza-pyrimidones        205 
b. Six-membered ring closure on heteroaromatic nitrogen        206 
 
Conclusion                210 
 
Experimental part              211 
  9 
Abbreviations 
 
Ac    acetyl 
AIBN    2,2’-azo-bis-isobutyronitrile 
Ar    aryl 
Bn    benzyl 
Boc    tert-butoxycarbonyl 
CSA    camphorsulfonic acid 
DBP    dibenzoyl peroxide 
DBU    1,8-diazabicyclo[5.4.0]undec-7-ene 
DCE    1,2-dichloroethane 
DCM    dichloromethane 
DDQ    2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DIPEA   N,N-diisopropylethylamine 
DLP    dilauroyl peroxide 
DMAP   4-dimethylaminopyridine 
DMC    dimethylcarbonate 
DMF    N,N-dimethylformamide 
DTBP   di-tert-butyl peroxide 
EDG    electron donating group 
EP    petroleum ether 
Et    ethyl 
EWG    electron withdrawing group 
i-Pr    isopropyl 
LDA    lithium diisopropylamide 
m-CPBA   meta-chloroperoxybenzoic acid 
Me    methyl 
Ms    mesyl 
Ph    phenyl 
PhCl    chlorobenzene 
Pht    phtalimide 
  10 
Piv    pivalate 
t-Bu    tert-butyl 
TEA    triethylamine 
TFA    trifluoroacetic acid 
THF    tetrahydrofuran 
TMS    trimethylsilyl 
Ts    tosyl 
Xa    O-ethyl xanthate 
 
cat.    catalytic quantity 
°C    degree Celsius 
eq.    eq.alents 
Δ    heating 
Hz    hertz 
h    hour 
IR    infrared 
In    initiator 
min    minute 
M    mole per litre 
NMR    nuclear magnetic resonance 
Nu    nucleophile 
Ox.    oxidation 
ppm    parts per million 
hν    photochemical irradiation 
Red.   reduction 
TLC    thin layer chromatography 
  
 
 
 
 
 
 
 
Avant-propos 
 
 
 
 
 
 
 

Avant-propos 
 13 
Avant-propos 
 
Au cours de cette thèse nous nous sommes intéressés à la synthèse d’hétérocycles azotés 
dérivés de benzazépinones et de composés pyridiniques et pyrimidiniques. Ces travaux 
ont été menés sous la direction du Pr. Samir Z. Zard au Laboratoire de Synthèse 
Organique à l’Ecole Polytechnique. Ce manuscrit est composé de cinq chapitres. 
 
Dans un premier temps, nous presentons brièvement les grands principes de la chimie 
radicalaire (Chapitre 1), et puis plus particulièrement la chimie radicalaire des xanthates 
qui a été développée au laboratoire (Chapitre 2), afin de familiariser le lecteur à la chimie 
radicalaire par transfert de xanthate.  
 
 
Le Chapitre 3 concerne une nouvelle synthèse de benzazépin-2-ones et 5-arylpipéridin-2-
ones par voie radicalaire à partir de matières premières simples, via une cyclisation 
radicalaire sur noyau aromatique de type 7-endo-trig.  
 
 
 
δ’optimisation de l'étape de cyclisation a permis d’obtenir des rendements modérés à 
excellents. De plus, grâce à la présence de substituents halogènes sur le noyau aromatique, 
il est possible de combiner ce processus radicalaire avec d'autres réactions importantes, 
ce qui pourrait avoir des applications intéressantes. 
 
 
Le Chapitre 4 traite de la préparation de nouveaux 3,4-disubstitués-5,6-difluoro-7-
azaindoles et 7-azaindolines avec de bons rendements par voie radicalaire à partir de la 
pentafluoropyridine.  
Avant-propos 
 14 
 
 
La formation de ces deux composés comprend la rupture homolytique d'une très forte 
liaison C-F, ce qui est très rare dans de telles conditions douces. L'efficacité de cette 
cyclisation radicalaire se trouve être très sensible à la propriété électronique de la 
substitution en C-4. Sur la base de ce travail, une mini-librairie de composés divers de 7-
azaindoles et 7-azaindolines pourrait être créée. 
 
Enfin, le dernier chapitre a été réalisé en collaboration avec M. Ling QIN, que j’ai été 
amené à encadrer au cours de ma thèse. Dans cette partie, nous nous sommes interessés à 
de nouvelles cyclisations radicalaires de xanthates sur des noyaux hétéroaromatiques bis-
azotés.  
 
 
 
L'un des développements de ce travail est la possibilité d'utiliser des substrats où l'azote 
non aromatique n’est pas protégé. La méthode pourrait être partiellement étendue à des 
pyridines. En outre, la première cyclisation radicalaire à l'azote hétéro-aromatique de type 
6-endo-trig a également été réalisé. Les développements de ces voies de synthèse a 
permis de mieux comprendre certains mécanismes réactionnels ainsi que d’en découvrir 
de nouveaux. 
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General Introduction 
 
In this thesis we are interested in the synthesis of nitrogen-containing heterocyclic 
derivatives, which are based on benzazepinones, pyridines and pyrimidines. These works 
are carried out under the supervision of Prof. Samir Z. Zard in Laboratory of Organic 
Synthesis in Ecole Polytechnique. This manuscript consists of five chapters. 
 
At first, we will briefly introduce the general concepts of radical chemistry (Chapter 1), 
and then especially the radical chemistry of xanthates which was developed in the 
laboratory (Chapter 2), to familiarize the reader with the radical xanthate transfer 
processes. 
 
 
In Chapter 3, we will describe a novel synthesis of benzazepin-2-ones and 5-
arylpiperidin-2-ones using the xanthate transfer technique from simple starting materials, 
via a seven-membered ring radical cyclization.  
 
 
 
Optimized conditions for the ring closure step afford moderate to excellent yields for this 
synthesis. Moreover, the ease of introduction of halogen atoms into the aryl group of the 
products makes it possible to combine this radical process with powerful transition metal 
catalyzed coupling reactions, allowing the rapid construction of novel libraries with 
potential use in medicinal chemistry. 
 
 
In Chapter 4, the concise synthesis of 3,4-disubstituted-5,6-difluoro-7-azaindoles and 7-
azaindolines starting from the commercially available pentafluoropyridine will be 
described. 
General Introduction 
 18 
 
 
The formation of these two important families includes the homolytic rupture of a very 
strong C-F bond, which is extremely rare. The efficiency of this intramolecular radical 
cyclization was found to be very sensitive to the electronic properties of the C-4 
substituents. This approach combines the xanthate transfer radical process with 
traditional ionic reactions, and provides a convenient access to a diverse library of 7-
azaindolines and 7-azaindoles. 
 
In Chapter 5, a direct route to novel polycyclic aza-pyrimidine structures, including 5-, 6-, 
7-membered rings, is presented, involving intermolecular radical additions and 
cyclizations of xanthates. 
 
 
 
One of the main developments of this work is the possibility of using substrates which 
are unprotected at the non-aromatic nitrogen. This methodology could be partially 
extended to pyridine series. Furthermore, the first radical cyclization onto the 
heteroaromatic nitrogen atom in a 6-endo-trig manner has also been accomplished. The 
development of these syntheses provided better understanding of some reaction 
mechanisms as well as to discover new processes. 
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Introduction 
 
The first ever free radical identified in history was the triphenylmethyl radical, which was 
described in 1900 by Gomberg in his publication “An instance of trivalent carbon: 
triphenylmethyl”.1 From since then, people started to realize progressively that besides 
the traditional anions and cations, another neutral species “radicals” also existed and had 
great potential applications in organic synthesis.  
 
In 1920s, Paneth and Hofeditz first prepared the methyl free radical 2  by heating 
tetramethyllead in a rapid current of hydrogen under low pressure. Later on, photo-
chemical decomposition of alkyl halides and the aliphatic azo compounds was also 
shown to give free radicals, and the research work in this field rapidly developed.3 
 
In 1930s, another remarkable work was published by Kharasch explaining how an anti-
Markovnikov orientation could be achieved via free radical chain process, which was 
defined as the “peroxide effect”.4  During the years of 1950s and 1960s, there were 
numerous radical transformations studied by many groups. One important discovery 
involved organotin hydrides, which were shown to have the capability of bringing about 
the replacement of the halogen atom in alkyl,5 aryl6 and acyl7 halides by hydrogen under 
mild conditions. In 1962, Kuivila confirmed the existence of a chain mechanism based on 
free radicals in the reduction of alkyl halides,8 in which an organotin radical abstracts a 
halogen atom from the halide in one step, and the resulting alkyl radical abstracts a 
hydrogen atom from the organotin hydride in the second step (the chain mechanism will 
be described in detail later in this chapter). 
                                                 
1
 Gomberg, M. J. Am. Chem. Soc. 1900, 22, 757-771. 
2
 Paneth, F.; Hofeditz, W. Chem. Ber. 1929, 62, 1335. 
3
 Hey, D. H.; Waters, W. A. Chem. Rev. 1937, 21, 169-208. 
4
 Kharasch, M. S.; Mayo, F. R. J. Am. Chem. Soc. 1933, 55, 2468-2496. 
5
 (a) Noltes, J. G.; Vanderkerk, G. J. M. Chem. Ind. 1959, 294.; (b) Kupchik, E. J.; Connolly, R. E. J. Org. 
Chem. 1961, 26, 4747. 
6
 (a) Rothman, L. A.; Becker, E. I. J. Org. Chem. 1959, 24, 294.; (b) Rothman, L. A.; Becker, E. I. J. Org. 
Chem. 1960, 25, 2203-2206. 
7
 Kuivila, H. G. J. Org. Chem. 1960, 25, 284-285. 
8
 Kuivila, H. G.; Menapace, L. W.; Warner, C. R. J. Am. Chem. Soc. 1962, 84, 3585. 
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During the following decades, a variety of other chain and non-chian radical processes 
were discovered, such as the SRN1 reactions (Substitution Radical Nucleophilic 
Unimolecular)9, the Minisci alkylation10 and the Meerwein arylations,11 etc.  
 
In 1975, the Barton-McCombie deoxygenation of alcohols via xanthates and similar 
thiocarbonyl derivatives12  was reported and proved to be one of the most important 
transformations based on radical chemistry in this period (Chapter 2). In 1983, another 
important reaction, the decarboxylation of carboxylic acids via the now well known 
Barton esters13 was also accomplished (Chapter 1). Later in 1985, the reductive additions 
of electron-rich radicals to electrophilic alkenes reported by Giese 14  illustrated the 
potential of carbon-carbon bond formation achieved by a radical strategy. It also proved 
that polymerization was not the only destination of radical additions to alkenes. 
 
Ever since then, radical chemistry has evolved considerably and its favorable features 
have become more widely recognized by chemists for solving difficult synthetic 
problems. One of the most important achievements is the discovery and development of 
the new radical process with O-alkyl dithiocarbonates, or xanthates. This report will 
focus on understanding and exploring the radical chemistry of xanthates, which was 
developed in our laboratory. Before we begin the journey with xanthate chemistry, let’s 
review some general concepts about radicals and some important reactions. 
 
 
 
                                                 
9
 Kim, J. K.; Bunnett, J. F. J. Am. Chem. Soc. 1970, 92, 7463. 
10
 (a) Minisci, F. Acc. Chem. Res. 1975, 165-171.; (b) Minisci, F. Top. Curr. Chem. 1976, 62, 1 
11
 Rondestvedt, C. S. Org. React. 1976, 24, 225. 
12
 Barton, D. H. R.; Mccombie, S. W. J. Chem. Soc., Perkin Trans.1 1975, 1574-1585. 
13
 Barton, D. H. R.; Crich, D.; Motherwell, W. B. J. Chem. Soc., Chem. Commun. 1983, 939-941. 
14
 Giese, B. Angew. Chem. Int. Ed. 1985, 24, 553-565. 
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ĉ. Geometry, stability and reactivity of radicals 
 
1. Geometry of radical 
 
A free radical reaction is a chemical process that involves molecules with unpaired 
electrons. In most of the cases, radical species generated by homolytic bond cleavages are 
used as intermediates. EPR studies15 and theoretical calculations suggest that simple alkyl 
radicals could be either planar or very shallow pyramids. The barrier to inversion is very 
small (no more than 4-8 kJ/mol16), so very rapid inversion occurs. This kind of radical is 
defined as a π-radical.  
 
 
Scheme 1.1 The geometries of π-radical and σ-radical. 
 
However, electronegative substituents on carbon radicals can significantly affect their 
geometry by increasing the s-character of the orbital occupied by the single electron. 
Analysis of EPR spectra of mono-, di-, and tri-fluoromethyl radicals indicated a 
progressive distortion from the planarity.17 For example, the trifluoromethyl radical has 
almost pure sp3 hybridization and one of the studies from DFT (Density Functional 
Theory) calculation with C3v symmetry showed its geometry to be pyramidal.18 This kind 
of radical is called σ-radical. Generally it tends to be more electrophilic than a π-radical. 
Since both of them invert very quickly, in most cases the stereochemical information of 
the precursors will be lost in a radical process. 
 
                                                 
15
 The distinguishing feature of free radicals is the presence of an unpaired electron. For the purpose of 
detecting and characterizing them, the most efficient tool is the Electron Paramagnetic Resonance (EPR) 
spectroscopy, also known as Electron Spin Resonance (ESR) spectroscopy. 
16
 Carey, F. A.; Sundberg, R. J.  Advanced Organic Chemistry, Part A: Structure and Mechanisms Fourth 
Edition 2001, Kluwer Academic Plenum Publishers.  
17
 (a) Bernardi, F.; Cherry, W.; Shaik, S.; Epiotis, N. D. J. Am. Chem. Soc. 1978, 100, 1352-1356.; (b) 
Krusic, P. J.; Meakin, P. J. Am. Chem. Soc. 1976, 98, 228-230. 
18
 Lund, A.; Gustafsson, H.; Maruani, J.; Shiotani, M. Spectrochim. Acta, Part A 2006, 63, 830-835. 
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2. Radical stability and reactivity 
 
Normally free radicals in solution have a very short lifetime since the unpaired electrons 
are desperate to be paired up again. However, in some special cases, certain structural 
features, such as steric hindrance and electronic stabilization, 19  can enhance their 
persistence. The exceptional stability of some persistent radicals normally comes from a 
mixture of these effects. For example, in the well known commercial chemical product 
TEMPO, the unpaired electron is delocalized between nitrogen and oxygen with an N-O 
bond order of 1.5. Besides, the four adjacent methyl groups prevent the 
disproportionation from taking place. In Scheme 1.2, the right hand side radical, which 
enjoys the same electronic stablisation as TEMPO is much less persistent because of  
decomposition through disproportionation.20 
 
Scheme 1.2 Electronic conjugation and steric hindrance stabilized radical 
 
Another example is that of di-tert-butylmethyl radical, which has a significantly long half 
time in the absence of oxygen at 25°C. However, the tri-tert-butylmethyl radical has an 
even longer lifetime due to both the electronic stabilization and especially the steric 
hindrance provided by the third tert-butyl group.21 In this case, the radical is sterically 
shielded by three bulky tert-butyl groups, making it harder to undergo further reactions. 
 
 
Scheme 1.3 Steric hindrance protection of the tri-tert-butylmethyl radical 
                                                 
19
 It includes adjacent conjugation, electron-withdrawing group (EWG) and electron-donating group (EDG) 
20
 Clayden, J.; Greeves, N.; Warren, S.; Wothers, P. Organic Chemistry Second Edition 2001, Oxford 
University 
21
 Mendenha.Gd; Ingold, K. U. J. Am. Chem. Soc. 1973, 95, 2963-2971. 
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From a synthetic viewpoint, electronic (polar) factors usually play a more important role 
than steric hindrance. From a detailed analysis of the interaction between the orbitals of 
the substituents and the SOMO22 of the radicals, both EDG and EWG stabilize radicals. 
 
The EDG has a filled n orbital with relatively high energy. When it overlaps with the 
SOMO of a radical, two new molecular orbitals are obtained. Three electrons are then 
available to fill them, with two electrons decreasing in energy and one electron increasing. 
As a result, the resulting SOMO is higher in energy than the initial one, but the lone pairs 
(two electrons) occupy a lower energy orbital than before. One electron rises but two 
drop in energy, so there is an overall net stabilization of the whole system. 
 
 
Scheme 1.4 Orbital interaction of single electron with filled and empty orbitals 
 
In a similar manner, we can analyze the interaction between the SOMO of a radical and 
the low lying empty π* orbital of an EWG. This time only one electron from the original 
SOMO is available for filling the two new orbitals. As a result, it enters the lower energy 
orbital which becomes the new SOMO of the whole system. An overall stabilization is 
achieved since the electron drops in energy. 
 
Although both EDGs and EWGs can stabilize radicals, EDGs tend to raise the energy of 
the new formed SOMO, while EWGs tend to lower it. As a result, the high energy 
                                                 
22
 The orbital containing the unpaired electron in radicals is called Singly Occupied Molecular Orbital 
(SOMO) 
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SOMO (with adjacent EDG) has the tendency to give up its unpaired electron and is 
considered as a radical with nucleophilic character, while the low energy SOMO 
(adjacent to EWG) tends to accept one electron to pair its single one and is viewed as a 
radical with electrophilic character. This ambiphilic property enriches the reactivity of 
radicals, since they can react with both electron-poor and electron-rich species. 
 
From the discussion above, we can see that the persistency of radicals is their natural 
property. It is associated with the substituents and the geometry. Enhanced persistency 
means an increased half-life, and normally that means a relatively lower reactivity, 
especially in dimerization. But the reactivity of radicals is used more to determine their 
tendency for reacting with the other radicophiles. It depends on the relative positions of 
the involved molecular orbitals. For a “nucleophilic” radical it depends on the position of 
its SOMO and the LUMO of the radicophile, while for an “electrophilic” radical it 
depends on its SOMO and the radicophile’s HOMO. The closer the energy levels of the 
orbitals involved, the higher the reactivities. 
 
General Introduction to Radical Chemistry 
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Ċ. Sources of radicals  
 
1. Common sources for radicals 
 
Peroxides undergo homolysis of the weak O-O bond relatively easily,23 and that is why 
they are commonly used as radical sources in organic synthesis and polymer chemistry. 
Normally the initiation with peroxides can occur at moderate temperatures. For example, 
di-tert-butyl peroxide (DTBP) is stable at room temperature but undergoes homolytic 
cleavage to give methyl radicals beyond 80°C, 24  and more usefully at temperatures 
around 130°C (half-life ~ 10h). 
 
 
Scheme 1.5 Initiation of DTBP 
 
Diacyl peroxides are also sources of alkyl radicals since the carboxyl radicals which are 
formed initially lose carbon dioxide rapidly.  
 
Scheme 1.6 Initiation of DLP 
 
Another extensively used radical sources are azo compounds. For example, 
azobisisobutyronitrile (AIBN) is one of the most freq.uently used precursors to initiate 
radical chain processes, especially those based on stannanes. The thermal homolysis of 
AIBN produces nitrogen and nitrile-stabilized radicals. 
 
Scheme 1.7 Initiation of AIBN 
                                                 
23
 The dissociation energy for O-O bond in CH3O-OCH3 is about 151kJ/mol, while that for H-O bond in 
water is 498kJ/mol. 
24
 The half-time (t1/2) of DTBP in benzene at 80°C is 103 days. 
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The decomposition of peroxides and azo compounds can also be accomplished by 
photochemical excitation, since light is a possible energy source for the homolysis of 
bonds: red light has an associated energy of 167kJ/mol, blue light has about 293kJ/mol, 
and ultraviolet (200nm) has about 586kJ/mol. 
 
Other radical sources freq.uently used involve organometallic compounds and boron 
alkyl compounds (such as triethylborane). The former have in some cases weak bonds 
between carbon and the metals which can easily be homolysed to give carbon centered 
radicals, while the latter generate alkyl radicals (via peroxide intermediate) when exposed 
to air (oxygen), even at low temperatures (autoxidation). 
 
 
 
Scheme 1.8 Initiation of triethylborane 
 
Another method for generating radicals is based on single electron transfer (SET). The 
electron normally comes from the dissolving metals like Na, Mg, Zn, or Al. The first 
example in Scheme 1.9 illustrates the formation of a ketyl radical anion, which is 
involved in the pinacol coupling reaction and the McMurry reaction.25 Ketyl radicals 
produced from the reduction of benzophenone with sodium are used as the desiccant for 
drying certain solvents.26 The second example shows that a solvated electron can add to 
an aromatic ring to give a radical anion, which is the case in the well known Birch 
reduction. 
 
 
 
Scheme 1.9 Radical anion formation via single electron transfer 
                                                 
25
 Mcmurry, J. E.; Fleming, M. P. J. Am. Chem. Soc. 1974, 96, 4708-4709. 
26
 Sodium reduces benzophenone to the soluble ketyl radical, which reacts quickly with the water and 
oxygen dissolved in the solvent. The deep blue coloration qualitatively indicates dry and oxygen-free 
conditions. 
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2. Half-life of radicals 
 
The most important data for evaluating the ability of different initiators is their half-life 
(t1/2). It is the time needed to consume one half of a given quantity of the initiator in a 
solution at a given temperature. It heavily depends on the bonds that must be broken and 
the nature of the free radical generated. At the same temperature, half-lives can vary 
based on the manner in which they are sampled, especially the solvent used. 
 
 
Table 1.1 Half-life of some common initiators 
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ċ. How do radicals react? 
 
a. radical + radical → closed-shell molecule 
 
Radicals without special stabilization rapidly dimerize (with the same or different 
radicals) or disproportionate. In the disproportionation process, a hydrogen abstraction by 
one of the radicals leads to an alkane and an alkene. 
 
 
 
Scheme 1.10 Radical dimerization and disproportionation 
 
b. radical + closed-shell molecule → new radical + new closed-shell molecule 
 
Normally, highly reactive radicals are unselective when reacting with other species. 
Although they can meet other radicals and dimerize with them, they are more likely to 
collide with solvent or other closed-shell molecules present in the reaction medium. 
However, radical-radical interactions are extremely fast. Thus, addition to oxygen is often 
a process which needs to be avoided in radical synthesis.  
 
 
 
Scheme 1.11 Radical addition to oxygen 
 
Radicals can also rapidly abstract hydrogen atoms from many types of compounds or 
solvents: 
 
 
 
Scheme 1.12 Hydrogen abstraction by a radical 
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They can also add to olefins and aromatic rings, and this process is more useful from a 
synthetic viewpoint:  
 
 
 
Scheme 1.13 Radical addition to olefin and aromatic ring 
 
c. radical → new radical + closed-shell molecule 
 
As mentioned above, the thermal dissociation of diacyl peroxides gives first the carboxyl 
radicals, which fragment rapidly to alkyl radicals, losing carbon dioxide.  
 
 
 
Scheme 1.14 Radical generated by fragmentation 
 
The reverse processes of additions to olefins and aromatic rings also belong to this 
category: 
 
 
 
Scheme 1.15 Radical generated by fragmentation 
 
d. radical ±e- → anion or cation 
 
When single electron transfer processes are possible, radicals can form the corresponding 
cation by losing one electron or form the anion by capturing one electron. 
 
 
 
Scheme 1.16 Radical modified by single electron transfer process 
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Č. Radical chain processes 
 
1. The mechanism of a radical chain process 
 
One of the earliest radical chain mechanisms was proposed by Kharasch in the course of 
his research on the anti-Markovnikov addition of hydrogen bromide to olefins. 
Adventitious oxygen or peroxide serves as the initiator for the chain process. This early 
discovery not only established the role of radicals as the reactive intermediates in solution, 
but also influenced the subseq.uent development of radical chemistry and polymer 
chemistry. In a radical chain process, three basic concepts are involved: initiation, 
propagation, and termination. 
 
 
 
Scheme 1.17 Kharasch reaction 
 
a. Initiation 
 
In a chain process, initiation radicals X·  can first be introduced into the system by 
thermal or photochemical dissociation of some common precursors, or through redox 
processes involving metals. They will then attack the substrate R-Y to generate the new 
radicals R·  for the following reactions. 
 
 
 
Scheme 1.18 Initiation of chain processes 
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b. Propagation 
 
These new radicals R·  will then react with a radicophile present in the system, such as an 
alkene, and form other radicals which will attack R-Y again to give the product and 
regenerate the R· . Theoretically, only one X·  is needed to consume all the starting 
material. In fact, the initiator is needed in a certain amount, say 5% ~ 10%, in order to 
complete the chain process. Normally, the attack of initiator X·  on the olefin is a side 
reaction that must be minimized by controlling the relative reactivities. 
 
 
 
Scheme 1.19 Propagation steps 
 
c. Termination 
 
If the steady-state concentration of the radicals in the system is kept very low, then their 
recombination becomes rare but still occurs to a certain extent. So this is why it is not in 
practice possible to complete the reaction with only one X· , and more initiator is needed 
to start the chains again. The faster the propagation steps, the less initiator is needed and 
the more insignificant will be the termination steps. 
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Scheme 1.20 Termination of radicals 
 
2. Applications based on the radical chain processes 
 
a. Triorganotin hydrides 
 
Triorganotin hydrides are the most freq.uently used reagents in the radical chain process. 
They can convert organic halides and various other groups into the corresponding 
hydrocarbons.  
 
 
Scheme 1.21 General form of stannane based chain process 
 
Chain reactions involving tributyltin hydride (or tributylstannane) are normally triggered 
by the nitrile-stabilized radical generated from the thermal homolysis of AIBN. Since the 
Sn-H bond of Bu3SnH is not very strong, the relatively unreactive nitrile-stabilized 
radical can better minimize the side-products compared to the more reactive RO·  from 
peroxides. The stannyl radical can then react with R-X to give the radical R· , which 
abstracts the hydrogen from the tributyltin hydride to form the hydrocarbon and 
General Introduction to Radical Chemistry 
 35 
simultaneously reproduce the stannyl radical to complete the chain cycle. Here, the R-X 
can represent many species besides halides (except fluorides), such as sulfides, selenides, 
isocyanides, nitro compounds, etc. 
 
For example, the first synthesis of (trifluoromethyl)deoxoartemisinin FC-1-2 was 
accomplished by debromination using tributyltin hydride in the key step.27  The mild 
conditions used for this dehalogenation could obviate the possible alteration of the 
endoperoxide bridge. 
 
 
Scheme 1.22 Debromination mediated by organotin hydride 
 
b. The Barton decarboxylation 
 
The Barton decarboxylation13 is a general and powerful method for decarboxylating 
carboxylic acids discovered by Sir Derek Barton in 1980s. The carboxylic acid is first 
converted into the corresponding ester of N-hyroxypyridine-2-thione or Barton ester by 
the usual methods for ester synthesis.  
 
 
 
Scheme 1.23 Formation of Barton esters 
                                                 
27
 Chorki, F.; Grellepois, F.; Crousse, B.; Hoang, V. D.; Van Hung, N.; Bonnet-Delpon, D.; Begue, J. P. 
Org. Lett.  2002, 4, 757-759.  
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The radical chain process is then triggered by the stannyl radicals from the homolysis of 
tributyltin hydride initiated by AIBN. The high affinity of the stannyl radical for the 
thiocarbonyl group will drive it to attack the sulfur of the N-hydroxypyridine-2-thione, 
followed by the homolytic cleavage of the weak N-O bond driven by rearomatization. 
The carboxyl radical DB-1-1 formed then undergoes decarboxylation and extrudes 
carbon dioxide. Finally, the remaining alkyl radical abstracts hydrogen from the 
tributyltin hydride to form the reduced alkane, and regenerates the stannyl radical to 
propagate the chain.  
 
 
 
Scheme 1.24 The chain process for Barton decarboxylation 
 
There is a competing route in this process, which involves the attack of the alkyl radical 
on the thiocarbonyl group to form intermediate DB-1-3. The chain is propagated since the 
alkyl radical is regenerated when this intermediate undergoes fragmentation to give a 
pyridyl sulfide. This competing pathway can be minimized by proper modifications, such 
as changing the concentration or temperature. 
 
 
 
Scheme 1.25 The background reaction in the Barton decarboxylation 
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c. Atom and group transfer reactions 
 
Atom and group transfer reactions refer to a broad range of radical additions in which a 
R-Y species is added across alkenes, alkynes, or other multiply bonded functionalities.28 
The first example is concerned with the C-C bond formation during the addition of CCl4 
to 1-octene in the presence of a radical initiator. 29  Reactions involving transfer of 
halogens, aryl chalcogens, as well as dithiocarbonyl groups were then later developed. 
The general mechanism for the atom and group transfer process is shown below. 
 
 
 
Scheme 1.26 General mechanism for atom and group transfer process 
 
Process I is the reaction between the radical and its precursor R-Y, which is reversible 
and degenerate. The outcome is needed to emphasize that the radical R·  will be present in 
the medium with a relatively long lifetime, which allows it to react with many kinds of 
radical traps, even with comparatively unreactive substrates. In process II the radical 
R·  has a enough lifetime to react with, for example, unactivated olefins. The new radical 
generated then undergoes process III and gives the final product, as well as regenerating 
the radical R·  to propagate the chain. During all these process, the main deleterious 
                                                 
28
 Renaud, P.; Sibi, M. P. Radicals in Organic Synthesis Volume 1: Basic Principles First Edition 2001, 
WILEY-VCH 
29
 Kharasch, M. S.; Jensen, E. V.; Urry, W. H. Science 1945, 102, 128-128. 
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interaction is the hydrogen abstraction between the radicals and the solvent or other side-
products. However, these undesired reactions can be obviated or reduced by modifying 
the various parameters. 
 
 
 
 
Conclusion 
 
Radical chemistry in organic synthesis is a broad domain and is still under rapid 
development nowadays. They play an important role in many fields such as 
polymerization, biochemistry, and many other chemical processes. The short introduction 
above only covers a tiny fraction, which involves a brief history and some fundamental 
conceptions and reactions. More detailed processes and relevant cases will be discussed 
in the following chapters. Chapter 2 will focus mainly on the radical chemistry of 
xanthates, which was developed mainly in our laborotary. 
 
  
 
 
 
 
 
 
Chapter 2 
 
The Radical Chemistry of Xanthates 
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Introduction 
 
Xanthates 30  or dithiocarbonates have the general structure shown in Scheme 2.1. 
Although they were described first by Zeise almost two centuries ago,31 their chemistry 
did not receive much attention for a relatively long period of time.  
 
Scheme 2.1 Structure of Xanthates 
 
One early application of xanthates is the Chugaev elimination, 32  in which the 
decomposition of S-methyl xanthate produces an olefin as well as methanethiol and 
carbon oxysulfide (Scheme 2.2). This reaction is useful for the overall dehydration of 
secondary and more rarely tertiary alcohols into the corresponding olefins without 
rearrangement of the carbon skeleton.  
 
 
Scheme 2.2 Chugaev elimination (Tschugaeff Olefin Synthesis) 
 
Some applications were also reported in 1965, in which xanthates could serve as 
photosensitizers in the polymerization of vinyl monomers.33 However, it is the discovery 
of the powerful Barton-McCombie deoxygenation in the early 1970s, that revealed 
xanthates to be such useful intermediates in synthetic radical chemistry. During the past 
two decades, the degenerative transfer of xanthates was developed mainly in our 
laboratory and proved to be very effective for the formation of carbon-carbon bonds. This 
chapter deals mainly with the underlying principles and applications of the xanthate 
chemistry. 
                                                 
30
 This name comes from Greek which has the meaning of “yellowish, golden”. 
31
 (a) Zeise, W. C. J. Chem. Phys.  1822, 35, 173.; (b) Zeise, W. C. J. Chem. Phys. 1822, 36, 1. 
32
 Depuy, C. H.; King, R. W. Chem. Rev. 1960, 60, 431-457. 
33
 Okawara, M.; Nakai, T.; Otsuji, Y.; Imoto, E. J. Org. Chem. 1965, 30, 2025. 
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ĉ. The Barton-McCombie deoxygenation: mechanism and 
applications 
 
In 1975, Barton and McCombie discovered an important radical process that can 
effectively achieve the deoxygenation of the secondary alcohols. 34  It is the most 
widespread application of xanthates, and is still freq.uently used, especially in the area of 
carbohydrates and aminoglycosides. 
 
Scheme 2.3 Barton-McCombie deoxygenation 
 
In this reaction, the alcohol is initially converted into the thiocarbonyl derivative then 
according to the mechanism depicted in Scheme 2.4, it is reduced with Bu3SnH using a 
small amount of AIBN as initiator. The tributylstannyl radical attacks the radicophilic 
thiocarbonyl sulfur of BM-2-1 to form a strong S-SnBu3 bond and generates a new 
carbon centered radical BM-2-2, which is followed by breaking of the carbon-oxygen 
bond to complete the deoxygenation. The alternative fragmentation (to break the carbon-
sulfur bond) is unlikely to happen since the primary methyl radical is comparatively high 
in energy. The fragmented carbon radical abstracts hydrogen from the tributyltin hydride 
to give the desired alkane and new tributylstannyl radical to propagate the chain. The 
driving force for this transformation is the conversion of a carbon-sulfur double bond to 
the much stronger carbon-oxygen double bond.  
 
Scheme 2.4 The mechanism of Barton-McCombie deoxygenation 
                                                 
34
 Barton, D. H. R.; Mccombie, S. W. J. Chem. Soc., Perkin Trans. 1 1975, 1574. 
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The Barton-McCombie deoxygenation has been very 
freq.uently used and continues to be applied in present 
times. For example, in a recent total synthesis of 
Polygalolide A by Adachi’s group 35  (Scheme 2.5), the 
Barton-McCombie reaction was used to remove the oxygen 
functionality (OTBS) in MA-2-1. Deprotection of the TBS 
group followed by treatment with n-BuLi, CS2, and MeI 
afforded the xanthate MA-2-2, which was then treated with 
Bu3SnH in the presence of AIBN. This furnished the 
desired key intermediate MA-2-3. 
 
Scheme 2.5 Key deoxygenation in the total synthesis of Polygalolide A 
 
Another example involves a formal synthesis of (-)-
Echinosporin by the Hale’s group. 36  After detaching the 
TES group from FH-2-1, O-phenyl carbonochloridothioate 
was used as the reagent to form the deoxygenation precursor 
FH-2-2. Standard Barton’s conditions were then applied to 
obtain FH-2-3, the intermediate to the target compound. 
 
 
Scheme 2.6 Key deoxygenation step in the total synthesis of (-)-Echinosporin 
                                                 
35
 Adachi, M.; Yamada, H.; Isobe, M.; Nishikawat, T. Org. Lett.  2011, 13, 6532-6535. 
36
 Flasz, J. T.; Hale, K. J. Org. Lett.  2012, 14, 3024-3027. 
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Ċ. A discovery during a mechanism study 
 
However in 1984, almost 10 years after the discovery of the Barton-McCombie reaction, 
Barker and Beckwith proposed an alternative pathway which involved the intermediacy 
of alkoxythiocarbonyl radicals37 (Scheme 2.7).  
 
 
Scheme 2.7 An alternative mechanism of Barton-McCombie deoxygenation 
 
In this alternative route, the tributylstannyl radical initially attacks the sulfide sulfur (SH2 
process) rather than attacking the thiocarbonyl sulfur. An alkoxythiolcarbonyl radical is 
thus generated and identified by ESR signal. The absence of a carbonyl absorption in IR 
also seems to support this explanation.  
 
In order to clarify the mechanism, a systematic study was carried by the Barton group 
(Scheme 2.8). For example, a competition experiment was operated with eq.alent 
mixtures of DB-2-1 and DB-2-2.38 When they were treated with one eq.alent of Bu3SnH 
at 80°C, the reaction took place within a few minutes with isopropyl derivative DB-2-2 
and gave DB-2-3 as the sole product. Furthermore, if isopropyl was replaced by a more 
bulky mesityl group, a similar reaction took place even at room temperature. These 
phenomena are incompatible in a homolytic substitution process, which is subject to 
steric hindrance. But in the original mechanism, such observations are reasonable since 
the attack on the thiocarbonyl group is fast and reversible. 
 
                                                 
37
 Barker, P. J.; Beckwith, A. L. J. J. Chem. Soc., Chem. Commun. 1984, 683.  
38
 Barton, D. H. R.; Crich, D.; Lobberding, A.; Zard, S. Z. J. Chem. Soc., Chem. Commun. 1985, 646-647. 
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Scheme 2.8 Competitive experiment 
 
Other competition experiments were also performed to exclude the SH2 mechanism. 
Furthermore, the absence of the carbonyl absorption in IR could be explained by the fact 
that the tin thiocarbonate is unstable and extrudes carbonyl sulfide to form the tributyltin 
methyl sulfide (Scheme 2.7). Moreover, the ESR experiment was conducted under very 
different conditions compared with the usual deoxygenation process, and thus different 
pathways can therefore be applied in each case. With all these proofs, conclusion could 
be made to confirm the original mechanism, with the small but important modification 
that the addition of the stannyl radicals onto the thiocarbonyl group is both fast and 
reversible. 
 
Another conclusion could also be drawn with the above experiment: in the rate 
determining β-scission step, the carbon-sulfur bond is more easily broken than the 
carbon-oxygen bond, at least kinetically other factors being eq.ual.39  Since both the 
isopropyl radical and the 3-cholestannyl radical have similar stabilities, the more 
favorable cleavage of the carbon-sulfur bond takes place to give propane as the major 
product. 
 
 
                                                 
39
 Zard, S. Z. Angew.Chem.Int.Ed. 1997, 36, 673-685. 
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Scheme 2.9 detailed mechanism of the competition experiment 
 
This accidental observation during the mechanistic study opened another door of the 
xanthates chemistry. Thus, rather than generating radicals by the homolytic cleavage of 
the carbon-oxygen bond (Barton-McCombie mode), radicals could be produced in a 
much more general chain process from the reversible scission of the carbon-sulfur bond. 
This strategy was developed systematically during the past two decades as the 
degenerative transfer of xanthates, and various carbon-carbon bond formations based on 
this approach have been achieved. 
 
 
 
 
ċ. Degenerative transfer of xanthates 
 
The degenerative transfer of xanthates is an efficient and convenient method to form 
alkyl and acyl radicals, and provide them with a long enough lifetime that allow them to 
add even to un-activated olefins. This cannot normally be achieved by triorganotin 
hydride chemistry, since the intermolecular addition is much slower than hydrogen 
abstraction and this large difference in rates cannot be overcome by controlling the 
concentration. Moreover, this technique uses simple, cheap, and environment friendly 
reagents rather than the toxic organotin derivatives which also have well-known 
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problems with purifications.40 Other advantages are tolerance for many commonly used 
functional groups, the need of only a small volume of solvent, and a trivial experimental 
set-up. Thus, complex and highly functionalized structures can be assembled cleanly and 
rapidly under mild conditions. 
 
 
1. Mechanism 
 
The simplified mechanistic manifold for the degenerative transfer of xanthates is shown 
in Scheme 2.10. Initiation affords a small amount of radicals In·  that readily add to 
xanthate 2-1 and form intermediate 2-2, which is relatively stable and too hindered to 
dimerize. This step is in principle reversible but radical 2-2 evolves in a different 
direction in the bond cleavage: rather than breaking the carbon-oxygen bond to form the 
adduct 2-3 as in the Barton deoxygenation, intermediate 2-2 undergoes a reversible β-
scission via carbon-sulfur cleavage to generate a new radical R·  as well as adduct 2-4. 
The primary alkyl substituents (methyl, ethyl, etc.) on oxygen make the Barton route 
unlikely to happen since the primary alkyl radical is relatively high in energy. Therefore 
the sole macroscopically detectable change with the radical species 2-2 will be through 
the pathway involving rupture of carbon-sulfur bond. 
 
The radical R·  generated during this process can either add reversibly to the thiocarbonyl 
group of xanthate 2-1, or add to the olefin traps 2-6 to give another new radical 2-7. Even 
un-activated olefins can be used in this reaction, since the radical R·  has an effectively 
long lifetime. A new intermediate 2-9 is then formed by the addition of radical 2-7 to 
xanthate 2-1, which can undergo fragmentation (half-headed curly arrows depicted for 
adduct 2-9) to generate the desired product 2-10.  
 
 
                                                 
40
 (a) Boyer, I. J. Toxicology 1989, 55, 253-298; (b) Appel, K. E. Drug Metab. Rev. 2004, 36, 763-786; (c) 
Dopp, E.; Hartmann, L. M.; Florea, A. M.; Rettenmeier, A. W.; Hirner, A. V. Crit. Rev. Toxicol.  2004, 34, 
301-333.  
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Scheme 2.10 Mechanism for the xanthates transfer reaction 
 
In the addition process, the relative stabilities of the starting radical R·  and the new 
adduct radical 2-7 is a key factor. Unlike the Barton deoxygenation, in the xanthate 
transfer reaction the driving force generated is the addition to the alkene, where a strong 
σ bonf replaces the weaker π bond. If the new radical 2-7 is more stable than R· , the 
intermediate 2-9 will prefer returning to 2-7, which will ultimately add to more alkene 2-
6 to form oligomers. Furthermore, the peroxide initiator is able sometimes to oxidize the 
radical intermediate 2-7 to the cation 2-8, which can then undergo typical ionic 
transformations. 
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2. Preparation of the xanthates 
 
Three general methods have been used in the present thesis to prepare the req.uisite 
xanthates: (a) reaction of a xanthate salt with an alkylating agent; (b) radical reaction with 
a bis-xanthate; and (c) radical addition-transfer of xanthate on an alkene. Based on these 
methods, a variety of xanthates with different functional groups were conveniently 
obtained from commercially available materials or easily made products. 
 
a. Reaction of a xanthate salt with an alkylating agent 
 
Generally, xanthates can be obtained simply by reaction of a xanthate salt with an 
alkylating agent RX (X here refers to leaving groups such as halide or sulfonate, etc.). 
Potassium O-ethyl xanthate salt is freq.uently used since it has an excellent 
nucleophilicity and is commercially available and very cheap.  
 
This approach is efficient but mainly limited to xanthates with primary and secondary R 
groups. For example, xanthate 2-11 can be readily synthesized from the commercially 
available 1-chloro-3,3-dimethylbutan-2-one; 41  xanthate 2-12 can be prepared from 
oxazolidin-2-one in two steps;42 xanthate 2-13 can be generated from the 5-chloromethyl 
tetrazole adduct accessibly by a three-steps seq.uence; 43  and xanthate 2-14 can be 
obtained starting from the hemiacetal of trifluoroacetaldehyde via N-(2,2,2-trifluoro-1-
chloroethyl)-acetamide.44 
 
 
                                                 
41
 Cholleton, N.; Zard, S. Z. Tetrahedron Lett. 1998, 39, 7295-7298. 
42
 Bacqué, E.; Pautrat, F.; Zard, S. Z. Chem. Commun. 2002, 2312-2313. 
43
 (a) Uchida, M.; Komatsu, M.; Morita, S.; Kanbe, T.; Nakagawa, K. Chem. Pharm. Bull.  1989, 37, 322-
326. ; (b) Biadatti, T.; Quiclet-Sire, B.; Saunier, J. B.; Zard, S. Z. Tetrahedron Lett. 1998, 39, 19-22. 
44
 (a) Tanaka, K.; Ishiguro, Y.; Mitsuhashi, K. Bull. Chem. Soc. Jpn. 1993, 66, 661-663. ; (b) Gagosz, F.; 
Zard, S. Z. Org. Lett.  2003, 5, 2655-2657. 
Chapter 2 
 50 
 
Scheme 2.11 Xanthates generated based on potassium o-ethyl xanthate salt 
 
b. Reaction with bis-dithiocarbonates 
 
Since the xanthates with tertiary R group are more hindered and not easily available 
through the usual nucleophilic substitution, a more efficient route was developed 
involving radical reaction with symmetrical bis-xanthate (bis-dithiocarbonate). The usual 
radical source is a slight excess of an azo-compound, such as AIBN. For example, 
xanthate 2-15 was readily prepared based on this strategy:45 thermal decomposition of the 
azo-initiator gives two eq.alents of the same tertiary radicals, which are captured by the 
bis-xanthate to give the desired product. 
 
 
Scheme 2.12 A xanthate generated from a the bis-dithiocarbonate 
                                                 
45
 Bouhadir, G.; Legrand, N.; Quiclet-Sire, B.; Zard, S. Z. Tetrahedron Lett. 1999, 40, 277-280. 
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Another reaction involving bis-xanthate is known, namely a nucleophilic substitution by 
carbanions.46 
 
c. Radical addition-transfer of xanthate 
 
One of the useful features of the radical chain addition of xanthates is that the end 
product is also a xanthate which can be used as a starting material for another radical 
process. This strategy is usually combined with the other methods and starts with a 
common and easily made xanthate, a more complex xanthate can then be produced by the 
radical addition to various olefinic traps. 
 
 
 
Scheme 2.13 Radical addition-transfer of xanthate 
 
For example, the previously mentioned xanthate 2-14 can be made to add to vinylene 
carbonate and the resulting new xanthate GF-2-1 used as a springboard for accessing 
more complex xanthates, such as GF-2-2.47  Based on this strategy, various complex 
xanthates can be constructed from simpler processes. 
 
 
Scheme2.14 Complex xanthates by successive radical addition-transfers 
 
                                                 
46
 Maslak, V.; Cekovic, Z.; Saicic, R. N. Synlett. 1998, 1435-1437.  
47
 Gagosz, F.; Zard, S. Z. Org. Lett.  2003, 5, 2655-2657. 
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Other than the above general methods for preparing xanthates, special strategies were 
sometimes needed when facing specific cases. For example, in order to make the S-
trifluoromethyl xanthate FB-2-2, direct substitution of a trifluoromethyl halide is not 
feasible. As shown in Scheme 2.15, a special procedure involving decarbonylation of the 
S-trifluoroacetyl xanthate FB-2-1 proved to be a reasonable route.48 Here the reason for 
using an O-phenethyl group to replace the common O-ethyl was to avoid having to 
handle a potentially volatile and perhaps malodorous substance.  Although the initial 
yield was modest as ~40%, it has recently been optimized to up to ~60% with 
modification of the O-alkyl group.49 
 
 
Scheme2.15 Preparation of the S-trifluoromethyl xanthate 
 
Other than the methods listed above, there are a number of other routes for the synthesis 
of xanthates. For example, xanthates containing tertiary carboxyl groups can be prepared 
via ring-opening of a dichloroepoxide intermediate with a nucleophilic carbodithioate salt 
as the key step.50 Conjugate addition of xanthic acid to electrophilic olefins was also 
reported as an efficient method to synthesize various xanthates.51 Thioacylation reactions 
with thiophosgene or 1,1’-thiocarbonyldiimidazole is also documented.52 
 
                                                 
48
 Bertrand, F.; Pevere, V.; Quiclet-Sire, B.; Zard, S. Z. Org. Lett.  2001, 3, 1069-1071. 
49
 Li, S. Doctoral Work 2012 
50
 Lai, J. T.; Shea, R. J. Polym. Sci., Part A: Polym. Chem.  2006, 44, 4298-4316.  
51
 Binot, G.; Quiclet-Sire, B.; Saleh, T.; Zard, S. Z. Synlett 2003, 382-386.  
52
 Wood, M. R.; Duncalf, D. J.; Rannard, S. P.; Perrier, S. Org. Lett.  2006, 8, 553-556. 
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3. Synthetic potential of the degenerative addition-transfer of xanthates 
 
With xanthate transfer radical chemistry, numerous polycyclic and heterocyclic 
compounds can be obtained in one-pot reactions or addition-cyclization procedures. 
Furthermore, the dithiocarbonate group present in the compounds can be modified either 
by ionic or radical methods. Complex structures and new molecular skeletons can 
therefore be rapidly constructed. 
 
a. Radical Additions 
 
The most important feature of the xanthate transfer process is to provide long-lifetime 
intermediate active radicals to react with a wide range of alkenes through intermolecular 
addition. This transformation is possible with a number of xanthates containing various 
functional groups, including ketones, esters, nitriles, boronates, and even heterocyclic 
rings. 
 
The example below is concerned with a general process established for the regioselective 
aminomethylation of alkenes.53 When exposed to DLP, xanthate QM-2-1 gives rise to 
radical QM-2-2 quite efficiently since the thermal decomposition of the peroxide 
generates ultimately primary undecyl radicals which rapidly add to the thiocarbonyl 
group, and the intermediate collapses preferentially in the direction of the more stable 
radicals.  
 
In this reaction, the coupling of the two carbonyls in an imide structure like QM-2-1 was 
found to be very important to stabilize the primary aminoalkyl radical, which leads to a 
clean radical addition to the olefins. However, if only one carbonyl is presented in the 
xanthate, the desired mono-adduct QM-2-4 will be replaced by the oligomer. These 
results confirmed the importance of the relative stabilities of the original radical and the 
adduct radical in the degenerative transfer of xanthate. 
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 Quiclet-Sire, M.; Zard, S. Z. Org. Lett.  2008, 10, 3279-3282.  
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Scheme 2.16 Addition of primary radical to unactivated alkene 
 
 
 
Another example involves the xanthate 2-14 which was mentioned earlier. This xanthate 
was considered to be an efficient reagent to give a stabilized secondary radical and to 
introduce the α-trifluoromethylamine motif to many olefinic partners, and which tolerates 
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various common functional groups. 54  With this approach a variety of fluorinated 
compounds can be prepared in a practical manner. 
 
 
Scheme 2.17 Addition of secondary radical to unactivated alkene 
 
Even hindered tertiary radicals can be obtained from the corresponding xanthates and 
added to the terminal alkenes to construct the corresponding structures,55 as illustrated by 
the example in Scheme 2.18.  
 
 
Scheme 2.18 Addition of tertiary radical to alkene 
 
Besides, various special radicals can be generated from the corresponding xanthates, such 
as trifluoromethyl48, cyclopropylacyl 56  and propargyl radicals, 57  and captured with 
different olefinic partners to create functionalized structures not accessible using 
traditional ionic or organometallic chemistry. 
 
                                                 
54
 (a) Gagosz, F.; Zard, S. Z. Org. Lett.  2003, 5, 2655-2657; (b) Quiclet-Sire, B.; Zard, S. Z. Chem. Eur. J. 
2006, 12, 6002-6016. 
55
 (a) Quiclet-Sire, M.; Zard, S. Z. Org. Lett.  2008, 10, 3279-3282; (b) Bouhadir, G.; Legrand, N.; Quiclet-
Sire, B.; Zard, S. Z. Tetrahedron Lett. 1999, 40, 277-280. 
56
 Heinrich, M. R.; Zard, S. Z. Org. Lett.  2004, 6, 4969-4972. 
57
 Denieul, M. P.; QuicletSire, B.; Zard, S. Z. Tetrahedron Lett. 1996, 37, 5495-5498. 
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Scheme 2.19 Uncommon radicals generated from xanthates 
 
Another advantage of the xanthate transfer technique is that various functionalized 
alkenes can be made to react efficiently with xanthates. A selection of examples is 
displayed in Scheme 2.20 illustrating the compatibility with various substituents.58 The 
products thus bear functionality derived from both the starting xanthates and the alkene 
and can be subseq.uently modified by more traditional reactions. Furthermore, it is often 
not necessary to protect many of the polar groups typically encountered in synthesis 
(ketones, alcohols, carboxylic acids, etc.). This represents a considerable advantage of 
radical processes in general. 
 
 
                                                 
58
 (a)Legrand, N.; Quiclet-Sire, B.; Zard, S. Z. Tetrahedron Lett. 2000, 41, 9815-9818; (b) Corbet, M.; Zard, 
S. Z. Org. Lett.  2008, 10, 2861-2864; (c) Gagosz, F.; Zard, S. Z. Org. Lett.  2002, 4, 4345-4348. 
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Scheme 2.20 Addition of xanthate to different kinds of alkenes 
 
Another important process is the direct addition of xanthates to aromatic systems and this 
subject will be discussed later in Chapter 5.  
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b. Radical Cyclisation 
 
Using xanthates as precursors for radical cyclizations turns out to be a particularly 
efficient strategy to access cyclic compounds as well as polycyclic systems. Based on this 
strategy, the xanthate group contained in the molecules can be added either to an olefinic 
partner or to an aromatic ring (or heteroaromatic ring) through an intramolecular process. 
 
1) Ring-closure onto internal alkene 
 
The formation of the eight-membered ring present in Pleuromutilin by direct cyclization 
of xanthate EB-2-1 underscores the tremendous synthetic advantages accruing from the 
relatively long lifetime of radicals generated from xanthates. 
 
 
 
Scheme 2.21 Synthesis of the tricyclic skeleton of Pleuromutilin 
 
2) Ring-closure to aromatic derivatives 
 
We have presented in Scheme 2.20 compound GF-2-3, the product of radical addition to 
1-(3-butenyl)-benzimidazole. This addition product can in fact be transformed into a 
more complex molecule by implementing a further radical cyclization by exploiting the 
presence of the xanthate. Although the radical GF-2-4 can react with its precursor GF-2-
3, this process is degenerate. Radical GF-2-5 is too stabilized to propagate the chain but 
its conversion to the final product can occur either through dismutation or by oxidation 
through electron transfer to the peroxide and loss of a proton. Therefore, instead of the 
submolar amounts of peroxide needed in the radical addition, the cyclization to aromatic 
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system req.uires stoichiometric quantities. As a result, the tricyclic compound GF-2-6 
was finally obtained through a continuous radical cyclization.59 
 
 
Scheme 2.22 Cyclization of xanthate to five-membered ring 
 
It’s worthy to note that the isolation of the radical addition product is not always 
necessary when the same solvent and initiator are used. The two operations can be carried 
out in one pot, with only modifying the concentration, since the intermolecular addition 
prefers a high concentration while the intramolecular cyclization prefers a low 
concentration. This one-pot procedure simplifies the synthesis of some target molecules 
or if scale up is considered. 
 
Furthermore, not only five-membered ring can be generated through the intramolecular 
cyclization of xanthates, larger rings such as six-membered60  and seven-membered61 
rings are also accessible. With these strategies, various combinations of polycyclic rings 
can be constructed by modifying the xanthate precursors. 
                                                 
59
 Gagosz, F.; Zard, S. Z. Org. Lett.  2002, 4, 4345-4348. 
60
 Lebreux, F.; Quiclet-Sire, B.; Zard, S. Z. Org. Lett.  2009, 11, 2844-2847. 
61
 Kaoudi, T.; Quiclet-Sire, B.; Zard, S. Z. Angew. Chem. Int. Ed. 2000, 39, 731. 
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Scheme 2.23 Radical cyclizations to generate larger rings 
 
 
c. Transformation of xanthates into other functional groups 
 
According to the discussion above, radical addition of xanthates to simple un-activated 
olefins is considered to be a powerful tool for creating carbon-carbon bonds in an 
intermolecular fashion. However, the addition products still contain the dithiocarbonate 
functionality which can lead to a number of subseq.uent radical and non-radical 
transformations. This feature represents a tremendous advantage of xanthate chemistry, 
since it expands considerably the synthetic possibilities. 
 
1) by ionic methods 
 
The xanthate group can be readily cleaved by exposure to excess ethylenediamine in 
ethanol under an inert atmosphere to afford the corresponding thiol. The resulting thiol 
can be then engaged in nucleophilic substitutions under either basic 62  or acidic 63 
conditions to give, for example, benzothiepinone NZ-2-3 or thiolactone JB-2-3.  
 
                                                 
62
 Boutillier, P.; Quiclet-Sire, B.; Zafar, S. N.; Zard, S. Z. Tetrahedron-Asymmetry 2010, 21, 1649-1665. 
63
 Boivin, J.; Ramos, L.; Zard, S. Z. Tetrahedron Lett. 1998, 39, 6877-6880. 
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Scheme 2.24 Transformation of xanthates to thiols by aminolysis 
 
Furthermore, the dithiocarbonyl moiety can also serve as a building block in the 
construction of many sulfur containing polycyclic compounds. For example, in 
combination with the Horner-Wadsworth-Emmons reaction, β-keto-İ-xanthyl 
phosphonate MC-2-1 can be transformed into thieno[2,3-b]thiopyran-4-ones MC-2-2 
through a one-pot base-induced intramolecular seq.uence of req.ctions.64 
 
 
Scheme 2.25 Transformation of xanthates into thieno[2,3-b]thiopyranone 
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2) by radical methods 
 
Besides ionic transformations, xanthates are capable of participating in a number of 
different radical processes. For example, a practical reductive dexanthylation was 
documented in 1996,65 involving the cleavage of the carbon-sulfur bond in the presence 
of stoichiometric amounts of lauroyl peroxide in isopropanol. The hydrogen on the 
tertiary carbon of isopropanol serves as the hydrogen source for this procedure. With this 
method the dithiocarbonate moiety can be removed from radical addition derivatives, and 
the resulting alkanes could either be the final products or substrates for subseq.uent ionic 
chemistry. 
 
 
Scheme 2.26 Reductive de-xanthylation with DLP-isopropanol 
 
Another reaction is the replacement of a xanthate by a bromine using ethyl 
bromoisobutyrate as the bromine transfer agent.66 An example is given in Scheme 2.27. 
 
 
 
Scheme 2.27 Transformation of xanthate group to bromine 
 
                                                 
65
 Liard, A.; QuicletSire, B.; Zard, S. Z. Tetrahedron Lett. 1996, 37, 5877-5880. 
66
 Barbier, F.; Pautrat, F.; Quiclet-Sire, B.; Zard, S. Z. Synlett 2002, 811-813. 
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Numerous radical based transformations such as allylation,67 vinylation,68  azidation,69 
and more complex olefination70 have also been described. A few representative examples 
are pictured in Scheme 2.28 and 2.29. 
 
Scheme 2.28 Various transformations of xanthate group 
 
Scheme 2.29 Controlled olefination of xanthate group 
 
                                                 
67
 Sire, B.; Seguin, S.; Zard, S. Z. Angew. Chem. Int. Ed. 1998, 37, 2864-2866. 
68
 Bertrand, F.; Quiclet-Sire, B.; Zard, S. Z. Angew. Chem. Int. Ed. 1999, 38, 1943. 
69
 Ollivier, C.; Renaud, P. J. Am. Chem. Soc. 2000, 122, 6496-6497. 
70
 (a) Charrier, N.; Quiclet-Sire, B.; Zard, S. Z. J. Am. Chem. Soc. 2008, 130, 8898; (b) Braun, M. G.; 
Quiclet-Sire, B.; Zard, S. Z. J. Am. Chem. Soc. 2011, 133, 15954. 
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d. Applications to the total synthesis of natural products 
 
Using the xanthate mediated seq.uence of radical addition and cyclization, some natural 
products could be rapidly constructed. For example, in the total synthesis of two natural 
products 10-norparvulenone and O-methylasparvenone, the xanthate was instrumental in 
the formation of the key α-tetralone framework71 (Scheme 2.30).  
 
Scheme 2.30 Total synthesis of 10-norparvulenone and O-methylasparvenone  
 
Another example is the intermolecular radical addition-cyclization cascade used in 
constructing the tricyclic indole structures such as BA-2-2, a key intermediate in the 
synthesis of Mersicarpine (Scheme 2.31). Numerous potential bioactive derivatives can 
be prepared by simply replacing the alkene partner.72 
 
Scheme 2.31 Synthesis of tricyclic indole structures 
                                                 
71
 Vargas, A. C.; Quiclet-Sire, A.; Zard, S. Z. Org. Lett.  2003, 5, 3717-3719. 
72
 Biechy, A.; Zard, S. Z. Org. Lett.  2009, 11, 2800-2803. 
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Conclusion 
 
From the above discussions, we could see that the xanthates exhibit a perfect balance of 
reactivity, stability and accessibility, and the radical xanthate transfer process has proved 
to be an efficient method for both intermolecular and intramolecular additions, which can 
bring together a variety of functional groups under mild conditions. Furthermore, 
experimental simplicity, absence of heavy and toxic metals, mild and neutral reaction 
conditions, the possibility of operating under quite concentrated conditions, and the 
compatibility with a wide range of functional groups, etc. are all advantages that must be 
underscored. They would be especially useful when large scale preparations are being 
considered. 
 
Some of the other important applications of xanthates are not included in this section, 
such as the RAFT (Reversible Addition Fragmentation Transfer) and MADIX 
(Macromolecular Design by Interchange of the Xanthates), which are considered to be 
the most powerful technologies for constructing block polymers both in industry and in 
academia.73 
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Introduction 
 
The piperidine ring is a ubiquitous molecular skeleton, which exists in natural products 
and synthetic biologically active molecules. A search of the chemical and patent literature 
shows that several thousands of compounds in clinical and preclinical research are 
derived from this simple ring system.74 For instance, as shown in Scheme 3.1, preclamol 
is the first selective D2-like dopamine autoreceptor agonist, and such kinds of substances 
are potential drugs for the treatment of depression and drug addiction, Parkinson’s and 
Alzheimer’s diseases, and schizophrenia. εK-4827 developed by Merck is another 
example of this useful structure, and it has entered clinical trials as an antitumor drug.75 
Piperidinone is less commonly found in the structures of bioactive molecules. However, 
we can still find it in many molecules which have activities on the central nervous system, 
such as anticholinergics 76  and antidepressants (e.g. UK-224,671 is a potent selective 
antagonist of the neurokinin 2 receptor 77 ), in diabetic II 78  and in antithrombotic 
treatments. 79  It is also well documented that piperidin-2-ones are common synthetic 
precursors for piperidines and biologically important polycyclic alkaloids, such as 
indolo[2,3-a]quinolizidines and benzo[a]quinolizidines.80 
 
Scheme 3.1 Examples of 3-aryl-piperidine and 5-arylpiperidin-2-one drugs 
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 Watson, P. S.; Jiang, B.; Scott, B. Org. Lett., 2000, 2, 3679-3681. 
75
 Jones, P.; Altamura, S.; Boueres, J.; Ferrigno, F.; Fonsi, M.; Giomini, C.; Lamartina, S.; Monteagudo, E.; 
Ontoria, J. M.; Orsale, M. V.; Palumbi, M. C.; Pesci, S.; Roscilli, G.; Scarpelli, R.; Schultz-Fademrecht, C.; 
Toniatti, C.; Rowley, M. J. Med. Chem.  2009, 52, 7170-7185. 
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 Bishop, D. C.; Cavalla, J. F. J. Chem. Soc. C 1966, 802-805. 
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 MacKenzie, A. R.; Marchington, A. P.; Middleton, D. S.; Newman, S. D.; Jones, B. C. J. Med. Chem.  
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ĉ. Synthesis of 5-substituted piperidin-2-ones 
 
 
1. Oxidation and reduction 
 
Among all the synthetic strategies for constructing the piperidone skeleton, oxidation of 
piperidine and reduction of pyridinone are of special importance due to the advantage 
that no more cyclic structure is added. Therefore, a number of methods were established 
for these transformations. 
 
 
a. Oxidation of the piperidine in position-2 
 
Piperidinones are generally the precursors for obtaining piperidines, by reducing the 
carbonyl group of the ring. As the opposite reactions, the oxidation of piperidines by the 
mercuric derivatives,81 a mixture of bromine and acetic acid,82 and ruthenium oxides83 are 
also mentioned in the literature. 
 
For example, Occhiato et al. have mentioned in their publication that the key intermediate 
piperidin-2-one OP-3-1 in the synthesis of cyclopenta-fused azacycle OP-3-2 was 
prepared by the oxidation of the commercially available 3-methylpiperidine using 
hydrated RuO2 in the presence of NaIO484 (Scheme 3.2). 
 
                                                 
81
 (a) Fujii, T.; Ohba, M.; Yoshifuji, S. Chem. Pharm. Bull.  1977, 25, 3042-3048. (b) Wenkert, E.; Angell, 
E. C. Synth. Commun. 1988, 18, 1331-1337. (c) Bentley, N.; Singh, G.; Howarth, O. W. Tetrahedron 1993, 
49, 4315-4320. 
82
 Castro, A.; Juarez, J.; Gnecco, D.; Teran, J. L.; Orea, L.; Bernes, S. Synth. Commun. 2006, 36, 935-942. 
83
 (a) Torii, S.; Inokuchi, T.; Yukawa, T. Chem. Lett. 1984, 1063-1066. (b) Matsumura, Y.; Takeshima, Y.; 
Okita, H. Bull. Chem. Soc. Jpn. 1994, 67, 304-306. (c) Carpes, M. J. S.; Correia, C. R. D. Tetrahedron Lett. 
2002, 43, 741-744. 
84
 Occhiato, E. G.; Prandi, C.; Ferrali, A.; Guarna, A.; Venturello, P. J. Org. Chem. 2003, 68, 9728-9741. 
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Scheme 3.2 Oxidation of substituted piperidine 
 
b. Reduction of the pyridinone 
 
As depicted in Scheme 3.3, piperidinones could also be generated from 
dihydropyridinones and pyridinones by reducing the unsaturated bond(s) of the ring with 
a hydrogen source. 
 
 
Scheme 3.3 Reduction of pyridinones 
 
For example, this strategy was applied in a general synthetic route for the construction of 
lupin alkaloids, such as (+)-cytisine.85 The 5-substituted-2-piperidone intermediate TG-3-
2 was obtained by partial reduction of the precursor TG-3-1 with catalytic hydrogenation 
over palladium. 
 
 
Scheme 3.3 partial reduction of dihydropyridinone 
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2. Intramolecular C-N bond formations 
 
Intramolecular C-N bond formation is another efficient way to construct 2-piperidone, 
and a number of studies have focused on this strategy, using intramolecular 
lactamizations, the Mitsunobu reaction, and Michael addition-cyclization seq.uences, etc. 
 
a. Lactamization of δ-amino carboxylates 
 
Scheme 3.4 depicts a synthetic strategy involving lactamization in an approach to 
varencline, a drug for smoking cessation. Maier et al. thus reported a method to prepare 
the precursor of 1,5-methano-3-benzazocines MM-3-4, 86  a lead compound in the 
development of varencline. After the condensation between the aldehyde MM-3-1 and 
benzylamine, the imine was then mildly reduced by sodium cyanoborohydride to form 
the intermediate MM-3-2, followed by intramolecular lactamization to generate the 
piperidin-2-one MM-3-3. 
 
Scheme 3.4 Reductive amination followed by lactam formation 
 
b. Formation of the amide followed by cyclization 
 
This strategy to generate the six-membered ring of piperidin-2-one relies on the 
formation of an acyclic chain containing an amide, followed by cyclization. There are 
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 Satyanarayana, G.; Maier, M. E. Tetrahedron 2008, 64, 356-363.  
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several strategies to conduct the cyclization. For example, the C-N bond could be formed 
by the direct replacement of a mesylate group with the nitrogen of the amide.87 The 
photocyclization of a compound that contain an active methylene can also furnish the 
ring of piperidin-2-one.88 Another method is based on the application of the Mitsunobu 
reaction on an open-chain amido-alcohol, such as PS-3-1, as displayed in Scheme 3.5.89 
 
 
Scheme 3.5 Intramolecular Mitsunobu reaction based on an amido-alcohol 
 
 
c. Michael addition and cyclization seq.uence 
 
The last strategy cited here is to create the C-N bond by a seq.uence of Michael addition 
and cyclization. For instance, Koelsch developed a synthetic route to efficiently construct 
piperidin-2-ones, as depicted in Scheme 3.6.90 Michael addition of benzonitrile to an 
unsaturated acrylate ester produces cyano-ester CK-3-1, which is transformed to a 
primary amine by catalytic reduction, followed by a spontaneous cyclization with the 
ester group to form piperidin-2-one CK-3-2. 
 
 
Scheme 3.6 Seq.uence of Michael addition and cyclization 
                                                 
87
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3. Intramolecular C-C bond formations 
 
In addition to the intramolecular C-N bond formation, C-C bond can also be created with 
a similar strategy based on an intramolecular process, such as the Diels-Alder reaction 
and the Ring-Closing Metathesis (RCM). 
 
 
a. Intramolecular Diels-Alder reaction 
 
An approach to the synthesis of the DE rings of the yohimbinoid alkaloids, such as 
alloyohimbane, has been described by Shea et al.91 employing an intramolecular Diels-
Alder reaction of N-3,5-hexadienoyl ethyl acrylimidates. This cycloaddition afforded a 
high proportion of the cis-fused hexahydroisoquinolone SS-3-1 in good yield, which 
could be reduced to provide the 4,5-disubstituted piperidin-2-one SS-3-2.  
 
 
Scheme 3.7 Diels-Alder reaction using N-acylvinyl imidates 
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b. Metathesis cyclization 
 
RCM is also an efficient way for this synthetic purpose. For instance, following the work 
of different groups,92 Martin and his co-workers developed an expedient route to form the 
unsaturated lactam SM-3-3, which involved the intramolecular metathesis of the 
tryptamine derivative SM-3-2 using first generation Grubbs catalyst.93 Serving as the key 
intermediate for the synthesis of various alkaloids (ring D), SM-3-3 could be easily 
reduced to give the substituted piperidin-2-ones (Scheme 3.8). 
 
 
 
Scheme 3.8 Metathesis cyclization to form the precursor of piperidin-2-ones 
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4. Intermolecular processes 
 
Apart from the above intramolecular reactions, intermolecular processes are also capable 
of leading to the piperidine-2-one framework. Two examples of intermolecular Diels-
Alder reaction and multicomponent process are presented below to illustrate this 
alternative synthetic route. 
 
a. Intermolecular Diels-Alder reaction 
 
Ihara and his co-workers used a [4+2] cycloaddition of an unsaturated amide IM-3-1 with 
methyl acrylate to form the six-membered ring skeleton of the 4,5-disubstituted-2-
piperidone IM-3-2. This method can be used effectively to synthesize the functionally 
complex piperidines, such as Paroxetine, an antidepressant.94 
 
 
 
Scheme 3.9 Intermolecular Diels-Alder reaction to form substituted 2-piperidone  
 
b. Multi-component reaction 
 
Multi-component reactions allow the rapid building up of functionalized molecules in a 
one-pot operation, with high bond forming efficiency and minimal functional group 
manipulation. In this respect, Landais and his co-workers have developed three- and four-
component reactions to synthesize the multi-substituted-2-piperidones through a formal 
[2 + 2 + 2] process.95 
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Scheme3.10 Three-component reaction to synthesize the substituted 2-piperidone 
 
This method is based on a tandem radical intermolecular additions-lactamization 
seq.uence, starting from readily available reagents. After the initiation with triethylborane 
and oxygen, the stabilized radical LY-3-1 reacts with vinyl pivalate to give a new 
nucleophilic carbon centered radical LY-3-2, which is then trapped by the protected 
oxime. Two C-C bonds are formed during these two intermolecular radical events, and 
the seq.uence is terminated by the formation of the C-N bond via an irreversible ionic 
ring closure. 
 
 
Scheme 3.11 Mechanism of the three-component reaction proposed by Landais 
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Ċ. Desulfonylative radical ring closure onto aromatics: synthesis of 
benzazepin-2-ones and 5-arylpiperidin-2-ones 
 
 
1. Investigation of 5-arylpiperidin-2-one synthesis 
 
a. Initial strategy to synthesize 5-arylpiperidin-2-ones 
 
As stated in the introduction of part I, the arylpiperidin-2-one moiety widely exists in 
bioactive molecules. In order to investigate its synthesis through the radical chemistry of 
xanthates, a route to 5-arylpiperidin-2-one involving a radical 1,4-aryl migration was 
studied previously in our group96 (Scheme 3.12). 
 
 
Scheme 3.12 Synthesis of 5-arylpiperidin-2-one via 1,4-aryl migration 
 
In continuation of this work, an alternative strategy to 5-arylpiperidin-2-ones was next 
conceived. This route involves the initial formation of an α-tetralone, followed by a 
Baeyer-Villiger oxidation, and finally a spontaneous lactamization after liberating the 
protected amine (Scheme 3.13). 
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Scheme 3.13 Retrosynthesis for 5-arylpiperidin-2-one 
 
The study commenced with the synthesis of the α-tetralone motif. In a previous work,97 
α-tetralone derivatives like AL-3-5 could be readily prepared from an addition-
cyclization seq.uence of the substituted S-phenacyl xanthate AL-3-1 (Scheme 3.14). A 
variety of olefinic traps can also be incorporated into this seq.uence and the substituents 
on the acetophenone moiety can be both electron withdrawing and electron donating 
groups. 
Scheme 3.14 Synthesis of an α-tetralone 
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It is worth mentioning that this type of cyclization is relatively slow and thus cannot be 
achieved by the other radical processes. In the initial procedure, the α-tetralone AL-3-5 
was generated by portionwise addition of DLP to a refluxing solution of AL-3-2 in DCE 
over 37 hours. Later, it was found more expedient to heat the intermediate xanthate in the 
higher boiling point chlorobenzene and to add the DLP over a shorter period, since its 
half-life is much shorter at ~130°C. This allowed a faster operation and the yields were 
usually comparable. 
 
We thus applied this procedure in our own approach (Scheme 3.15). The corresponding 
precursors NC-3-1 and NC-3-2 were readily obtained starting with S-phenacyl xanthates 
and Boc-protected allylamine. However, although the intermolecular radical addition 
proceeded efficiently, the ring closure step leading to tetralones NC-3-3 and NC-3-4 gave 
varying and also lower yields compared to earlier work. 
 
 
Scheme 3.15 Initial strategy to synthesize the 5-arylpiperidin-2-one 
 
Partial destruction of the Boc-protected amine by the co-produced lauric acid at the high 
reaction temperature could be responsible for this setback. When the DLP was replaced 
with DTBP, which does not give any acidic products upon thermolysis or induced 
decomposition, the yield of tetralone was significantly increased. For example, the 
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cyclization of NC-3-2 performed originally with DLP (0.1eq. every 15min, 0.03M in 
chlorobenzene) gave tetralone NC-3-4 in 26% yield. By using DTBP (5eq. at the 
beginning, 0.1M in chlorobenzene), the yield was improved by almost two folds to 
43%.98 
 
Unfortunately, the subseq.uent ring expansion by the Baeyer-Villiger oxidation afforded 
variable results. In the case of the methoxy substituted tetralone NC-3-3, treatment with 
m-chloroperoxybenzoic acid (3.0eq. mCPBA, 0.1M in chloroform) furnished the desired 
lactone NC-3-5 in good yield. In contrast, the chlorine substituted analog did not give any 
lactone NC-3-6 under identical conditions. No clear explanation for this unexpected 
discrepancy can be put forward at the moment.  
 
With lactone NC-3-5 in hand, the deprotection of the amide group followed by 
rearrangement of the free amine intermediate afforded the final 5-arylpiperidin-2-one 
NC-3-7 in good yield. It is worth noting that an attempt to obviate the capricious Baeyer-
Villiger oxidation99 by direct cyclization of xanthate precursor NC-3-9 failed completely 
(Scheme 3.16), presumably because of a disfavored s-trans conformation of the ester 
motif. Prematurely reduced product NC-3-10 was generated instead of the desired 
bicyclic lactone. 
 
 
Scheme 3.16 Attempt to obviate Baeyer-Villiger oxidation 
                                                 
98
 Charrier, N. PhD thesis Ecole Polytechnique, 2008. 
99
 ten Brink, G. J.; Arends, I. W. C. E.; Sheldon, R. A. Chem. Rev. 2004, 104, 4105-4123. 
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b. An improved synthetic strategy involving a mesylate as the protecting group 
 
Faced with this unexpected setback, we examined another potentially efficient strategy 
inspired by an earlier work. 100  This strategy is based on the accessibility of 
benzazepinone derivatives such as TK-3-3 by direct radical ring closure (Scheme 3.17). 
 
 
Scheme 3.17 Synthesis of benzazepinone TK-3-3 by direct radical cyclization 
 
As depicted in Scheme 3.18, the radical addition of the xanthate NC-3-11 to the Boc-
protected allylamine furnished a high yield of the normal adduct NC-3-12. In view of the 
discussion above regarding the fragile Boc group, DTBP was used as the initiator in 
refluxing chlorobenzene to accomplish the cyclization and this gave benzazepinone NC-
3-13 in a yield of 47%. Finally, after deprotecting the amide group with TFA, 
spontaneous rearrangement of the free amine afforded efficiently the more stable 
piperidine-2-one NC-3-14. 
 
 
 
Scheme 3.18 Improved strategy to synthesize the 5-arylpiperidin-2-one 
 
                                                 
100
 Kaoudi, T.; Quiclet-Sire, B.; Seguin, S.; Zard, S. Z. Angew. Chem. Int. Ed. 2000, 39, 731. 
Radical Synthesis of 5-Arylpiperidin-2-ones 
 83 
This first success encouraged us to extend this approach to anilines. Unfortunately, as 
shown in Scheme 3.19, the synthesis starting from commercially available 4-
trifluoromethylaniline was not successful: instead of the desired cyclization product 
benzazepinone NC-3-17, only the reduced compound NC-3-17’ was isolated. 
 
 
Scheme 3.19 Failure of the cyclization by a possible 1,5-hydrogen shift 
 
Since a 1,5-hydrogen migration could be responsible for this failure, we decided to place 
a substituent on the nitrogen of the aniline moiety. A mesyl group was selected to avoid 
rotamers that complicate spectroscopic analyses on one hand, and to facilitate the 
transamidation step by improving the leaving group ability of the aniline nitrogen on the 
other. 
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2. Results and optimizations 
 
a. Unexpected loss of mesyl group during the radical cyclization 
 
As outlined in Scheme 3.20, various substituted anilines were first protected as the 
corresponding sulfonamides using methanesulfonyl chloride. This protection diminished 
the reactivity of the aniline nitrogen and it was necessary to deprotonate the sulfonamides 
using sodium hydride to generate the anion, prior to reaction with chloroacetyl chloride 
and displacement of the chlorine with potassium O-ethyl xanthate salt to form the desired 
xanthates 3-1 to 3-7. 
 
 
 
Scheme 3.20 Formation of the xanthate precursor 
 
The following intermolecular addition to Boc-protected allylamine proceeded 
uneventfully to give the corresponding adducts 3-8 and 3-9 in high yields. However, 
when the ring closure was performed by heating them with DLP in refluxing 
chlorobenzene, we were surprised to find that the sulfonamide group was absent in the 
products 3-10 and 3-11 which were obtained with yields of 53% and 27% respectively101 
(Scheme 3.21). Moreover, if the initiator was replaced by DTBP, which did not release 
the deleterious lauric acid, we were pleased to find that the yields of benzazepinones 
improved significantly to a respectable 68% and 73%. 
                                                 
101
 This phenomenon was first observed by Dr. Charrier, N. 
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Scheme 3.21 Unexpected loss of the mesyle group 
 
The mechanism of this ring closure step is outlined for xanthate 3-8 in Scheme 3.22. The 
methyl radical from DTBP attacks the sulfur to create a new radical intermediate 3-8-a, 
which cyclizes onto the aromatic ring and forms another new bicyclic radical 3-8-b. 
Extrusion of methylsulfonyl radical and phototropic shift finally gives rise to the 
observed benzazepinone 3-10. The methylsulfonyl radical extrudes one molecule of 
sulfur dioxide and generates another methyl radical which participates in propagating the 
radical chain. 
 
 
Scheme 3.22 Mechanism for the cyclization of xanthate 3-8 
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The mesyle group was used extensively in our laboratory in the synthesis of indolines,102 
yet no such fragmentation was hitherto observed. For instance, the xanthate precursor 
BS-3-1 was used in the synthesis of the corresponding indoline, and the mesyle 
protecting group remained in the cyclized compound BS-3-2103 (Scheme 3.23). 
 
 
Scheme 3.23 Synthesis of substituted 5-methoxyindoline with mesyl protection 
 
For a more direct comparison, the corresponding cyclization was performed under 
identical conditions as above with xanthate 3-12, which was obtained by addition of 
cyanomethyl xanthate to N-allyl-N-methanesulfonyl-4-iodoaniline (Scheme 3.24). As 
expected, no desulfonylated indoline was formed; the cyclization furnished the N-
methanesulfonylindoline 3-14 as the sole product in 66% yield. 
 
 
Scheme 3.24 Synthesis of substituted 5-iodoindoline with Mesyl protection 
 
One plausible explanation is that the more flexible benzazepinone structure in the 
intermediate 3-8-b allows the correct alignment of the single electron containing orbital 
with the nitrogen-sulfur antibonding orbital and thus allows the scission to occur (Scheme 
3.25). In contrast, a similar arrangement in the intermediate radical 3-13-b of the smaller 
indoline ring is more difficult and more energy is needed due to the significantly more 
strained five-membered ring. 
                                                 
102
 Ly, T. M.; Quiclet-Sire, B.; Sortais, B.; Zard, S. Z. Tetrahedron Lett. 1999, 40, 2533-2536. 
103
 Quiclet-Sire, B.; Sortais, B.; Zard, S. Z. Chem. Commun. 2002, 1692. 
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Scheme 3.25 Comparative mechanisms for the cyclizations 
 
The loss of the sulfonamide group eliminated the need for a subseq.uent deprotection step 
and fortunately had no deleterious effect on the rest of the seq.uence. The eq.uilibrium 
still favored the formation of the desired 5-arylpiperidin-2-ones. Based on this successful 
seq.uence, we decided to expand the range of the substrates in order to make this strategy 
more versatile for application. The modified retrosynthesic route is displayed in Scheme 
3.26: xanthates A arise from substituted anilines by mesylation, chloroacetylation and 
nucleophilic substitution with potassium O-ethyl xanthate salt. Addition-cyclization of 
the xanthates with Boc-protected allylamine produce benzazepinone C, and finally, Boc-
deprotection followed by rearrangement of the free amine D leads to the desired 5-
arylpiperidin-2-ones E. 
 
 
Scheme 3.26 Retosynthesis of 5-arylpiperidin-2-one 
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b. Optimization of the ring closure by dilution and addition of base 
 
Initial experiments confirmed the choice of chlorobenzene as the solvent and DTBP as 
the initiator for the ring closure step. As summarized in Table 3.1, three different 
conditions involving ethyl acetate and chlorobenzene as well as DLP and DTBP were 
tested for adduct 3-9. According to the results, we could see that at a fixed concentration, 
the best yields of up to ~70% were obtained with the combination of DTBP and 
chlorobenzene. Such a good yield is not often achieved for the radical cyclizations on 
aromatic rings leading to the direct fusion of a seven-membered ring. In the proposed 
mechanism sulfur dioxide is expelled as a co-product, and the use of high boiling point 
solvent could promote this process. As for the initiator, besides the advantage of no acidic 
by-product released as discussed before, the long half-life (~10h in 130°C) and the 
absence of undecyl xanthate by-product add to the convenience of this method. 
 
 
 
Table 3.1 Cyclization of xanthate 3-9 
 
In order to maximize the yield of this key step, other comparative experiments were 
carried out under various conditions, and two optimizations were generally realized. The 
first improvement was accomplished by lowering the concentration of the reaction 
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mixture. Normally, diluting the medium is preferred in a unimolecular process. Undesired 
intermolecular processes are thus minimized and therefore lead to better results. For 
example, as illustrated in Table 3.2, the general yields for the cyclization of xanthate 3-15 
were almost doubled when the concentration was changed from 0.1M (entry 1 and 2) to 
0.02M (entry 3 and 4). It is worth noting that in the cyclization of xanthate 3-16, a further 
two-fold dilution from 0.02M (entry 8) to 0.01M (entry 9) did not seem to alter the yield 
significantly. 
 
 
Table 3.2 Cyclizations of xanthates 3-15 to 3-17 
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Another optimization was realized by adding small amount of base in order to neutrolise 
any traces of hydrogen chloride that could arise from radical addition to the 
chlorobenzene solvent and which could cause the destruction of the Boc group. 2,6-
Lutidine was chosen because of its weak basicity (pKa ~ 6.60) and its moderate 
nucleophilicity blocked by the methyl groups. As revealed in Table 3.2, 0.5 eq.alent of 
2,6-lutidine was used as the additive base in the cyclization of 3-15 (entries 2 and 4), and 
for both concentrations a modest improvement in the yield was observed. 
 
However, an increase in the amount of base to 1.0 eq.alent proved to be ambiguous or 
even harmful to the cyclization process (entries 5 and 12). The reasons are not clear yet, 
but may have to do with the nucleophilicity of 2,6-lutidine. Although 2,6-lutidine is 
weakly nucleophilic and sterically hindered, several hours of heating in refluxing 
chlorobenzene could still have a negative effect on either the intermediate or on the final 
product. A preliminary test was operated with 3-20 which was heated with 2~3 eq.alent 
of 2,6-lutidine in refluxing chlorobenzene for 2 hours. High boiling DMSO (bp~189°C) 
was added at the beginning as an internal standard as shown in the spectra of Scheme 
3.27. We can see that after heating with base, the integration indicates that almost half the 
starting material is lost in the reaction medium. 2,6-Lutidine must therefore be used with 
care in these cyclization and , if needed, perhaps replaced with the more bulky 2,6-di-t-
butylpyridine. 
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Scheme 3.27 Influence of 2,6-lutidine with DMSO as the internal standard 
 
With these optimized conditions, various benzazepinones were generated in moderate to 
good yields from a range of anilines (Table 3.3). As mentioned above, the req.uired 
xanthate precursors were prepared from various substituted anilines by mesyl group 
protection, chloroacetylation of the nitrogen, and nucleophilic substitution with xanthate 
salt. One advantage of this seq.uence was that it can be performed without purification 
between each step, and the final xanthates could be obtained by simple recrystallization. 
The synthesis of the precursors can therefore be easily scaled up. 
 
The examples cited in Table 3.3 give an idea of the scope and functional group tolerance 
of this approach. As for substituents of the starting anilines, both electron withdrawing 
(e.g. chloride, bromide, etc.) and electron donating (e.g. methoxy) groups could be 
tolerated, thus significantly expanding the utility of this method. It is also worth 
mentioning that in the former case, a classical Friedel-Craft mode of cyclization would be 
difficult with these deactivated aromatic rings.104 Moreover, the presence of an aromatic 
bromide and iodide allows further modification to the products through the rich transition 
metal catalyzed coupling reactions. 
                                                 
104
 K.M. Johnston, R.G. Shotter Tetrahedron 1974, 30, 4059-4064. 
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Table 3.3 Results of the radical additions and cyclizations 
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c. Rearrangement leading to 5-arylpiperidin-2-ones 
 
In order to convert the benzazepin-2-ones into piperidin-2-ones, the tert-butyl carbamate 
was deprotected by a solution of 30% TFA in DCM, and the resulting amine 
trifluoroacetate salt was neutralized by TEA in toluene. The liberated primary amine 
spontaneously reacted with the carbonyl to open the seven-membered ring and gave the 
arylpiperidin-2-one as the final product. For example, in the case of 3-10, the above 
seq.uence afforded the desired 5-arylpiperidin-2-one 3-25 with a yield of 30% for two 
steps (Scheme 3.28). 
Scheme 3.28 Synthesis the 5-arylpiperidin-2-one 
 
We observed that some of the products will change color from white to pink indicating 
that oxidation occurring on the substituted anilines to some extent. Thus, for the 
compounds which were sensitive to air, protection of the aniline was accomplished by 
acetylation with TEA and acetic anhydride to provide more stable derivatives (Scheme 
3.29).  
 
Scheme 3.29 Acetylation of 5-arylpiperidin-2-ones 
 
What is particularly noteworthy is that some of the final unprotected products were found 
to be unstable to oxidation during the flash chromatography purification and extensive 
loss as compared with the TLC estimation appeared unavoidable. However, since both 
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the protected and the unprotected 5-arylpiperidin-2-ones were insoluble in the usual 
solvents, e.g. DCM, EtOAc, or even acetone, purification could be simply accomplished 
by centrifugation. In fact, the final products were thus seperated and washed with the 
corresponding cold solvent to afford the pure material in modest to excellent yields 
(Table 3.4) 
 
 
Table 3.4 Results for generating the 5-arylpiperidin-2-ones 
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d. Generalization of the synthesis of benzazepin-2-ones 
 
Although the original purpose of this work was to synthesize the arylpiperidin-2-ones 
through a radical pathway, the bicyclic intermediates are themselves of great medical 
potential since they belong to one of the most studied classes of pharmacophores. For 
instance, benazepril105 is a medication used to treat high blood pressure (hypertension), 
congestive heart failure, and chronic renal failure. Mozavaptan (OPC-31260) 106  is a 
vasopressin receptor antagonist and tolvaptan107 is a selective, competitive vasopressin 
receptor 2 antagonist, both of which are used to treat hyponatremia (Scheme 3.30). 
 
 
Scheme 3.30 Examples of biologically active benzazepinones 
 
The Boc-protected allylamine can therefore be replaced by other olefins in the above 
transformations, thus providing a simple way for introducing various functional groups 
into the side-chain of the bicyclic benzazepinone skeleton. 
 
Three examples using this strategy were achieved by changing the olefins as well as by 
modifying the substitution pattern of the aromatic ring in the xanthates, as displayed in 
Table 3.5 with the yields shown below the structures. Different functional groups ranging 
from an ester group to silane or boronate were included in these N-unsubstituted 
benzazepinones. From our experience in the xanthate mediated radical addition-
                                                 
105
 Yu, L. T.; Huang, J. L.; Chang, C. Y.; Yang, T. K. Molecules 2006, 11, 641-648 
106
 Kondo, K.; Ogawa, H.; Yamashita, H.; Miyamoto, H.; Tanaka, M.; Nakaya, K.; Kitano, K.; Yamamura, 
Y.; Nakamura, S.; Onogawa, T.; Mori, T.; Tominaga, M. Bioorg. Med. Chem.  1999, 7, 1743-1754. 
107
 Kondo, K.; Ogawa, H.; Shinohara, T.; Kurimura, M.; Tanada, Y.; Kan, K.; Yamashita, H.; Nakamura, S.; 
Hirano, T.; Yamamura, Y.; Mori, T.; Tominaga, M.; Itai, A. J. Med. Chem.  2000, 43, 4388-4397. 
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cyclization seq.uence, many other groups which were not examined in this study would 
also be compatible with this approach. It is worth stressing that the rapid synthesis of the 
boronate substituted benzazepinone 3-36 is particularly interesting since such derivatives 
would be exceedingly tedious to make by the traditional routes. 
 
Table 3.5 Results of the expanded bicyclic benzazepinones 
 
Another point worth emphasizing about this present route is that the alternative access to 
N-unsubstituted benzazepinones by direct radical cyclization of secondary amide 
xanthates cannot be achieved. The reasons are not clear yet, but it is probably due to 
competing 1,5-hydrogen shifts and/or unfavorable conformation as discussed in Scheme 
3.19. With this in mind, our approach is of particular importance since numerous 
functionalized benzazepinones become readily available within five easy steps starting 
from cheap commercial reagents. 
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Conclusion 
 
In summary, we have established a concise access combining simplicity, cheapness, 
convergence, and flexibility to both benzazepinones and 5-arylpiperidin-2-ones, 
unsubstituted on the nitrogen of the ring. In the key step of radical cyclization, 
methanesulfonyl radical is extruded from the intermediates and N-unsubstituted 
benzazepinones were generated in moderate to excellent yields under partially optimized 
conditions. This method demonstrates the potential of the xanthates technique in 
providing biologically active compounds which are not readily available by traditional 
methods. Furthermore, one notable advantage of this synthesis is the presence of halogen 
atoms in the products, which makes it possible to combine the radical reaction with some 
of the most powerful transition metal catalyzed processes, such as the Heck, Suzuki, 
Sonogashira and Buchwald-Hartwig reactions. They represent therefore interesting 
scaffolds for the pharmaceutical industry. 
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Introduction 
 
The azaindole ring system is a structural motif present in a variety of natural products, 
pharmaceuticals, and diverse synthetic intermediates. Compared to the analogous, more 
common indoles, azaindoles are supposed to overcome some of their drawbacks such as 
poor water solubility.108 The related azaindolines, which are less common in the literature, 
are also pharmaceutically interesting derivatives109 as well as important precursors to the 
corresponding azaindoles. As depicted in Scheme 4.1, replacing one carbon atom at 
positions 4 to 7 of indoles or indolines with an sp2-hybridized nitrogen gives the so-called 
4-, 5-, 6-, and 7-azaindoles or azaindolines, respectively.110 Most of these one-nitrogen 
analogs of indoles are synthetic products, although some of them exist in nature. 
 
 
Scheme 4.1 Structures of azaindole and azaindoline 
 
Among all these isomeric structures, 7-azaindoles have attracted more attention due to 
their physicochemical and pharmacological properties. They can be considered as 
bioisosteres of indoles or purines. The supplementary nitrogen makes the 7-azaindole a 
stronger base (pKa=4.59)111 than indole and provides a skeleton containing the hydrogen-
bond donor/acceptor in a rigid three-atom arrangement.112 But in contrast to indoles, 
which are widely present in nature, 7-azaindoles are only contained in a few natural 
products and most of them are found in alkaloids from the Variolin family. For instance, 
Variolin B which was isolated from the marine sponge Kirkpatrickia varialosa, displays 
                                                 
108
 Schirok, H. Synlett 2005, 1255-1258. 
109
 Southon, I.W.; Buckingham, J. Dictionary of Alkaloids 1989, Chapman and Hall, London. 
110
 For a review on the synthesis and reactivity of 4-, 5-, and 6-azaindoles, see: Popowycz, F.; Merour, J. Y.; 
Joseph, B. Tetrahedron 2007, 63, 8689-8707 and references cited therein. 
111
 Adler T. K.; Albert A. J. Chem. Soc. 1965, 2531. 
112
 Zheng, X.; Kerr, M. A. Org. Lett. 2006, 8, 3777. 
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strong in vitro activity against the P388 murine leukaemia cell line as well as moderate 
antiviral activity113 (Scheme 4.2). 
 
 
Scheme 4.2 Representative 7-azaindole derivatives 
 
Unnatural bioactive 7-azaindoles in contrast are also freq.uently exploited in the design 
of biologically interesting molecules. For example, BMS-378806 is found to be a 
prototype of novel HIV attachment inhibitors that block the first step of HIV-1 entry into 
cells.114 Hydroxypropyl-substituted 7-azaindolylmaleimide, which behaves as a specific 
Glycogen synthase kinase 3β (GSK-3β) inhibitor, has a potential usage for the treatment 
of elevated levels of GSK-3β related diseases.115 Furthermore, due to the two adjacent 
nitrogen atoms, 7-azaindole derivatives also have good coordination ability which is very 
useful in inorganic chemistry. 116  For example, new palladium complexes with the 
azaindolyl-phosphine ligand were developed as active catalysts for the co-polymerization 
of CO and ethene. For all these reasons, chemists are increasingly interested in these 
compounds, and many relevant synthetic methods have been developed.  
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 (a) Perry, N. B., Ettouati, L., Litaudon, M., Blunt, J. W., Munro, M. H. G., Parkin, S., Hope, H. 
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Blunt, J. W., Munro, M. H. G., Jameson, G. B. Tetrahedron 1994, 50, 3993 ; (c) Anderson, R. J.; Morris, J. 
C. Tetrahedron Lett. 2001, 42, 8697-8699.; (d) Song, J. J.; Reeves, J. T.; Gallou, F.; Tan, Z. L.; Yee, N. K.; 
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This chapter aims to present a novel synthesis of 7-azaindoles and 7-azaindolines based 
on xanthate technology, which was developed in our laboratory during the past years. In 
order to give a general idea related to our work, the existing methodologies for 
synthesizing these useful structures are briefly summarized in the first part. 117  An 
efficient method for preparing 5,6-difluoro-4-substituted 7-azaindoles and 7-azaindolines 
by an uncommon radical ipso-substitution of a C-F bond will then be described in detail. 
 
 
ĉ. Synthesis of 7-azaindole derivatives 
 
Compared to indoles and indolines, the corresponding azaindoles and azaindolines are far 
more challenging to prepare, especially in highly functionalized forms. Although a 
variety of related compounds have been prepared and characterized118 during the past 
decades, the general synthetic routes to these simple heterocycles are somewhat limited. 
In this part, we will summarize in detail the methods used for the synthesis of 7-
azaindoles, in order to give the readers an overview of this area. Related methods to 
generate azaindolines are disregarded here since they have been summarized by Dr. 
Laurent Petit in his thesis. 
 
7-azaindole contains one pyridine-like nitrogen atom in the six-membered ring which 
behaves as a π and σ acceptor, and one pyrrole-like nitrogen atom in the five-membered 
ring which acts as a π donor and σ acceptor.119 Thus the property of 7-azaindole is 
governed by the involvement in their condensed bicyclic system of two N-heteroatomic 
rings with opposite π-electron effects: pyridine with a deficiency of π-electrons and 
pyrrole with an excess of π-electrons.  
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Many classical methods for preparing the indole moiety, such as the Fischer reaction,120 
the Madelung cyclization,121 and the Reissert reaction122 are usually not applicable or less 
efficient for the synthesis of azaindoles. The electron poor nature of the pyridine nucleus 
alters the property of the π-system and thus affects the formation of azaindoles using 
these traditional methods. 
 
Generally there are three strategies to synthesize this bicyclic skeleton (Scheme 4.3):  
1. by creating the pyrrole rings from substituted pyridine derivatives;  
2. by generating the pyridine rings on substituted pyrroles;  
3. by oxidizing the corresponding 7-azaindolines. 
 
 
Scheme 4.3 Three general strategies in synthesizing 7-azaindoles 
                                                 
120
 (a) Fischer, E.; Jourdan, F. Ber. Bunsen-Ges. Phys. Chem.1883, 16, 2241. ; (b) Robinson, B. Chem. Rev. 
1963, 63, 373. 
121
 Madelung, W. Ber. Bunsen-Ges. Phys. Chem.1912, 45, 1128. 
122
 Reissert, A. Ber. Bunsen-Ges. Phys. Chem.1897, 30, 1030. 
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1. Pyrrolo annulation into preformed pyridine rings 
 
From a synthetic point of view, the most freq.uently employed strategy for 7-azaindole 
synthesis starts with preformed pyridine derivatives, followed by the formation of pyrrole 
rings. Generally, three kinds of substituted pyridines could serve as the precursor of this 
strategy: 3-substituted-2-aminopyridines, 3-(2-aminoethyl)-pyridines, and 3-halo-2-
aminopyridines. 
 
a. Construction of 7-azaindoles via 3-alkyl/vinyl/alkynyl -2-aminopyridines 
 
7-azaindoles can be constructed by forming the C(2)-N(1) bond as indicated in the 
retrosynthetic analysis (Scheme 4.4). This disconnection leads back to 3-substituted-2-
aminopyridines, in which the substituents could be alkyl, vinyl, and alkynyl, etc. a 
number of lithiation methods have been reported based on this retrosynthesis. 
 
 
Scheme 4.4 Synthesis of 7-azaindole from 3-substituted-2-aminopyridines 
 
The first example involves the lithiation of 3-methyl-2-aminopyridine.123 Acylation of 6-
ethyl-2-aminopyridine with pivaloyl chloride, followed by alkylation with methyl iodide 
gives the 3-methyl substituted pyridine MC-4-1. Treatment with tert-butyl lithium 
provides the bis-anion which, after quenching with DMF and hydrolysis, furnishes the 
intermediate aldehyde. Cyclization with 6N hydrochloric acid then affords the desired 7-
azaindole MC-4-2 in synthetically useful yield.  
                                                 
123
 Van Zandt, M. C.; Doan, B.; Sawicki, D. R.; Sredy, J.; Podjarny, A. D. Bioorg. Med. Chem. Lett. 2009, 
19, 2006-2008. 
Chapter 4 
 106
 
Scheme 4.5 Synthesis of 7-azaindole from 3-methyl-2-aminopyridine 
 
It is worth noting that in this synthesis, the C(2)-C(3) bond is formed before the C(2)-N(1) 
bond formation. An alternative bond-forming seq.uence, eg. C(2)-N(1) bond formation 
followed by intramolecular C(2)-C(3) bond formation, represents the traditional 
Madelung synthesis which generally req.uires very harsh conditions and has a very 
limited scope in azaindole synthesis.124 
 
O’Shea described another synthesis of 7-azaindoles from 3-vinyl-2-aminopyridine, which 
involves a controlled lithiation of the vinyl double bond as the key synthetic step.125 The 
starting material CB-4-1 is obtained in high yields by the Suzuki-Miyaura cross coupling 
of substituted 3-bromo-2-aminopyridine with the 2,4,6-trivinyl-cyclotriboroxane-pyridine 
complex (not shown in Scheme 4.6). After that, the reaction of substituted 3-vinyl-2-
aminopyridine with phenyl and butyl organolithiums126 followed by addition of suitable 
electrophiles leads to the desired 7-azaindole CB-4-3. Replacement of DMF by other 
electrophiles, such as nitriles, opens up access to a wide range of 2,3-difunctionalized 7-
azaindoles in modest to good yields. 
 
Scheme 4.6 Synthesis of 7-azaindole from 3-vinyl-2-aminopyridine 
                                                 
124
 Turner J.A. J. Org. Chem. 1983, 48, 3401. 
125
 Cottineau, B.; O'Shea, D. F. Tetrahedron Lett. 2005, 46, 1935-1938. 
126
 In order to avoid the ineffective vinyl carbolithiation, NH deprotonation was first carried out with 
phenyllithium prior to treatment with an alkyllithium. 
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Although the lithiation of pyridine systems has been extensively employed, other 
methods have also been studied for the synthesis of 7-azaindoles. For example, Pearson 
and co-workers investigated the microwave-assisted CuI catalyzed cyclization of 3-
alkynyl-2-aminopyridine SP-4-1, which was derived from the Sonogashira coupling of 
the unprotected 3-iodo-2-aminopyridine precursor and trimethylsilylacetylene, in the 
synthesis of 5-amino-7-azaindole SP-4-3.127 It was found that the microwave-promoted 
process provided a faster reaction than the original thermal conditions.128 
 
 
Scheme 4.7 Synthesis of 7-azaindole from 3-alkynyl-2-aminopyridine 
 
Nevertheless, this method usually req.uires quite harsh conditions (e.g. 80-190°C in a 
polar solvent). In order to optimize this synthesis with milder conditions, several new 
processes have been developed. For example, Knochel and co-workers reported a similar 
synthesis of 7-azaindole via the intramolecular addition of nitrogen nucleophiles to a 
triple bond, mediated by potassium or cesium bases in N-methylpyrrolidinone.129 The 
method employs 3-alkynyl-2-aminopyridine as the ring closure precursor, and proceeds 
by a 5-endo-dig cyclization under mild conditions. As depicted in Scheme 4.8, 5-methyl-
3-(phenylethynyl)-2-aminopyridine KP-4-1 affords subseq.uently 5-methyl-2-phenyl-7-
azaindole KP-4-2 in 72% yield. This approach could also serve as a general strategy for 
preparing 2-substituted indoles. 
                                                 
127
 Pearson, S. E.; Nandan, S. Synthesis 2005, 2503-2506. 
128
 (a) V. Kumar, J. A. Dority, E. R. Bacon, B. Singh and G. Y. Lesher, J. Org. Chem., 1992, 57, 6995.; (b) 
L. Xu, I. R. Lewis, S. K. Davidsen and J. B. Summers, Tetrahedron Lett., 1998, 39, 5159. 
129
 (a) Rodriguez, A. L.; Koradin, C.; Dohle, W.; Knochel, P. Angew. Chem. Int. Ed. 2000, 39, 2488.; (b) 
Koradin, C.; Dohle, W.; Rodriguez, A. L.; Schmid, B.; Knochel, P. Tetrahedron 2003, 59, 1571-1587.; (c) 
Sun, L. P.; Huang, X. H.; Wang, J. X. J. Chin. Chem. Soc.  2007, 54, 569-573. 
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Scheme 4.8 Synthesis of 7-azaindole by 5-endo-dig cyclization 
 
The last example cited here is based on the Gassman indole synthesis. Merck researchers 
reported a convenient process to prepare 7-azaindole from 2-aminopyridine and keto 
sulfides via a Sommelet-Hauser type rearrangement.130  
 
 
Scheme 4.9 Gassman-based route to substituted 7-azaindoles 
 
This one pot reaction is divided into three steps. The first step is the oxidation of the 2-
aminopyridine using tert-butyl hypochlorite to give chloramine DS-4-1. The second is the 
addition of the ketone to give the sulfonium ion DS-4-2 which is typically done at low 
temperatures. The final step is the addition of base. Upon warming to room temperature, 
the base deprotonates the sulfonium ion and forms the sulfonium ylide DS-4-3, which 
rapidly undergoes a [2,3]-sigmatropic rearrangement to give ketone DS-4-5, which in 
turn undergoes a facile condensation to give the desired 3-thiomethyl-7-azaindole DS-4-6. 
Treatment with Raney Ni in ethanol provides the desulfurized 7-azaindole DS-4-7 in a 
near quantitative yield. 
                                                 
130
 (a) Gassman, P. G.; van Bergen, T. J. J. Am. Chem. Soc. 1973, 95, 590–591; (b) Debenham, S. D.; Chan, 
A.; Liu, K.; Price, K.; Wood, H. B. Tetrahedron Lett. 2005, 46, 2283–2285. 
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b. Construction of 7-azaindoles from 3-(2-aminoethyl)-pyridine derivatives 
 
 
Scheme 4.10 Synthesis of 7-azaindole from 3-(2-aminoethyl)-pyridines 
 
Rather than starting from the 2-aminopyridines, another effective synthesis uses the 3-(2-
aminoethyl)-pyridine derivatives as the key intermediate. For example, Wakefield and his 
co-workers developed a one pot synthesis of 7-azaindole involving the metalation of 3-
picoline and subseq.uent addition of nitriles.131 As shown in Scheme 4.11, the lithium 
anion of 3-picoline with pivalonitrile gives intermediate DM-4-1, which readily cyclizes 
onto the pyridine ring in the presence of an excess of strong base. The intermediate is 
then oxidized to afford 2-substituted-7-azaindole DM-4-3. The cyclization is highly 
regioselective for the C-2 of pyridine. The isomeric azaindole resulting from ring closure 
onto the C-4 position was also observed as a by-product (5-azaindole) in trace amounts. 
 
 
Scheme 4.11 Synthesis of 7-azaindole from 3-picoline 
 
Another example of this strategy involves the nucleophilic cyclization of 2-chloro-3-
ethylaminopyridine derivatives, which was reported by Schirok in 2005.132 This approach 
proved to be an efficient way for preparing 3-substituted-6-chloro-7-azaindoles, such as 
SH-4-2 (Scheme 4.12). After deprotonation of 2,6-dichloropyridine at the C-3 position 
with LDA, the addition of chloroacetone directly led to epoxide intermediate SH-4-1, 
                                                 
131
 (a) Davis, M. L.; Wakefield, B. J.; Wardell, J. A. Tetrahedron 1992, 48, 939-952.; (b) Ma, Y.; Breslin, 
S.; Keresztes, I.; Lobkovsky, E.; Collum, D. B. J. Org. Chem. 2008, 73, 9610-9618. 
132
 Schirok, H. Synlett 2005, 1255-1258. 
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which was then treated with primary amines (e.g. benzylamine), followed by acidification 
with HCl to furnish the target compound. 
 
 
Scheme 4.12 Synthesis of a 7-azaindole via 2-chloro-3-ethylaminopyridine 
 
 
c. Construction of 7-azaindoles via heteroannulation of 3-halo-2-aminopyridine 
 
 
Scheme 4.13 Synthesis of 7-azaindole from 3-halo-2-aminopyridines 
 
As a result of the rapid development in transition metal catalyzed cross-coupling 
reactions, palladium catalysis has been extensively employed in the synthesis of 
azaindole scaffold. For example, the 3-alkynyl-2-aminopyridine mentioned above as the 
precursor for 7-azaindoles, is prepared via the Sonogashiha coupling of aryl halides with 
terminal alkynes.  
 
Moreover, the palladium-catalyzed heteroannulation of internal alkynes has also been 
applied to the construction of azaindoles (Scheme 4.13). This strategy was originally 
reported by Larock in 1990s for indole synthesis,133 and later developed for the synthesis 
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 R. C. Larock and E. K. Yum, J. Am. Chem. Soc., 1991, 113, 6689. 
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of azaindoles.134 For example, Yum and co-workers carried out extensive studies on this 
heteroannulation strategy for preparing 7-azaindole (Scheme 4.14). In this reaction, the 
use of LiCl and certain nitrogen protecting groups (alkyl and aryl groups) were found to 
be crucial for obtaining good yields. It worth noting that a high regioselectivity was 
obtained for most of the alkynes, with the more sterically bulky group (R’) at the C(2) 
position. 
 
 
Scheme 4.14 Palladium-catalyzed heteroannulation to prepare 7-azaindoles 
 
As shown in Scheme 4.13, the palladium-catalyzed annulation of 3-halo-2-
aminopyridines with regular ketones has also been used to synthesize azaindoles. 
Generally, the reaction starts with enamine formation followed by an intramolecular 
Heck reaction. For example, Nazare and co-workers reported an effective synthetic route 
for preparing a 7-azaindole via the direct annulation of 5-trifluoromethyl-3-chloro-2-
aminopyridine MN-4-1 with 2-oxopropanoic acid135 (Scheme 4.15). The use of Pd(Pt-
Bu3)2 as catalyst and a K3PO4-HOAc base-additive mixture was found to be essential for 
obtaining high yields.  
 
 
Scheme 4.15 Palladium-catalyzed annulation of 3-halo-2-aminopyridines with ketones 
 
                                                 
134
 (a) D. Wensbo, A. Eriksson, T. Jeschke, U. Annby, S. Gronowitz and L. A. Cohen, Tetrahedron Lett., 
1993, 34, 2823; (b) S. S. Park, J.-K. Choi and E. K. Yum, Tetrahedron Lett., 1998, 39, 627; (c) M. S. Lee 
and E. K. Yum, Bull. Korean Chem. Soc., 2002, 23, 535. 
135
 Nazare, M.; Schneider, C.; Lindenschmidt, A.; Will, D. W. Angew. Chem. Int. Ed. 2004, 43, 4526-4528. 
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2. Pyridine ring formation starting from substituted pyrrole derivatives 
 
 
Scheme 4.16 Synthesis of 7-azaindole from substituted pyrroles 
 
Although most of the syntheses of 7-azaindoles have pyridine derivatives as starting 
materials, some preparations starting from a pyrrole moiety have also been reported. 
Early work around this strategy can be traced back to the 1970s, albeit the yields for the 
key steps were unsatisfactory.136 In 1994, Quéguiner described an improved synthesis of 
3,5-disubstituted 7-azaindoles from the 2-aminopyrrole derivative LV-4-2 and the 
sodium salt of 3,3-dimethoxy-2-fromylpropanenitrile137 (Scheme 4.17).  
 
 
Scheme 4.17 Synthesis of 7-azaindole LV-4-3 based on a 2-aminopyrrole 
 
Later on, further optimized one pot procedures were developed proceeding in 
synthetically useful yields, whereby enamine LV-4-1 is not isolated and the pH kept 
under careful control (pH > 9). 
 
 
 
Scheme 4.18 One pot procedure for the same synthesis of LV-4-3 
                                                 
136
 (a) Abramenko, P. I. Zh. Vse. Khim. Obshchest. 1973, 18, 715; (b) Gilchrist et al. Chem. Abstr. 1974, 80, 
95788; (c) Brodrick A., Wibberley D.G. J. Chem. Soc., Perkin Trans. 1 1975, 1910 
137
 Levacher V., Leroy C., Dupas G., Bourguignon J., Quéguiner G. Synth. Commun. 1994, 24, 2697 
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Based on the process for preparing intermediate aminopyrrole derivatives, HC-4-3 an 
antagonist of the corticotropin-releasing hormone receptor, which had shown clinically 
beneficial properties in combating anxiety and depression, was generated from HC-4-1 in 
two steps (Scheme 4.19). In acidic medium, bicyclic 7-azaindole HC-4-2 is first obtained 
from 4-cyano-2-aminopyrrole and acetylacetone in good yield. Subseq.uent hydrolysis 
and final decarboxylation afford HC-4-3 in 66% yield.138 
 
 
Scheme 4.19 Synthesis of bioactive 7-azaindole HC-4-3 
 
Recently, a new optimized synthesis of ZG-4-2 was achieved by the reaction of 4-cyano-
2-aminopyrrole with 1,1,3,3-tetramethoxypropane in the presence of a catalytic amount 
of p-toluenesulfonic acid, followed by removal of the tert-butyl group using AlCl3.139 The 
key aminopyrrole intermediate ZG-4-1 was prepared from the inexpensive succinonitrile 
and ethyl formate in a three steps’ procedure. This cost-effective synthesis can be 
regarded as suitable for industrial production. 
 
 
 
Scheme 4.20 Optimized cost-effective synthesis of 7-azaindole ZG-4-2 
                                                 
138
 Hodge, C. N.; Aldrich, P. E.; Wasserman, Z. R.; Fernandez, C. H.; Nemeth, G. A.; Arvanitis, A.; 
Cheeseman, R. S.; Chorvat, R. J.; Ciganek, E.; Christos, T. E.; Gilligan, P. J.; Krenitsky, P.; Scholfield, E.; 
Strucely, P. J. Med. Chem. 1999, 42, 819. 
139
 Allegretti, M.; Anacardio, R.; Cesta, M. C.; Curti, R.; Mantovanini, M.; Nano, G.; Topai, A.; Zampella, 
G. Org. Process Res. Dev. 2003, 7, 209-213. 
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3. Oxidation of the corresponding 7-azaindolines 
 
7-azaindolines, possessing the 7-azaindole structure with a saturated C(2)-C(3) bond, are 
also an important family of compounds. For example, 1,4,6-trimethyl-5-hydroxy-7-
azaindoline was reported to be an efficient antioxidant, which displayed 88-fold larger 
inhibition rate constants than R-Tocopherol (a form of vitamin E) in quenching the 
oxidation of methyl linoleate in benzene solution.140 
 
Scheme 4.21 Tocopherol-like antioxidant 
 
By oxidation or dehydrogenation, 7-azaindolines can be converted into the corresponding 
7-azaindoles. Thus, an alternative strategy for generating 7-azaindoles is to oxidize the 
related 7-azaindoline derivatives. 
 
 
 
Scheme 4.22 7-azaindoline and 7-azaindole transformation 
 
Since the 3-position of 7-azaindole is most susceptible to electrophilic attack, blocking 
the pyrrole ring by introducing 7-azaindoline is a promising approach for certain 
syntheses. In 1959, with the aim of installing a substitution on the pyridine ring, 
Robinson reported a procedure to prepare 5-amino-7-azaindole with a 21% overall yield 
in four steps from 7-azaindoline.141 More recently, chemists at AstraZeneca optimized 
this procedure starting from commercially available 7-azaindole142 (Scheme 4.23). 
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 Lu, J.; Cai, X. Q.; Hecht, S. M. Org. Lett.  2010, 12, 5189-5191. 
141
 M. Robinson, J. Am. Chem. Soc. 1959, 743 
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 Pearson, S. E.; Nandan, S. Synthesis Stuttgart 2005, 2503-2506, and references cited therein. 
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Scheme 4.23 Optimized Robinson procedure by chemists at AstraZeneca 
 
7-azaindoline can be generated via many types of reactions, such as reductive 5-exo aryl 
radical cyclization, 143  intramolecular carbolithiation of aryllithiums, 144  intramolecular 
inverse electron demand Diels-Alder reaction, 145  and many other processes. 146  For 
example, condensation of 1,2-dicarbonyl compounds with S-methylthio-semicarbazide 
smoothly provides the 3-methylthio-1,2,4-triazine, which is subseq.uently oxidized with 
mCPBA to the 3-methylsulfonyl-1,2,4-triazine. 147  Nucleophilic displacement of 
methylsulfinate with 4-aminobutyne in DMF affords the triazolo compound ET-4-1. The 
latter undergoes intramolecular cycloaddition via the intermediate ET-4-2 in refluxing 
bromobenzene to yield the 7-azaindoline.148 Final aromatization with DDQ furnishes the 
7-azaindole. 149  However, this strategy is sometimes limited when preparing more 
elaborate 7-azaindoles due to the high temperature req.uired for the Diels-Alder reaction. 
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 Viswanathan, Rajesh; Prabhakaran, Erode N.; Plotkin, Michael A.; Johnston, Jeffrey N., J. Am. Chem. 
Soc., 2003, 125, 163-168. 
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 Taylor, E. C. Bull. Soc. Chim. Belg. 1988, 97, 599. 
146
 Dr. Petit, L. PhD thesis Ecole Polytechnique, 2008. 
147
 Taylor E. C., Macor J. E. Tetrahedron Lett. 1986, 27, 431 
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Scheme 4.24 Intramolecular inverse electron demand Diels-Alder process 
 
In our laboratory, the synthesis of 7-azaindolines has also been extensively explored 
based on the radical chemistry of xanthates. Many syntheses have been realized by direct 
radical cyclization of related substituted pyridine precursors. For example, as displayed in 
Scheme 4.25, following the seq.uence of intermolecular addition and intramolecular 
cyclization to the pyridine nucleus, 7-azaindolines BS-4-3 and BE-4-3 were obtained 
with yields of 42% and 57% respectively.150 These early studies were important since 
they showed that the nitrogen of pyridine was not deleterious to the xanthate precursor if 
its nucleophilicity could be blocked by appropriate substituents. 
 
 
 
Scheme 4.25 Synthesis of 7-azaindolines by radical addition-cyclization 
 
                                                 
150
 (a) Ly, T. M.; Quiclet-Sire, B.; Sortais, B.; Zard, S. Z. Tetrahedron Lett. 1999, 40, 2533-2536; (b) 
Bacqué, E.; El Qacemi, M.; Zard, S. Z. Org. Lett.  2004, 6, 3671-3674. 
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Ċ. Synthesis of 7-azaindoles and 7-azaindolines by an uncommon 
radical ipso-substitution of a C-F bond 
 
1. Discovery of an unexpected radical ipso-substitution-demethylation 
 
“In chemistry, minor and seemingly harmless modifications can have a profound effect 
on reactivity”.151 During a study of pyridine based substrates, a dramatic effect on the 
regioselectivity was found in the radical cyclization of substrates such as BE-4-2 
(Scheme 4.25), which indicated that the protecting groups on the extranuclear nitrogen 
played a significantly important role in the regioselectivity.152 As shown in Scheme 4.26, 
when an acetyl group is present in the precursor xanthate EQ.-4-1, the radical cyclization 
proceeds on C-3 and gives the 7-azaindoline EQ.-4-2. However, if the side chain nitrogen 
is protected by a Boc group, the radical cyclization takes place on the ring nitrogen to 
give the corresponding pyridinone EQ.-4-3. It was also noticed that the Boc group can be 
replaced by a smaller carbamyl group, and the presence of halogen substitutions like 
chlorine or fluorine is necessary in this selective process.153 This special regioselectivity 
will be further discussed in the next chapter. 
 
 
Scheme 4.26 Divergent radical cyclization on a pyridine ring 
 
In the attempt to expand the scope of this unexpected transformation as well as generate 
more mechanistic information, a related radical process of another derivative YL-4-1 was 
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 Laot, Y.; Petit, L.; Zard, S. Z. Org. Lett.  2010, 12, 3426-3429. 
152
 El Qacemi, M.; Ricard, L.; Zard, S. Z. Chem. Commun. 2006, 4422-4424. 
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examined, with the idea of using fluorine substituent to block the aromatic carbon and 
thus force the radical to cyclize on the pyridine nitrogen154 (Scheme 4.27).  
 
 
Scheme 4.27 Unexpected radical ipso-substitution-demethylation 
 
However, the cyclization did not proceed as expected on the pyridine nitrogen to furnish 
the corresponding pyridinone YL-4-2. Instead, bicyclic azaindoline YL-4-3 was 
surprisingly generated in a modest yield, with loss of the ortho-fluorine atom as well as 
one of the methyl groups from the dimethylamino substituent on C-4 (Scheme 4.27).  
 
A plausible mechanism is depicted below to explain the formation of the azaindoline 
(Scheme 4.28). After initiation, the radical species YL-4-1-a undergoes an ipso-
substitution on the ortho-carbon next to the extra-nucleus nitrogen to give an intermediate 
radical YL-4-1-b, which is then oxidized by the peroxide to form an allylic cation YL-4-
1-c. This intermediate cation is destabilized by the adjacent electron withdrawing 
fluorines, but stabilized by the two exocyclic nitrogen substituents. After losing the 
hydrogen fluoride as depicted, an iminium species YL-4-1-e is obtained which is readily 
hydrolyzed upon workup to complete the demethylation and give the final azaindoline 
YL-4-3. 
 
                                                 
154
 (a) Laot, Y.; Petit, L.; Ngoc, D. M. T.; Zard, S. Z. Aust. J. Chem. 2011, 64, 416-425; (b) Laot, Y.; Petit, 
L.; Zard, S. Z. Org. Lett. 2010, 12, 3426-3429. 
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Scheme 4.28 A plausible mechanism for the unexpected cyclization 
 
A modification to the substrate of YL-4-1 was made by our colleagues later on, which 
installed the xanthate-containing side chain directly at C-4, as illustrated in Scheme 4.29. 
In this way, the cation LP-4-2-c which is generated from the ipso-substituted 
intermediate LP-4-2-b, would not be stabilized by a second nitrogen substituent and the 
5-azaindoline LP-4-3 is thus obtained with a reasonable yield after losing the fluorine 
atom. 
 
 
Scheme 4.29 Synthesis of 5-azaindoline by radical ipso-substitution of C-F 
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2. Clarification of the mechanism 
 
In order to confirm the proposed mechanism for the ipso-substitution-demethylation and 
perhaps gain some additional mechanistic insight into this reaction, a related study was 
carried out with the substrates in which the dimethylamino substituent was replaced by 
pyrrolidyl and piperidyl group. With these modifications, further information might be 
acquired from the changes in the substituent rings. 
 
a. With pyrrolidyl substituted precursors 
 
At this point, xanthate precursor 4-16 was readily prepared by radical addition of 
xanthate Xa-i to the Boc-protected N-allylaminopyridine 4-1, which was obtained 
following the general procedures 155  starting from the commercially available 
pentafluoropyridine. However, a complicated reaction mixture was obtained from the 
exposure of 4-16 to the action of dilauroyl peroxide in AcOEt, and only 32% of 
prematurely reduced material 4-16’ was isolated and identified (Scheme 4.30). An 
observation based on NMR analysis was that deprotection occurred to the molecules in 
the reaction mixture. The Boc-protecting group was partially destroyed by the acidic 
side-products in the medium. 
 
 
Scheme 4.30 Radical cyclization of xanthate 4-16 
 
We then attempted to employ another initiator DTBP, which does not produce any acidic 
product upon thermolysis or induced decomposition, and replaced the collidine with a 
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slightly less basic 2,6-lutidine as the hydrogen fluoride scavenger. Higher boiling point 
chlorobenzene was also employed to match the half-life of the initiator DTBP, which can 
be added all at once at the beginning.  
 
When the starting material was completely consumed, the solvent was removed under 
reduced pressure and the residue was purified by flash chromatography. Surprisingly, the 
cyclization this time of 4-16 was successful, affording an unexpected azaindoline 4-36’, 
the pyrrolidyl at C-4 was replaced by a pyrrolyl group (Scheme 4.31). Although the yield 
for ring closure was far from being useful from a preparative standpoint, the observation 
of this transformation was still encouraging.156 We also repeated the former conditions 
with DLP in AcOEt and got 28% of 4-16’ as well as 8% of the cyclized compound 4-36’ 
which was not identified previously in the complicated reaction mixture. 
 
 
Scheme 4.31 Radical cyclization of xanthate 4-16 
 
Based on this new observation, the radical cyclization of LP-4-1 was repeated with the 
new conditions (see Scheme 4.32). For a more direct comparison, the cyclization was 
also repeated with the original method and furnished 25% of LP-4-3 with 37% reduced 
material. However, with the new method only 18% of LP-4-3 and 13% of reduced 
material were obtained. Based on the mechanism proposed above, the decrease of yield in 
generating LP-4-3 was reasonable since DLP is a better oxidant than DTBP, and lower 
temperature as well as long heating duration also favors the formation of cation species. 
Furthermore, the relative instability of Boc group towards prolonged heating at high 
temperature could also be responsible for the low yield. 
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Scheme 4.32 Unexpected radical ipso-substitution-demethylation 
 
Significant improvement was observed by replacing the relatively sensitive Boc group157 
with a similar but more robust methoxycarbonyl group. With this modification, xanthate 
precursors 4-17 and 4-18 were readily prepared and subjected to the radical cyclization 
(Scheme 4.33). Even more surprising was that this time not only the yield of pyrrolyl 
substituted product 4-37’ jumped from 18% to 30%, but a second pyrrolidyl substituted 
7-azaindoline 4-37 was also generated in a yield of 26%. At this point, the reaction 
resulted in a relatively efficient ring closure with an overall yield of 50% ~ 56%. 
 
 
Scheme 4.33 Radical cyclizations with a different protecting group 
 
It is worth mentioning that as indicated above, the cyclization of 4-17 in chlorobenzene 
without an additive base gave rise to a dark colored medium at the end of the heating 
period. The ensuing purification was somewhat laborious and only furnished 17% of 4-37 
as well as 10% of 4-37’. However, with the addition of base as the hydrogen fluoride 
scavenger, the reaction was not only cleaner but also gave a higher yield of the desired 
azaindolines 4-37 and 4-37’. 
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 The deprotection of Boc group can be achieved under thermal conditions; El Kazzouli, S.; Koubachi, J.; 
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A revised mechanism for this transformation can now be proposed as shown in Scheme 
4.34. The first pathway (Path A) includes a cationic intermediate 4-17-c, which is 
generated by electron transfer to the peroxide, followed by elimination of hydrogen 
fluoride and aromatization by further oxidation by the peroxide. The second pathway 
(Path B) starts with the radical attack at the C-3 of pyridine and ends by loss of a fluorine 
atom directly from intermediate 4-17-b. This process is favored by a high temperature.  
 
 
Scheme 4.34 Radical cyclization of xanthate 4-17 
 
Although an overall ring closure yield of 50% ~ 60% was realized, the specificity of the 
reaction was still dashed by the fact that two products were generated in the ratio of ~1:1.  
A better transformation leading to one major compound either by oxidation or reduction 
had to be developed.158 Experiments aimed at oxidizing the pyrrolidyl derivative 4-38 to 
pyrrolyl derivative 4-38’ were carried out with DDQ, but failed. We then tried benzoyl 
peroxide (DBP) in refluxing chlorobenzene as an oxidant for 4-38 (Scheme 4.35). We 
were pleased to find that the desired product 4-38’ was isolated in a modest yield of 38%. 
 
                                                 
158
 Robison, M. M.; Butler, F. P.; Robison, B. L. J. Am. Chem. Soc. 1957, 79, 2573-2578. 
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Scheme 4.35 Non-optimized oxidation of 4-38 
 
We didn’t go any further than this, since this transformation was not the target of our 
project. However, these preliminary results showed that with optimized reagents and 
conditions, a one-pot seq.uence of cyclization-oxidation could in principle be realized, 
giving 4-pyrrolyl-7-azaindoline specifically. 
 
 
b. With piperidyl substituted precursors 
 
In order to figure out whether there would be any similar changes to the C-4 substituent, 
a larger nitrogen ring was installed on the xanthate precursors. At this point, we studied 
the piperidyl substituted olefinic precursors 4-3 and 4-4, which were prepared from 
pentafluoropyridine by two steps of substitution followed by the corresponding 
protection. 159  They were then employed to perform initial comparative studies. The 
radical addition was accomplished using the standard procedure with DLP in refluxing 
AcOEt and afforded the xanthates 4-19, 4-20 and 4-21 in reasonable yields (Scheme 
4.36). The subseq.uent cyclizations then gave 7-azaindolines 4-39, 4-40 and 4-41 in 
similar yields for all three cases.160  
                                                 
159
 See page 135 for the general procedure in preparing olefinic precursors. 
160
 An important difference between the cyclizations of 4-19 and 4-21 was found later which will be 
discussed in page 132. 
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Scheme 4.36 Radical cyclizations with piperidyl substituted precursor 
 
However, it was interesting that the products were isolated in a somewhat impure state, 
indicated by the presence of two correlated eq.alent impurity peaks161 at į~6.20 and 
į~4.95 (Scheme 4.37). Two rounds of purification were needed to remove these peaks in 
order to get the clean spectra for these three products.  
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Scheme 4.37 1H NMR spectra of the 7-azaindolines from the first purification 
 
                                                 
161
 
1H Cosy NMR confirmed that the two peaks were correlated. 
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Based on the previous discussion of the mechanism, the enamine species with piperidyl 
substitution could also be formed. Although it was not isolated to be completely 
characterized, the indirect proof from NMR analyses partially confirmed its existence. 
 
 
Scheme 4.38 Radical cyclization of xanthate 4-19 
 
It should be noted that none of the product from Path A was obtained when we repeated 
the cyclization of YL-4-1, two products in similar yields were produced from the 
cyclization of 4-17, and less product from Path B was observed from the cyclization of 4-
19. The reasons underlying this behavior are not clear yet. In the case of YL-4-1-e only 
hydrolysis can take place to give the demethylated product, while in the case of 4-17-e, 
further oxidation furnishes a stable pyrrole. For 4-19-e, the iminium cannot easily 
proceed to an aromatic structure nor does it hydrolyse cleanly. In the absence of a good 
mass balance for the reaction, we cannot draw solid conclusions. 
 
Scheme 4.39 Imines intermediates with different C-4 substitutions 
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3. Further investigations of the scope 
 
a. Discovery of another product: 7-azaindole 
 
With the aim of further investigating the influence of substituted ring size, another cyclic 
substituent cyclopropylamine was chosen at C-4, and the standard radical addition-
cyclization procedure was applied to olefin 4-5 using xanthate Xa-h (Scheme 4.40). 
Unfortunately, a complicated reaction mixture was obtained and only 12% of 7-
azaindoline 4-42 could be isolated. 
 
 
Scheme 4.40 Radical cyclizations with smaller ring substitution 
 
During the preparation of olefin 4-5, the bis-acetylated adduct 4-6 was also obtained. 
Although this compound was just a by-product and the intrinsic electron withdrawing 
nature of the substituent should destabilize the cationic intermediate (c.f. 4-19-c), it was 
nevertheless worth a try, as it was already available. Thus, the addition-cyclization 
seq.uence was applied to 4-6 as shown in Scheme 4.41 and, surprisingly, this time the 
desired azaindoline 4-43 was isolated in a yield up to 46%!  
 
 
Scheme 4.41 Radical cyclizations with bis-acetylated precursor 
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This observation reminded us that with an electron withdrawing substituent at C-4, the 
nucleophilic radical addition followed by a β-scission (“Path B”) becomes dominant. 
With this idea in mind, we then examined another olefinic precursor 4-7 incorporating a 
weaker electron-releasing pyrrolyl substituent at the C-4. This olefinic precursor was 
accessible through substitution of pentafluoropyridine with pyrrole, then with N-
allylamine followed by acetylation (Scheme 4.42). The subseq.uent radical addition was 
realized with xanthate Xa-h in a reasonable yield to give the xanthate 4-24. 
 
 
Scheme 4.42 Preparation of xanthate precursor 4-24 
 
Xanthate precursor 4-24 was then subjected to the usual conditions with an even more 
surprising result (Scheme 4.43). From the radical cyclization we isolated the expected 7-
azaindoline 4-44 in a modest yield (38%); however, we also observed another spot on the 
TLC plate adjacent to the starting material. Usually such spots correspond to the 
prematurely reduced material (i.e. the xanthate group simply replaced with hydrogen) as 
these side-products are difficult to avoid when difficult cyclization are involved. 
However, it was not the case this time. One new product, 7-azaindole 4-44’, was obtained 
in a yield of 14% thus raising the total yield of cyclized products to 52%. 
 
 
Scheme 4.43 Radical cyclization of 4-24 
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b. A more complete view of the mechanism 
 
The discovery of 7-azaindole 4-44’ not only increased the ring closure efficiency, but 
also made this synthesis more versatile. However, a question arose automatically: how 
was this 7-azaindole formed? We therefore repeated the cyclization of 4-24 with an 
increased amount of DTBP under similar concentration in chlorobenzene162 (Table 4.1).  
 
 
Table 4.1 Analyses of the role of DTBP 
 
It is clear that when more DTBP is added, the total yield for cyclization was gently 
increased and the ratio of 4-44’ to 4-44 increased as well. Thus, the 7-azaindole was very 
likely generated from 7-azaindoline via partial oxidation by DTBP in refluxing 
chlorobenzene.163 
 
Anyway, this newly found 7-azaindole was derived from a reasonably efficient ring 
closure of the electron-accepting group substituted xanthate 4-24. In that case, a similar 
compound should be generated from the cyclization of xanthate 4-23, which also has an 
electron-withdrawing N-substituent at C-4. In fact, when we re-examined a minor 
fraction, which was previously thought to be the prematurely reduced material, the 
corresponding 7-azaindole 4-43’ was identified with a yield of 18%. Conseq.uently, the 
actual yield for cyclization is now a respectable 64% (Scheme 4.44).  
 
                                                 
162
 In the first two entries, DTBP was added once and the reaction took about 3h; while in the third, DTBP 
was added twice, 10.0 eq. for 4h and then 5.0 eq. for 1h 
163
 Later, we tried the oxidation of 4-47 with benzoyl peroxide (DBP), a more powerful oxidant. However, 
only part of the 7-azaindoline was oxidized to the corresponding 7-azaindole 4-47’. A more efficient 
oxidation will be discussed in the next part. 
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Scheme 4.44 Recover of the 7-azaindole 4-43’ 
 
Furthermore, we also repeated the cyclization of 4-23 under the former conditions (b) 
with DLP in refluxing AcOEt. Although poor yields were obtained, it was interesting that 
7-azaindole 4-43’ was also isolated, even as the major product. None of the 
corresponding 7-azaindole was observed during the early study with C-4 EDG substituent 
under these conditions, which meant that the C-4 EWG was not only essential for 
improving the cyclization, but also important to the oxidation step (Scheme 4.45). 
 
 
Scheme 4.45 Mechanism for obtaining 4-43 and 4-43’ 
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c. Clarification of two previous results 
 
1) When the pyrrolidyl was oxidized to the pyrrolyl? 
 
Since the cyclization of 4-24 gave a much improved overall yield for ring-closure, could 
the pyrrolyl substituted 7-azaindoline 4-36’ be derived from the cyclization of a pre-
oxidized xanthate 4-16’? If so, the mechanism for this reaction should be modified by 
adding the Path II depicted in Scheme 4.46, which includes the seq.uence of pre-
oxidation and radical ipso-substitution. 
 
Scheme 4.46 Alternative possibility for generating 4-36’ 
 
At this point, direct oxidation of the pyrrolidyl substituted derivative 4-16-a was 
attempted under usual radical cyclization conditions. As shown in Scheme 4.46, the 
xanthate group in 4-16 was reductively removed by treatment with a stoichiometric 
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amount of DLP in isopropanol. Then same conditions for the cyclization were applied to 
compound 4-16-a. However, no trace of an oxidized compound 4-16-b was observed, 
which therefore excludes this possible pathway and confirmes previous analysis. 
 
 
2) The role of the nitrogen protecting group at C-2 
 
Another “lost” 7-azaindole 4-41’ was also discovered in a yield of 10% when we 
carefully re-examined residues from two previous experiments (Scheme 4.47). 
Interestingly, no azaindole was observed in the cyclization of COOMe-protected xanthate 
precursor 4-19, which indicated that the electronic modification to the pyridine nucleus 
by the C-2 N-substituent also contributed to the efficiency in ring closure as well as to the 
ease of oxidation leading to the 7-azaindole.164 
 
 
Scheme 4.47 Radical cyclization of piperidine substituted xanthates  
 
                                                 
164
 Further studies with the trifluoroacetate CF3CO-protected xanthates were pursued by Mr. Ling QIN. 
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d. Further rationalization 
 
In the light of the above studies, the processes involved in this transformation were now 
clearer. Electronic modification to the pyridine nucleus with EWGs in C-4 and C-2 
promotes the radical cyclization by facilitating the first attack of secondary alkyl 
(nucleophilic) radical to an electron-poor ring. The radicals formed in the transition state 
are stabilized by both EWGs and EDGs (Scheme 4.48). However, the SOMOs of these 
radicals have different proclivities towards oxidation to the corresponding cations, and 
this leads to two different reaction pathways. 
 
Scheme 4.48 Possible explanation by Frontier Molecular Orbital Theory 
 
In the case of an EWG substituent, the newly formed radical is less inclined to proceed to 
the cation by electron-transfer to the peroxide, but it is still stabilized and capable of 
undergoing homolytic rupture of the C-F bond which permits aromatization to take place. 
 
However, the newly formed SOMO with an EDG substituent is more likely to undergo 
oxidation to the cation, allowing at least partially following the path leading to 
aromatization ultimately by ionic elimination of hydrogen fluoride. 
 
Furthermore, the use of a high boiling solvent speeds up the rate of ipso-substitution165 
but, more importantly, speeds up considerably the rate of fragmentation of the C-F bond. 
This fragmentation step has a high positive entropy and therefore is very sensitive to 
                                                 
165
 The reactions proceeded >10h in refluxing AcOEt while <3h in refluxing chlorobenzene 
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temperature (ΔG = ΔH − TΔS). In the present case, the C-F bond is very strong and does 
not fragment easily in a homolytic manner. A high temperature and the powerful driving 
force of the aromatization are necessary.  
 
With a better appreciation of the factors governing the process, we examined the behavior 
of other C-4 N-substituents. As depicted in Scheme 4.49, simple functional groups, such 
as methyl, hydrogen, acetyl and mesyl were employed in these syntheses. 
 
 
Scheme 4.49 Radical cyclization examples  
 
From these results we could see that as long as one C-4 N-substituent is electron-
withdrawing, the desired cyclized products are readily obtained in good combined yields. 
It should be noted that in comparing the cyclization of 4-22 and 4-26, both of the 
substrates contain hydrogen on the C-4 nitrogen. In the case of 4-26 which has an EWG 
at C-4 nitrogen, cyclization proceedes via the ipso-substitution with extrusion of a 
fluorine atom without interference from the amide proton; whereas in the case of 4-22, 
the absence of an EWG favors oxidation of the cyclized radical leading to many side 
reactions involving the strained cyclopropyl group and thus resulting in a very low yield 
of 7-azaindoline 4-42. 
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4. Diversity and perspectives 
 
Based on the previous study, we decided to expand the scope of this synthesis by 
introducing yet more different C-4 substituents as well as the diverse functional groups 
on the xanthate partners. We also explored briefly the possibility of extending this 
approach to 1,2,3,4-tetrahydro-1,8-naphthyridines (piperidopyridines). 
 
a. Further examples 
 
A number of diverse substrates were prepared by reacting pentafluoropyridine with 
various amines, anilines, and nitrogen heteroaromatic compounds. Pentafluoropyridine 
usually reacts first at C-4 and then at C-2. 166  Depending on the strength of the 
nucleophiles, the substitution was accomplished by either stirring the mixture of 
pentafluoropyridine with the nucleophile in ethanol, or by slowly adding a pre-
deprotonated nitrogen-containing component to the solution of pentafluoropyridine in 
anhydrous THF. Normally the substitution was rapid and quantitative, but sometimes a 
second substitution at the C-2 was observed which lowered the yields.167 It is worth 
mentioning that since the pentafluoropyridine is volatile and very electron deficient, this 
reaction could not be easily monitored by NMR or TLC analyses. 
 
Scheme 4.50 General synthesis of the olefinic precursors 
 
In the second substitution step with allyamine, consistent results were obtained although 
the reactivities were different according to the C-4 substitution. For instance, in the case 
                                                 
166
 (a) Hargreaves, C. A.; Sandford, G.; Slater, R.; Yufit, D. S.; Howard, J. A. K.; Vong, A. Tetrahedron 
2007, 63, 5204-5211; (b) Amii, H.; Uneyama, K. Chem. Rev. 2009, 109, 2119-2183. 
167
 For example, during the preparation of 4-3 and 4-4, double substitutions gave 6% of 1,1'-(3,5,6-
trifluoropyridine-2,4-diyl)dipiperidine as a yellow oil. 
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of an EDG substituent (eg. dimethylamine, cyclopropylamine, pyrolidine or piperidine), 
the electrophilic character at C-2 was decreased and the substitution normally took 3 to 6 
days. However, when EWGs were installed at C 4, the substitution of allylamine is much 
easier and took only 1 hour at most. 
 
Finally, the protection of 2-pyridyl allylamine was preformed with Boc anhydride, 
methyl chloroformate or acetyl chloride to give the desired olefinic precursors in 
moderate to good yields.168 
 
Various 7-azaindolines and 7-azaindoles were prepared by radical addition and 
cyclization as shown by the results listed in Table 4.2. The radical addition step gave 
yields from 56% to 84% (see experimental part), and the intrinsically difficult cyclization 
afforded quite respectable yields ranging from 52% to 79%. The possibility of 
introducing different substituents by modifying both the xanthates and the nitrogen 
containing nucleophiles allowed ultimately access to a broad assortment of novel fluoro-
7-azaindolines and fluoro-7-azaindoles. It should be noted that functionalities like the 
important azole subunits169 also proved compatible with our synthesis. 
 
It is also interesting to note that in the cyclization of 4-29, a small amount (5%) of 
tetralone was isolated arising from cyclization of the intermediate radical on the phenyl 
ring instead of on the pyridine nucleus. This indicates that the rate of ipso-closure on the 
pyridine ring while being a difficult process, is still faster than the ring-closure leading to 
a six-membered tetralone. The fact that the xanthate technology also allows the 
construction of tetralones, 170  a process extensively studied in our laboratory, is a 
testimony to its immense synthetic potential. 
 
                                                 
168
 These one-pot three steps reactions were carried out without optimization. 
169
 Azoles are freq.uently present in biologically active compounds. For instance, the marketed drug 
rizatriptan (trade name Maxalt) is used in the treatment of migraine and contains a triazole motif. 
170
 Liard, A.; QuicletSire, B.; Saicic, R. N.; Zard, S. Z. Tetrahedron Lett. 1997, 38, 1759-1762. 
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Table 4.2 Synthesis of various 7-Azaindoles and 7-Azaindolines 
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b. Optimization of the reaction selectivity 
 
The process we have developed furnishes a mixture of 7-azaindoline and 7-azaindole. 
From a synthetic standpoint, it would be useful if the azaindoline could be cleanly 
oxidized into the azaindole. 
 
By analogy with a related transformation on a non-fluorinated analog, 171  we first 
examined DDQ as the oxidant to access the 7-azaindole. Thus pyrrolidyl substituted 7-
azaindoline 4-37 was chosen to test the oxidation with DDQ in dioxane (Scheme 4.51). 
Any form of oxidation was interesting, no matter which nitrogen-containing ring is 
modified. 
 
 
Scheme 4.51 Oxidation of 4-37 with DDQ 
 
In the event, no oxidation was observed under these conditions. We also examined the 
unprotected azaindoline 4-47-a which should be easier to oxidize, but reaction was 
obscured172 (Scheme 4.52). 
 
 
Scheme 4.52 Oxidation of 4-47 with DDQ after deprotection 
                                                 
171
 El Qacemi, M.; Ricard, L.; Zard, S. Z. Chem. Commun. 2006, 4422-4424. 
172
 In a later study, this condition was succeeded with substrate 4-52-a, but far less efficient (see Scheme 
4.54, condition a). 
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From these preliminary tests, we could see that the presence of the electronegative 
fluorine atoms strongly deactivate the 7-azaindoline core. Thus DDQ was not a 
sufficiently powerful reagent to oxidize these compounds. 
 
Since we noted that the amount of 7-azaindoles increased generally with further additions 
of DTBP into the reaction medium, we decided to try the oxidation with benzoyl 
peroxide (DBP), which is a more potent oxidizing agent as compared with DTBP.  
 
Scheme 4.53 Oxidation of 4-47 with DBP 
 
Although no quantitative results were generated, we did observe the formation of the 
corresponding 7-azaindole 4-47’ in the reaction medium according to TLC analysis. 
However, it was still not efficient enough to be employed to completely finish this 
transformation. 
 
 
Scheme 4.54 Oxidation of 4-52-a with different oxidants 
 
Finally, we decided to use the o-iodoxybenzoic acid (IBX) in DMSO, which was 
employed previously in a related case in our laboratory. This reagent system was 
developed by Nicolaou173  as an oxidant for indolines. An overall 12% of yield was 
obtained in the oxidation of compound 4-52 into the 1-H-7-azaindole 4-52-a’. This 
preliminary test was performed with a very limited quantity, which explains partly the 
low overall yield. In contrast, when the same procedure was used to oxidize another 
                                                 
173
 K. C. Nicolaou, C. J. N. Mathison, T. Montagnon, J. Am. Chem. Soc. 2004, 126, 5192 and references 
therein. 
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substrate 4-49, a more satisfactory yield of 44% was achieved for the two steps (Scheme 
4.55). 
 
Scheme 4.55 Oxidation of 4-49-a with IBX in DMSO 
 
To extend this oxidation as well as to make this seq.uence more practical, we tried to 
perform the cyclization, deprotection, and oxidation all in one-pot.  
 
 
Scheme 4.56  One-pot synthesis of 1-H-7-azaindole 4-55 
 
1-H-7-Azaindole 4-55 was obtained in a modest yield for four steps. It is interesting to 
note that the fluorine atom at C-6 was substituted by an ethoxy group in the deacetylation 
step, which was carried out in ethanol as solvent. The C-6 fluorine is selectively 
substituted by various nucleophiles in these systems. The adjacent C-5 fluorine is not 
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activated by the nitrogen of the pyridine nucleus and remains intact.174 We did not go any 
further to explore the chemistry of the final 7-azaindolines and 7-azaindoles.
                                                 
174
 Laot, Y.; Petit, L.; Ngoc, D. M. T.; Zard, S. Z. Australian Journal of Chemistry 2011, 64, 416-425. 
references 13 cited therein 
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c. Preliminary study towards the synthesis of piperidopyridine 
 
As an extension of this approach, we examined the possibility of using a similar 
procedure to prepare piperidopyridine derivatives, which also exhibit interesting activities 
in the pharmaceutical domain.175 For example, as shown on the left hand side of Scheme 
4.57, the 7-substituted-piperidopyridine developed by Merck was identified as a selective 
antagonist of the ανβ3 receptor with a potential usage for the prevention and treatment of 
osteoporosis.176 The multi-substituted-piperidopyridine on the right hand side of Scheme 
4.57 is an efficient antioxidant, displaying a 28-fold larger inhibition rate constants 
relative to R-Tocopherol, a form of vitamin E, in quenching the oxidation of methyl 
linoleate in benzene solution.177 
 
 
Scheme 4.57 Examples of bioactive piperidopyridines 
 
Based on the successful radical cyclization to create a five-membered ring fused pyridine, 
a similar transformation with the aim of constructing a six-membered ring fused pyridine 
was also tested. As shown in Scheme 4.58, the synthesis of the piperidopyridine 4-58 was 
accomplished by the cyclization of precursor 4-57, prepared by a similar procedure 
starting from pentafluoropyridine and 3-buten-1-amine. In the event, the radical addition 
step proceeded well, but treatment of xanthate 4-57 with DTBP under the usual 
                                                 
175
 The general preparation of this molecular skeleton has been summarized in the thesis of Dr. M. El 
Qacemi. Here we just present an updated progress towards these compounds using our methodology. 
176
 Hutchinson, J. H.; Hatczenko, W.; Brashear, K. M.; Breslin, M. J.; Coleman, P. J.; Duong, L. T.; 
Fernandez-Metzler, C.; Gentile, M. A.; Fisher, J. E.; Hartman, G. D.; Huff, J. R.; Kimmel, D. B.; Leu, C. T.; 
Meissner, R. S.; Merkle, K.; Nagy, R.; Pennypacker, B.; Perkins, J. J.; Prueksaritanont, T.; Rodan, G. A.; 
Varga, S. L.; Wesolowski, G. A.; Zartman, A. E.; Rodan, S. B.; Duggan, M. E. J. Med. Chem.  2003, 46, 
4790-4798. 
177
 Lu, J.; Cai, X. Q.; Hecht, S. M. Org. Lett.  2010, 12, 5189-5191. 
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conditions afforded the expected product in a normally low yield (~16%). Since the 
radical cyclization leading to a six-membered ring is less favored than that forming a 
five-membered ring, hydrogen abstraction from the medium could seriously compete 
with the desired process. Optimization of this synthesis will be continued by Mr. Ling 
QIN. 
 
 
Scheme 4.58 Piperidopyridine generated via radical ipso-substitution (non-optimized) 
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Conclusion 
 
In summary, we have described a useful route to an uncommon class of fluorinated 
heterocyclic derivatives which could be of significant interests.178 In the structures that 
we have prepared, diversity can be introduced by modifying the substituent at C-4 in the 
first step; by modifying the amine side-chain in the second step; by modifying the 
xanthate partner; and by modifying the nucleophile during substitution of the fluorine at 
C-6. A vast library of analogs can thus be readily obtained. 
 
From a fundamental standpoint, this work has demonstrated the efficient homolytic 
rupture of the strong C-F bond 179  under mild conditions. Such fragmentations are 
extremely rare and in fact hardly documented in the literature. The very success in 
accomplishing such a different process is a testimony to the power of the radical 
chemistry of xanthates. 
 
The previous work concerning the synthesis of the related trifluoro-5-azaindolines used 
the same initiator in a higher boiling point solvent. There is therefore the possibility that 
the corresponding trifluoro-5-azaindoles were also produced in the reaction but were 
overlooked. The reported yields of the 5-azaindolines vary from 27% to 51%, but could 
be a little higher if the corresponding 5-azaindoles are indeed formed (Scheme 4.55). 
 
 
Scheme 4.55 Synthesis of 5-azaindolines by radical ipso-substitution of C-F 
                                                 
178
 A rapid growth of interest in fluoro-organics has occurred in many areas of application, including 
polymers, materials, specialty solvents, performance fluids, medicinal agents, agrochemicals and numerous 
reagents and intermediates for chemical synthesis. For example, in the pharmaceutical industry, about 20% 
of commercialized drugs contain fluorine since even one single atom can improve its chemical reactivity. 
179
 Bond energy: C-F  485 kJmol-1, C-H  411 kJmol-1, C-C  346 kJmol-1, C-Cl  327 kJmol-1 
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Introduction 
 
The pyrimidine ring can be seen as an amidine moiety incorporated into a diazine system 
(1,3-diazine). It has wide occurrence in nature as substituted and ring fused compounds 
or as their related pyrimidone derivatives, including the nucleotides, thiamines and 
alloxans. Such motifs are also found in many synthetic compounds such as barbiturates, 
P-3A,180 bleomycin A2,181 and the HIV drug, zidovudine.182 
 
 
Scheme 5.1 Biological active pyrimidine derivatives 
 
The bicyclic derivatives based on pyrimidine rings are of significant interest to the field 
of modern biological organic chemistry. They are widely distributed in natural products 
and have important biological activity. It is sufficient to note that such biologically 
important compounds as purines and pteridines are related to bicyclic pyrimidines. 
 
                                                 
180
 (a) Boger, D. L.; Honda, T.; Menezes, R. F.; Colletti, S. L.; Dang, Q.; Yang, W. J. J. Am. Chem. Soc. 
1994, 116, 82-92. (b) Boger, D. L.; Dang, Q. J. Org. Chem. 1992, 57, 1631-1633. 
181
 Boger, D. L.; Menezes, R. F.; Dang, Q. J. Org. Chem. 1992, 57, 4333-4336. 
182
 Lagoja, I. M. Chem. Biodivers. 2005, 2, 1-50. 
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Scheme 5.2 Biological active bicyclic pyrimidines 
 
For example, CP-154526 is one of the first CRF-1 antagonists183 and shows high affinity 
as well as interesting signs of in vivo activity in animal models of anxiety and depression. 
The bicyclic pyrimidine core is substituted in the top region of this molecule, and the 
aromatic nitrogen serves as the H-bond acceptor.184 Piritrexim (PTX)185 is a clinically 
tested compound against PCP186 in AIDS patients and is currently used for the treatment 
of this opportunistic infection. 
 
This chapter will focus on the application of the radical chemistry of xanthates to the 
modification of the pyrimidine nucleus. Relevant methodologies for constructing the 
bicyclic aza-pyrimidines are briefly summarized in the first part. In the second part, a 
dramatic effect of the protecting group on the regioselectivity of the radical cyclization in 
the pyridine and pyrimidine series will be discussed in detail. Next, efficient methods to 
access novel polycyclic aza-pyrimidine structures including 5, 6, and 7-membered rings, 
are described involving radical addition and cyclization of xanthates. Finally, preliminary 
results concerning radical additions to the heteroaromatic nitrogen to create six-
membered rings will be presented. 
                                                 
183
 Corticotropin-releasing factor (CRF), a 41 amino acid peptide synthesized by specific hypothalamic 
nuclei in the brain, was originally isolated by Wale in 1981 from ovine hypothalamus. The identification of 
CRF-1 antagonists is an attractive therapeutic approach for the treatment of depression and anxiety. 
184
 (a) Gentile, G.; Di Fabio, R.; Pavone, F.; Sabbatini, F. M.; St-Denis, Y.; Zampori, M. G.; Vitulli, G.; 
Worby, A. Bioorg. Med. Chem. Lett. 2007, 17, 5218-5221.; (b) Zorrilla, E. P.; Koob, G. F. Drug Discov. 
Today 2010, 15, 371-383. 
185
 (a) Kovacs, J. A.; Allegra, C. J.; Swan, J. C.; Drake, J. C.; Parrillo, J. E.; Chabner, B. A.; Masur, H. 
Antimicrob. Agents Chemother. 1988, 32, 430-433.; (b) Gangjee, A.; Devraj, R.; Queener, S. F. J. Med. 
Chem.  1997, 40, 470-478. 
186
 Pneumocystis pneumonia (PCP) is a form of pneumonia caused by yeast-like fungus. 
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ĉ. Synthesis of bicyclic aza-pyrimidine derivatives 
 
1. Five-membered ring fused bicyclic aza-pyrimidines (5,7-diazaindolines) 
 
    
Scheme 5.1 5,7-diazaindoline 
 
Generally, there are four synthetic strategies for constructing the five-membered ring 
fused bicyclic aza-pyrimidines. The first method is to build up the pyrimidine part after 
synthesizing the functionalized five-membered pyrrole or pyrrolidine rings. 187 
Alternatively, one can also construct the five-membered ring unit starting with the 
pyrimidine derivatives.188 Another approach employs the Diels-Alder reaction starting 
from 1,3,5-triazines, which can also be applied to synthesize the six-membered ring fused 
bicyclic aza-pyrimidines as we will discuss in detail later.189 In addition, reduction of 
diazaindoles can give the corresponding diazaindolines.190 The detailed synthetic routes 
for the above strategies are not presented here in order to avoid a lengthy literature study. 
More information about this subject can be found in the doctoral thesis of Dr. L. Petit. 
                                                 
187
 (a) Takahata, H.; Nakajima, T.; Yamazaki, T. Synthesis Stuttgart 1983, 226-228. (b) Sonoda, M.; 
Kuriyama, N.; Tomioka, Y.; Yamazaki, M. Chem. Pharm. Bull.  1986, 34, 886-892. (c) Aso, K.; Hitaka, T.; 
Yukishige, K.; Ootsu, K.; Akimoto, H. Chem. Pharm. Bull.  1995, 43, 256-261. (d) Kuyper, L. F.; Garvey, 
J. M.; Baccanari, D. P.; Champness, J. N.; Stammers, D. K.; Beddell, C. R. Bioorg. Med. Chem.  1996, 4, 
593-602. (e) Kiselyov, A. S. Tetrahedron Lett. 2005, 46, 1177-1179. 
188
 (a) St-Denis, Y.; Di Fabio, R.; Bernasconi, G.; Castiglioni, E.; Contini, S.; Donati, D.; Fazzolari, E.; 
Gentile, G.; Ghirlanda, D.; Marchionni, C.; Messina, F.; Micheli, F.; Pavone, F.; Pasquarello, A.; Sabbatini, 
F. M.; Zampori, M. G.; Arban, R.; Vitulli, G. Bioorg. Med. Chem. Lett. 2005, 15, 3713-3716. (b) Choi, H. 
S.; Wang, Z. C.; Richmond, W.; He, X. H.; Yang, K. Y.; Jiang, T.; Sim, T. B.; Karanewsky, D.; Gu, X. J.; 
Zhou, V.; Liu, Y.; Ohmori, O.; Caldwell, J.; Gray, N.; He, Y. Bioorg. Med. Chem. Lett. 2006, 16, 2173-
2176. (c) Kempson, J.; Pitts, W. J.; Barbosa, J.; Guo, J. Q.; Omotoso, O.; Watson, A.; Stebbins, K.; Starling, 
G. C.; Dodd, J. H.; Barrish, J. C.; Felix, R.; Fischer, K. Bioorg. Med. Chem. Lett. 2005, 15, 1829-1833. (d) 
Boros, E. E.; Thompson, J. B.; Katamreddy, S. R.; Carpenter, A. J. J. Org. Chem. 2009, 74, 3587-3590. 
189
 Boger, D. L.; Kochanny, M. J. J. Org. Chem. 1994, 59, 4950-4955. 
190
 (a) Shih, C.; Gossett, L. S. Heterocycles 1993, 35, 825-841. (b) Amarnath, V.; Madhav, R. Synthesis 
Stuttgart 1974, 837-859. (c) Harcken, C.; Ward, Y.; Thomson, D.; Riether, D. Synlett 2005, 3121-3125. (d) 
Song, J. H. J.; Tan, Z. L.; Reeves, J. T.; Fandrick, D. R.; Lee, H.; Yee, N. K.; Senanayake, C. H. 
Tetrahedron Lett. 2009, 50, 3952-3954. (e) Whelligan, D. K.; Thomson, D. W.; Taylor, D.; Hoelder, S. J. 
Org. Chem. 2010, 75, 11-15. 
Chapter 5 
 150
2. Six-membered ring fused bicyclic aza-pyrimidines (piperido[2,3-
d]pyrimidines) 
 
Scheme 5.2 Piperido[2,3-d]pyrimidines 
 
Piperido[2,3-d]pyrimidine or triazanaphthalene is a saturated six-membered ring fused 
bicyclic aza-pyrimidine. Similar to 5,7-diazaindoline, the synthesis of this structure could 
be based on four general strategies. 
 
 
a. Condensation of functionalized piperidines 
 
The condensation of guanidine with a β-ketoester represents one of the most useful and 
general methods for preparing the pyrimidine ring. As an extension of this strategy, the 
first condensation of guanidine with a β-amidoester to form the bicyclic piperido[2,3-
d]pyrimidine was achieved by DeGraw191 in his investigations on the synthesis of JD-5-2.  
 
 
Scheme 5.3 Condensation of guanidine with a β-amidoester 
 
A series of 2-substituted 4-hydroxy-piperido[2,3-d]pyrimidines BP-5-2 were synthesized 
by reacting the lactim ether of 3-carboethoxy-2-piperidone BP-5-1 with guanidine, 
acetimidamide, carbamimidic acid, and 1-cyanoguanidine, in yields of 58%, 49%, 44%, 
                                                 
191
 Degraw, J.; Goodman, L. Can. J. Chem.-Revue Canadienne De Chimie 1963, 41, 3137 
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and 19% respectively.192 These structural analogs of pteridones are of interest on account 
of their biological activity. 
 
 
Scheme 5.4 Synthesis of 2-substituted 4-hydroxy-piperido[2,3-d]pyrimidines 
 
Although the guanidine cyclization route is often used for constructing the pyrimidine 
ring in various synthetic approaches, they often req.uire use of problematic intermediates 
that have low solubility. To overcome this shortcoming, other methods were explored.  
 
O-Methyl-į-valerolactim RL-5-1 is readily generated from the corresponding lactam. C-
Acylation occurred when it was treated firstly with lithium diisopropylamide (LDA) and 
then with an aromatic nitrile in benzene solution. The piperido[2,3-d]pyrimidine RL-5-2 
was obtained along with 2,4,6-triaryltriazines RL-5-3 as the side-product.193 A 2+2+2 
component combination was proposed for this transformation.194 
 
 
Scheme 5.5 Three component reaction for preparing RL-5-2 
                                                 
192
 Pyatin, B. M.; Glushkov, R. G. Pharm. Chem. J. 1968, 488 
193
 Lalonde, R. T.; Elkafrawy, A.; Muhammad, N.; Oatis, J. E. J. Org. Chem. 1977, 42, 1808-1809. 
194
 Morita, K.; Kobayashi, S.; Shimadzu, H.; Ochiai, M. Tetrahedron Lett. 1970, 11, 861 
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b. Intramolecular ring closure on substituted pyrimidines 
 
A synthetic procedure for the preparation of tetraazaacenaphthylene195 was described in 
Scheme 5.6 The functionalized pyrimidine YD-5-1 was readily obtained by condensation 
of acetamidine hydrochloride with 2-ethoxycarbonyl–succinic acid diethyl ester. 196 
Allylation followed by reduction of the ethyl ester yielded an alcohol, which was 
protected by a tert-butyldiphenylsilyl group to give YD-5-2. Nucleophilic aromatic 
substitution with dichloroaniline followed by protection of the amino group by a Boc 
group gave intermediate YD-5-3. Ozonolysis followed by reductive workup gave the 
intermediate alcohol, which reacted with methanesulfonyl chloride in the presence of 
TEA to give YD-5-4. This mesylate then underwent cleavage of the Boc group, followed 
by treatment with TEA to give the desired substituted piperidinopyrimidines YD-5-5.  
 
Scheme 5.6 Synthesis of substituted piperidinopyrimidines YD-5-5 
 
 
 
                                                 
195
 St-Denis, Y.; Di Fabio, R.; Bernasconi, G.; Castiglioni, E.; Contini, S.; Donati, D.; Fazzolari, E.; Gentile, 
G.; Ghirlanda, D.; Marchionni, C.; Messina, F.; Micheli, F.; Pavone, F.; Pasquarello, A.; Sabbatini, F. M.; 
Zampori, M. G.; Arban, R.; Vitulli, G. Bioorg. Med. Chem. Lett. 2005, 15, 3713-3716. 
196
 Chen, Y.L. WO 95/33750 A1, 1995.; Chen, Y.L. US 5962479 A, 1999. 
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c. Inverse electron demand Diels-Alder reaction of heterocyclic azadienes 
 
This strategy employs the inverse electron demand Diels-Alder reaction of electron-
deficient heteroaromatic azadienes (1,3,5-triazine) with amidines. 197  The general 
transformation in this reaction is shown below (Scheme 5.7). 
 
 
 
Scheme 5.7 Formation of pyrimidines via an inverse electron demand Diels-Alder reaction 
 
The mechanism of this reaction is outlined below (Scheme 5.8). It starts from in situ 
tautomerization of an amidine into its corresponding 1,1-diaminoethene. Subseq.uently, it 
is trapped by the symmetrical 1,3,5-triazine through a [4+2] cycloaddition and loses 
ammonia from the initial intermediate DB-5-1 to give the corresponding imine DB-5-2. 
An imine to enamine DB-5-3 tautomerization followed by a retro Diels-Alder with 
elimination of ethyl cyanoformate finally gives the desired 4-aminopyrimidine. 
 
 
 
Scheme 5.8 Details of the route using the inverse electron demand Diels-Alder reaction 
                                                 
197
 (a) Boger, D. L.; Panek, J. S. J. Am. Chem. Soc. 1985, 107, 5745-5754.; (b) Boger, D. L.; Kochanny, M. 
J. J. Org. Chem. 1994, 59, 4950-4955. 
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Generally, the reaction proceeds smoothly in polar aprotic solvents including DMF under 
modest thermal reaction conditions (80-120°C). Heating (>80°C) is req.uired to promote 
the amidine tautomerization and accelerate the loss of ethyl cyanoformate leading to the 
aromatic pyrimidine ring. Both acyclic and cyclic amidines are capable of undergoing 
this cycloaddition, although slightly lower yields were observed with cyclic amidines. 
The reaction is completely regioselective. Furthermore, the amidine hydrochloride salts 
proved to be more efficient for this conversion than the corresponding free bases. 
 
With this strategy, highly substituted and functionalized pyrimidine derivatives can be 
obtained, such as (+)-P-3A, bleomycin A2, as well as bicyclic compounds related to our 
subject (Scheme 5.9). 
 
 
Scheme 5.9 Formation of DB-5-4 via a Diels-Alder reaction 
 
 
d. Reduction of pyrido[2,3-d]pyrimidines 
 
Piperido[2,3-d]pyrimidines may be seen as 5,6,7,8-tetrahydro-pyrido[2,3-d]pyrimidines, 
the hydrogenated derivatives of the corresponding pyrido[2,3-d]pyrimidines. An early 
catalytic reduction of 2-amino-4-hydroxypyrido[2,3-d]pyrimidine JD-5-3 was 
investigated in order to confirm the structure of JD-5-2 produced in condensation 
mentioned above. When an aqueous suspension of JD-5-3 was treated with hydrogen at 
atmospheric pressure over platinum oxide, approximately 2 moles of hydrogen were 
absorbed and the corresponding piperido[2,3-d]pyrimidine JD-5-2 was smoothly 
generated. 
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Scheme 5.10 Piperido[2,3-d]pyrimidine formed by reduction 
 
This method appears to be more convenient and is widely used in generating 
piperido[2,3-d]pyrimidines. For example, in the course of synthesizing a series of 2,4-
diaminopyrido[2,3-d]pyrimidine based antifolates, useful as antineoplastic and 
antiarthritic agents,198 piperido[2,3-d]pyrimidine LG-5-2 was obtained by hydrogenation 
of precursor LG-5-1. 
 
 
Scheme 5.11 Piperido[2,3-d]pyrimidine LG-5-2 generated by hydrogenation 
 
Synthesis of aromatic derivatives of pyrido[2,3-d]pyrimidines has been better 
investigated due to their biological significance. Generally, these structures could be 
elaborated by two methods, either from derivatives of 2,3-disubstituted pyridines199 or 
from 4-aminopyrimidines. 200  For example, the well known nonclassical antifolate 
Piritrexim (PTX) was synthesized by Grivsky as a lipophilic analog of the anticancer 
                                                 
198
 Gossett, L. S.; Habeck, L. L.; Shackelford, K. A.; Mendelsohn, L. G.; Gates, S. B.; Worzalla, J. F.; Self, 
T. D.; Theobald, K. S.; Andis, S. L.; Schultz, R. M.; Shih, C. Bioorg. Med. Chem. Lett. 1999, 9, 75-78. 
199
 (a) Degraw, J. I.; Christie, P. H.; Kisliuk, R. L.; Gaumont, Y.; Sirotnak, F. M. J. Med. Chem.  1990, 33, 
673-677. (b) Vercek, B.; Leban, I.; Stanovnik, B.; Tisler, M. J. Org. Chem. 1979, 44, 1695-1699. (c) 
Kuyper, L. F.; Garvey, J. M.; Baccanari, D. P.; Champness, J. N.; Stammers, D. K.; Beddell, C. R. Bioorg. 
Med. Chem.  1996, 4, 593-602. 
200
 (a) Gangjee, A.; Devraj, R.; Queener, S. F. J. Med. Chem.  1997, 40, 470-478.; (b) Rosowsky, A.; Chen, 
H.; Fu, H. M.; Queener, S. F. Bioorg. Med. Chem.  2003, 11, 59-67. 
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drug MTX.201 In this synthesis, ethyl 2-(2,5-dimethoxybenzyl)-3-oxobutanoate GM-5-1 
is condensed with 2,4,6-triaminopyrimidine to afford the bicyclic lactam GM-5-2, 
whereupon dehydrative chlorination followed by catalytic dechlorination yields PTX.202 
Three other synthetic routes to PTX have also been reported in the literature,203 all of 
which use the same strategy for constructing the diaminopyridopyrimidine by 
condensation of the substituted pyridine and guanidine. 
 
 
Scheme 5.12 Synthesis of Piritrexim 
 
Further syntheses of pyrido[2,3-d]pyrimidines are not included in this section because of 
limited space. 
 
 
3. Seven-membered ring fused bicyclic aza-pyrimidines (6,7,8,9-tetrahydro-5H-
pyrimido[4,5-b]azepanes) 
 
Scheme 5.13 Pyrimido[4,5-b]azepine 
 
Pyrimido[4,5-b]azepine as pictured in Scheme 5.13 has a bicyclic structure based on a 
seven-membered ring fused to a pyrimidine nucleus. Such compounds have potential 
                                                 
201
 Methotrexate (MTX) is an antimetabolite and antifolate drug. It is used in treatment of cancer, 
autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions. 
202
 Grivsky, E. M.; Lee, S.; Sigel, C. W.; Duch, D. S.; Nichol, C. A. J. Med. Chem.  1980, 23, 327-329. 
203
 (a) Hill, J. A.; Wisowaty, J. C.; Darnofall, M. E. J. Labelled Compd. Radiopharm. 1993, 33, 1119-1130. 
(b) Troschutz, R.; Zink, M.; Gnibl, R. J. Heterocycl. Chem. 1999, 36, 703-706.; (c) Chan, D. C. M.; 
Rosowsky, A. J. Org. Chem. 2005, 70, 1364-1368. 
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applications in medicinal chemistry but, although some derivatives are commercially 
available, the strategies for their synthesis are very limited. Generally, these compounds 
can be constructed by three pathways: pyrimidine formation on a functionalized azepane; 
intramolecular ring closure of a functionalized side chain on a pyrimidine; and multi-
component reactions.  
 
 
a. Pyrimidine formation on a functionalized azepane 
 
In 1970, Morita and co-workers described a one-pot method to synthesize 
pyrimidoazepine KM-5-1 by heating azepan-2-one and 2 eq.alents of formamide in the 
presence of phosphorus oxychloride. They successfully formed the desired product but in 
a very low yield. 
 
 
Scheme 5.14 One-pot synthesis of pyrimidoazepine KM-5-1 
 
In 1973, Kobayashi improved this one-step strategy by introducing an aromatic ring on 
the azepan-2-one.204 The reactivity was dramatically affected by the substituents on the 
supplementary aromatic ring. The highest yield turned out to be 42%, which is still 
relatively low. 
 
 
Scheme 5.15 One-pot method to synthesize pyrimidoazepine KS-5-1 
                                                 
204
 Kobayash.S Bull. Chem. Soc. Jpn. 1973, 46, 2835-2839. 
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Since amidines are convenient for obtaining pyrimidine structures, another approach to 
synthesize the bicyclic pyrimidoazepine is based on these starting materials which are 
shown below.205 Heating N-cyanoamidine with 1,1-diethoxy-N,N-dimethylmethanamine 
in dry xylene leads to formation of 3-dimethylaminomethylene-2-N-cyanoimino-
hexahydroazepine ED-5-2. The N-cyano group and the enamino double bond of this 
intermediate enaminoamidine favor closure to the pyrimidine ring. Therefore, 
condensation by heating ED-5-2 with NH3 produces the desired 2-amino-6,7,8,9-
tetrahydropyrimido[4,5-b]-5H-azepine ED-5-3. This method could also be applied to the 
synthesis of 2-amino-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine and other related 
compounds. 
 
Scheme 5.16 Synthesis of pyrimidoazepine ED-5-3 
 
 
b. Intramolecular closure of a side chain on a pyrimidine ring 
 
In the searching for potential new drugs for COPD206 treatment, 6,7,8,9-tetrahydro-5H-
pyrimido[4,5-b]azepine derivative was synthesized via the intermediacy of a side chain 
substituted 4,6-dihydroxypyrimidine LP-5-1, acquired by condensation of 2-substituted 
dialkylmalonate with amidine mediated by sodium ethoxide. Reaction with phosphorus 
oxychloride in the presence of N,N-diethylaniline afforded the deprotected 4,6-
dihydroxypyrimidine, which was then heated at high temperature to give the desired 
cyclized compound LP-5-2.207 
                                                 
205
 Dozorova, E. N.; Grizik, S. I.; Persianova, I. V.; Syubaev, R. D.; Shvarts, G. Y.; Granik, V. G. Khimiko-
Farmatsevticheskii Zhurnal 1985, 19, 154-158. 
206
 Chronic obstructive pulmonary disease (COPD) is a pair of commonly co-existing diseases of the lungs 
in which the airways become narrowed. 
207
 Provins, L.; Christophe, B.; Danhaive, P.; Dulieu, J.; Durieu, W.; Gillard, M.; Lebon, F.; Lengele, S.; 
Quere, L.; van Keulen, B. Bioorg. Med. Chem. Lett. 2006, 16, 1834-1839. 
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Scheme 5.17 Synthesis of pyrimidoazepines LP-5-2 by intramolecular cyclization 
 
c. Multi-component reaction 
 
More recently, El Kaim and co-workers208  reported an ugi-smiles-metathesis strategy 
toward the synthesis of pyrimidoazepines. This method involved Ugi-Smiles coupling 
followed by ring-closure metathesis which was catalyzed by the Hoveyda-Grubbs second 
generation catalyst. They successfully obtained the desired pyrimidoazepines in a 
synthetically useful yield. 
 
 
Scheme 5.18 Synthesis of pyrimidoazepine via an Ugi-Smiles/RCM combination 
 
                                                 
208
 El Kaim, L.; Grimaud, L.; Oble, J. J. Org. Chem. 2007, 72, 5835-5838. 
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Ċ. Synthesis of bicyclic aza-pyrimidines using xanthates 
 
1. Investigation of the “carbamate puzzle”209 
 
a. An unusual radical addition to the heteroaromatic nitrogen 
 
In 2005, our colleagues made a remarkable and very surprising observation while 
studying a new approach to azaindolines and related substances.152 As shown in Scheme 
5.19, when an acetyl group was present in the precursor xanthate EQ.-5-1, the radical 
cyclization proceeded as expected on C-3 to give the 7-azaindoline EQ.-5-2. However, 
when the side chain nitrogen was protected by a carbamyl group, the radical cyclization 
mainly take place on the ring nitrogen to give the corresponding pyridinone EQ.-5-3 as 
the major product, although a very small amount of the analogous azaindoline was 
observed. It was established that the presence of a halogen such as chlorine or fluorine on 
C-6 was necessary for this process. The cyclization onto nitrogen worked slightly better 
with a chlorine substituent. 
 
 
Scheme 5.19 Dramatic effect of the protecting group on the regioselectivity  
 
A theoretical analysis was carried out in order to have a better understanding of this 
selectivity,210 but no completely satisfactory explanation has yet emerged.  
                                                 
209
 Zard, S. Z. J. Phys. Org. Chem. 2012, 25, 953-964. 
210
 We wish to acknowledge in this respect our collaboration on the theoretical aspects with Dr. Michelle 
Coote at Australian National University. 
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As illustrated in Scheme 5.20, the formation of pyridinone and azaindoline can arise 
through ring closure of radicals a and b, where a stands for PG = Ac (Acetyl) and b for 
PG = Boc (t-butoxycarbonyl) group. Each of radicals of a and b can proceed to 1a or 2a 
and 1b or 2b by reactions 1 and 2 respectively. Reaction 1 is the attack to C atom of 
pyridine ring while reaction 2 is the attack to N atom of the ring. 
 
Scheme 5.20 Theoretical analysis 
 
Table 5.1 showed a summary of thermodynamic and kinetic study211 of reactions 1 and 2. 
The barrier energies for conversion of a to 2a and b to 2b (attack to N atom) are less than 
those for conversion of a to 1a and b to 1b (attack to C atom). However the difference 
between barrier energies for the case of PG = Boc is more than that of PG = Ac 
(approximately 10 kJ.mol-1).  
 
Table 5.1 Thermodynamic and kinetic analyses 
                                                 
211
 Computational details: careful conformational search have been performed for both radicals of a and b 
using B3LYP/6-31G(d) level of theory. 160 different conformers for b and 45 conformers for a have been 
fully optimised. The most stable conformer has been selected for further calculations. Figure 1 shows the 
optimised structures of radicals a and b. Transition structures for reactions 1 and 2 for four cases (a  1a , 
a  2a , b  1b and b  2b) have been carefully trapped using freq.uency calculations. Large imaginary 
freq.uencies of -496.5, -502.0, -499.6, -494.4 cm-1 have been found for studied transition states, respectively. 
The B3-LYP/6-31G(d) thermodynamic corrections were then used in conjunction with the ROMP2/6-
311+G(3df,2p) energy to calculate a Gibbs free energy G and the barriers. Harmonic oscillator 
approximation has been used for freq.uency calculations. 
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From a kinetic point of view, reaction 2, which is the attack on the N atom, is faster in 
both cases. However from thermodynamic point of view, reaction 1 is more favourable 
than reaction 2 for a (PG = Ac) while reaction 2 is more favourable than reaction 1 for 
the case of b (PG = Boc). This means that although the barrier for conversion of a  2a 
is less than the barrier for conversion a  1a, the conversion of a  1a is 
thermodynamically more favourable. This implies that the radical attack in both cases is 
reversible. The conversion of b  2b is favored by both kinetic and thermodynamic 
effects, i.e. a smaller energetic barrier and a greater stability for 2b.  
 
However, results from our later study were not completely in harmony with the 
theoretical analysis above, and other factors need perhaps to be be included in explaining 
this unexpected phenomenon. 
 
The same tendency was also found later in the pyrimidine series. 212  The normal 
cyclization product diazaindoline LP-5-2 was obtained when an acetyl group was used. 
However, when it was changed to a Boc group, the generated carbon radical in the 
intermediate preferred to attack the adjacent heteroaromatic nitrogen rather than the 
carbon.  
 
Scheme 5.21 Unusual regioselectivity in the pyrimidine series 
 
A preliminary experiment indicated that a mixture of C-cyclised product LP-5-2’213 (14%) 
and two regioisomeric N-cyclised products (LP-5-3 43% and LP-5-3’ 9%) were obtained. 
It mentioned briefly that the last two regioisomeric products were difficult to separate and 
                                                 
212
 Laot, Y.; Petit, L.; Zard, S. Z. Chem. Commun. 2010, 46, 5784-5786. 
213
 Similar structure to LP-5-2 but with Boc protection instead of Ac, which is not shown in Scheme 5.21 
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only the major one LP-5-3 was obtained in sufficiently pure form for complete 
characterisation. In principle, the two N-cyclized products were supposed to be derived 
from the attack of the laurate anion to either of the allylic cation formed in position C-2 
or C-6. And since the C-6 was less hindered than C-2, the former was the major product.  
 
b. Identification of the minor N-cyclized product 
 
Before further investigating the underlying reasons for this uncommon regioselectivity, 
we corrected the structure of the unidentified product LP-5-3’. 
 
When we repeated this reaction, the C-cyclised product and the two N-cyclised products 
were isolated in very different yields, 9%(LP-5-2’), 33%(LP-5-3), and 18%(LP-5-3’). In 
particular, the ratio of the two regioisomeric pyrimidinones changed from 4.8 to 1.8. It is 
very strange to have such different ratios for the same reaction under identical conditions. 
 
 
Scheme 5.22 Radical cyclization with unusual regioselectivity 
 
We next examined the same cyclization but changing the size of the terminal group (2-
oxooxazolidine-3-carbonyl). Surprisingly, no second regioisomeric N-cyclized product 
was observed, but only the normal diazaindoline 5-2 and pyrimidinone 5-3 were isolated 
in yields of 10% and 51%, respectively (Scheme 5.22).  
 
Two points should be emphasized here. First, a strong dependence on the size of the side 
chain was observed, which was not found in the previous pyridine ring cyclization. 
Second, the N-cyclized products (LP-5-3 and LP-5-3’) in the original and repeated 
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reactions had a similar combined yield (published result 52%, and repeated result 51%). 
If the unidentified compound LP-5-3’ was derived from the pyrimidinone LP-5-3 during 
purification (acidic medium) or storage (exposure to air), both of the above observations 
would seem to be reasonable. 
 
Therefore, we designed another reaction (Scheme 5.23) in order to evaluate the influence 
of an acidic medium.214 A methoxycarbonyl protecting group was selected to replace the 
acid sensitive Boc group. Dichloroethane was used here to overcome a possible problem 
of solubility caused by salt formation. 
 
 
Scheme 5.23 Regioselective radical cyclization in the presence of camphorsulfonic acid 
 
 
Surprisingly, instead of two spread spots at the bottom of the monitoring TLC, one 
concentrated spot was observed with a similar Rf to the unidentified compound. This 
compound was ultimately isolated and found to possess structure of 5-9’, and its 1H NMR 
spectrum was coinsident with the previous unidentified compound, which was obtained 
from the purification on silica gel after radical cyclization under normal conditions 
(Scheme 5.24). 
                                                 
214
 Camphorsulfonic acid was added to protonate the pyrimidine ring. 
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Scheme 5.24 1H NMR comparison of 5-9’ prepared from different conditions 
 
This result confirmed the previous hypothesis that a further modification happened to 
pyrimidinone 5-8. In the presence of acid, a cationic species is readily formed by 
protonation and is then attacked by moisture to give the corresponding 2,3-dihydro-
imidazo[1,2-c]pyrimidine-5,7(1H, 6H)-dione 5-9’ after elimination of a chlorine atom 
(Scheme 5.23).  
 
This proposed mechanism was confirmed by the simple test of treating the pyrimidinone 
5-3 with trifluoroacetic acid in an NMR tube (Scheme 5.25).  
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Scheme 5.25 Qualitative NMR analysis of 5-3 with TFA 
 
Based on the analysis above, we can now modify the previous picture as outlined in 
Scheme 5.26, where the second N-cyclized product LP-5-3’ is in fact derived from the 
hydrolysis of LP-5-3. Therefore, a selective synthesis of bicyclic imidazo[1,2-
c]pyrimidine-dione derivatives could be achieved in principle by hydrolysis with acid 
following the radical cyclization. 
 
 
Scheme 5.26 Modified radical cyclization of LP-5-1 (C-cyclized product not shown) 
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c. Further investigations of the regioselectivity with various protecting groups 
 
As we know, both amides and carbamates exhibit the approximately planar N-C=O 
framework, which is responsible for their rotation barriers.215 However, the additional 
oxygen of the carbamate functional group exerts unique steric and electronic 
perturbation.216 Conseq.uently, the regioselectivity in the previous pyridine series could 
be explained by the dipole-dipole interaction217 between the additional oxygen of the 
carbamate and the pyridine nitrogen. This interaction might force the alkoxy portion of 
the carbamate group to rotate to the opposite side, as shown in Scheme 5.27. The radical 
generated on the side chain thus has a better chance to approach the adjacent nitrogen and 
to form the C-N bond. 
 
 
Scheme 5.27 Dipole-dipole interaction between carbamate and pyridine nitrogen 
 
However, since later we observed the same but lower regioselectivity in the pyrimidine 
series (Scheme 5.28), this explanation started to become less persuasive. Since the two 
nitrogen and chlorine atoms render the dichloropyrimidine ring more electron-deficient 
than the chloropyridine ring, the C(Ar)-N bond in 5-1 must be slightly shorter than that of 
EQ.-5-1. The conseq.uence of this difference should result in a better regioselectivity in 
the pyrimidine series, which is clearly not the case. Although both the reactant and the 
products could be deprotected due to the somewhat fragile Boc group,218 and this might 
                                                 
215
 The barrier for rotation in carbamates is around 16kcal/mol, which is usually 3-4 kcal/mol (about 15-
20%) lower than that for the corresponding amide. For more information, see: (a) Kost, D.; Kornberg, N. 
Tetrahedron Lett. 1978, 3275-3276. (b) Cox, C.; Lectka, T. J. Org. Chem. 1998, 63, 2426-2427. (c) Rablen, 
P. R. J. Org. Chem. 2000, 65, 7930-7937. 
216
 Cox, C.; Lectka, T. J. Org. Chem. 1998, 63, 2426-2427. 
217
 Deetz, M. J.; Forbes, C. C.; Jonas, M.; Malerich, J. P.; Smith, B. D.; Wiest, O. J. Org. Chem. 2002, 67, 
3949-3952. 
218
 Thermal decomposition of Boc group was observed under similar conditions. 
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alter the selectivity, other factors besides electrostatic repulsion should still be explored. 
At the same time, since the dipole-dipole interactions between the amide oxygen and the 
pyridine or pyrimidine nitrogen could not be completely neglected, the lack of nitrogen 
cyclized products from the acetyl protected xanthates EQ.-5-1 and LP-5-1 was hard to 
understand on the basis of dipole-dipole repulsion.  
 
 
Scheme 5.28 Regioselectivity comparison with different ring systems  
 
Furthermore, according to the theoretical analysis which was presented above,219 this 
regioselectivity could be rationalized in the case of Boc group, while the results were not 
solid enough for the acetyl protecting group.  
 
Since the reason for this unexpected effect of the nitrogen protecting group was still 
unclear, we carried out additional experiments in order to understand better this 
phenomenon. Some preliminary conclusions might be drawn from these studies, and 
more detailed investigations are still ongoing. 
 
In order to confirm the unique role of the carbamate group, we undertook additional 
experiments to compare with other protecting groups. In some cases, the compounds 
were difficult to separate and only the major product could be completely characterized. 
The general tendency is summarized in Table 5.2. The pyrimidones were the only major 
products isolated when carbamyl groups were used for protecting the extranulear nitrogen. 
A similar proportion of each kind of cyclization was found in both cases, which excludes 
a steric influence of the bulky tert-butyl group. Various functional groups introduced by 
the xanthate partner also proved to be unrelated to this effect.  
                                                 
219
 See pages 161 to 162 
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Table 5.2 Regioselective cyclization with different protecting groups 
 
Groups with very different electronic properties such as acetyl and methyl on precursors 
LP-5-4 and 5-15 were examined. However, both of these substrates gave the 
corresponding diazaindolines LP-5-5 and 5-22 in similar yields. The electronic property 
of the protecting groups is apparently not responsible for the regioselectivity. The mesyl 
group was also tried but its cyclization led to complex mixtures which were difficult to 
analyze. Only the major product 5-21 could be obtained in enough purity for complete 
characterization. Nevertheless, no evidence pointed to the formation of the corresponding 
pyrimidone.  
 
 
Scheme 5.29 Radical cyclization of trifluoromethylcarbonyl protected xanthate 5-11 
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Moreover, we also tested the more electron-withdrawing trifluoromethylcarbonyl 
protected xanthate 5-11 in a one-pot addition-cyclization seq.uence under standard 
conditions (Scheme 5.29). The C-cyclized compound was obtained in an overall yield of 
30%, with no evidence supporting the existence of N-cyclized products.  
 
Based on all the observation above, the carbamyl protecting groups clearly plays a special 
role in this regioselectivity, and a more detailed study will concentrate on this moiety. 
 
 
d. Preliminary evidence for an enhanced intramolecular hydrogen bond 
 
Occasionally, we found a strange tendency in the 1H NMR chemical shift of the aromatic 
hydrogens in the xanthate precursors. As depicted in Table 5.3, the general trend was that 
when an EDG (such as methyl) was substituted at the extranuclear nitrogen, the 
corresponding 1H NMR signal of the C-5 hydrogen appeared at relatively high field; 
while if an EWG (such as acetyl) was attached to the nitrogen, downfield shifts were well 
recognized. This observation coincided with our knowledge that an electron-donating 
alkyl group leads to increased shielding of the hydrogen while electron-withdrawing 
substituents lead to deshielding. 
 
 
Table 5.3 Dramatic effect of the protecting group for regioselectivity  
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However, we noticed that the chemical shifts of the aromatic hydrogens in carbamyl 
protected xanthates (5-10 and 5-6) showed unexpected downfield shifts with respect to 
the other analogs.220 Since the N-cyclized product was only observed with a carbamyl 
protecting group, we wondered if these two phenomena could be related. 
 
Similar observations were also acquired when we examined other precursor xanthates 
which belonged to the same family (with different chain lengths and different position of 
the extranuclear nitrogen). We focused only on acetyl and Boc groups. As shown in 
Table 5.4, a similar tendency was found when the extranuclear nitrogen is positioned at 
C-4 of the pyrimidine, regardless of the chain length. But when it was installed at C-2, a 
similar chemical shifts were found for both protecting groups. Therefore, a regiochemical 
influence obviously arises from the substituent of the extranulear nitrogen. 
 
 
Table 5.4 Chemical shifts of the relevant xanthates with pyrimidine rings 
 
It is worth mentioning that since the acetyl group is more electron-withdrawing, its 
deshielding effect should normally cause a more downfield shift for the signals. This 
theoretical prediction is generally correct for the C-5 position, as shown in Table 5.3 and 
5.4. However, in the case of aromatic hydrogens, it is correct only when the protecting 
groups were away from the C-5 position (5-103 and 5-104).  
 
                                                 
220
 Theoretically, since acetyl group is more electron-withdrawing, more downfield shift should be found 
when an acetyl group is used. Therefore, such contrary shifts to low field with carbamyl groups cannot be 
ascribed only to its moderately electron-withdrawing character. 
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We further examined the related precursor xanthates with pyridine ring, since a 
regiochemical issue also existed in this series. As shown in Table 5.5, the unusual 
downfield shifts of the aromatic hydrogens were observed only when the carbamyl 
protecting groups were used, without regard to the chain functionalities or the halogen 
substitutions.  
 
Table 5.5 Chemical shifts of the relevant xanthates in the pyridine series 
 
Based on the comparison, the electronic property of the adjacent substituent seemed not 
to be the only reason to cause this strange trend in hydrogen chemical shifts. This may be 
an indication that the rotamer with the carbonyl oxygen near the C-5 hydrogen is greatly 
dominant causing a downfield shift in the signal. A weak hydrogen bonding could even 
be present. 
 
In fact, intramolecular hydrogen bonding in related structures was observed by Zanda’s 
group in the X-ray diffraction study of the single crystals of 3-(2,6-dichloro-pyrimidin-4-
yl)oxazolidin-2-one.221 Since C–H groups can act as weak hydrogen bond donors,222 one 
important structural feature of this molecule in the solid-phase is the presence of an 
intramolecular  hydrogen bond, involving the pyrimidine C-5 hydrogen and the 
                                                 
221
 Montebugnoli, D.; Bravo, P.; Corradi, E.; Dettori, G.; Mioskowski, C.; Volonterio, A.; Wagner, A.; 
Zanda, M. Tetrahedron 2002, 58, 2147-2153. 
222
  Desiraju, G. R. Acc. Chem. Res. 1996, 29, 441-449. 
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carbonyl oxygen.223 Furthermore, the predominance of the s-trans arrangement between 
the oxazolidone C=O and the pyrimidine C=N in CDCl3 solution was also observed, 
which is in accordance with the previous hypothesis of the unfavorable dipole-dipole 
interactions between C=O and C=N in the s-cis conformation.  
 
 
Scheme 5.30 H-bond in 4-N-alkoxycarbonyl-amino 2,6-dichloropyrimidine 
 
Although theoretical studies suggest that the carbonyl oxygen of carbamates is a 
relatively weaker hydrogen bond acceptor than the amide carbonyl, 224  an enhanced 
intramolecular hydrogen bond could still be formed between the carbamate group and the 
pyrimidine-ring hydrogen. 
 
 
Scheme 5.31 Possible intramolecular H-bonding directing the regiochemistry 
 
As shown in Scheme 5.30 and 5.31, the intramolecular hydrogen bond in DM-5-1 was 
observed and estimated to be 2.257~2.278Å.221 If the oxazolidone ring is disconnected, 
                                                 
223
 (a) Steiner, T. Chem. Commun. 1997, 727-734.; (b) Steiner, T.; Desiraju, G. R. Chem. Commun. 1998, 
891-892. (c) Mazik, M.; Blaser, D.; Boese, R. Tetrahedron Lett. 2000, 41, 5827. 
224
 Bandekar, J.; Okuzumi, Y. THEOCHEM. 1993, 100, 113-122. 
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the intramolecular hydrogen bond would be enhanced by the closer carbonyl oxygen (A) 
as well as the liberated ether-like oxygen (B).  
 
Furthermore, the strong electron-withdrawing feature of the dichloropyrimidine ring also 
dramatically lowers the rotation barrier of the carbamate, which should facilitate the 
formation of the hydrogen bond. This enhanced intramolecular hydrogen bond could in 
part explain the previous regioselectivity. 
 
According to the above observation, we propose a possible explanation for the 
regiochemistry. The xanthate precursor possesses a predominant conformation to cyclize 
on the heteroaromatic nitrogen as shown in Scheme 5.31 (A and B). The general electron 
deficiency of the pyrimidine ring, increased by the presence of the two chlorine 
substituents, also shortens the C(4)-N bond and extends the C(carbonyl)-N bond, which 
leads to an overall lower rotation barrier of the carbamate moiety. Therefore, rapid 
rotation allows the two oxygens of the carbamate group to form alternating hydrogen 
bonds and thus enhance the bond strength in the neutral reaction medium. In the case of 
an amide, the hydrogen bond is not strong enough since only one oxygen can interact 
with the aromatic hydrogen. Furthermore, the dipole-dipole repulsion between the 
heteroaromatic nitrogen and the carbonyl oxygen must not be neglected. 
 
 
e. Preliminary study in evaluating the mechanistic hypothesis 
 
Evidence for this hypothesis was partly adduced by performing the reaction in solvents 
which can disturb the hydrogen bonding by interacting with the carbamate oxygens. 
Therefore, tert-butanol (pKa~17.0) and trifluoroethanol (pKa~12.5) were chosen for this 
study. An attempt at testing the cyclization with a Boc protected extranuclear nitrogen 
was unsuccessful, since the acid sensitive Boc group was lost in refluxing 
trifluoroethanol before the desired cyclization225 took place (Scheme 5.32). 
                                                 
225
 The yields of prematurely reduced material and the C-cyclized product are similar to those of the 
cyclization with unprotected xanthate precursor, see page 179. 
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Scheme 5.32 Unsuccessful test with Boc protected substrate 
 
Conseq.uently, a methoxycarbonyl was employed as the protecting group. As shown in 
Table 5.6, with increasing acidity of solvents, the proportion of the “normal” C-cyclized 
product increased significantly. 
 
 
Table 5.6 Radical cyclization of xanthate 5-5 in different solvents 
 
Since the acidic proton of the solvent is supposed to interact with the carbamate oxygens 
and thus weaken the intramolecular hydrogen bond and formation of the N-cyclized 
product should therefore be disturbed to different extents according to the acidity. This 
prediction is in agreement with the results listed in Table 5.6 
 
Up to now, we have proposed a hypothesis to explain the “carbamate puzzle”, and all 
related indirect evidence seems to point in the right direction. Some studies still need to 
be done. For example, according to the hypothesis, the sulfonamide which has two 
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oxygens should also have an enhanced intramolecular hydrogen bonding. But a complex 
mixture was obtained and only the C-cyclized product was observed in a moderate yield. 
Thus, it might be necessary to further examine this reaction by collecting and analyzing 
each product in the reaction medium. More information might be gained with the similar 
but more electronegative trifluorosulfonamide substituted xanthate precursor. Another 
possibility is to use a base to disturb the hydrogen bonding by interacting with the 
polarized hydrogen.226  
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2. Synthesis of bicyclic aza-pyrimidines and related derivatives 
 
The above studies have underscored the important role played by protecting groups on 
the extranuclear nitrogen in the outcome of the radical cyclization process. However, we 
had never tried the cyclization without protecting the extranuclear nitrogen. We therefore 
embarked on an investigation of the radical cyclization without protecting group, and this 
resulted in an interesting approach to a wide range of bicyclic and tricyclic structures 
(Scheme 5.33). 
 
Scheme 5.33 Bicyclic pyrimidine and pyridine fused saturated N-containing rings 
 
 
a. Synthesis of 5,7-diazaindolines without protecting groups 
 
As shown above in Table 5.2, C-cyclized products could be obtained in modest to good 
yields according to the different extranulear nitrogen protecting groups. Thus N-
acetylated 5,7-diazaindoline derivatives with various pendant functional groups had 
already been obtained in good yield by our colleagues.216 N-Cyclized products could also 
be prepared in synthetically useful yields (>50%) starting with Boc protected xanthate 
precursors, followed by hydrolysis to the pyrimidone. 
 
However, we had not attempted these cyclizations without protecting the extranuclear 
nitrogen. In fact, the original reason for installing a protecting group was to avoid any 
possible nucleophilic attack on the xanthate moiety. For instance, if an intramolecular 
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attack occurs to the alkoxythiocarbonyl group of 5-I, the resulting thiol 5-II would react as 
a serious inhibitor for the following radical process.227 
 
 
Scheme 5.34 Undesired intramolecular ionic attack on the alkoxythiocarbonyl group 
 
However, curiosity drove us to think about the outcome in the absence of the protection. 
Therefore we decided to test the cyclization on the unprotected substrate 5-III using the 
usual experimental conditions. Two precursors (5-24228 and 5-25) were indeed readily 
obtained in good yield by DLP initiated radical addition of S-phthalimidomethyl and 
cyanomethyl xanthates on the unprotected N-allylamino-dichloropyrimidine LP-5-6 
(Scheme 5.35). 
 
 
Scheme 5.35 Preparation of the cyclization precursors 
 
Unfortunately, the subseq.uent radical cyclizations into diazaindolines 5-26 and 5-27 
proceeded unexpectedly in low yields. Most of the xanthate precursors were prematurely 
reduced by hydrogen abstraction from the solvent and thus formed the undesired 
compounds 5-26’ and 5-27’ (Scheme 5.36). 
                                                 
227
 Bacqué, E.; El Qacemi, M.; Zard, S. Z. Org. Lett.  2004, 6, 3671-3674. 
228
 Secondary products were found while preparing 5-24, which opened another door for intramolecular 
radical additions to heteroaromatic rings. The details of this side reaction will be discussed in page 189. 
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Scheme 5.36 Formation of five-membered ring fused pyrimidines without protection 
 
The formation of five-membered rings by radical cyclization is usually the most efficient 
process. The reasons for the inefficient formation of diazaindoline 5-3 and 5-4 are not 
clear but may be related to an increased C-N-C(Ar) bond angles compared with the 
protected analogs. Since no values are available for the compounds in hand, the C-N-
C(Ar) bond angle of the closely related 4-methylaminopyridine is used to illustrate this 
tendency. 
 
 
Scheme 5.37 Related bond angles of 4-methylaminopyridine 
 
As shown in Scheme 5.37, the calculated bond angle for 4-methylaminopyridine is 
124.2° which is larger than the 120° of a theoretical pure sp2-hybridized extranuclear 
nitrogen.229 The substituted side chain of 5-III is more bulky than a small methyl group, 
thus this bond angle is expected to be even bigger in our case. The large opening of the 
C-N-C(Ar) angle places the carbon centered radical further away from the pyrimidine 
nucleus and the strain in the transition state leading to a fused five-membered ring would 
be significantly increased.  
 
Although no efficient five-membered ring cyclization was achieved, one positive aspect 
of these preliminary experiments was that the feared thiol was in fact not observed. That 
meant that the problematic S- to N-migration of the alkoxythiocarbonyl group did not 
                                                 
229
 Akai, N.; Ohno, K.; Aida, M. J. Photochem. Photobiol. A 2007, 187, 113. 
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occur to any deleterious level during both the intermolecular and the intramolecular 
radical steps. It appears therefore that the electron-withdrawing effect of the 
dichloropyrimidine ring decreases sufficiently the nucleophilicity of the extranuclear 
nitrogen and obviates the need for its protection.  
 
Furthermore, the fact that cyclization did proceed in the case of xanthates 5-III, albeit in 
modest yield, encouraged us to examine the behavior of the higher homologues 5-IV. As 
shown in Scheme 5.38, the cyclization in these cases would lead to piperidopyrimidine 
(n=1) and pyrimidoazepine (n=2). 
 
 
Scheme 5.38 Designed cyclization of the higher homologue 5-IV 
 
In contrast to the somewhat unfavorable formation of 5,7-diazaindolines, larger ring 
cyclization might be favored since the generated radical is more flexible in approaching 
the pyrimidine ring (Scheme 5.39). This phenomenon is well documented in radical 
cyclizations.230 Thus, we expected the desired cyclization would take place better in the 
homologous series. 
 
 
Scheme 5.39 Radical cyclizations in the homologous series 
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b. A route to unprotected bicyclic aza-pyrimidine derivatives 
 
Based on the analysis above, the homologous series was explored with cyclizations 
leading to fused six- and seven-membered rings. The starting olefins were obtained by 
reaction of the corresponding primary amines with 2,4,6-trichloropyrimidine. The 
req.uisite but-3-en-1-amine and pent-4-en-1-amine could be obtained through the 
classical Gabriel synthesis of primary amines, 231  which were transformed into the 
corresponding hydrochloride salts for the convenience of storage. The req.uired olefin 
precursors 5-28 and 5-29 were formed by mixing 2,4,6-trichloropyrimidine and the 
corresponding amine hydrochloride salts in ethanol in the presence of TEA. For example, 
substitution of one chlorine with pent-4-en-1-amine furnished an easily separable mixture 
of the desired 2,6-dichloro-N-(pent-4-en-1-yl)pyrimidin-4-amine 5-29 and its regioisomer 
5-29’232 (Scheme 5.40). 
 
 
Scheme 5.40 Synthesis of the olefinic precursors 
 
A similar radical seq.uence with the unprotected N-butenylamino-dichloropyrimidine 
furnished the desired cyclized products in much better yield. As shown in Scheme 5.41, 
addition of various xanthates to 5-28 afforded the corresponding adducts 5-30 to 5-33 in 
good yield. Further treatment with stoichiometric amounts of lauroyl peroxide gave the 
desired 5-substituted-piperido[2,3-d]pyrimidine 5-34 to 5-37 in synthetically useful 
yields. 
                                                 
231
 Crimmin, M. R.; Arrowsmith, M.; Barrett, A. G. M.; Casely, I. J.; Hill, M. S.; Procopiou, P. A. J. Am. 
Chem. Soc. 2009, 131, 9670-9685. 
232
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Scheme 5.41 Radical addition-cyclization seq.uence leading to piperidopyrimidines 
 
Furthermore, bicyclic 5-substituted-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]azepane 5-42 
to 5-45 could also be readily generated by subjecting N-pentenylamino-dichloro-
pyrimidine 5-29 to the same seq.uence (Scheme 5.42).  
 
 
Scheme 5.42 Radical addition-cyclization seq.uence leading to pyrimidoazepines 
 
As shown in Scheme 5.43, cyclization of the analogs with the protecting groups in the 
extranulear nitrogen afforded similar or even lower yields. If the protecting group is 
replaced by Boc, the corresponding yields for the radical cyclization decreased to 33% 
and 18% respectively. Enhanced hydrogen bonding between the aromatic hydrogen and 
the protecting groups could also explain this phenomenon via the disfavored 
conformation. The use of unprotected precursors is not only of importance to the reaction 
mechanism, but also important to the convenience of this methodology. 
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Scheme 5.43 Comparison of the corresponding cyclizations with protection of the nitrogen 
 
Another point to emphasize is that, since the solvent and the initiator are same in both the 
radical addition and the cyclization, we combined these two steps into a one-pot process 
by just changing the reaction concentration: once TLC showed that the intermolecular 
addition of the xanthates to the olefin was almost finished, the reaction mixture was 
diluted and a stoichiometric amount of lauroyl peroxide was added portionwise to 
complete the cyclization. Thus 5-35 and 5-43 can be synthesized using this strategy in 
comparable overall yields for the two steps, 41% and 34% respectively. 
 
 
Scheme 5.44 One-pot synthesis of bicyclic aza-pyrimidines 
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c. Parallel study of the substrates based on pyridine ring 
 
Bicyclic pyridine derivatives are an important class of heterocyclic structures, widely 
used in industry in pharmaceuticals, agrochemicals, vitamins, food flavorings, paints, 
dyes, rubber products, and adhesives, etc. Therefore, their preparation has garnered much 
attention both in academia and in industry.  
 
For example, Merck has developed the processes to produce both six and seven 
membered ring fused pyridines. As shown in Scheme 5.45, compound JH-5-4 was 
identified as a potent αvβ3 antagonist for the prevention and treatment of osteoporosis.233 
The synthesis starts with the glycine derivative JH-5-1, which is obtained from 3-(2-
methyl-1,3-dioxolan-2-yl)propanal via a three step procedure (reductive amination, 
protection, and deketalization). Then Friedlander condensation between the methyl 
ketone moiety of JH-5-1 and 2-amino-3-formylpyridine affords naphthyridine JH-5-2, 
which is then regioselectively hydrogenated in the presence of Pt2O and H2 gas to give 
the key tetrahydronaphthyridine structure JH-5-3. 
 
 
Scheme 5.45 Synthetic route to tetrahydronaphthyridine by Merck 
 
Also selected as a nonpeptidic αvβ3 antagonist, the drug candidate SK-5-3 was prepared 
by Merck in kilogram quantities (~2kg scale) using a convergent seq.uence.234 Highlights 
of this synthesis include a one-pot alkylation-cyclization process to construct the seven-
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 Hutchinson, J. H.; Duggan, M. E. J. Med. Chem.  2003, 46, 4790-4798. 
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membered ring of the tetrahydropyrido[2,3-b]azepane SK-5-2. As depicted in Scheme 
5.46, dilithiation of N-Boc aminopyridine SK-5-1 with hexyllithium/TMEDA at -78°C, 
followed by addition of 1-chloro-4-iodobutane and warming to room temperature results 
in a clean conversion to the chlorobutyl intermediate. Then upon refluxing the resulting 
reaction mixture, the desired pyridoazepine structure is generated in a good yield. 
 
 
Scheme 5.46 Synthetic route to a tetrahydropyrido[2,3-b]azepane by Merck 
 
Based on the xanthates technology, the synthesis of bicyclic pyridines has been well 
investigated in our laboratory over the past decade. All the substrates had a protecting 
group on the extranuclear nitrogen, due to the feared nucleophilicity as mentioned above. 
However, following the synthesis of N-unprotected bicyclic pyrimidine structures, a 
similar strategy would also be valuable in the pyridine series. If the protection could be 
avoided, the synthetic seq.uence would be significantly simplified. Conseq.uently, 
heterocyclic substrates fused on the fluoropyridine motif were tested with the established 
seq.uence. This work could also serve as an ancillary study to better understand the 
related pyrimidine system. 
 
As shown in Scheme 5.47, N-alkenyl-fluoropyridine-2-amines were prepared through 
reaction of the corresponding primary amines with 2,6-difluoropyridine. Allyl-(6-fluoro-
pyridin-2-yl)-amine (n=1) was prepared by refluxing for 7 hours a mixture of 2,6-
difluoropyridine and 2 eq.alents of N-allylamine in distilled THF. But this procedure only 
afforded 7% yield of N-(but-3-enyl)-6-fluoropyridin-2-amine (n=2). A moderately 
improved yield of 15% could be achieved with the reaction in DMF at 95°C for 18 hours. 
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Although fluorine is preferred in nucleophilic aromatic substitutions due to its strong 
inductive effect and small size, reactions of 2,6-difluoropyridine with 4-butenylamine or 
5-pentenylamine did not proceed as efficiently as expected. However, reaction under high 
pressure overcame this setback. For example, we obtained a yield of 92% in the 
preparation of 6-fluoro-N-(pent-4-enyl)pyridin-2-amine (n=3) when a mixture of 2,6-
difluoropyridine, 5-pentenylamine hydrochloride and 2 eq.alent of DIPEA were heated in 
a sealed tube under 110°C for 40 hours. 
 
 
Scheme 5.47 Synthesis of xanthate precursors with pyridine ring 
 
With the N-alkenyl fluoropyridine-2-amines in hand, the subseq.uent intermolecular 
addition proceeded in reasonable yield, albeit somewhat less efficiently (Scheme 5.47). 
However, cyclization of the resulting adducts 5-54 ~ 5-56 occurred only when a six-
membered fused ring is generated. Two products were formed when 5-55 was subjected 
to the action of lauroyl peroxide in refluxing ethyl acetate. The first product, isolated in 
41% yield, was the desired cyclized compound 5-58. The second product turned out to be 
the prematurely reduced xanthate 5-58’, obtained in 48% yield (Scheme 5.48). 
 
 
Scheme 5.48 Radical cyclization of xanthates based on a pyridine ring 
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Treatment of xanthates 5-54 and 5-56 with a stoichiometric amount of lauroyl peroxide in 
the usual manner did not produce any of the corresponding azaindoline 5-57 or 
pyridoazepine 5-59. Prematurely reduced compounds (5-57’ and 5-59’) were observed as 
the sole products but were not isolated. 
 
We were not so surprised that five-membered rings were not formed in this radical 
cyclization. Although the reasons are not clear yet, this is probably the result of the 
unfavorable bond angle as discussed above. However, the absence of seven-membered 
ring fused pyridine is puzzling in this study. Since formation of the prematurely reduced 
compound is faster than attack on the pyridine ring by the intermediate radical, this raised 
the question of which hydrogen atom is abstracted by the intermediate radical, from the 
solvent or from the substrate itself?  
 
Although the undesired 1,5-hydrogen atom shift did not materialize to any significant 
level in the previous dichloropyrimidine substrates, it could nevertheless be problematic 
with the less electrophilic fluoropyridine ring. Polar effects are known to influence 
considerably the rate of hydrogen atom abstraction. 235  We therefore performed the 
cyclization on deuterated xanthate 5-56’ and indeed observed partial intramolecular 
deuterium abstraction. 
 
 
Scheme 5.49 Mechanism study based on deuterated substrate 5-56’ 
 
                                                 
235
 Tedder, J. M. Angew.Chem.Int.Ed. 1982, 21, 401-410. 
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As shown in Scheme 5.49, about 20-25% (by MS) of 5-59” was isolated. 236  The 
proportion of intramolecular abstraction in the case of the hydrogen analog must be 
higher because of the kinetic isotope effect.237  
 
Hence, experiments with protected substrates 5-62 and 5-63 were launched in the usual 
manner, but none of the desired bicyclic compounds were obtained. Only prematurely 
reduced products 5-64’ and 5-65’ were isolated as major products or observed on TLC as 
the sole products. In this case, the radical intermediate must abstract the hydrogen atom 
from the solvent.  
 
 
Scheme 5.50 Unsuccessful cyclization to form the seven-membered ring 
 
Apparently, the radical cyclization onto the fluoropyridine ring is significantly slower as 
compared with the corresponding dichloropyrimidine ring under similar conditions. Since 
the fluoropyridine nucleus is more aromatic and less electrophilic than the 
dichloropyrimidine nucleus, reduced reactivity towards the mildly nucleophilic carbon 
radicals might explain this failure. 
 
                                                 
236
 See experimental part for details. 
237
 An N-H bond is slightly weaker than an N-D bond. 
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d. C-C bond formation via intermolecular radical addition to aromatic ring 
 
Intermolecular addition of a radical to an aromatic ring followed by oxidation of the new 
resonance stabilized radical to produce back the aromatic system is a process which has 
considerably synthetic utility. During our study in preparing unprotected bicyclic aza-
pyrimidines, we observed the oxidative intermolecular addition of certain xanthates to the 
pyrimidine ring (Scheme 5.51). Similar phenomenon was also observed when using the 
same xanthate to add to olefin 5-29 (not depicted here). 
 
 
Scheme 5.51 Preparation of the cyclization precursors 
 
Although the yields of 5-24’ and 5-24” were not comparable with the normal addition 
product 5-24, this observation was still encouraging since it opened another door to form 
a C-C bond onto the pyrimidine ring. A modification was then made to the substrate in 
order to remove the addition to an olefin. As shown in Scheme 5.52, 2,6-dichloro-4-N-
methylamino pyrimidine and 4,6-dichloro-2-N-methylamino pyrimidine were readily 
obtained in 61% and 36% yield by substitution of trichloropyrimidine with methylamine. 
Treatment with various xanthates in the presence of stoichiometric DLP in refluxing 
AcOEt furnished the desired addition products in moderate yields. Although the yields 
were not quite satisfactory, it should be noted that this intermolecular addition is 
normally more difficult than the corresponding intramolecular process. 
 
 
Scheme 5.52 Intermolecular addition of xanthates to the pyrimidine ring 
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Combined with more traditional reactions, these compounds could serve as universal 
building blocks to construct various structures based on the pyrimidine moiety. For 
example, diazaindolines and pyrido[2,3-d]pyrimidines could be prepared from 5-68 
following the synthetic route depicted in Scheme 5.53. Moreover, the presence of 
halogen containing aromatic system allowed the further functionalization employing 
cross coupling technologies.  
 
 
Scheme 5.53 Synthesis of five and six-membered ring fused pyrimidine by 5-68 
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3. Expansion of the reaction scope 
 
As discussed above, we now have in hand a modular, flexible and concise route to 
bicyclic pyrimidines. We next investigated the scope of this approach in order to 
delineate its applicability to more complex structures. First, functional groups on the side 
chain between the nitrogen and the xanthate were introduced; second, an alternative 
synthetic route was designed for generating the seven-membered ring fused pyrimidine; 
and last, ionic inter- and intra-molecular substitutions on the dichloropyrimidine moiety 
were explored and found to lead to numerous interesting structures, including novel 
polycyclic pyrimidines.  
 
a. Synthesis of 7,7-disubstituted piperido[2,3-d]pyrimidines 
 
As shown in Scheme 5.54, functional groups were installed on the side chain of 5-VIII 
between the nitrogen and the xanthate group. In principle, the radical cyclization of these 
precursors should lead to the formation of 7,7-disubstituted piperido[2,3-d]pyrimidine 5-
IX. 
 
Scheme 5.54 Expended synthesis to generate bicyclic compound 5-IX 
 
In the first attempt, diethyl 2-allyl-2-((tert-butoxycarbonyl)amino)malonate was obtained 
in two steps from diethyl aminomalonate. Unfortunately, the following substitution 
reaction to the trichloropyrimidine was unsuccessful, probably due to the steric bulk of 
the liberated primary amine, as well as its weak nucleophilicity caused by two adjacent 
electron-withdrawing ester functionalities.238 
                                                 
238
 A reaction in a sealed tube was not tested. 
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Scheme 5.55 Attempts to prepare the olefinic precursor 5-VI 
 
We therefore adopted another strategy239 based on a three-component reaction of a ketone 
with excess ammonia and allylboronate. This method proved to be more convenient in 
providing the desired homoallylic amine 5-VII.  
 
Scheme 5.56 Synthesis of the olefinic precursor 5-VII 
 
A diverse range of ketones could be used in this allylation of N-unsubstituted imines. We 
chose 1-tosylpiperidin-4-one to illustrate this synthetic strategy. As shown in Scheme 
5.57, 4-allyl-1-tosylpiperidin-4-amine was readily obtained by this reaction. Nucleophilic 
substitution with trichloropyrimidine afforded the desired alkene in a modest yield, due to 
the competing substitution at C-2.240 
 
Scheme 5.57 Synthesis of the olefinic precursor 5-69 
                                                 
239
 (a) Sugiura, M.; Hirano, K.; Kobayashi, S. J. Am. Chem. Soc. 2004, 126, 7182-7183.(b) Dhudshia, B.; 
Tiburcio, J.; Thadani, A. N. Chem. Commun. 2005, 5551-5553. 
240
 The regioisomer 5-107 was even more useful in another reaction, see page 205. 
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With this olefin in hand, radical addition of tetrazole xanthate followed by intramolecular 
cyclization afforded a highly functionalized spiro derivative 5-71. It is very difficult to 
access such structures using conventional ionic and organometallic reactions. As far as 
we know, this is the first synthesis of this tricyclic skeleton. It is also worth noting that 
the radical cyclization of the side chain substituted xanthate 5-70 is more effective than 
that with a naked chain, probably due to the conformational proximity of the generated 
radical to the aromatic ring. The protected piperidine ring further compresses the radical 
terminus toward the pyrimidine nucleus and thus promotes the cyclization (Thorpe-
Ingold effect). 
 
 
Scheme 5.58 Synthesis of highly functionalized spiro derivative 5-71 
 
The tetrazole ring introduced by the xanthate part is also of interest. Since this unit is not 
only comparable to a carboxylic acid moiety, both in size and in acidity, but is also 
metabolically more stables. It has been used as a carboxylic acid mimic in a wide number 
of compounds of biological importance, especially in relation to antagonists of 
angiotensin II. 241  The radical seq.uence above provides a particularly convenient 
installation of this functional group and this should prove useful in designing other 
bioactive derivatives. Furthermore, the benzyl group on the tetrazole moiety could be in 
principle removed later if a naked tetrazole is needed in the final product. 
 
 
                                                 
241
 Biadatti, T.; Quiclet-Sire, B.; Saunier, J. B.; Zard, S. Z. Tetrahedron Lett. 1998, 39, 19-22. and reference 
cited therein. 
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b. Alternative strategy for preparing pyrimidoazepines 
 
An alternative strategy could also be applied for the synthesis of pyrimidoazepines, as 
depicted in Scheme 5.59. This synthetic route uses a different radical addition, whereby 
the aromatic ring now bears the xanthate group as in compound 5-72. This xanthate 
readily adds to various olefinic partners to generate the adducts 5-X, which can then 
undergo ring closure to create the bicyclic products 5-XI. One advantage of this method is 
that the R’ group introduced through olefinic partners enriches the functionalities 
contained in the pyrimidoazepines. The additional carbonyl group in the saturated seven-
membered ring provides the possibility of further modifying these derivatives. 
Conseq.uently, together with the former method, a broad range of bicyclic 
pyrimidoazepines can be obtained by short synthetic routes. 
 
 
Scheme 5.59 An alternative strategy to synthesize pyrimidoazepines 
 
Xanthate 5-72 is prepared from 2,6-dichloro-4-N-methylamino pyrimidine by reaction 
with chloroacetyl chloride to give 2-chloro-N-(2,6-dichloropyrimidin-4-yl)-N-methyl-
acetamide, followed by displacement of the chlorine atom with potassium O-
ethyldithiocarbonate (Scheme 5.60). 
 
Scheme 5.60 Synthesis of precursor xanthate 5-72 
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Xanthate 5-72 readily adds to allylacetate following initiation with DLP in refluxing ethyl 
acetate to give the corresponding addition product 5-73. Treatment of 5-73 with 
stoichiometric amount of DLP results in ring-closure onto the pyrimidine to form a new 
radical species 5-73-b, which is oxidized to cation 5-73-c by electron transfer to the 
peroxide and finally aromatized by loss of a proton into the desired compound 5-74 
(Scheme 5.61). 
 
 
Scheme 5.61 Alternative strategy for the synthesis of pyrimidoazepines 5-74 
 
Our efforts at improving the yield of 5-73 were not successful: the radical addition of 5-
72 to allyl acetate was repeated very carefully but gave the same modest yield, i.e. 40%. 
However, we noticed that the color of xanthate 5-72, which is light yellow just after 
purification, changes to deep yellow after a few weeks of storage, even when covered 
with aluminum foil and kept in refrigerator. This phenomenon is rather uncommon in 
comparison with other freq.uently used xanthates in our laboratory.  
 
Furthermore, attempts at preparing related analogous 5-75 and 5-76 afforded unreliable 
results. For example, when newly purified 5-72 was reacted with Boc-protected 
allylamine, the addition product 5-75 could be generated in a somewhat better yield as 
compared to the first example 5-73; but if the xanthate was kept several days in 
refrigerator and was not repurified before using, only 26% of the addition product 5-76 
was generated (Scheme 5.62).  
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One possible explanation for the variability and generally modest yields is the direct 
cyclization of 5-72 via radical species 5-72-a to give the diazaoxindole 5-77. This 
hypothesis was confirmed by obtaining this bicyclic compound in good yield after 
treatment of 5-72 with a stoichiometric amount of DLP in refluxing ethyl acetate.  
 
 
Scheme 5.62 Modest yields of radical addition of 5-72 caused by its self-cyclization  
 
Although we could limit this side-reaction by playing with the reaction conditions such as 
adding an excess of olefin, this inherent defect still made this synthetic strategy less 
efficient. However, since we had shown that protection of extranuclear nitrogen was 
unnecessary and that five-membered ring formation was unfavored in the absence of a 
substituent on the nitrogen, a simple modification involving an unprotected xanthate 
precursor 5-78 could be envisaged to avoid the competitive oxindole formation.  
 
 
Scheme 5.63 Radical addition of the unprotected xanthate 5-78 
Radical Synthesis of Pyrimidine Derivatives 
 197 
As expected, direct ring-closure of xanthate 5-78 under usual conditions did not happen, 
and this opened the possibility of intermolecular addition to an olefinic partner, such as 
allyl acetate. As indicated in Scheme 5.63, the radical addition was accomplished 
efficiently to give the xanthate precursor 5-79. However, the following cyclization did 
not proceed as expected and only prematurely reduced compound was isolated (Scheme 
5.64).  
 
Scheme 5.64 Unsuccessful cyclization of 5-79 because of a possible intrmolecular 
hydrogen abstraction 
 
A similar trend in lactam formation by radical cyclization has been documented in a 
recent review.242 For example, treatment of xanthate SZ-5-3 with peroxide furnished the 
desired azepinone SZ-5-6 in 60% yield, whereas only prematurely reduced material was 
obtained from the N-unsubstituted analog SZ-5-2. Thus even a small methyl group is 
sufficient to promote the desired cyclization, which is in any case a difficult process that 
cannot usually be accomplished by other radical methods. However, the related six-
membered ring-closure exhibited a very different picture: the presence of a substituent on 
                                                 
242
 Zard, S. Z. J. Phys. Org. Chem.  2012, 25, 953-964. 
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the extranuclear nitrogen was not necessary for the cyclization to take place. For example, 
dihydroazaquinolone SZ-5-4 could be obtained by the radical cyclization of the 
corresponding xanthate precursor in a reasonable yield. 
 
 
Scheme 5.65 Curious aspects of lactam formation 
 
Although the underlying causes are not yet clear, we suspected that this phenomenon is 
probably due to a combination of several factors.  
 
In the case of the azaoxindoles, the substituent is needed on the nitrogen to compress the 
side chain (and bring the radical closer to the aromatic nucleus) and to modify the 
rotamer population toward the rotamer with geometry favorable for cyclization. It must 
be remembered that fusing a five-membered lactam to a six-membered aromatic or 
heteroaromatic ring introduces some strain into the structure. 
 
In the case of a six-membered lactam, the cyclization process does not introduce a 
significant strain and the rotamer population, even if it is tilted towards the ones with an 
unfavorable geometry, is in a dynamic eq.uilibrium. The rate of rotation around the amide 
bond is greater when the nitrogen is substituted by an aryl or heteroaryl group, because of 
the diminished π-bond character between the nitrogen and the carbonyl carbon: 
 
 
Scheme 5.66 Rotation around the amide bond 
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In the case of seven-membered ring lactams, the problem now is not due to strain or 
rotamer population, but to an unfavorable entropy term due to the longer distance 
between the radical located on a floppy side-chain and the aromatic ring. The slower 
ring-closure opens up a greater probability of a premature hydrogen atom abstraction 
from the solvent. Furthermore, the intermediate carbon radical can also abstract the 
hydrogen on the amide nitrogen as it is now within an ideal distance. Thus the simple 
introduction of a methyl group on the nitrogen removes this possibility and compensates 
for the floppiness of the side-chain by modifying the rotamer population in a more 
favorable direction. 
 
While all these factors are individually energetically of a small magnitude in absolute 
terms, they can dramatically affect the outcome of the radical process. 
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c. Functionalization of the bicyclic aza-pyrimidine derivatives 
 
The presence of halogen atoms on the bicyclic aza-pyrimidines allows the potential 
modification of these structures. In order to diversify the products within our subject, 
further substitutions in either intermolecular or intramolecular fashion were investigated. 
A number of interesting fused pyrimidines with various substituents and related 
polycyclic compounds were thus generated. Many of these structures are not readily 
prepared by more classical methods. 
 
 
1) Intermolecular substitution 
 
An earlier work by Mohamed 243  describes the selective synthesis of differentially 
substituted 2,4-diamino pyrimidines. As depicted in Scheme 5.67, derivatives TM-5-2 
were obtained in two steps from 2,4-dichloropyrimidine. In the first step, nucleophilic 
aromatic substitution was accomplished at C-4 using primary amines with a base such as 
DIPEA. The second more difficult substitution of TM-5-1 afforded moderate to good 
yields ranging from 60% to 75%. In the second step, the C-2 chlorine was replaced by 
various cyclic amines under vigorous conditions in a sealed tube. 
 
 
Scheme 5.67 Selective substitution of 2,4-dichloropyrimidine 
 
                                                 
243
 Mohamed, T.; Zhao, X. B.; Habib, L. K.; Yang, J. R.; Rao, P. P. N. Bioorg. Med. Chem.  2011, 19, 
2269-2281. 
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In view of the similarity of 2,4-dichloropyrimidine with the bicyclic compounds in our 
study, we decided to employ these conditions in our synthesis. The first attempt was 
performed with adduct 5-50, which was heated with 1eq. of benzylamine and 1.1eq. 
DIPEA in ethanol. But no substitution took place and the sole product generated was the 
deprotected product 5-35. 
 
 
Scheme 5.68 Unsuccessful substitution of acetylated substrate 
 
Further treatment of 5-35 with 7eq. of the smaller cyclopropylamine and 10eq. DIPEA in 
ethanol still gave no desired substitution, with only recovery of the starting material.  
 
 
Scheme 5.69 Unsuccessful substitution of unprotected piperidopyrimidine 
 
Since similar structures (diazaindolines) were prepared earlier on a relatively large scale, 
we decided to try the substitution with analog 5-21. According to the literature, both of 
the chlorine atoms in the pyrimidine ring can be replaced by a proper nucleophile. 
However, due to the presence of the side chain, only the chlorine at the less hindered 
position should be attacked under the conditions used. Primary amines and thiol were 
used as the nucleophiles to illustrate this substitution. Good yields were obtained as 
shown by the results depicted in Scheme 5.70. 
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Scheme 5.70 Nucleophilic substitutions of diazaindoline 5-21 
 
Compound 5-21, with an electrophilic mesyl protecting group, improves the reactivity of 
the pyrimidine ring towards nucleophilic substitution. We therefore introduced this 
protecting group to the previous substrate 5-35 and obtained the desired product 5-85 in 
excellent yield (Scheme 5.71).  
 
 
Scheme 5.71 Nucleophilic substitution to mesyl protected piperidopyrimidine 
 
Since we mainly concentrated on illustrating the feasibility of the substitution, we did not 
investigate the utility of other solvents, such as DMF. Nor did we attempt a second 
intermolecular substitution of C-4 chlorine. 244  We rather directed our attention on 
investigating the synthetic potential of an intramolecular substitution. 
 
 
                                                 
244
 Theoretically this could be achieved using somewhat vigorous conditions. 
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2) Intermolecular substitution: a convenient way to tricycles 
 
As mentioned above, the incorporation of various xanthate partners provides the ability to 
introduce various functional groups into the products. Thus, a latent nucleophile can be 
installed via the xanthate on the bicyclic structure, allowing a third ring to be constructed 
by simple application of an ionic process.  
 
As shown in Scheme 5.72, the mesyl protected olefin 5-86 readily obtained by 
deprotonation and mesylation of the parent amine, undergoes radical addition to give 
product 5-87. This compound is obtained as two separable diastereoisomers in a good 
yield. Treatment of these two diastereoisomers with stoichiometric amounts of lauroyl 
peroxide in the usual manner furnished the bicyclic compounds 5-88 in exactly the same 
yield. 
 
 
Scheme 5.72 Preparation of the novel tricyclic compound 5-89 
 
Bicyclic product 5-88 was converted into intermediate 5-88-a by removal of the Boc 
group with TFA, and induced to cyclize by exposure to a moderate base in ethanol to 
give the novel tricyclic compound 5-89. 
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In the similar way, bicyclic products 5-34 and 5-42 could be transformed into the 
tricyclic compounds 5-91 and 5-92 by cleavage of the phthalimido group with hydrazine 
and treatment with base. Interestingly, the same seq.uence failed with compound 5-26, 
presumably because of the strain introduced in to the structure 5-90 (Scheme 5.73). 
 
 
Scheme 5.73 Synthesis of novel tricyclic compounds 
 
The presence of a larger seven-membered ring in compound 5-80 could allow the 
formation of a five-membered ring leading to the tricyclic structure in Scheme 5.74. This 
synthesis has not yet been attempted. 
 
 
Scheme 5.74 Possible access to an oxygen-containing tricycle 
 
It should be noted that all these tricycles, which may have some interest in medicinal 
chemistry or as ligands in organometallic processes, would not be easy to make by more 
traditional routes. 
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4. Synthesis of bicyclic aza-pyrimidones via C-N bond formation 
 
a. Preliminary study in synthesizing tricyclic aza-pyrimidones 
 
In parallel to investigating the “carbamate puzzle”, we examined another series of radical 
cyclizations. As shown in Scheme 5.75, because of the symmetry, the radical derived 
from LP-5-7 has no choice but to cyclize on either of the two heteroaromatic nitrogen to 
furnish pyrimidinone LP-5-8. 
 
 
Scheme 5.75 Related N-cyclization with regioisomeric precursor LP-5-4 
 
Diversity was introduced by using different xanthate partners.245 We repeated three of 
these reactions with the initial purpose of cyclizing the nucleophilic nitrogen terminus by 
substitution of the adjacent chlorine atom and then create tricyclic compounds (Scheme 
5.76). 
 
 
Scheme 5.76 Related N-cyclization with regioisomeric precursors 
                                                 
245
 (a) Laot, Y.; Petit, L.; Ngoc, D. M. T.; Zard, S. Z. Aust. J. Chem. 2011, 64, 416-425; (b) Laot, Y.; Petit, 
L.; Zard, S. Z. Org. Lett. 2010, 12, 3426-3429. 
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However, the original purpose for synthesizing the tricyclic compounds was not achieved, 
no matter the size of the third ring (six-membered ring for 5-96 and seven-membered ring 
for 5-97). In order to investigate the reactivity of the chlorine, we decided to study the 
intramolecular substitution, by analogy with our previous experiments.  
 
 
Scheme 5.77 Substitution of the chlorine in bicycle 5-96 
 
As illustrated in Scheme 5.77, substitution indeed readily proceeded with the mesyl 
protected substrate 5-99 by heating with cyclopropylamine in DMF. However, 
surprisingly, the liberated primary amine from the phthalimido group did not furnish the 
desired cyclized product under the same conditions. Again, this could be due to the strain 
inherent to the structure as in the case of compound 5-26 (Scheme 5.73).  
 
Could we however start with a six-membered ring fused pyrimidone? The radical 
cyclization to the aromatic nitrogen to create a six-membered ring is a much more 
interesting and challenging problem and was therefore studied next. 
 
 
b. Six-membered ring closure on heteroaromatic nitrogen  
 
Starting from olefin 5-28’, two olefinic precursors 5-101 and 5-102 were readily prepared 
following the common protection procedure. While the radical addition proceeded well as 
usual, the final ring closure step gave none of the desired cyclization to the 
heteroaromatic nitrogen (Scheme 5.78). For both of the two reactions, only prematurely 
reduced materials were identified from the complex reaction mixtures. Other compounds 
observed by TLC plate were not identified. 
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Scheme 5.78 Failed cyclizations on the nitrogen atom of pyrimidines 
 
This failure reminded us of the difficulty inherent in such a process. However, during the 
previous study, the side-chain substituent proved to be useful in promoting the radical 
cyclization. As the regioisomer 5-107 of 5-69 was already in hand, we converted it into 
adduct 5-108 and tested again the cyclization on the nitrogen. Surprisingly, this time we 
obtained the desired spiro derivative 5-109, together with the prematurely reduced 
material 5-109”, and a chloro-substituted compound 5-110. 
 
 
Scheme 5.79 N-Cyclization on the nitrogen of pyrimidines 
 
Chloride 5-110 is possibly derived through substitution by the chlorine anion on the 
cyclized intermediate, as shown in Scheme 5.80. Since its spot on the TLC plate is very 
close to that of the prematurely reduced material, it is easily overlooked in a complex 
reaction mixture. It is worth mentioning that we found that tricyclic structures like 5-109 
are readily identified as strong clear yellow spots on the TLC plate when revealed with 
hot acidic vanillin solution. This observation simplified our subseq.uent study. 
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Scheme 5.80 Related N-cyclization with regioisomeric precursors 
 
The formation of chloro compound 5-110 is quite important, since it helps to explain 
some of the previous unclear results, such as the variable cyclization yields. With the 
knowledge that the chlorine anion is detrimental to this radical process, we attempted to 
remove it from the reaction medium. We first employed high temperature (refluxing 
chlorobenzene) and a different initiator/oxidant (DTBP). 
 
 
Scheme 5.81 Radical cyclization of 5-103 in a high boiling solvent 
 
We were pleased to find that, even without the spiro substitution, the radical cyclization 
could happen to some extent when the problematic chlorine anion was removed (Scheme 
5.81).  
 
Camphorsulfonic acid and 2,6-lutidine were also used as adjuvants. Addition of a solid 
acid was supposed to facilitate the evaporation of HCl and activate the pyrimidine ring 
through protonation. However, no significant cyclization was observed under these 
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conditions. In contrast, addition of 2,6-lutidine as a non-nucleophilic HCl scavenger 
proved more promising, as indicated by the transformations displayed in Scheme 5.82.  
 
 
Scheme 5.82 Radical cyclization of 5-108 with 2,6-lutidine as HCl scavenger 
 
Same conditions for the cyclization were then applied to prepare a number of six-
membered ring fused pyrimidones with various functional groups246 (Scheme 5.83). 
 
Scheme 5.83 Preparation of six-membered ring fused pyrimidones 
                                                 
246
 These results are taken from the work of Mr. Ling QIN, who has pursued this study. 
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Conclusion  
 
In summary, compounds containing a pyrimidine nucleus fused to a saturated N-
containing ring were prepared in modest to good yield starting from 2,4,6-
trichloropyrimidine. Various new tricyclic compounds were also constructed by SNAr 
reactions of a nucleophilic terminus and displacement of the chlorine of the pyrimidine 
ring. Diversity could be introduced by modifying the starting xanthate or by further 
transformation of the functional groups present in the xanthate component, or by 
exploiting the presence of the chlorine atom in the final products. The resulting 
polycyclic aza-pyrimidines could serve as novel templates for potential drug discovery 
programs. 
 
In the course of this study, we have also investigated the uncommon regioselectivity 
caused by the protecting group on the extranuclear nitrogen. This unusual phenomenon 
has confused us for quite a while. We hope this work will contribute to a satisfactory 
solution of this puzzle in the future. 
 
Finally, we have discovered an unprecedented radical cyclization to heteroaromatic 
nitrogen to form a six-membered ring. This again opens the way to numerous novel 
nitrogen heterocycles. 
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General Experimental Methods 
 
Anhydrous solvents were obtained by distillation under nitrogen, and from the solvent 
drying columns. Other solvents were used as supplied by commercial sources. Petroleum 
ether refers to the fraction of light petroleum ether, boiling between 40-60°C.  
 
Purification procedures were in accordance with the instructions in D. D. Perrin and W. L. 
F. Armarego, “Purification of δaboratory Chemicals”, Fourth Edition, The Bath Press, 
Bath, 2002. All reactions were carried out under dry, oxygen free nitrogen.  
 
Recrystallization was performed following the procedure of dissolving the impure 
substance in hot ethyl acetate with the minimum volume, cooling down the hot solution 
by adding cold petroleum ether which causing the dissolved substance to crystallise out, 
then separating the crystals from the supernatant solution.  
 
Flash chromatography was performed on silica gel (SDS, 60 Å C. C. 40-63 m) as the 
stationary phase. Thin Layer Chromatography (TLC) was performed on alumina plates 
pre-coated with silica gel (Merck silica gel, 60 F254), which were visualized by the 
quenching of UV fluorescence (max = 254 nm and/or 366 nm) and/or by staining with 
anisaldehyde in acidic ethanol and/or KMnO4 in basic water followed by heating.  
 
Melting points were recorded by heating on Reichert plates under a microscope and are 
uncorrected. For the substances whose melting points were higher than 230°C, they were 
recorded by Automatic Melting Point Apparatus Model SMP40.  
 
Infrared spectra were recorded as solutions in CCl4 or CDCl3 using CaF2 cells or as solids 
in Nujol using KBr cells, on a Perkin-Elmer FT 1600. Absorption maxima (max) are 
reported in wavenumbers (cm-1) and only selected peaks are reported.  
 
Nuclear magnetic resonance spectra were recorded at ambient temperature on a Bruker 
Avance DPX 400 instrument. Proton magnetic resonance spectra (1H NMR) were 
recorded at 400 MHz and coupling constants (J) are reported to ± 0.5 Hz. The following 
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abbreviations were utilized to describe peak patterns when appropriate: br = broad, s = 
singlet, d = doublet, t = triplet, q = quartet and m = multiplet. Carbon magnetic resonance 
spectra (13C NMR) were recorded at 100.6 MHz. Chemical shifts (H, C) are quoted in 
parts per million (ppm) and are referenced to the residual solvent peak (CDCl3: H = 7.26 
and C = 77.0 ; DMSO: H = 2.50 and C = 39.43 ; Acetone-d6: H = 2.05 and C = 30.83 ; 
CD3OD: H = 3.31 and C = 49.05).  
 
High-resolution mass spectra were recorded by positive electron impact ionization (EI+) 
at 70 eV on a JEOL JMS-GCmate II mass spectrometer. The quoted masses are accurate 
to ± 4 ppm. 
 
 
Xanthates cited in the work 
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Molecules cited in the experimental part 
 
Molecules of chapter 3 
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Molecules of chapter 4 
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Molecules of chapter 5 
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Chapter 3 
 
 
General procedure 3-I for preparing the xanthates of 3-1 to 3-7 
 
 
 
A magnetically stirred solution of substituted aniline (1 eq.) in distillated 1,2-dichloroethane 
(1.2-1.6M of corresponding aniline) was cooled to 0°C. Methanesulfonyl-chloride (1.1 eq.) 
was then added prior to a dropwise addition of pyridine (1.1-2.2 eq.). The mixture was 
warmed to room temperature and stirred for 2-3 hours. Then normal 1,2-dichloroethane was 
added and the organic phase was washed once with solution of 2N hydrochloric acid, twice 
with a saturated solution of sodium hydrogenocarbonate, twice with water, and once with 
brine, dried over anhydrous magnesium sulfate and filtered. The solvent was evaporated 
under reduced pressure. The crude product was recrystallized by AcOEt / EP to yield the 
desired protected anilines.  
 
Then to a magnetically stirred solution of the protected aniline (1 eq.) in dry DMF (0.4-0.6M 
of the protected aniline) under nitrogen in an ice bain, was added sodium hydride (60% in 
mineral oil, 1.2 eq.) little by little. The resulting mixture was warmed to room temperature 
for about 10-20min. Chloroacetylchloride (1.5 eq.) was then added and the solution was 
stirred for 2-3 hours. Ethyl acetate was added and the solution was washed with water 3 
times and once with brine. The organic phase was dried over anhydrous magnesium sulfate 
and filtered. Then the solvent was removed under reduced pressure. The crude product was 
recrystallized with AcOEt or AcOEt / EP to yield the desired halogenides.  
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Then to a magnetically stirred solution of the halogenide (1 eq.) in acetone (0.2-0.4M of 
halogenide) under nitrogen at room temperature, was added potassium O-ethylxanthogenate 
(1.1 eq.). The resulting mixture was stirred at room temperature for 2-3 hour. The solvent 
was then removed under reduce pressure and the residue was dissolved in AcOEt. The 
organic phase was washed by water and brine, dried over anhydrous magnesium sulfate and 
filtered. Then the solvent was removed under reduced pressure. The crude product was 
recrystallized with AcOEt / EP or purified by flash chromatography on silica gel to yield the 
desired xanthates 3-1 to 3-7. 
 
 
 
General procedure 3-II for the radical addition to olefin  
 
 
 
A magnetically stirred solution of the corresponding xanthates (1 eq.) and the desired olefin 
(1.5-2 eq.) in AcOEt (0.7-1.0M of xanthate) was refluxed for about 15-30min under nitrogen. 
Lauroyl peroxide (DLP) (5%mol) was then added to the refluxing solution, followed by 
additional portions (5%mol) every 60min until the starting xanthate was completely 
consumed. The reaction mixture was then cooled down to room temperature, concentrated 
under reduced pressure and purified by flash chromatography on silica gel to yield the 
desired compounds.  
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General procedure 3-III for the radical cyclization using DTBP  
 
 
 
A magnetically stirred solution of the corresponding addition products from xanthates (1 eq.) 
in chlorobenzene (0.02M of xanthate) together with 2,6-lutidine (1 eq.) were refluxed for 
about 15min under nitrogen. Di-tert-butylperoxide (DTBP) (5 eq.) was then added to the 
refluxing solution. The reaction was monitored by TLC every hour until the starting xanthate 
was completely consumed. The reaction mixture was then cooled down to room temperature, 
concentrated under reduced pressure and purified by flash chromatography on silica gel to 
yield the desired compounds.  
 
 
General procedure 3-IV for the preparation of piperidin-2-ones 
 
 
 
To a round-bottomed flask which contained the corresponding N-Boc protected bicycles (1 
eq.) was added trifluoroacetic acid (TFA) (8 eq.), in the form of a solution of 30% TFA in 
DCM. The mixture was stirring at room temperature under nitrogen for about 1 hour to 
complete the reaction. Then the solvent was removed under reduced pressure and to the 
residue was added directly toluene (0.05M of the starting material) and triethylamine (TEA) 
Experimental Part 
 234
(12 eq.). The resulting mixture was stirred at 70~90°C for about 1~2 hours to complete the 
reaction. Then for the products of 3-10, 3-20, 3-22 and 3-23, the precipitation was separated 
by centrifuge and washed by cold acetone to yield the desired compounds 3-25, 3-27, 3-29 
and 3-30.  
 
For the series of 3-11, 3-21, and 3-24, acetic anhydride (Ac2O) (8 eq.) was added directly and 
the mixture was kept stirring at ~90°C for about 30 minutes to complete the reaction. Then 
the precipitation was seperated by centrifuge, and washed by cold AcOEt to yield the desired 
compounds 3-26, 3-28, and 3-31. 
 
 
 
Dithiocarbonic acid S-{2-[(4-iodo-phenyl)-methanesulfonyl-amino]-2-oxo-ethyl} ester 
O-ethyl ester (3-1) 
 
 
 
Following the general procedure 3-I for the preparation of the corresponding xanthate, the 
reaction was started with the mesylation of a solution of 4-iodoaniline (3.24g, 14.8mmol) in 
distillated 1,2-dichloroethane (10ml, 1.5M), methanesulfonylchloride (1.3mL, 16.3mmol) 
and pyridine (1.3ml, 16.3mmol). Recrystallization with AcOEt / EP afforded the protected 4-
iodoaniline (3.93 g, 89%) as a light violet solid. Then the chloroacetylation was carried out 
with the solution of the above solid (2.96g, 9.96mmol) in dry DMF (26.5ml, 0.4M), 
chloroacetylchloride (1.19mL, 14.9mmol) and sodium hydride (60% in mineral oil, 478mg, 
12.0mmol). Recrystallization with AcOEt / EP afforded the halogenide (3.06g, 51%) as a 
white solid. Then the reaction was carried out with the solution of the halogenide (1.04g, 
2.77mmol) in acetone (10.5ml, 0.3M) and potassium O-ethylxanthogenate (0.49g, 3.05mmol). 
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Flash chromatography on silica gel with CH2Cl2 / EP / AcOEt / = 70 / 25 / 5 afforded 3-1 
(1.05g, 82%) as a yellow oil.  
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.87 (d, 2H, J=8.1Hz, I-C-CH), 7.18 (d, 2H, J=8.0Hz, 
CN-CH), 4.62 (q, 2H, J=7.1Hz, CH2CH3), 3.76 (s, 2H, CO-CH2), 3.47 (s, 3H, SO2-CH3), 
1.41 (t, 3H, J=7.1Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.2 (S=C), 167.2 (O=C), 139.5 (s, 2 I-C-C), 
134.4 (s, N-C), 131.7 (s, 2 N-C-C), 96.9 (s, I-C), 71.3 (CH2CH3), 42.2 (S-C), 41.3 (CO-C), 
13.7 (CH2CH3) 
IR (ν, cm-1, CDCl3)  2985, 2937, 1725, 1479, 1365, 1300, 1239, 1155, 1113, 1050   
HRMS (EI+)    Calcd. for C12H14INO4S3 : 458.9130      Found : 458.9146 
 
 
Dithiocarbonic acid S-{2-[(3,5-dimethoxy-phenyl)-methanesulfonyl-amino]-2-oxo-ethyl} 
ester O-ethyl ester (3-2) 
 
 
 
Following the general procedure 3-I for the preparation of the corresponding xanthate, the 
reaction was started with the mesylation of a solution of 3,5-dimethoxyaniline (3.80g, 
24.8mmol) in distillated 1,2-dichloroethane (20ml, 1.2M), methanesulfonylchloride (2.1mL, 
27.3mmol) and pyridine (4.4ml, 54.5mmol). Recrystallization with AcOEt / EP afforded the 
protected 3,5-dimethoxyaniline (5.23 g, 91%) as a grey solid. Then the chloroacetylation was 
carried out with the solution of the above solid (2.86g, 12.4mmol) in dry DMF (29ml, 0.4M), 
chloroacetylchloride (1.82mL, 22.9mmol) and sodium hydride (60% in mineral oil, 713mg, 
17.8mmol). Recrystallization with AcOEt afforded the halogenide (2.74g, 72%) as a white 
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solid. Then the reaction was carried out with the solution of the halogenide (1.63g, 5.28mmol) 
in acetone (23ml, 0.2M) and potassium O-ethylxanthogenate (0.951g, 5.9mmol). 
Recrystallization with AcOEt / EP afforded 3-2 (1.78g, 86%) as a pale pink solid.  
 
m.p. : 131-134°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.62 (m, 3H, aromatic H), 4.67 (q, 2H, J=7.1Hz, 
CH2CH3), 3.90 (s, 2H, CO-CH2), 3.88 (s, 6H, 2 OCH3), 3.52 (s, 3H, S-CH3), 1.47 (t, 3H, 
J=7.1Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.2 (S=C), 167.5 (O=C), 161.6 (2 MeO-C), 
136.1 (N-C), 108.3 (2 N-C-CH), 102.5 ( MeOC-CH-COMe ), 71.1 (CH2CH3), 55.7 (2 OCH3), 
42.1 (CO-C), 40.9 (SO2-CH3), 13.7 (CH2CH3) 
IR (ν, cm-1, CDCl3)  2966, 2942, 2842, 1715, 1609, 1473, 1429, 1364, 1292, 1238, 1207, 
1159, 1113, 1050   
HRMS (EI+)    Calcd. for C14H19NO6S3 : 393.0375      Found : 393.0374 
 
 
Dithiocarbonic acid S-{2-[(4-bromo-phenyl)-methanesulfonyl-amino]-2-oxo-ethyl} ester 
O-ethyl ester (3-3) 
 
 
 
Following the general procedure 3-I for the preparation of the corresponding xanthate, the 
reaction was started with the mesylation of a solution of 4-bromoaniline (6.00g, 34.9mmol) 
in distillated 1,2-dichloroethane (25ml, 1.4M), methanesulfonylchloride (3.0mL, 38.8mmol) 
and pyridine (3.2ml, 39.6mmol). Recrystallization with AcOEt / EP ether afforded the 
protected 4-bromoaniline (8.36 g, 95%) as a pale white solid. Then the chloroacetylation was 
carried out with the solution of the above solid (4.70g, 18.8mmol) in dry DMF (41ml, 0.5M), 
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chloroacetylchloride (2.2mL, 27.7mmol) and sodium hydride (60% in mineral oil, 900mg, 
22.5mmol). Recrystallization with AcOEt / EP afforded the halogenide (4.82g, 78%) as a 
white solid. Then the reaction was carried out with the solution of the halogenide (2.67g, 
8.2mmol) in acetone (27ml, 0.3M) and potassium O-ethylxanthogenate (1.44g, 9.0mmol). 
Flash chromatography on silica gel with AcOEt / EP = 15 /85 ~ 20 / 80 afforded 3-3 (2.70g, 
80%) as a yellow foam.  
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.67 (d, 2H, J=8.6Hz, Br-C-CH), 7.32 (d, 2H, 
J=8.6Hz, CH-CN), 4.62 (q, 2H, J=7.1Hz, CH2CH3), 3.76 (s, 2H, CO-CH2), 3.48 (s, 3H, SO2-
CH3), 1.42 (t, 1H, J=7.1Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100 MHz)  213.2 (S=C), 167.2 (O=C), 133.7 (N-C), 133.5 (2 
Br-C-C), 131.6 (2 N-C-C), 125.1 (Br-C), 71.3 (CH2CH3), 42.2 (S-C), 41.3 (CO-C), 13.7 
(CH2CH3) 
IR (ν, cm-1, CDCl3)  2987, 2938, 1714, 1488, 1365, 1300, 1239, 1155, 1112, 1050   
HRMS (EI)    Calcd. for C12H14NO4S3Br : 410.9268      Found : 410.9265 
 
 
Dithiocarbonic acid S-{2-[(4-fluoro-phenyl)-methanesulfonyl-amino]-2-oxo-ethyl} ester 
O-ethyl ester (3-4) 
 
 
 
Following the general procedure 3-I for the preparation of the corresponding xanthate, the 
reaction was started with the mesylation of a solution of 4-fluoroaniline (5.45g, 49mmol) in 
distillated 1,2-dichloroethane (34ml, 1.4M), methanesulfonylchloride (4.2mL, 54.3mmol) 
and pyridine (4.4ml, 54.5mmol). Recrystallization with AcOEt / EP afforded the protected 4-
fluoroaniline (7.32 g, 79%) as a light brown solid. Then the chloroacetylation was carried out 
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with the solution of the above solid (2.73g, 14.4mmol) in dry DMF (25ml, 0.6M), 
chloroacetylchloride (1.72mL, 21.6mmol) and sodium hydride (60% in mineral oil, 694mg, 
17.4mmol). Recrystallization with AcOEt / EP afforded the halogenide (2.82g, 74%) as a 
pale white solid. Then the reaction was carried out with the solution of the halogenide (1.10g, 
4.14mmol) in acetone (11ml, 0.4M) and potassium O-ethylxanthogenate (0.73g, 4.55mmol). 
Flash chromatography on silica gel with AcOEt / EP = 20 / 80 afforded 3-4 (1.18g, 81%) as a 
yellow oil.  
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.43 (m, 2H, CH-CN), 7.22 (m, 2H, F-C-CH), 4.62 (q, 
2H, J=7.1Hz, CH2CH3), 3.76 (s, 2H, CO-CH2), 3.48 (s, 3H, SO2-CH3), 1.41 (t, 1H, J=7.1Hz, 
CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.2 (S=C), 167.4 (O=C), 163.5 (d, J=252.3Hz, 
F-C), 132.0 (d, J=9.1Hz, 2 N-C-C), 130.6 (d,  J=3.5Hz, N-C), 117.3 (d, J=23.1Hz, 2F-C-C), 
71.3 (CH2CH3), 42.1 (S-C), 41.3 (CO-C), 13.7 (CH2CH3) 
IR (ν, cm-1, CDCl3)  2987, 2937, 1716, 1601, 1506, 1364, 1302, 1155, 1113, 1050   
HRMS (EI+)    Calcd. for C12H14FNO4S3 : 351.0069      Found : 351.0066 
 
 
Dithiocarbonic acid S-{2-[(3,5-bis(trifluoromethyl)-phenyl)-methanesulfonyl-amino]-2-
oxo-ethyl} ester O-ethyl ester (3-5) 
 
 
 
Following the general procedure 3-I for the preparation of the corresponding xanthate, the 
reaction was started with the mesylation of a solution of 3,5-bis(trifluoromethyl)aniline 
(7.46g, 32.5mmol) in distillated 1,2-dichloroethane (20ml, 1.6M), methanesulfonylchloride 
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(2.8mL, 36.2mmol) and pyridine (2.9ml, 35.9mmol). Recrystallization with AcOEt / EP 
afforded the protected 3,5-bis(trifluoromethyl)aniline (9.19 g, 92%) as a white solid. Then 
the chloroacetylation was carried out with the solution of the above solid (4.03g, 13.1mmol) 
in dry DMF (24ml, 0.6M), chloroacetylchloride (1.6mL, 19.7mmol) and sodium hydride 
(60% in mineral oil, 629mg, 15.7mmol). Recrystallization with AcOEt / EP afforded the 
halogenide (3.47g, 69%) as a white crystal. Then the reaction was carried out with the 
solution of the halogenide (3.10g, 8.1mmol) in acetone (31ml, 0.3M) and potassium O-
ethylxanthogenate (1.42g, 8.9mmol). Flash chromatography on silica gel with AcOEt / EP = 
5 / 95 afforded 3-5 (2.70g, 71%) as a light yellow crystal.  
 
m.p. : 116-120°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  8.04 (s, 1H, CF3C-CH-CCF3), 7.91 (s, 2H, CF3C-CH-
CN), 4.62 (q, 2H, J=7.1Hz, CH2CH3), 3.81 (s, 2H, CO-CH2), 3.54 (s, 3H, S-CH3), 1.42 (t, 1H, 
J=7.1Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.4 (S=C), 166.9 (O=C), 136.4 (N-C), 133.7 (q, 
J=34.5Hz, 2 CF3-C), 130.7 (2 N-C-C), 124.5 (CF3-C-C-C-CF3), 122.4 (q, J=273.0Hz, 2 CF3), 
71.7 (CH2CH3), 42.6 (S-C), 41.4 (CO-C), 13.7 (CH2CH3) 
IR (ν, cm-1, CDCl3)  2989, 2935, 1719, 1622, 1468, 1375, 1279, 1186, 1147, 1112, 1049   
HRMS (EI+)    Calcd. for C14H13F6NO4S3 : 468.9911      Found : 468.9917 
 
 
Dithiocarbonic acid S-{2-[(3,5-dichloro-phenyl)-methanesulfonyl-amino]-2-oxo-ethyl} 
ester O-ethyl ester (3-6) 
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Following the general procedure 3-I for the preparation of the corresponding xanthate, the 
reaction was started with the mesylation of a solution of 3,5-dichloroaniline (7.20g, 
44.4mmol) in distillated 1,2-dichloroethane (27ml, 1.6M), methanesulfonylchloride (3.8mL, 
49.1mmol) and pyridine (4.0ml, 49.6mmol). Recrystallization with AcOEt / EP afforded the 
protected 3,5-dichloroaniline  (10.1 g, 95%) as a violet solid. Then the chloroacetylation was 
carried out with the solution of the above solid (5.10g, 21.2mmol) in dry DMF (50ml, 0.4M), 
chloroacetylchloride (2.5mL, 31.4mmol) and sodium hydride (60% in mineral oil, 1.02g, 
25.5mmol). Recrystallization with AcOEt / EP afforded the halogenide (5.21g, 77%) as a 
white solid. Then the reaction was carried out with the solution of the halogenide (2.61g, 
8.2mmol) in acetone (26ml, 0.3M) and potassium O-ethylxanthogenate (1.45g, 9.1mmol). 
Recrystallization with AcOEt / EP afforded 3-6 (2.69g, 81%) as a light brown powder.  
 
m.p. : 144-147°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.53 (t, 1H, J=1.7Hz, ClC-CH-CCl), 7.37 (d, 2H, 
J=1.7Hz, ClC-CH-CN), 4.63 (q, 2H, J=7.1Hz, CH2CH3), 3.81 (s, 2H, CO-CH2), 3.49 (s, 3H, 
S-CH3), 1.42 (t, 1H, J=7.1Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.2 (S=C), 167.0 (O=C), 136.5 (N-C), 136.3 (2 
Cl-C), 131.1 (Cl-C-C-C-Cl), 128.9 (2 N-C-C), 71.5 (CH2CH3) 42.5 (S-C), 41.2 (CO-C), 13.8 
(CH2CH3) 
IR (ν, cm-1, CDCl3)  2987, 2938, 1718, 1574, 1366, 1299, 1158, 1113, 1050   
HRMS (EI+)    Calcd. for C12H13NO4S3Cl2 : 400.9384      Found : 400.9389 
 
 
Dithiocarbonic acid S-{2-[(4-trifluoromethoxy -phenyl)-methanesulfonyl-amino]-2-oxo-
ethyl} ester O-ethyl ester (3-7) 
 
 
Experimental Part 
 241 
 
Following the general procedure 3-I for the preparation of the corresponding xanthate, the 
reaction was started with the mesylation of a solution of 4-(trifluoromethoxy)aniline (8.09g, 
45.7mmol) in distillated 1,2-dichloroethane (33ml, 1.4M), methanesulfonylchloride (3.9mL, 
50.2mmol) and pyridine (4.2ml, 52.0mmol). Recrystallization with AcOEt / EP afforded the 
protected 4-(trifluoromethoxy)aniline (10.2 g, 87%) as a pale white solid.  
 
Then the chloroacetylation was carried out with the solution of the above solid (4.88g, 
19.1mmol) in dry DMF (25ml, 0.6M), chloroacetylchloride (3.27mL, 28.9mmol) and sodium 
hydride (60% in mineral oil, 916mg, 22.9mmol). Recrystallization with AcOEt / EP afforded 
the halogenide (4.68g, 74%) as a pale white solid. 
 
Then the reaction was carried out with the solution of the halogenide (2.52g, 7.60mmol) in 
acetone (25ml, 0.3M) and potassium O-ethylxanthogenate (1.34g, 8.36mmol). Flash 
chromatography on silica gel with AcOEt / EP = 20 / 80 afforded 3-7 (2.70g, 85%) as a 
yellow oil.  
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.49 (m, 2H, CH-CN), 7.37 (d, 2H,  J=8.7Hz, 
CF3OC-CH), 4.62 (q, 2H, J=7.1Hz, CH2CH3), 3.76 (s, 2H, CO-CH2), 3.49 (s, 3H, SO2-CH3), 
1.41 (t, 1H, J=7.1Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.2 (S=C), 167.3 (O=C), 150.5 (d, J=1.6Hz, 
CF3O-C), 132.9 (s, N-C), 131.8 (s, 2 N-C-C), 122.2 (s, 2CF3O-C-C), 120.2 (q, J=258.9Hz, 
CF3), 71.3 (CH2CH3), 42.2 (S-C), 41.3 (CO-C), 13.7 (CH2CH3) 
IR (ν, cm-1, CDCl3)  2988, 2937, 1717, 1507, 1364, 1263, 1112, 1050   
HRMS (EI+)    Calcd. for C13H14O5NF3S3 : 416.9986      Found : 416.9981 
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Dithiocarbonic acid S-{1-(tert-butoxycarbonylamino-methyl)-4-[(4-iodo-phenyl)-
methanesulfonyl-amino]-4-oxo-butyl} ester O-ethyl ester (3-8) 
 
 
 
Following the general procedure 3-II for the addition of xanthate to olefin, the reaction was 
carried out with the solution of 3-1 (1.05g, 2.28mmol) and N-Boc-allylamine (0.54g, 
3.44mmol) in AcOEt (2.5ml, 0.9M), with 10%mol of DLP. Flash chromatography on silica 
gel with AcOEt / DCM = 5 / 95 afforded 3-8 (1.11g, 79%) as a light yellow foam. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.80 (d, 2H, J=8.5Hz, I-C-CH), 7.01 (d, 2H, J=8.4Hz, 
CH-CN), 4.81 (br s, 1H, NH), 4.62 (m, 2H, CH2CH3), 3.82-3.76 (m, 1H, CHS), 3.45 (s, 3H, 
SO2-CH3), 3.43-3.38 (m, 1H, CH2NHBoc), 3.32-3.25 (m, 1H, CH2NHBoc), 2.35-2.22 (m, 2H, 
CO-CH2), 2.17-2.08 (m, 1H, CH2-CH2CO), 1.85-1.75 (m, 1H, CH2-CH2CO), 1.42 (s, 9H, 
C(CH3)3), 1.41 (t, 3H, J=7.1Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.2 (S=C), 172.7 (O=C-NMs), 155.8 (O=C-NH), 
139.3 (2 I-C-C),    134.8 (N-C), 131.6 (2 N-C-C), 96.4 (I-C), 79.7 (C(CH3)3), 70.5 (CH2CH3), 
51.0 (CHS), 43.6 (CH2-NH), 42.2 (SO2-C), 33.8 (CH2-CO), 28.3 (C(CH3)3), 26.0 (CH2-
CH2CO), 13.8 (CH2CH3) 
IR (ν, cm-1, CDCl3)  3451, 2982, 2936, 1698, 1505, 1367, 1235, 1156, 1112, 1050   
HRMS (EI+)    Calcd. for C20H29N2O6S3I : 616.0232      Found : 616.0247  
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Dithiocarbonic acid S-{1-(tert-butoxycarbonylamino-methyl)-4-[(3,5-dimethoxy-
phenyl)-methanesulfonyl-amino]-4-oxo-butyl} ester O-ethyl ester (3-9) 
 
 
 
Following the general procedure 3-II for the addition of xanthate to olefin, the reaction was 
carried out with the solution of 3-2 (1.00g, 2.54mmol) and N-Boc-allylamine (0.80g, 
5.11mmol) in AcOEt (3.5ml, 0.7M), with 15%mol of DLP. Flash chromatography on silica 
gel with AcOEt / EP = 35 / 65 ~ 40 / 60 afforded 3-9 (1.18g, 84%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.54 (t, 1H, J=1.9Hz,  MeOC-CH-COMe), 6.40 (d, 
2H, J=1.7Hz, 2CH-CN), 4.81 (br s, 1H, NH), 4.61 (dq, 2H, J=1.8Hz, J=7.1Hz, CH2-CH3), 
3.84-3.77 (m+s, 7H, CHS + 2OCH3), 3.45 (s, 3H, SO2CH3), 3.44-3.38 (m, 1H, CH2NHBoc), 
3.32-3.27 (m, 1H, CH2NHBoc), 2.45-2.31 (m, 2H, CH2CO), 2.17-2.08 (m, 1H, CH2), 1.84-
1.75 (m, 1H, CH2), 1.41 (s, 9H, C(CH3)3), 1.40 (t, 3H, J=7.2Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.3 (S=C), 173.1 (O=C-NMs), 161.4 (2 MeO-C), 
155.8 (O=C-NH), 136.5 (N-C), 108.1 (2 N-C-C), 102.1 ( MeOC-C-COMe ), 79.6 (C(CH3)3), 
70.4 (CH2CH3), 55.6 (2 O-CH3), 50.9 (CHS), 43.6 (CH2-NH), 42.0 (SO2-C), 33.3 (CH2-CO), 
28.3 (C(CH3)3), 26.0 (CH2-CH2CO), 13.7 (CH2CH3) 
IR (ν, cm-1, CDCl3)  3451, 2982, 2939, 2842, 1709, 1610, 1505, 1473, 1429, 1367, 1208, 
1159, 1064   
HRMS (EI+)    Calcd. for C22H34N2O8S3 : 550.1477      Found : 550.1490 
 
 
Experimental Part 
 244
(7-iodo-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylmethyl)-carbamic acid tert-butyl 
ester (3-10) 
 
 
 
Following the general procedure 3-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 3-8 (568mg, 0.92mmol) and 2,6-lutidine (0.11ml, 0.92mmol) 
in chlorobenzene (46ml, 0.02mmol/ml), with DTBP (0.85ml, 4.60mmol) for 70min. Flash 
chromatography on silica gel with AcOEt / EP = 60 / 40 afforded 3-10 (289mg, 75%) as a 
white powder. 
 
m.p. : 142-145°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.75 (br s, 1H, CO-NH), 7.59-7.57 (m, 2H, CH-C-I), 
6.75 (d, 1H, J=8.1Hz, I-C-CH-CH), 4.63 (br s, 1H, NHBoc), 3.63-3.56 (m, 1H, CH2NHBoc), 
3.45-3.39 (m, 1H, CH2NHBoc), 3.14-3.06 (m, 1H, CH), 2.44-2.25 (m, 3H, CHH-CH2CO + 
CH2CO), 1.83-1.75 (m, 1H, CHH-CH2CO), 1.43 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  174.5 (O=C-NH), 155.7 (O=C-NHBoc), 137.6 (s, 
N-C), 136.7 (s, NC-C-CH), 136.6 (s, NC-C), 136.1 (s, NC-CH-CH), 124.1 (s, NC-CH), 90.2 
(s, I-C), 79.7 (C(CH3)3), 42.3 (CH2-NHBoc), 39.8 (CH-CH2NHBoc), 32.2 (CH2-CH2CO), 
32.1 (CH2-CONH), 28.4 (3 C(CH3)3) 
IR (ν, cm-1, CDCl3)  3452, 3393, 2981, 2935, 1676, 1509, 1393, 1249, 1165   
HRMS (EI+)    Calcd. for C16H21N2O3I : 416.0597      Found : 416.0590       
 
 
 
 
Experimental Part 
 245 
(6,8-dimethoxy-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylmethyl)-carbamic acid 
tert-butyl ester (3-11) 
 
 
 
Following the general procedure 3-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 3-9 (251mg, 0.46mmol) and 2,6-lutidine (0.05ml, 0.46mmol) 
in chlorobenzene (23ml, 0.02mmol/ml), with DTBP (0.42ml, 2.28mmol) for 70min. Flash 
chromatography on silica gel with AcOEt / DCM = 33 / 67 afforded 3-11 (130mg, 81%) as a 
light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.34 (br s, 1H, CO-NH), 6.31 (d, 1H, J=2.3Hz, MeO-
C-CH-C-OMe), 6.09 (d, 1H, J=2.3Hz, MeO-C-CH-C-N), 4.40 (br s, 1H, NHBoc), 3.79 (s, 
3H, -OCH3), 3.78 (s, 3H, -OCH3), 3.76-3.71 (m, 1H, CH), 3.47-3.40 (m, 1H, CH2NHBoc), 
3.38-3.31 (m, 1H, CH2NHBoc), 2.50-2.42 (m, 1H, CHH-CH2CO), 2.34-2.26 (m, 2H, CHH-
CH2CO + CHHCO), 2.07-2.00 (m, 1H, CHHCO), 1.42 (s, 2H, C(CH3)3), 1.35 (s, 7H, 
C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  175.2 (O=C-NH), 159.5 (2 C-OMe), 155.8 (O=C-
NHBoc), 139.0 (s, N-C), 114.6 (s, C-C-N), 99.6 (s, CH-C-N), 95.9 (s, MeO-C-C-C-OMe), 
78.9 (C(CH3)3), 55.9 (OCH3), 55.4 (OCH3), 43.8 (CH2-NH), 32.9 (CH-CH2NHBoc), 32.5 
(CH2-CH2CO), 30.0 (CH2-CONH), 28.3 (3 C(CH3)3) 
IR (ν, cm-1, CDCl3)  3453, 3394, 2979, 2937, 1674, 1613, 1504, 1459, 1368, 1155   
HRMS (EI+)    Calcd. for C18H26N2O5 : 350.1842      Found : 350.1837       
 
 
 
 
Experimental Part 
 246
N-allyl-N-(4-iodophenyl)-methanesulfonamide (3-12)  
 
 
 
To a magnetically stirred solution of the protected 4-iodoaniline (388mg, 1.31mmol) in 
anhydrous DMF (13ml, 0.1M) under nitrogen in an ice bain, was added sodium hydride 
(78mg, 1.96mmol, 60% in mineral oil) little by little. The resulting mixture was warmed to 
room temperature for about 10min. Allylbromide (0.17ml, 1.96mmol) was then added and 
the solution was stirred for 2 hours. Ethyl acetate was added and the solution was washed 
with water 3 times and once with brine. The organic phase was dried over anhydrous 
magnesium sulfate and filtered. Then the solvent was removed under reduced pressure. The 
crude product was purified by flash chromatography on silica gel with AcOEt / EP = 15 / 85 
~ 20 / 80 to afford 3-12 (436mg, 99%) as a colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.71 (d, 2H, J=8.6Hz, IC-CH), 7.08 (d, 2H, J=8.6Hz, 
CH-CN), 5.85-5.75 (m, 1H, CH=CH2), 5.16 (dd, 2H, J=6.4Hz, J=13.1Hz, CH=CH2), 4.26 (d, 
2H, J=6.3Hz, N-CH2), 2.90(s, 3H, S-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  139.0 (N-C), 138.5 (2 I-C-C), 132.5 (CH=CH2), 
130.1 (2 N-C-C), 119.5 (CH=CH2), 93.3 (I-C), 53.5 (N-CH2), 38.1 (S-C) 
IR (ν, cm-1, CDCl3)  3088, 2933, 1645, 1486, 1420, 1345, 1217, 1159, 1070, 1009, 958   
HRMS (EI+)    Calcd. for C10H12INO2S : 336.9633      Found : 336.9638 
 
 
 
 
 
Experimental Part 
 247 
S-1-(4-iodophenyl-methanesulfonyl-amino)-4-cyanobutan-2-yl O-ethyl carbonodithioate 
(3-13) 
 
 
 
A magnetically stirred solution of S-cyanomethyl O-ethyl carbonodithioate (204mg, 
1.27mmol) and the olefin 3-12 (212mg, 0.63mmol) in AcOEt (1.3ml, 1.0M of the xanthate) 
were refluxed for about 30min under nitrogen. DLP (51mg, 10%mol) was then added to the 
refluxing solution, followed by the addition of DLP (26mg, 5%mol) after 60min. 1 hour later 
the reaction was completed. The reaction mixture was then cooled down to room temperature, 
concentrated under reduced pressure and purified by flash chromatography on silica gel with 
AcOEt / EP = 20 / 80 ~ 30 / 70  to yield the desired compounds 3-13 (279mg, 89%) as a light 
yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.79 (d, 2H, J=8.7Hz, I-C-CH), 7.14 (d, 2H, J=8.7Hz, 
CH-CN), 4.58 (q, 2H, J=7.1Hz, CH2CH3), 3.99-3.88 (m, 2H, CH2NMs), 3.76-3.68 (m, 1H, 
CHS), 2.88 (s, 3H, SO2-CH3), 2.63-2.55 (m, 1H, CHH-CN), 2.51-2.34 (m, 2H, CHH-CN + 
CHH-CH2CN), 1.97-1.87 (m, 1H, CHH-CH2CN), 1.36 (t, 3H, J=7.1Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  211.2 (S=C), 139.0 (2 I-C-C), 137.9 (N-C), 130.4 
(2 N-C-C), 118.6 (I-C), 94.4 (CN), 70.7 (CH2CH3), 53.0 (CH2-NMs), 47.7 (CHS), 43.6 
(CH2-NH), 37.2 (SO2-C), 26.4 (CH2-CH2CN), 14.9 (CH2CN), 13.6 (CH2CH3) 
IR (ν, cm-1, CDCl3)  3690, 2986, 2933, 1483, 1444, 1348, 1230, 1159, 1111, 1050, 1009, 963   
HRMS (EI+)    Calcd. for C15H19IN2O3S3 : 497.9602      Found : 497.9607 
 
 
 
Experimental Part 
 248
3-(1-methanesulfonyl-5-iodoindolin-3-yl)propanenitrile (3-14) 
 
 
 
A magnetically stirred solution of the xanthate 3-13 (121mg, 0.24mmol) in chlorobenzene 
(15ml, 0.02M of xanthate) together with 2,6-lutidine (0.04ml, 0.34mmol) were refluxed for 
about 30min under nitrogen. Di-tert-butylperoxide (DTBP) (0.28ml, 1.5mmol) was then 
added to the refluxing solution. The reaction was monitored by TLC until 3 hours when the 
starting xanthate was completely consumed. The reaction mixture was then cooled down to 
room temperature, concentrated under reduced pressure and purified by flash 
chromatography on silica gel with AcOEt / DCM = 1 / 99 ~ 2 / 98 to afford 3-14 (60mg, 66%) 
as a light yellow oil.  
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.57 (dd, 1H, J=1.6Hz, J=8.5Hz, I-C-CH-CH), 7.52 
(s, 1H, I-C-CH-C), 7.19 (d, 1H, J=8.5Hz, I-C-CH-CH), 4.04 (dd, 1H, J=9.0Hz, J=10.4Hz, 
CHHNMs), 3.73 (dd, 1H, J=4.9Hz, J=10.4Hz, CHHNMs), 3.55-3.49 (m, 1H, CH), 2.91 (s, 
3H, SO2-CH3), 2.45 (t, 2H, J=7.2Hz,CH2-CN), 2.14-2.04 (m, H, CHH-CH2CN), 2.00-1.91 (m, 
1H, CHH-CH2CN) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  141.6 (N-C), 138.0 (I-C-CH-CH), 135.1 (N-C-C), 
133.7 (I-C-CH-C), 118.5 (I-C), 115.5 (NC-CH), 86.5 (CN), 55.4 (CH2-N), 38.4 (CH), 34.9 
(SO2-C), 30.1 (CH2-CH2CN), 14.8 (CH2CN) 
IR (ν, cm-1, CDCl3)  2934, 2880, 1593, 1476, 1357, 1247, 1165, 1121, 1069, 994, 955   
HRMS (EI+)    Calcd. for C12H13IN2O2S : 375.9742      Found : 375.9743       
 
 
 
Experimental Part 
 249 
Dithiocarbonic acid S-{1-(tert-butoxycarbonylamino-methyl)-4-[(4-bromo-phenyl)-
methanesulfonyl-amino]-4-oxo-butyl} ester O-ethyl ester (3-15) 
 
 
 
Following the general procedure 3-II for the addition of xanthate to olefin, the reaction was 
carried out with the solution of 3-3 (1.06g, 2.6mmol) and N-Boc-allylamine (0.82g, 5.2mmol) 
in AcOEt (3ml, 0.9M), with 10%mol of DLP. Flash chromatography on silica gel with 
AcOEt / EP = 30 / 70 afforded 3-15 (1.27g, 86%) as a white powder. 
 
m.p. : 126-129°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.61 (d, 2H, J=8.5Hz, Br-C-CH), 7.15 (d, 2H, 
J=8.5Hz, CH-CN), 4.79 (br s, 1H, NH), 4.62 (m, 2H, CH2CH3), 3.80 (dt, 1H, J=5.8Hz, 
J=11.1Hz, CHS), 3.46 (s, 3H, SO2-CH3), 3.43-3.38 (m, 1H, CH2NHBoc), 3.33-3.26 (m, 1H, 
CH2NHBoc), 2.34-2.23 (m, 2H, CO-CH2), 2.17-2.09 (m, 1H, CH2-CH2CO), 1.85-1.76 (m, 
1H, CH2-CH2CO), 1.42 (s, 9H, C(CH3)3), 1.42 (t, 3H, J=7.1Hz, CH2CH3)  
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.3 (S=C), 172.8  (O=C-NMs), 155.8 (O=C-NH), 
134.1 (N-C), 133.3 (2 Br-C-C), 131.4 (2 N-C-C), 124.6 (Br-C), 79.7 (C(CH3)3), 70.5 
(CH2CH3), 51.0 (CHS), 43.6 (CH2-NH), 42.2 (SO2-C), 33.8 (CH2-CO), 28.3 (C(CH3)3), 26.0 
(CH2-CH2CO), 13.8 (CH2CH3) 
IR (ν, cm-1, CDCl3)  3451, 2982, 2936, 1710, 1505, 1367, 1230, 1157, 1112, 1050   
HRMS (EI+)    Calcd. for C20H29N2O6S3Br : 568.0371      Found : 568.0358 
 
 
Experimental Part 
 250
Dithiocarbonic acid S-{1-(tert-butoxycarbonylamino-methyl)-4-[(4-fluoro-phenyl)-
methanesulfonyl-amino]-4-oxo-butyl} ester O-ethyl ester (3-16) 
 
 
 
Following the general procedure 3-II for the addition of xanthate to olefin, the reaction was 
carried out with the solution of 3-4 (1.16g, 3.3mmol) and N-Boc-allylamine (0.78g, 5.0mmol) 
in AcOEt (4ml, 0.8M), with 10%mol of DLP. Flash chromatography on silica gel with Et2O / 
EP = 1 / 1 afforded 3-16 (1.20g, 72%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.24 (m, 2H, CH-CN), 7.13 (m, 2H, CF-CH), 4.87 (br 
s, 1H, NH), 4.58 (m, 2H, CH2CH3), 3.76 (dt, 1H, J=5.9Hz, J=11.1Hz, CHS), 3.43 (s, 3H, 
SO2-CH3), 3.40-3.33 (m, 1H, CH2NHBoc), 3.29-3.22 (m, 1H, CH2NHBoc), 2.27-2.24 (m, 2H, 
CO-CH2), 2.14-2.05 (m, 1H, CH2-CH2CO), 1.82-1.73 (m, 1H, CH2-CH2CO), 1.39 (s, 9H, 
C(CH3)3), 1.37 (t, 3H, J=7.1Hz, CH2CH3)  
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.1 (S=C), 172.9  (O=C-NMs), 163.1 (d, 
J=251.4Hz, F-C), 155.7 (O=C-NH), 131.6 (d, J=9.0Hz, 2 N-C-C), 131.0 (d, J=3.4Hz, N-C), 
117.0 (d, J=23.0Hz, 2 F-C-C), 79.5 (C(CH3)3), 70.3 (CH2CH3), 50.8 (CHS), 43.4 (CH2-NH), 
41.9 (SO2-C), 33.7 (CH2-CO), 28.2 (3 C(CH3)3), 25.8 (CH2-CH2CO), 13.6 (CH2CH3) 
IR (ν, cm-1, CDCl3)  3451, 2982, 2935, 1710, 1602, 1506, 1366, 1223, 1158, 1050  
HRMS (EI+)    Calcd. for C20H29N2O6FS3 : 508.1172      Found : 508.1158 
 
 
 
Experimental Part 
 251 
Dithiocarbonic acid S-{1-(tert-butoxycarbonylamino-methyl)-4-[(3,5-bis(trifluoromethyl) 
-phenyl)-methanesulfonyl-amino]-4-oxo-butyl} ester O-ethyl ester (3-17) 
 
 
 
Following the general procedure 3-II for the addition of xanthate to olefin, the reaction was 
carried out with the solution of 3-5 (1.64g, 3.5mmol) and N-Boc-allylamine (0.82g, 5.2mmol) 
in AcOEt (3.5ml, 1.0M), with 15%mol of DLP. Flash chromatography on silica gel with 
AcOEt / EP = 15 / 85 afforded 3-17 (1.77g, 81%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.99 (s, 1H, CF3C-CH-CCF3), 7.77 (s, 2H, CF3C-CH-
CN), 4.83 (br s, 1H, NH), 4.60 (m, 2H, CH2CH3), 3.88-3.84 (m, 1H, CHS), 3.53 (s, 3H, SO2-
CH3), 3.46-3.39 (m, 1H, CH2NHBoc), 3.32-3.26 (m, 1H, CH2NHBoc), 2.38-2.26 (m, 2H, 
CO-CH2), 2.22-2.16 (m, 1H, CH2-CH2CO), 1.85-1.76 (m, 1H, CH2-CH2CO), 1.41 (s, 9H, 
C(CH3)3), 1.40 (t, 3H, CH2CH3)  
13C-NMR (į, ppm) (CDCl3, 100 MHz)  213.8 (S=C), 172.0 (O=C-NMs), 155.8 ( O=C-NH), 
136.8 (N-C), 133.8 (q, J=34.4Hz, 2 CF3-C), 130.5 (d, J=3.0Hz, 2 N-C-C), 124.0 (m, CF3-C-
C-C-CF3), 122.3 (q, J=273.2Hz, 2 CF3), 79.6 (C(CH3)3), 70.6 (CH2CH3), 51.2 (CHS), 43.5 
(CH2-NH), 42.4 (SO2-C), 33.9 (CH2-CO), 28.2 (C(CH3)3), 26.0 (CH2-CH2CO), 13.5 
(CH2CH3) 
IR (ν, cm-1, CDCl3)  3452, 2982, 2933, 1713, 1505, 1462, 1371, 1279, 1230, 1151, 1110, 
1050   
HRMS (EI+)    Calcd. for C22H28F6N2O6S3 : 626.1014      Found : 626.0987 
 
 
Experimental Part 
 252
Dithiocarbonic acid S-{1-(tert-butoxycarbonylamino-methyl)-4-[(3,5-dichloro-phenyl)-
methanesulfonyl-amino]-4-oxo-butyl} ester O-ethyl ester (3-18) 
 
 
 
Following the general procedure 3-II for the addition of xanthate to olefin, the reaction was 
carried out with the solution of 3-6 (1.11g, 2.8mmol) and N-Boc-allylamine (0.87g, 5.5mmol) 
in AcOEt (3ml, 0.9M), with 10%mol of DLP. Flash chromatography on silica gel with 
AcOEt / EP = 25 / 75 afforded 3-18 (1.27g, 81%) as a yellow foam. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.49 (t, 1H, J=1.68Hz, ClC-CH-CCl), 7.21 (d, 2H, 
ClC-CH-CN), 4.80 (br s, 1H, NH), 4.65 (q, 2H, J = 7.1Hz, CH2CH3), 3.87-3.83 (m, 1H, 
CHS), 3.49 (s, 3H, SO2-CH3), 3.46-3.41 (m, 1H, CH2NHBoc), 3.34-3.28 (m, 1H, 
CH2NHBoc), 2.40-2.26 (m, 2H, CO-CH2), 2.22-2.11 (m, 1H, CH2-CH2CO), 1.85-1.74 (m, 
1H, CH2-CH2CO), 1.42 (s, 9H, C(CH3)3), 1.42 (t, 3H, J = 7.0Hz, CH2CH3)  
13C-NMR (į, ppm) (CDCl3, 100 MHz)  213.6 (S=C), 172.3 (O=C-NMs), 155.9 (O=C-NH), 
136.8 (N-C), 136.1 (2 Cl-C), 130.7 (Cl-C-C-C-Cl), 128.8 (2 N-C-C), 79.7 (C(CH3)3), 70.7 
(CH2CH3), 51.3 (CHS), 43.7 (CH2-NH), 42.4 (SO2-C), 33.8 (CH2-CO), 28.3 (C(CH3)3), 26.1 
(CH2-CH2CO), 13.8 (CH2CH3) 
IR (ν, cm-1, CDCl3)  3452, 2982, 2932, 1712, 1574, 1506, 1367, 1227, 1169, 1050   
HRMS (EI+)    Calcd. for C20H28Cl2N2O6S3 : 558.0487      Found : 558.0510 
 
 
 
Experimental Part 
 253 
Dithiocarbonic acid S-{1-(tert-butoxycarbonylamino-methyl)-4-[(4-trifluoromethoxy-
phenyl)-methanesulfonyl-amino]-4-oxo-butyl} ester O-ethyl ester (3-19) 
 
 
 
Following the general procedure 3-II for the addition of xanthate to olefin, the reaction was 
carried out with the solution of 3-7 (0.89g, 2.1mmol) and N-Boc-allylamine (0.52g, 3.2mmol) 
in AcOEt (2.5ml, 0.8m), with 10%mol of DLP. Recrystallization with AcOEt / EP afforded 
3-19 (0.99g, 82%) as a white powder. 
 
m.p. : 122-125°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.32 (m, 4H, H-Ar), 4.80 (br s, 1H, NH), 4.61 (m, 2H,  
J=1.0Hz, J=7.1Hz, CH2CH3), 3.80 (dt, 1H, J=5.6Hz, J=11.1Hz, CHS), 3.48 (s, 3H, SO2-CH3), 
3.46-3.39 (m, 1H, CH2NHBoc), 3.32-3.26 (m, 1H, CH2NHBoc), 2.32-2.28 (m, 2H, CO-CH2), 
2.18-2.10 (m, 1H, CH2-CH2CO), 1.87-1.76 (m, 1H, CH2-CH2CO), 1.42 (s, 9H, C(CH3)3), 
1.41 (t, 3H, J=7.1Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.3 (S=C), 172.8 (O=C-NMs), 155.8 (O=C-NH),  
150.2 (d, J=1.9Hz, CF3O-C), 133.4 (s, N-C), 131.5 (s, 2 N-C-C), 122.0 (s, 2 CF3O-C-C), 
120.3 (q, J=258.6Hz, OCF3), 79.7 (C(CH3)3), 70.5 (CH2CH3), 51.0 (CHS), 43.6 (CH2-NH), 
42.2 (SO2-C), 33.9 (CH2-CO), 28.3 (3 C(CH3)3), 26.0 (CH2-CH2CO), 13.7 (CH2CH3) 
IR (ν, cm-1, CDCl3)  3451, 2982, 2936, 1712, 1507, 1367, 1258, 1221, 1169, 1112, 1050   
HRMS (EI+)    Calcd. for C21H29N2O7F3S3 : 574.1089      Found : 574.1099 
 
 
Experimental Part 
 254
(7-bromo-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylmethyl)-carbamic acid tert-
butyl ester (3-20) 
 
 
 
Following the general procedure 3-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 3-15 (273mg, 0.48mmol) and 2,6-lutidine (0.03ml, 0.24mmol) 
in chlorobenzene (24ml, 0.02mmol/ml), with DTBP (0.44ml, 2.40mmol) for 120min. Flash 
chromatography on silica gel with AcOEt / EP = 50 / 50 ~ 67 / 33 afforded 3-20 (98mg, 56%) 
as a white powder. 
 
m.p. : 126-129°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  8.16 (br s, 1H, CO-NH), 7.40-7.38 (m, 2H, H-Ar), 
6.90 (d, 1H, J=8.7Hz, , Br-C-CH-CH), 4.78 (br s, 1H, NHBoc), 3.65-3.57 (m, 1H, CH2-
NHBoc), 3.43-3.37 (m, 1H, CH2NHBoc), 3.14-3.09 (m, 1H, CH), 2.35-2.27 (m, 3H, CHH-
CH2CO + CH2CO), 1.79-1.75 (m, 1H, CHH-CH2CO), 1.42 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  174.8 (O=C-NH), 155.7 ( O=C-NHBoc), 136.9 (s, 
N-C), 136.4 (s, N-C-C), 130.6 (s, Br-C-CH-C), 130.2 (s, Br-C-CH-CH), 123.8 (s, N-C-CH), 
119.2 (s, Br-C), 79.7 (C(CH3)3), 42.2 (CH2-NH), 39.8 (CH-CH2NHBoc), 32.2 (CH2-CH2CO), 
32.1 (CH2-CONH), 28.4 (3 C(CH3)3) 
IR (ν, cm-1, CDCl3)  3452, 3394, 2981, 2931, 1675, 1508, 1455, 1368, 1249, 1165   
HRMS (EI+)    Calcd. for C16H21N2O3Br : 368.0736      Found : 368.0737       
 
 
 
 
Experimental Part 
 255 
(7-fluoro-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylmethyl)-carbamic acid tert-
butyl ester (3-21) 
 
 
 
Following the general procedure 3-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 3-16 (233mg, 0.46mmol) and 2,6-lutidine (0.05ml, 0.46mmol) 
in chlorobenzene (30ml, 0.02mmol/ml), with DTBP (0.42ml, 2.29mmol) for 120min. Flash 
chromatography on silica gel with AcOEt / EP = 50 / 50 ~ 60 / 40 afforded 3-21 (81mg, 57%) 
as a white powder. 
 
m.p. : 154-157°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.67 (br s, 1H, CO-NH), 7.01-6.94 (m, 3H, H-Ar), 
4.65 (br s, 1H, NH), 3.62-3.55 (m, 1H, CH2NHBoc), 3.48-3.42 (m, 1H, CH2NHBoc), 3.17-
3.09 (m, 1H, CH), 2.43-2.24 (m, 3H, CHH-CH2CO + CH2CO), 1.81-1.73 (m, 1H, CHH-
CH2CO), 1.42 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  174.5 (O=C-NH), 160.7 (d, J=245.6Hz, F-C), 
155.7 (O=C-NHBoc), 136.6 (s, N-C), 133.7 (d, J=3.0Hz, N-C-C), 123.9 (d, J=8.5Hz, N-C-
CH), 114.23 (d, J=22.8Hz, F-C-CH-C), 113.96 (d, J=23.8Hz, F-C-CH-CH), 79.7 (C(CH3)3), 
42.3 (CH2-NH), 39.8 (CH-CH2NHBoc), 32.2 (CH2-CH2CO), 32.0 (CH2-CONH), 28.3 (3 
C(CH3)3) 
IR (ν, cm-1, CDCl3)  3452, 3396, 2930, 1674, 1500, 1456, 1368, 1249, 1170   
HRMS (EI+)    Calcd. for C16H21FN2O3 : 308.1536      Found : 308.1539       
 
 
 
Experimental Part 
 256
[6,8-bis(trifluoromethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylmethyl]-
carbamic acid tert-butyl ester (3-22)  
 
 
 
Following the general procedure 3-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 3-17 (526mg, 0.84mmol) and 2,6-lutidine (0.10ml, 0.84mmol) 
in chlorobenzene (42ml, 0.02mmol/ml), with DTBP (0.77ml, 4.20mmol) for 60min. Flash 
chromatography on silica gel with AcOEt / DCM = 20 / 80 afforded 3-22 (94mg, 26%) as a 
colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  8.30 (br s, 1H, CO-NH), 7.75 (s, 1H, CF3-C-CH-C- 
CF3), 7.44 (s, 1H, CF3-C-CH-C-N), 4.49 (br s, 1H, NHBoc), 4.06-3.98 (m, 1H, CH2NHBoc), 
3.65-3.59 (m, 1H, CH), 3.33-3.26 (m, 1H, CH2NHBoc), 2.46-2.20 (m, 4H, CHH-CH2CO + 
CH2CO), 1.25 (s, 2H, C(CH3)3), 1.22 (s, 7H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  174.2 (O=C-NH), 155.6 (O=C-NHBoc), 140.9 (N-
C), 137.3 (CF3-C-C), 132.8 (d, J=30.1Hz, CF3-C-CH-CN) 130.6 (d, J=31.4Hz, CF3-C-C-CN), 
123.8 (N-C-CH-C-CF3), 123.4 (d, J=275.1Hz, NC-CH-C-CF3), 122.9 (d, J=274.8Hz, NC-C-
C-CF3), 119.8 (CF3-C-CH-C-CF3), 79.4 (C(CH3)3), 42.4 (CH2-NHBoc), 38.8 (CH-CH2-
NHBoc), 31.6 (CH2-CONH), 30.5 (CH2-CH2CO), 28.1 (3 C(CH3)3) 
IR (ν, cm-1, CDCl3)  3456, 3386, 2930, 1698, 1509, 1460, 1355, 1274, 1189, 1142   
HRMS (EI+)    Calcd. for C18H20F6N2O3 : 426.1378      Found : 426.1384       
 
 
 
 
Experimental Part 
 257 
(6,8-dichloro-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylmethyl)-carbamic acid tert-
butyl ester (3-23) 
 
 
 
Following the general procedure 3-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 3-18 (342mg, 0.61mmol) and 2,6-lutidine (0.08ml, 0.61mmol) 
in chlorobenzene (31ml, 0.02mmol/ml), with DTBP (0.57ml, 3.06mmol) for 60min. Flash 
chromatography on silica gel with AcOEt / DCM = 45 / 55 afforded 3-23 (129mg, 59%) as a 
light yellow foam. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  9.00 (br s, 1H, CO-NH), 7.23 (s, 1H, Cl-C-CH-C-Cl), 
6.96 (s, 1H, Cl-C-CH-C-N), 4.63 (br s, 1H, NHBoc), 3.98-3.96 (m, 1H, CH), 3.55-3.47 (m, 
1H, CH2NHBoc), 3.39-3.33 (m, 1H, CH2NHBoc), 2.46-2.27 (m, 3H, CHH-CH2CO + 
CH2CO), 2.18-2.13 (m, 1H, CHH-CH2CO), 1.40 (s, 2H, C(CH3)3), 1.32 (s, 7H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  175.5 (O=C-NH), 155.7 ( O=C-NHBoc), 140.0 (s, 
N-C), 137.0 (s, Cl-C-C), 133.3 (s, Cl-C-CH), 130.4 (s, N-C-C-C-Cl), 126.3 (s, Cl-C-CH-C-
Cl), 122.0 (s, N-C-CH-C-Cl), 79.3 (C(CH3)3), 43.0 (CH2-NH), 37.7 (CH-CH2NHBoc), 32.1 
(CH2-CONH), 29.5 (CH2-CH2CO), 28.2 (3 C(CH3)3) 
IR (ν, cm-1, CDCl3)  3455, 3389, 2981, 1683, 1590, 1508, 1457, 1369, 1251, 1164 
HRMS (EI+)    Calcd. for C16H20Cl2N2O3 : 358.0851      Found : 358.0856 
 
 
 
 
 
Experimental Part 
 258
(7-trifluoromethoxy-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-5-ylmethyl)-carbamic 
acid tert-butyl ester (3-24) 
 
 
 
Following the general procedure 3-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 3-19 (649mg, 1.13mmol) and 2,6-lutidine (0.13ml, 1.13mmol) 
in chlorobenzene (56.5ml, 0.02mmol/ml), with DTBP (1.04ml, 5.65mmol) for 60min. Flash 
chromatography on silica gel with AcOEt / DCM = 45 / 55 afforded 3-24 (161mg, 38%) as a 
white powder. 
 
m.p. : 120-123°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  8.53 (br s, 1H, CO-NH), 7.16-7.05 (m, 3H, H-Ar), 
4.94 (br s, 1H, NHBoc), 3.68-3.60 (m, 1H, CH2NHBoc), 3.39-3.33 (m, 1H, CH2NHBoc), 
3.15-3.06 (m, 1H, CH), 2.35-2.12 (m, 3H, CHH-CH2CO + CH2CO), 1.78-1.72 (m, 1H, CHH-
CH2CO), 1.40 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  175.1 (O=C-NH), 155.7 (O=C-NHBoc), 146.9 (d, 
J=1.7Hz, CF3O-C), 136.4 (s, N-C-C), 136.2 (s, N-C), 123.4 (s, N-C-CH), 120.4 (q, J=258.2, 
OCF3), 120.2 (s, OCF3-C-CH-C), 120.1 (s, OCF3-C-CH-CH), 79.6 (C(CH3)3), 42.2 CH2-NH), 
39.7 (CH-CH2NHBoc), 32.15 (CH2-CH2CO), 32.05 (CH2-CONH), 28.3 (3 C(CH3)3) 
IR (ν, cm-1, CDCl3)  3452, 3395, 2931, 1680, 1504, 1456, 1369, 1262, 1171  
HRMS (EI+)    Calcd. for C17H21F3N2O4 : 374.1453      Found : 374.1458      
 
 
 
 
 
Experimental Part 
 259 
5-(2-amino-5-iodo-phenyl)-piperidin-2-one (3-25) 
 
 
 
Following the general procedure 3-IV, the reaction was carried out with 25mg of 3-10 
(0.06mmol) and 0.14ml of the solution of 30% TFA (0.57mmol) in DCM. After finishing the 
first step, which took 1 hour stirring at room temperature, the solvent was removed under 
reduced pressure. Then the reaction was carried out with 1.4ml toluene (0.05M) and 0.12ml 
TEA (0.85mmol). The mixture was kept stirring at 90°C for about 1 hour, and then the 
precipitation was seperated by centrifuge and washed by cold acetone to afford 3-25 (11mg, 
55%) as a white powder. 
 
m.p. : 207-210 °C 
1H-NMR (į, ppm) (DεSO, 400 εHz)  7.53 (d, 1H, J=2.9Hz, CO-NH), 7.19 (d, 2H, J=9.1Hz, 
CH-C-I), 6.47 (d, 1H, J=8.0Hz, I-C-CH-CH), 5.26 (s, 2H, NH2), 3.26-3.24 (m, 1H, CHH-
NHCO), 3.08-2.97 (m, 2H, CHH-NHCO + CH), 2.37-2.18 (m, 2H, CH2CO), 1.94-1.78 (m, 
2H, CH2-CH2CO) 
13C-NMR (į, ppm) (DεSO, 100.6 εHz)  169.7 (O=C-NH), 145.9 (NH2-C), 135.2 (NC-C-
CH), 133.8 (NC-CH-CH), 128.4 (NC-C), 117.4 (NC-CH), 76.9 (I-C), 45.6 (CH2-NHCO), 
32.4 (CH-CH2NHCO), 31.3 (CH2-CONH), 26.2 (CH2-CH2CO) 
IR (ν, cm-1, Nujol)  3343, 3211, 2950, 1633, 1460, 1377, 1261, 1211   
HRMS (EI+)    Calcd. for C11H13N2OI : 316.0073      Found : 316.0072 
 
 
 
 
 
 
Experimental Part 
 260
5-(2-acetyl-amino-4,6-dimethoxy-phenyl)-piperidin-2-one (3-26) 
 
 
 
Following the general procedure 3-IV, the reaction was carried out with 34mg of 3-11 
(0.10mmol) and 0.20ml of the solution of 30% TFA (0.78mmol) in DCM. After finishing the 
first step, which took 1 hour stirring at room temperature, the solvent was removed under 
reduced pressure. Then the reaction was carried out with 1.9ml toluene (0.05M) and 0.16ml 
TEA (1.16mmol). The mixture was kept stirring at 90°C for about 1 hour and then 0.07ml 
Ac2O (0.78mmol) was added directly. The mixture was kept stirring at 90°C for about 30 
minutes, and then the precipitation was seperated by centrifuge and washed by cold AcOEt to 
afford 3-26 (27mg, 95%) as a white powder. 
 
m.p. : 227-231°C 
1H-NMR (į, ppm) (εeOD, 400 εHz)  6.48 (s, 1H, εeO-C-CH-C-OMe), 6.38 (s, 1H, CH-
CN), 3.80 (s, 3H, NC-CH-C-OCH3), 3.75 (s, 3H, NC-C-C-OCH3), 3.77-3.72 (m, 1H, CHH-
NHCO), 3.18-3.12 (m, 2H, CHH-NHCO + CH-CH2-NHCO), 2.58-2.47 (m, 1H, CHH-
CH2CO), 2.43-2.28 (m, 2H, CO-CH2), 2.12 (s, 3H, CO-CH3) 1.76-1.72 (m, 1H, CHH-
CH2CO) 
13C-NMR (į, ppm) (εeOD, 100.6 MHz)  175.3 (O=C-NH), 173.1 (O=C-CH3), 161.3 (MeO-
C-CH-CN), 161.0 (MeO-C-C-CN), 138.1 (C-N), 119.7 (C-CN), 105.8 (CH-CN), 99.4 (MeO-
C-CH-C-OMe), 56.0 (CN-CH-C-OCH3), 55.9 (CN-C-C-OCH3), 45.0 (CH2-NHCO), 35.0 
(CH-CH2NH), 32.7 (CH2-CO), 25.6 (CH2-CH2CO), 22.9 (CO-CH3) 
IR (ν, cm-1, Nujol)  3260, 2923, 2855, 1671, 1583, 1466, 1276, 1150, 1110   
HRMS (EI+)    Calcd. for C15H20N2O4 : 292.1423      Found : 292.1416 
 
 
Experimental Part 
 261 
5-(2-amino-5-bromo-phenyl)-piperidin-2-one (3-27) 
 
 
 
Following the general procedure 3-IV, the reaction was carried out with 126mg of 3-20 
(0.34mmol) and 0.7ml of the solution of 30% TFA (2.74mmol) in DCM. After finishing the 
first step, which took 1 hour stirring at room temperature, the solvent was removed under 
reduced pressure. Then the reaction was carried out with 6.8ml toluene (0.05M) and 0.57ml 
TEA (4.10mmol). The mixture was kept stirring at 70-90°C for about 2 hours, and then the 
precipitation was seperated by centrifuge and washed by cold acetone to afford 3-27 (76mg, 
83%) as a very light yellow powder. 
 
m.p. :  263-266°C 
1H-NMR (į, ppm) (DεSO, 400 εHz)  7.54 (d, 1H, J=3.4Hz, NHCO), 7.07 (d, 1H, J=2.3Hz, 
BrC-CH-CH), 7.04 (dd, 1H, J=2.4Hz, J=8.4Hz, BrC-CH-C), 6.58 (d, 1H, J=8.5Hz, CH-CN), 
5.26 (s, 2H, NH2), 3.29-3.24 (m, 1H, CH2NHCO), 3.09-2.99 (m, 2H, CHS + CH2NHCO), 
2.37-2.18 (m, 2H, CO-CH2), 1.96-1.78 (m, 2H, CH2-CH2CO) 
13C-NMR (į, ppm) (DεSO, 100.6 εHz)  169.7 (O=C-NH), 145.4 (NH2-C), 129.4 (Br-C-
CH-C), 128.2 (Br-C-CH-CH), 127.8 (C-C-NH2), 116.7 (CH-C-NH2), 106.9 (C-Br), 45.6 
(CH2-NHCO), 32.5 (CH-CH2NH), 31.3 (CH2-CO), 26.2 (CH2-CH2CO) 
IR (ν, cm-1, Nujol)  3340, 3174, 2964, 2864, 1633, 1464, 1377, 1260, 1211   
HRMS (EI+)    Calcd. for C11H13BrN2O : 268.0211      Found : 268.0221 
 
 
 
 
 
 
Experimental Part 
 262
5-(2-acetyl-amino-5-fluoro-phenyl)-piperidin-2-one (3-28) 
 
 
 
Following the general procedure 3-IV, the reaction was carried out with 43mg of 3-21 
(0.14mmol) and 0.28ml of the solution of 30% TFA (1.12mmol) in DCM. After finishing the 
first step, which took 1 hour stirring at room temperature, the solvent was removed under 
reduced pressure. Then the reaction was carried out with 2.8ml toluene (0.05M) and 0.23ml 
TEA (1.67mmol). The mixture was kept stirring at 90°C for about 1 hour and then 0.11ml 
Ac2O (1.12mmol) was added directly. The mixture was kept stirring at 90°C for about 30 
minutes, and then the precipitation was seperated by centrifuge and washed by cold AcOEt to 
afford 3-28 (21mg, 60%) as a pale white powder. 
 
m.p. :  238-242 °C 
1H-NMR (į, ppm) (εeOD, 400 MHz)  7.25 (dd, 1H, J=5.5Hz, J=8.8Hz, N-C-CH), 7.15 (dd, 
1H, J=2.8Hz, J=10.0Hz, F-C-CH-CH), 7.01 (dt, 1H, J=2.9Hz, J=8.4Hz, F-C-CH-C), 3.41-
3.36 (m, 1H, CHH-NHCO), 3.25-3.19 (m, 2H, CHH-NHCO + CH-CH2NH), 2.48-2.45 (m, 
2H, CH2CO), 2.16 (s, 3H, O=C-CH3), 2.12-1.94 (m, 2H, CH2-CH2CO) 
13C-NMR (į, ppm) (εeOD, 100.6 εHz)  174.4 (O=C-NH), 173.3 (O=C-CH3), 163.1 (d, 
J=244.8Hz, F-C), 142.3 (d, J=7.6Hz, N-C-C), 132.5 (d, J=2.8Hz, N-C), 131.0 (d, J=8.7Hz, 
N-C-CH), 115.2 (d, J=22.5Hz, F-C-CH-C), 114.6 (d, J=23.4Hz, F-C-CH-CH), 48.3 (CH2-
NHCO), 35.6 (CH-CH2-NHCO), 32.1 (CH2-CONH), 28.2 (CH2-CH2CO), 22.9 (O=C-CH3) 
IR (ν, cm-1, Nujol)  3242, 1670, 1637, 1535, 1491, 1294, 1249, 1193 
HRMS (EI+)    Calcd. for C13H15N2O2F : 250.1118      Found : 250.1119 
 
 
 
Experimental Part 
 263 
5-[2-amino-4,6-bis(trifluoromethyl)-phenyl]-piperidin-2-one (3-29) 
 
 
 
Following the general procedure 3-IV, the reaction was carried out with 71mg of 3-22 
(0.17mmol) and 0.34ml of the solution of 30% TFA (1.34mmol) in DCM. After finishing the 
first step, which took 70min stirring at room temperature, the solvent was removed under 
reduced pressure. Then the reaction was carried out with 3.3ml toluene (0.05M) and 0.28ml 
TEA (2.0mmol). The mixture was kept stirring at 80°C for about 1.5 hours, and then the 
precipitation was seperated by centrifuge and washed by cold acetone to afford 3-29 (31mg, 
56%) as a white powder. 
 
m.p. : 270-273 °C 
1H-NMR (į, ppm) (DεSO, 400 εHz)  7.57 (s, 1H, CO-NH), 7.28 (s, 1H, NH2-C-CH), 7.07 
(s, 1H, CF3C-CH-CCF3), 5.89 (s, 2H, NH2), 3.78-3.73 (m, 1H, CHH-NHCO), 3.40-3.26 (m, 
1H, CH), 3.07-3.05 (m, 1H, CHH-NHCO), 2.61-2.58 (m, 1H, CHH-CH2CO), 2.33-2.21 (m, 
2H, CH2CO), 1.65-1.61 (m, 1H, CHH-CH2CO) 
13C-NMR (į, ppm) (DεSO, 100.6 εHz)  170.3 (O=C-NH), 148.9 (NH2-C), 129.7 (q, 
J=27.7Hz, CF3-C-CH-CN), 128.1 (q, J=31.5Hz, CF3-C-C-CN), 124.1 (q, J=275.0Hz, CF3-C-
CH-CN), 125.2 (NC-C), 123.5 (q, J=271.8Hz, CF3-C-C-CN), 116.3 (NC-CH), 108.9 (CF3-C-
CH-C-CF3), 40.3 (CH2-NHCO), 34.7 (CH-CH2NHCO), 31.4 (CH2-CONH), 21.2 (CH2-
CH2CO) 
IR (ν, cm-1, Nujol)  3453, 3368, 2972, 1644, 1461, 1377, 1269, 1213, 1169, 1119   
HRMS (EI+)    Calcd. for C13H12N2OF6 : 326.0854      Found : 326.0852 
 
 
 
Experimental Part 
 264
5-(2-amino-4,6-dichloro-phenyl)-piperidin-2-one (3-30) 
 
 
 
Following the general procedure 3-IV, the reaction was carried out with 129mg of 3-23 
(0.36mmol) and 0.73ml of the solution of 30% TFA (2.86mmol) in DCM. After finishing the 
first step, which took 1 hour stirring at room temperature, the solvent was removed under 
reduced pressure. Then the reaction was carried out with 7.2ml toluene (0.05M) and 0.60ml 
TEA (4.29mmol). The mixture was kept stirring at 80°C for about 30min, and then the 
precipitation was seperated by centrifuge and washed by cold acetone to afford 3-30 (76mg, 
81%) as a white powder. 
 
m.p. :   276-280 °C 
1H-NMR (į, ppm) (DεSO, 400 εHz)  7.52 (s, 1H, CO-NH), 6.67 (s, 1H, NH2-C-CH), 6.63 
(s, 1H, ClC-CH-CCl), 5.65 (s, 2H, NH2), 3.66 (t, 1H, J=11.5Hz, CHH-NHCO), 3.52-3.42 (m, 
1H, CH), 3.03-2.99 (m, 1H, CHH-NHCO), 2.61-2.44 (m, 1H, CHH-CH2CO), 2.34-2.21 (m, 
2H, CH2CO), 1.63 (d, 1H, J=12.0Hz, CHH-CH2CO) 
13C-NMR (į, ppm) (DεSO, 100.6 εHz)  170.2 (O=C-NH), 149.6 (NH2-C), 134.4 (Cl-C-C-
CN), 131.6 (Cl-C-CH-CN), 120.4 (NC-C), 116.6 (Cl-C-CH-C-Cl), 113.8 (NC-CH), 41.4 
(CH2-NHCO), 33.7 (CH-CH2NHCO), 31.7 (CH2-CONH), 22.9 (CH2-CH2CO) 
IR (ν, cm-1, Nujol)  3449, 3362, 3261, 1644, 1561, 1403, 1203, 1130   
HRMS (EI+)    Calcd. for C11H12Cl2N2O : 258.0327      Found : 258.0324 
 
 
 
 
 
Experimental Part 
 265 
5-(2-acetyl-amino-5-trifluoromethoxy-phenyl)-piperidin-2-one (3-31) 
 
 
 
Following the general procedure 3-IV, the reaction was carried out with 18mg of 3-24 
(0.05mmol) and 0.1ml of the solution of 30% TFA (0.39mmol) in DCM. After finishing the 
first step, which took 1 hour stirring at room temperature, the solvent was removed under 
reduced pressure. Then the reaction was carried out with 1.0ml toluene (0.05M) and 0.08ml 
TEA (0.58mmol). The mixture was kept stirring at 90°C for about 1 hour and then 0.04ml 
Ac2O (0.38mmol) was added directly. The mixture was kept stirring at 90°C for about 30 
minutes, and then the precipitation was seperated by centrifuge and washed by cold AcOEt to 
afford 3-31 (11mg, 75%) as a white powder. 
 
m.p. :  222-225 °C 
1H-NMR (į, ppm) (εeOD, 400 εHz)  7.37 (dd, 1H, J=3.8Hz, J=8.7Hz, N-C-CH), 7.29 (d, 
1H, J=2.9Hz, CF3O-C-CH-C), 7.19 (d, 1H, J=7.9Hz, CF3O-C-CH-CH), 3.41-3.36 (m, 1H, 
CHH-NHCO), 3.28-3.21 (m, 2H, CHH-NHCO + CH-CH2NH), 2.48-2.44 (m, 2H, CH2CO), 
2.17 (s, 3H, O=C-CH3), 2.12-1.94 (m, 2H, CH2-CH2CO) 
13C-NMR (į, ppm) (εeOD, 100.6 εHz)  174.3 (O=C-NH), 173.2 (O=C-CH3), 149.2 (d, 
J=1.6Hz, CF3O-C), 141.8 (N-C-C), 135.5 (N-C), 130.5 (N-C-CH), 121.9 (q, J=255.8Hz, 
CF3O), 121.0 (CF3O-C-CH-CH), 120.8 (CF3O-C-CH-C), 48.2 (CH2-NHCO), 35.4 (CH-CH2-
NHCO), 32.0 (CH2-CONH), 28.2 (CH2-CH2CO), 23.0 (O=C-CH3) 
IR (ν, cm-1, Nujol)  3261, 1634, 1538, 1494, 1342, 1268, 1220, 1151   
HRMS (EI+)    Calcd. for C14H15N2O3F3 : 316.1035      Found : 316.1030 
 
 
Experimental Part 
 266
Dithiocarbonic acid S-{1-(acetoxy-methyl)-4-[(3,5-dimethoxy-phenyl)-methanesulfonyl-
amino]-4-oxo-butyl} ester O-ethyl ester (3-32) 
 
 
 
Following the general procedure 3-II for the addition of xanthate to olefin, the reaction was 
carried out with the solution of 3-2 (98mg, 0.25mmol) and allyl acetate (50mg, 0.50mmol) in 
AcOEt (0.3ml, 0.8M), with 5%mol of DLP. Flash chromatography on silica gel with AcOEt / 
EP = 30/70 ~ 40/60 afforded 3-32 (85.4mg, 70%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.55 (t, 1H, J=2.2Hz,  MeOC-CH-COMe), 6.39 (d, 
2H, J=2.2Hz, 2CH-CN), 4.62 (dq, 2H, J=1.8Hz, J=7.1Hz, CH2-CH3), 4.28-4.15 (m, 2H, 
CH2OAc), 4.00-3.94 (m, 1H, CHS), 3.80 (s, 6H, 2OCH3), 3.46 (s, 3H, SO2CH3), 3.41-3.36 
(m, 2H, CH2CO), 2.23-2.15 (m, 1H, CH2), 2.05 (s, 3H, COCH3), 1.90-1.80 (m, 1H, CH2), 
1.41 (t, 3H, J=7.1Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  212.8 (S=C), 172.9 (O=C-NMs), 170.5 (COCH3), 
161.4 (2 MeO-C), 136.5 (N-C), 108.2 (2 N-C-C), 101.9 ( MeOC-C-COMe ), 70.5 (CH2CH3), 
65.6 (CH2-OAc), 55.6 (2 O-CH3), 48.7 (CHS), 42.1 (SO2-C), 33.2 (CH2-CO), 25.7 (CH2-
CH2CO), 20.7 (COCH3), 13.7 (CH2CH3) 
IR (ν, cm-1, CDCl3)  2965, 2942, 2842, 1741, 1699, 1610, 1472, 1429, 1363, 1208, 1159, 
1112, 1064   
HRMS (EI+)    Calcd. for C19H27NO8S3 : 493.0899      Found : 493.0844 
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Dithiocarbonic acid S-{1-(trimethylsilyl-methyl)-4-[(3,5-dichloro-phenyl)-methane 
sulfonyl-amino]-4-oxo-butyl} ester O-ethyl ester (3-33) 
 
 
 
Following the general procedure 3-II for the addition of xanthate to olefin, the reaction was 
carried out with the solution of 3-6 (420g, 1.04mmol) and allyltrimethylsilane (239g, 
2.09mmol) in AcOEt (1.0ml, 1.0M), with 5%mol of DLP. Flash chromatography on silica 
gel with AcOEt / EP = 10 / 90 ~ 20 / 80 afforded 3-33 (519mg, 96%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.48 (t, 1H, J=1.9Hz, ClC-CH-CCl), 7.20 (d, 2H, 
J=1.9Hz, 2CH-CN), 4.69-4.58 (m, 2H, CH2-CH3), 3.94-3.87 (m, 1H, CH), 3.50 (s, 3H, 
SO2CH3), 2.34-2.18 (m, 3H, CH2CO + CHH-CH2CO), 1.78-1.67 (m, 1H, CHH-CH2CO), 
1.42 (t, 3H, J=7.1Hz, CH2CH3), 1.03 (ddd, 2H, J=7.6Hz, J=14.9Hz, J=23.1Hz, TMS-CH2), 
0.08 (s, 9H, Si(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  215.1 (S=C), 172.4 (O=C-NMs), 136.9 (N-C), 
136.0 (2 Cl-C), 130.5 ( ClC-C-CCl ), 128.8 (2 N-C-C), 70.2 (CH2CH3), 48.5 (CHS), 42.4 
(SO2-C), 34.1 (CH2-CO), 32.2 (CH2-CH2CO), 24.3 (CH2-TMS), 13.8 (CH2CH3), -0.8 
(Si(CH3)3) 
IR (ν, cm-1, CDCl3)  2927, 2855, 1723, 1582, 1574, 1427, 1362, 1251, 1214, 1169, 1112, 
1051, 967   
HRMS (EI+)    Calcd. for C18H27Cl2NO4S3Si : 515.0249      Found : 515.0241 
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Dithiocarbonic acid S-{1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl-methyl)-4-[(4-
bromo-phenyl)-methanesulfonyl-amino]-4-oxo-butyl} ester O-ethyl ester (3-34) 
 
 
 
Following the general procedure 3-II for the addition of xanthate to olefin, the reaction was 
carried out with the solution of 3-3 (229mg, 0.556mmol) and allylboronic acid pinacolester 
(187mg, 1.11mmol) in AcOEt (0.6ml, 0.9M), with 10%mol of DLP. Flash chromatography 
on silica gel with AcOEt / EP = 30 / 70 afforded 3-34 (208mg, 84%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.59 (dd, 2H, J=1.6Hz, J=8.4Hz, Br-C-CH), 7.14 (dd, 
2H, J=1.7Hz, J=8.5Hz, CH-CN), 4.65-4.52 (m, 2H, CH2CH3), 3.90-3.83 (m, 1H, CHS), 3.46 
(s, 3H, SO2-CH3), 2.28-2.21 (m, 2H, CO-CH2), 2.18-2.07 (m, 1H, CHH-CH2CO), 1.96-1.87 
(m, 1H, CHH-CH2CO), 1.39 (t, 3H, J=7.1Hz, CH2CH3), 1.27-1.22 (m, 2H, CH2B), 1.22 (s, 
6H, 2CCH3), 1.21 (s, 6H, 2CCH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  214.2 (S=C), 173.0  (O=C-NMs), 134.2 (N-C), 
133.3 (2 Br-C-C), 131.4 (2 N-C-C), 124.5 (Br-C), 83.6 (2C(CH3)2), 69.8 (CH2CH3), 47.0 
(CHS), 42.2 (SO2-C), 34.2 (CH2-CO), 30.9 (CH2-CH2CO), 24.8 (2CH3), 24.7 (2CH3), 13.8 
(CH2CH3) 
IR (ν, cm-1, CDCl3)  2983, 2936, 1709, 1484, 1444, 1363, 1218, 1143, 1112, 1051, 1016, 966   
HRMS (EI+)    Calcd. for C21H31BBrNO6S3 : 579.0590      Found : 589.0608 
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(2,3,4,5-tetrahydro-6,8-dimethoxy-2-oxo-1H-benzo[b]azepin-5-yl)methyl acetate (3-35) 
 
 
 
Following the general procedure 3-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 3-32 (70mg, 0.14mmol) and 2,6-lutidine (0.02ml, 0.14mmol) 
in chlorobenzene (7ml, 0.02mmol/ml), with DTBP (0.13ml, 0.71mmol) for 90min. Flash 
chromatography on silica gel with Acetone / DCM = 10 / 90 ~ 20 / 80 afforded 3-35 (27mg, 
64%) as a colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.18 (br s, 1H, CO-NH), 6.30 (d, 1H, J=2.4Hz, MeO-
C-CH-C-OMe), 6.07 (d, 1H, J=2.3Hz, MeO-C-CH-C-N), 4.25 (d, 2H, J=7.8Hz, CH2OAc), 
3.90-3.83 (m, 1H, CH), 3.80 (s, 3H, -OCH3), 3.79 (s, 3H, -OCH3), 2.53-2.43 (m, 1H, CHH-
CH2CO), 2.36-2.27 (m, 2H, CHH-CH2CO + CHHCO), 2.19-2.11 (m, 1H, CHHCO), 1.97 (s, 
3H, COCH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  174.9 (O=C-NH), 170.9 (O=C-Ac), 159.7 (C-
OMe), 159.3 (C-OMe), 139.0 (s, N-C), 113.6 (s, C-C-N), 99.4 (s, CH-C-N), 95.8 (s, MeO-C-
C-C-OMe), 66.2 (CH2-OAc), 55.9 (OCH3), 55.4 (OCH3), 32.3 (CH2-CH2CO), 32.2 (CH-
CH2OAc), 28.9 (CH2-CONH), 20.9 (COCH3) 
IR (ν, cm-1, CDCl3)  3394, 2928, 2855, 1732, 1675, 1613, 1592, 1500, 1460, 1368, 1325, 
1242, 1203, 1155, 1116, 1035   
HRMS (EI+)    Calcd. for C15H19NO5 : 293.1263      Found : 293.1257      
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6,8-dichloro-4,5-dihydro-5-((trimethylsilyl)methyl)-1H-benzo[b]azepin-2(3H)-one (3-36) 
 
 
 
Following the general procedure 3-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 3-33 (145mg, 0.281mmol) and 2,6-lutidine (0.05ml, 
0.40mmol) in chlorobenzene (20ml, 0.02mmol/ml), with DTBP (0.37ml, 2.02mmol) for 
60min. Flash chromatography on silica gel with AcOEt / DCM = 30 / 70 afforded 3-36 
(60.3mg, 68%) as a white powder. 
 
m.p. : 127-131°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.82 (br s, 1H, CO-NH), 7.23 (d, 1H, J=2.0Hz, Cl-C-
CH-C-Cl), 6.89 (s, 1H, Cl-C-CH-C-N), 3.84 (q, 1H, J=7.4Hz, CH), 2.47-2.30 (m, 3H, CHH-
CH2CO + CH2CO), 2.14-2.06 (m, 1H, CHH-CH2CO), 1.11 (ddd, 1H, J=7.8Hz, J=14.9Hz, 
J=22.0Hz), -0.12 (s, 9H, Si(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  175.3 (O=C-NH), 139.6 (s, N-C), 135.1 (s, Cl-C-
C), 135.0 (s, Cl-C-CH), 132.6 (s, N-C-C-C-Cl), 126.3 (s, Cl-C-CH-C-Cl), 121.8 (s, N-C-CH-
C-Cl), 35.6 (CH2-CH2CO), 33.0 (CH), 32.0 (CH2-CONH), 23.1 (CH2-TMS), -1.3 (Si(CH3)3) 
IR (ν, cm-1, CDCl3)  3690, 3393, 2955, 1677, 1589, 1562, 1456, 1440, 1375, 1249, 1181, 
1097, 996   
HRMS (EI+)    Calcd. for C14H19Cl2NOSi : 315.0613      Found : 315.0610       
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7-bromo-4,5-dihydro-5-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)-1H-
benzo[b]azepin-2(3H)-one (3-37) 
 
 
 
Following the general procedure 3-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 3-34 (54mg, 0.09mmol) and 2,6-lutidine (0.01ml, 0.11mmol) 
in chlorobenzene (4.7ml, 0.02mmol/ml), with DTBP (0.09ml, 0.46mmol) for 120min. Flash 
chromatography on silica gel with AcOEt / EP = 70 / 30 afforded 3-37 (16mg, 45%) as a 
light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.84 (br s, 1H, CO-NH),  
7.42 (s, 1H, Br-C-CH-C), 7.33 (dd, 1H, J=2.0Hz, J=8.3Hz, Br-C-CH-CH), 6.84 (dd, 1H, 
J=3.6Hz, J=8.3Hz, Br-C-CH-CH), 3.32-3.23 (m, 1H, CH), 2.52-2.44 (m, 1H, CHH-CH2CO), 
2.30-2.26 (m, 2H, CH2CO), 1.77-1.67 (m, 1H, CHH-CH2CO), 1.29-1.20 (m, 2H, CH2B), 
1.20 (s, 6H, 2CCH3), 1.14 (s, 6H, 2CCH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  174.7 (O=C-NH), 140.5 (s, N-C), 136.6 (s, N-C-C), 
129.8 (2 Br-C-CH), 123.3 (s, N-C-CH), 119.0 (Br-C), 83.4 (2C(CH3)2), 37.1 (CH2-CH2CO), 
34.8 (CH), 32.9 (CH2-CO), 24.71 (2CH3), 24.66 (2CH3) 
IR (ν, cm-1, CDCl3)  3631, 2982, 2943, 2253, 1674, 1480, 1375, 1328, 1265, 1143, 1016   
HRMS (EI+)    Calcd. for C17H23BBrNO3 : 379.0954      Found : 379.0955       
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Chapter 4 
 
 
General procedure 4-I for preparing the olefinic precursors 
 
 
 
Depending on the R1 and R2 groups of the amines, generally there were two methods for 
preparing 4-substituted tetrafluoropyridines. With a strong nucleophilic amine, a solution of 
the corresponding primary or secondary amine (2.1 eq.) was slowly added to a stirred 
solution of pentafluoropyridine (1 eq.) in ethanol (0.75M) at 0℃ under nitrogen. The reaction 
was stirred at room temperature for 10-30 minutes, then concentrated in vacuo and the 
residue was taken up in dichloromethane. The mixture was treated with a saturated sodium 
carbonate solution and the aqueous phase was extracted once with dichloromethane. Then the 
combined organic phase was dried with magnesium sulphate, filtered and concentrated in 
vacuo to give the crude product. Normally it was pure enough to be involved in the next step 
without further purification.  
 
If the amines were not very strong nucleophiles, a solution of the corresponding secondary 
amine (1.1 eq.) was dissolved in anhydrous THF (1M), and then sodium hydride (1.2 eq.) 
was slowly added to this stirring solution in an ice-bain under nitrogen. The mixture was kept 
stirring for about 10 minutes followed by adding drop by drop to a solution of 
pentafluoropyridine (1.0 eq.) in anhydrous THF (1M) under nitrogen. The reaction mixture 
was then stirring at room temperature for 10-30 minutes. The reaction could not be 
monitored by TLC since the starting material was inactive to UV and other chromogenic 
reagent. Water was used to quench the reaction. The mixture was then taken up in 
dichloromethane and treated with a saturated sodium carbonate solution and the aqueous 
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phase was extracted once with dichloromethane. The combined organic phase was washed by 
water twice and dried with magnesium sulphate, filtered and concentrated in vacuo to give 
the crude product. Normally it was pure enough to be involved in the next step without 
further purification. 
 
Then 2-N-allylamine 4-substituted 3,5,6-trifluoropyridines were prepared following the 
protocol as: a mixture of allylamine (4 eq.) and the 4-substituted pentafluoropyridine (1 eq.) 
in THF (1.5M) under nitrogen was heated to reflux for several hours, during when more 
allylamine (13 eq. totally) was added several times, until the starting material was totally 
consumed. Then the mixture was concentrated in vacuo and the residue was taken up in 
dichloromethane and washed twice with a saturated sodium carbonate solution. Then the 
aqueous phase was extracted once with dichloromethane, and the combined organic phase 
was dried over magnesium sulphate, filtered and concentrated in vacuo. Normally the 
resulting crude product was pure enough for the following step, while it could also be 
purified by flash chromatography to give a pure product. 
 
Finally, the mixture of the 2-N-allylamine 4-substituted 3,5,6-trifluoropyridine (1 eq.) and 
acetyl chloride (1.6, 4.1 eq.) in DCM (0.7M, 1M) under nitrogen was kept stirring at room 
temperature for several hours, during when more acetyl chloride (4.1 eq. totally) was added if 
necessary, until the starting material was totally consumed. Then the mixture was 
concentrated in vacuo and the residue was taken up in dichloromethane and washed twice 
with a saturated sodium carbonate solution. Then the aqueous phase was extracted once with 
dichloromethane, and the combined organic phase was dried over magnesium sulphate, 
filtered and concentrated in vacuo. The resulting crude product was then purified by flash 
chromatography on silica gel to yield the corresponding precursor for the radical addition. 
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General procedure 4-II for radical addition of xanthates 
 
 
 
A magnetically stirred solution of the corresponding olefin (0.5-2.0 eq.) and the desired 
xanthates (1.0 eq.) in AcOEt (1.0M of xanthate) was refluxed for about 30min under nitrogen. 
Lauroyl peroxide (DLP) (10%mol) was then added to the refluxing solution, followed by 
additional portions (5%mol) every 90min until the starting xanthate was completely 
consumed. The reaction mixture was then cooled down to room temperature, concentrated 
under reduced pressure and purified by flash chromatography on silica gel to yield the 
desired compounds.  
 
 
General procedure 4-III for radical cyclisation of the corresponding xanthates 
 
 
 
A magnetically stirred solution of the corresponding xanthates (1.0 eq.) and 2,6-lutidine (1.2 
eq.) in chlorobenzene (0.05M of xanthate) was refluxed for about 30min under nitrogen. Di-
t-butyl-peroxide (DTBP) (5.0 eq.) was then added to the refluxing solution. The reaction was 
monitored by TLC every hour until the starting xanthate was completely consumed. The 
reaction mixture was then cooled down to room temperature, concentrated under reduced 
pressure and purified by flash chromatography on silica gel to yield the desired compounds. 
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tert-butyl allyl3,5,6-trifluoro-4-(pyrrolidin-1-yl)pyridin-2-ylcarbamate (4-1) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 1.43g pentafluoropyridine (8.45mmol, 1.0 eq.) and 1.50ml pyrrolidine (18.26 
mmol, 2.1 eq.) in 12ml EtOH (0.75 mmol/ml) for 30 minutes. After work-up, the crude 
product, as white crystal, was used directly in the next step without further purification.  
 
Then the reaction was carried out with 1.7g 4-substituted tetrafluoropyridine (7.7mmol, 1.0 
eq.) and 8.5ml allylamine (111mmol, 14.4eq.) in 5.5ml THF (1.5 mmol/ml) refluxing for 3 
days. After work-up, the crude product was purified by flash chromatography on silica gel 
with Et2O / EP = 3 / 97 afforded the 2,4-substituted intermediate (937mg, 47%) as a 
colourless oil. 
 
Finally, the protection was carried out with 760mg intermediate (2.95mmol, 1.0eq.) of last 
step and 5.66g di-tert-butyl-carbonate (25.9mmol, 8.8eq.) and 361mg DMAP (2.95mmol, 
1.0eq.) in 22ml dichloromethane (0.2 mmol/ml) for about 36 hours at room temperature. 
Flash chromatography on silica gel with AcOEt / EP = 5 / 95 afforded 4-1 (924mg, 85% for 3 
steps) as a colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.83 (qd, 1H, J=5.8Hz, J=11.0Hz, -CH=CH2), 5.10 
(ddd, 2H, J=1.5Hz, J=13.7Hz, J=35.9Hz, -CH=CH2), 4.24 (d, 2H, J=4.6Hz, NH-CH2), 3.72 
(tt, 4H, J=2.8Hz, J=5.4Hz, -CH2CH2NCH2CH2-), 1.92 (tt, 4H, J=2.7Hz, J=6.6Hz, -
CH2CH2NCH2CH2-), 1.43 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  153.1 (CO), 147.4 (dd, J=15.6Hz, J=229.9Hz, N-
CF), 141.5 (dt, J=3.2Hz, J=249.9Hz, CF-C-NBoc), 135.9 (td, J=5.0Hz, J=9.3Hz, N-C-NBoc), 
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134.2 (dt, J=3.2Hz, J=33.1Hz, N-C-CF), 133.6 (-CH=CH2), 132.7 (ddd, J=4.7Hz, J=33.1Hz, 
J=218.0Hz, N-CF-CF), 116.8 (-CH=CH2), 81.0 (CMe3), 51.2 (t, J=6.2Hz, -CH2-N-CH2-), 
50.1 (CH2-NBoc), 28.1 (C(CH3)3), 25.6 (t, J=1.9Hz, -CH2-CH2-N-CH2-CH2-) 
IR (ν, cm-1, CCl4)  2979, 2887, 1716, 1616, 1567, 1513, 1471, 1368, 1251, 1173, 1147, 1020 
HRMS (EI+)    Calcd. for C17H22F3N3O2 : 357.1664      Found : 357.1663 
 
 
methyl allyl(3,5,6-trifluoro-4-(pyrrolidin-1-yl)pyridin-2-yl)carbamate (4-2) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 2.10g pentafluoropyridine (12.4mmol, 1.0eq.) and 2.14ml pyrrolidine 
(26.1mmol, 2.1 eq.) in 16.6ml EtOH (0.75 mmol/ml) for 10 minutes. After work-up, ~2.7g 
crude product, as white crystal, was used directly in the next step without further purification.  
 
Then the reaction was carried out with 2.66g 4-substituted tetrafluoropyridine (12.1mmol, 
1.0 eq.) and 14.5ml allylamine (193mmol, 16eq.) in 8ml THF (1.5 mmol/ml) refluxing for 
112 hours. After work-up, ~3.0g crude product, as colourless oil, was used directly in the 
next step without further purification. 
 
Finally, the protection was carried out with 1.39g intermediate (5.41mmol, 1.0eq.) of last 
step in 13.5ml methyl chloroformate (0.4mmol/ml) refluxing for about 12 hours. Flash 
chromatography on silica gel with AcOEt / DCM = 2 / 98 afforded 4-2 (1.49g, 85% for 3 
steps) as white solid. 
 
m.p. 78~81 oC 
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1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.83 (qd, 1H, J = 11.0, 5.9 Hz, -CH=CH2), 5.12 (dd, 
2H, J = 33.8, 13.7 Hz, -CH=CH2), 4.28 (d, 2H, J = 5.0 Hz, NH-CH2), 3.76-3.69 (m + s, 7H, -
CH2CH2NCH2CH2- + CH3), 1.94-1.91 (m, 4H, -CH2CH2NCH2CH2-) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  154.9 (CO), 147.7 (dd, J = 231.6, 15.2 Hz, N-CF), 
141.9 (dt, J = 250.5 Hz, CF-C-NBoc), 136.3 (N-C-NBoc), 132.7 (dd, J = 177.4, 19.4 Hz, N-
C-CF), 133.15 (-CH=CH2), 117.4 (-CH=CH2), 53.2 (CH3), 51.3 (t, J = 6.18 Hz, -CH2-N-
CH2-), 50.6 (CH2-NBoc), 25.6 (-CH2-CH2-N-CH2-CH2-) 
IR (ν, cm-1, CDCl3)  3695, 2980, 2975, 2889, 1715, 1616, 1564, 1519, 1473, 1449, 1422, 
1368, 1355, 1309, 1277, 1252, 1198, 1179, 1139, 1116, 1022, 986 
HRMS (EI+)    Calcd. for C14H16F3N3O2 : 315.1195      Found : 315.1194 
 
 
methyl allyl(3,5,6-trifluoro-4-(piperidin-1-yl)pyridin-2-yl)carbamate (4-3) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 1.22g pentafluoropyridine (7.22mmol, 1.0eq.) and 0.78ml piperidine 
(7.94mmol, 1.1eq.) in 10ml EtOH (0.75 mmol/ml) for 30 minutes. After work-up, the crude 
product was used directly in the next step without further purification  
 
Then the reaction was carried out with the crude product of last step and 8.6ml allylamine 
(115mmol, 16eq.) in 4.8ml THF (1.5 mmol/ml) refluxing for 10 hours. After work-up, the 
crude product (~1.35g) was used directly in the next step without further purification. 
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Finally, the protection was carried out with 953mg intermediate (3.51mmol, 1.0eq.) of last 
step in 12.4ml methyl chloroformate (0.4mmol/ml) refluxing for about 12 hours. Flash 
chromatography on silica gel with Et2O / DCM = 12 / 88 afforded 4-3 (905mg, 73% for 3 
steps) as colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.83 (qd, 1H, J = 10.6, 5.8 Hz, CH=CH2), 5.12 (ddd, 
2H, J = 13.7, 11.6, 1.4 Hz, CH=CH2), 4.29 (d, 2H, J = 5.8 Hz, CH2-NCOOMe), 3.73 (s, 3H, 
COOCH3), 3.35 (br s, 4H, CH2-N-CH2), 1.68 (br s, 6H, CH2-CH2-CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  154.7 (CO), 147.0 (dd, J = 234, 15 Hz, N-CF) 
144.9 (d, J = 254 Hz, CF-C-NCO), 139.4-139.1 (m, N(piperidine)-C), 136.4 (dd, J = 256, 31 
Hz, C-CF-CF), 133.5 (dt, J = 16, 3.9 Hz, N-C-N-CO), 133.0 (CH=CH2), 117.3 (CH=CH2), 
53.3 (COOCH3), 51.5 (t, J = 5.0 Hz, CH2-N-CH2), 50.5 (CH2-NCOOMe), 26.3 (CH2-CH2-N-
CH2-CH2), 24.0 (-N-CH2-CH2-CH2) 
IR (ν, cm-1, CDCl3)    3424 ,3086, 2988, 2943, 2857, 1714, 1618, 1570, 1512, 1444, 1365, 
1331, 1246, 1190, 1155, 1123, 1104, 1071, 1027, 994 
HRMS (EI+)    Calcd. for C15H18F3N3O2 : 329.1351      Found :   329.1350 
 
 
N-allyl-N-(3,5,6-trifluoro-4-(piperidin-1-yl)pyridin-2-yl)acetamide (4-4) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 3.02g pentafluoropyridine (17.88mmol, 1.0 eq.) and 3.7ml pyrrolidine (37.56 
mmol, 2.1 eq.) in 24ml EtOH (0.75 mmol/ml) for 30 minutes. After work-up, the crude 
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product was purified by flash chromatography on silica gel with DCM / EP = 5 / 95 to give 
the 4-substituted intermediate (3.91g, 94%) as a colourless oil.  
 
Then the reaction was carried out with 3.91g 4-substituted tetrafluoropyridine (16.7mmol, 
1.0 eq.) and 10ml allylamine (134mmol, 8 eq.) in 11ml THF (1.5 mmol/ml) refluxing for 40 
hours. After work-up, the crude product was used directly in the next step without further 
purification. 
 
Finally, the acetylation was carried out with 4.53g 2,4-substituted intermediate (16.7mmol, 
1.0eq.) of last step in 20ml acetyl chloride (0.4 mmol/ml) for about 10 minutes at room 
temperature. After work-up, flash chromatography on silica gel with AcOEt / EP = 20 / 80 
afforded 4-4 (5.0g, 89% for 3 steps) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.80 (qd, 1H, J=6.1Hz, J=11.4Hz, CH=CH2), 5.15-
5.07 (m, 2H, CH=CH2), 4.31 (d, 2H, J=5.8Hz, CH2-NAc), 3.37 (s, 4H, CH2-N-CH2), 1.95 (s, 
3H, COCH3), 1.67 (s, 6H, CH2-CH2-CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  169.7 (COMe), 147.4 (dd, J=10.0Hz, J=232.2Hz, 
N-CF), 145.0 (d, J=253.6Hz, CF-C-NCO), 136.7 (dd, J=33.8Hz, J=258.0Hz, C-CF-CF), 
139.4 (N(piperidine)-C), 134.6 (m, N-C-N-CO), 132.7 (CH=CH2), 117.8 (CH=CH2), 51.5 (t, 
J=4.1Hz, CH2-N-CH2), 49.5 (CH2-NAc), 26.3 (CH2-CH2-N-CH2-CH2), 23.9 (-N-CH2-CH2-
CH2), 21.9 (COCH3) 
 
 
N-allyl-N-(4-(cyclopropylamino)-3,5,6-trifluoropyridin-2-yl)acetamide (4-5) 
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Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 3.10g pentafluoropyridine (18.32mmol, 1.0 eq.) and 1.4ml cyclopropylamine 
(20.15 mmol, 1.1 eq.) in 25ml EtOH (0.75 mmol/ml) for 30 minutes. After work-up, 2.68g 
crude product, as yellow oil, was used directly in the next step without further purification.  
 
Then the reaction was carried out with 2.68g 4-substituted tetrafluoropyridine (13.0mmol, 
1.0 eq.) and 19.6ml allylamine (261mmol, 20 eq.) in 9ml THF (1.5 mmol/ml) refluxing for 
74 hours. After work-up, 3.53g crude product was used directly in the next step without 
further purification. 
 
Finally, the acetylation was carried out with the crude product of last step and 10ml acetyl 
chloride (1.5mmol/ml) refluxing for about 20 hours. After work-up, flash chromatography on 
silica gel with AcOEt / EP = 40 / 60 afforded 4-5 (364mg, 79% for 3steps) as light brown oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.80 (qd, 1H, J=6.1Hz, J=11.5Hz, -CH=CH2), 5.11 
(dd, 2H, J=13.9Hz, J=21.0Hz, -CH=CH2), 4.79 (s, 1H, NH), 4.32 (d, 2H, J=6.0Hz, N-CH2), 
2.98 (br s, 1H, N-CH), 1.95 (s, 3H, COCH3), 0.87 (q, 2H, J=6.7Hz, -CHH-CHH-), 0.69 (m, 
2H, -CHH-CHH-) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  169.7 (COCH3), 147.0 (ddd, J=1.7Hz, J=13.5Hz, 
J=233.9Hz, N-CF), 141.2 (dd, J=2.4Hz, J=251.2Hz, CF-C-NAc), 136.6 (td, J=6.7Hz, 
J=13.8Hz, NH-C-CF), 132.6 (-CH=CH2), 132.5 (ddd, J=1.9Hz, J=34.1Hz, J=255.3Hz, N-CF-
CF), 132.3 (N-C-NAc), 117.8 (-CH=CH2), 49.5 (CH2-NAc), 26.7 (dd, J=1.7Hz, J=4.1Hz, 
CH-NH), 21.9 (d, J=1.9Hz, COCH3), 8.7 (dd, J=1.3Hz, J=2.9Hz, -CH2-CH2-) 
IR (ν, cm-1, CDCl3)    3428, 3016, 1669, 1625, 1527, 1477, 1455, 1419, 1361, 1259, 1226, 
1182, 1103, 1030, 983 
HRMS (EI+)    Calcd. for C13H14F3N3O : 285.1089      Found : 285.1083      
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N-(4-(N-cyclopropyl-N-acetylamino)-3,5,6-trifluoropyridin-2-yl)-N-allylacetamide (4-6) 
 
 
 
Following the procedure for preparing olefinic precursor 4-5, final purification by flash 
chromatography on silica gel with AcOEt / DCM / EP = 20 / 40 / 40 afforded 4-6 (2.88g, 
53% for 4 steps) as light brown oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.80 (qd, 1H, J=5.9Hz, J=11.2Hz, -CH=CH2), 5.12 (t, 
1H, J=12.6Hz, -CH=CH2), 4.38 (ddd, 1H, J=2.1Hz, J=13.1Hz, J=16.1Hz, N-CH2), 3.21 (s, 
1H, N-CH), 2.45 (s, 3H, CH3-CO-NCH), 2.03 (s, 3H, CH3-CO-NCH2), 1.01 (s, 2H, -CHH-
CHH-), 0.68 (s, 2H, -CHH-CHH-) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  171.8 (CO-NCH), 169.6 (CO-NCH2), 147.8 (d, 
J=255.0Hz, N-CF),  146.0 (dd, J=13.3Hz, J=239.9Hz, CF-C-NAc), 140.4 (dd, J=31.1Hz, 
J=268.0Hz, N-CF-CF), 134.6 (N-C-CF), 132.4 (-CH=CH2), 131.4 (N-C-NBoc), 118.1(-
CH=CH2), 49.8 (CH2-NAc), 31.4 (CH-NAc), 22.3 (CH3-CO-NCH), 21.9 (d, J=2.0Hz, CH3-
CO-NCH2), 9.49 (-CH2-CH2-) 
IR (ν, cm-1, CDCl3)    3018, 1682, 1618, 1484, 1464, 1423, 1376, 1316, 1257, 1230, 1186, 
1104, 1035, 981 
HRMS (EI+)    Calcd. for C15H16F3N3O2 : 327.1195      Found : 327.1193      
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N-allyl-N-(3,5,6-trifluoro-4-(1H-pyrrol-1-yl)pyridin-2-yl)acetamide (4-7) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 440mg pyrrole (6.45 mmol, 1.1 eq.) and 292mg NaH (7.04 mmol, 1.2 eq.) in 
6ml anhydrous THF (1.1 mmol/ml), with 992mg pentafluoropyridine (5.86 mmol, 1.0 eq.) in 
6ml anhydrous THF (1.0 mmol/ml) for 10 minutes. Flash chromatography on silica gel with 
DCM / EP = 5 / 95 afforded 2,3,5,6-tetrafluoro-4-(1H-pyrrol-1-yl)pyridine (783mg, 62%) as 
a white solid.  
 
Then the reaction was carried out with 783mg 4-substituted tetrafluoropyridine (3.6 mmol, 
1.0 eq.) and 2.2mg allylamine (29 mmol, 8.1 eq.) in 2.4ml THF (1.5 mmol/ml) refluxing for 
1 hour. After work-up, the crude product as a light brown oil was used directly in the next 
step without further purification.  
 
Finally, the acetylation was carried out with the crude product of the last step and 1.04ml 
acetyl chloride (14.6mmol, 4.1 eq.) in 4.6ml dichloromethane (0.7 mmol/ml) for about 40 
hours at room temperature. Flash chromatography on silica gel with AcOEt / EP = 40 / 60 
afforded 4-7 (1.03g, 97% for 2 steps) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.12 (m, 2H, CH-N-CH), 6.46 (m, 2H, CH-CH-CH-
CH), 5.83 (qd, 1H, J=5.8Hz, J=11.0Hz, CH), 5.17 (dd, 2H, J=13.8Hz, J=19.7Hz, CHCH2), 
4.41 (d, 2H, J=5.8Hz, CH-CH2-N), 2.10 (s, 3H, CO-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 169.5 (CO), 146.91 (dd, J=14.5Hz, J=241.5Hz, N-
CF), 144.41 (dd, J=5.5Hz, J=260.7Hz, N-CF-CF), 136.93 (dd, J=31.9Hz, J=266.3Hz, CO-N-
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C-CF), 135.67 (d, J=6.4Hz, CF-C-N-CO), 132.3(CH), 129.5 (CF-CF-C), 122.1 (t, J=4.7Hz, 
CH-N-CH), 118.2 (CHCH2), 112.0 (CH-CH-CH-CH), 50.2 (N-CH2-CH), 22.0 (CO-CH3) 
IR (ν, cm-1, CCl4)  2927, 2855, 1677, 1619, 1519, 1468, 1377, 1265, 1201, 1177, 1102, 1026, 
981 
HRMS (EI+)    Calcd. for C14H12F3N3O : 295.0932     Found : 295.0927 
 
 
N-allyl-N-(3,5,6-trifluoro-4-(N-methylacetamido)pyridin-2-yl)acetamide (4-8) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 2.80g pentafluoropyridine (16.58 mmol, 1.0 eq.) and 3.58ml MeNH2 (34.82 
mmol, 2.1 eq.) in 14ml EtOH (1.2 mmol/ml) for 30 minutes. After work-up, the crude 
product as a white acicrilar crystal was divided into two eq.alent parts and one of them was 
used directly in the next step without further purification.  
 
Then the reaction was carried out with 1.49g 4-substituted tetrafluoropyridine (8.3 mmol, 1.0 
eq.) and 13ml allylamine (29 mmol, 20.9 eq.) in 5.5ml THF (1.5 mmol/ml) refluxing for 117 
hours. After work-up, the crude product as a dark brown oil was used directly in the next step 
without further purification.  
 
Finally, the acetylation was carried out with the crude product of the last step and 0.95ml 
acetyl chloride (13.4mmol, 1.6 eq.) in 8.0ml dichloromethane (1.0 mmol/ml) for about 1.5 
hours at room temperature. Flash chromatography on silica gel with AcOEt / DCM = 5 / 95 
afforded 2-N-allylamine protected pyridine (1.04g, 48% for 3 steps) alone with 4-
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methylamine protected pyridine (116mg, 5.4% for 3 steps). Then 802mg of 2-N-allylamine 
protected pyridine (3.10mmol, 1.0 eq.) was dissolved by 2.0ml acetyl chloride (28.1mmol, 
9.1 eq.) and refluxed overnight to complete the acetylation. After work-up, the crude product 
was purified with flash chromatography on silica gel with AcOEt / EP = 30 / 70 afforded 4-8 
(813mg, 87%) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 5.85-5.78 (m, 1H, CH), 5.15 (t, J = 13.45 Hz, 2H, 
CHCH2), 4.48-4.37 (m, 2H, CH-CH2-N), 3.27 (br s, 3H, N-CH3), 2.31-1.98 (m, 6H, N-CO-
CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 169.7 (CH3-N-CO + N-CO), 147.5 (d, J = 258.91 
Hz, N-CF), 146.1 (d, J = 241.62 Hz, N-CF-CF), 140.1 (d, J = 252.95 Hz, CO-N-C-CF), 
136.18-134.08 (m, CF-C-N-CO), 133.8-132.6 (m, CF-CF-C), 132.4 (CH), 118.1 (CH-CH2), 
51.6-48.3 (m, CO-N-CH2), 37.9 + 35.5(m, N-CH3), 22.0 + 21.3 (N-CO-CH3) 
IR (ν, cm-1, CDCl3)  2986, 2942, 1681, 1618, 1489, 1471, 1468, 1464, 1422, 1376, 1332, 
1300, 1245, 1204, 1124, 1036, 1011, 980 
HRMS (EI+)    Calcd. for C13H14F3N3O2 : 301.1038     Found : 301.1035 
 
 
N-allyl-N-(3,5,6-trifluoro-4-(N-methylmethylsulfonamido)pyridin-2-yl)acetamide (4-9) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 2.80g pentafluoropyridine (16.58 mmol, 1.0 eq.) and 3.58ml MeNH2 (34.82 
mmol, 2.1 eq.) in 14ml EtOH (1.2 mmol/ml) for 30 minutes. After work-up, the crude 
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product as a white acicrilar crystal was divided into two eq.alent parts and one of them was 
used directly in the next step without further purification.  
 
The crude product of last step was dissolved in 8.3ml anhydrous THF (1.0 mmol/ml) in an 
ice-bain under nitrogen, and then 346mg sodium hydride (9.12mmol, 1.1 eq.) was slowly 
added to this stirring solution. The mixture was kept stirring for about 15 minutes followed 
by adding drop by drop 0.8ml methanesulfonyl chloride (9.95mmol, 1.2 eq.). The reaction 
mixture was then stirring at room temperature for 45 minutes until the starting material was 
totally consumed. After work-up, the crude product was purified with flash chromatography 
on silica gel with DCM / EP = 45 / 55 afforded 4-substituted tetrafluoropyridine (891mg, 
42% for 2 steps) as a light yellow oil.  
 
Then the reaction was carried out with 880mg 4-substituted tetrafluoropyridine (3.41 mmol, 
1.0 eq.) and 1.02ml allylamine (13.6 mmol, 4.0 eq.) in 7.3ml THF (0.5 mmol/ml) stirring at 
room temperature for 1 hour. After work-up, the crude product as an orange oil was used 
directly in the next step without further purification.  
 
Finally, the acetylation was carried out with the crude product of the last step, which was 
dissolved by 2.3ml acetyl chloride (32.3mmol, 9.5 eq.) and stirred at room temperature 
overnight and then refluxed for 20 minutes to complete the acetylation. After work-up, the 
crude product was purified with flash chromatography on silica gel with AcOEt / EP = 35 / 
65 afforded 4-9 (950mg, 83% for 2 steps) as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 5.81 (qd, 1H, J=5.7Hz, J=10.9Hz, CH), 5.15 (t, 2H, 
J=13.2Hz, CHCH2),  4.38 (d, 2H, J=5.7Hz, CH-CH2-N), 3.35 (s, 3H, N-CH3), 3.13 (s, 3H, 
Ms-CH3), 2.07 (s, 3H, CO-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 169.6 (COMe), 148.7 (dd, J=6.8Hz, J=262.5Hz, N-
CF), 146.1 (ddd, J=2.4Hz, J=14.5Hz, J=17.3Hz, CH3-N-C-CF), 141.6 (dd, J=30.3Hz, 
J=269.0Hz, CO-N-C-CF), 135.2 (m, N-C-N),  132.2 (s, CH), 130.3 (m, CH3-N-C-CF), 118.1 
(s, N-CH2-CH-CH2), 50.1 (m, N-CH2), 39.0 (s, SO2-CH3), 37.3 (s, N-CH3), 21.9 (d, J=1.8Hz, 
CO-CH3) 
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IR (ν, cm-1, CDCl3)  2940, 1710, 1681, 1618, 1484, 1467, 1430, 1359, 1329, 1244, 1222, 
1162, 993, 964 
HRMS (EI+)    Calcd. for C12H14F3N3O3S :337.0708      Found : 337.0726 
 
 
N-(4-acetamido-3,5,6-trifluoropyridin-2-yl)-N-allylacetamide (4-10) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 2.5g pentafluoropyridine (14.8 mmol, 1.0 eq.) and 10ml ammonia (25%) 
(64.4mmol, 4.3eq.) in 12ml EtOH (1.2 mmol/ml) refluxing for 16 hours. After work-up, the 
crude product as 2.09g white solid was used directly in the next step without further 
purification. Then 2.09g crude product of last step was dissolved by 12ml acetyl chloride 
(168.8mmol, 13.4 eq.) and refluxed overnight to complete the reaction. After work-up, the 
crude product as 2.48g white solid was used directly in the next step without further 
purification.  
 
Then the reaction was carried out with 1.07g crude product of last step (5.12 mmol, 1.0 eq.) 
and 1.54ml allylamine (20.5 mmol, 4.0 eq.) in 3.4ml THF (1.5 mmol/ml). The mixture was 
stirring at room temperature overnight and then refluxed for 1 hour to complete the reaction. 
After work-up, the crude product as a light pink solid was used directly in the next step 
without further purification.  
 
Finally, the acetylation was carried out with the crude product of the last step which was 
dissolved by 3.4ml acetyl chloride (47.8mmol, 9.3 eq.) and was stirring at room temperature 
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overnight and then refluxed for 1 hour to complete the acetylation. After work-up, the crude 
product was purified with flash chromatography on silica gel with AcOEt / DCM = 10 / 90 
afforded 4-10 (1.20g, 66% for 4 steps) as a white solid. 
 
m.p. 126-127 oC 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.89 (s, 1H, NH), 5.79 (m, 1H, CH), 5.15 (m, 2H, 
CHCH2), 4.33 (d, J=5.78 Hz, 2H, CH-CH2-N), 2.23 (s, 3H, NH-CO-CH3), 2.01 (brs, 3H, N-
CO-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 170.4 (NH-CO), 169.9 (N-CO), 146.2 (ddd, J = 
239.97, 14.43, 2.43 Hz, N-CF), 145.7 (dd, J = 260.56, 2.93 Hz, N-CF-CF), 138.5 (dd, J = 
267.64, 31.28 Hz, CO-N-C-CF), 134.06 ( m, CF-C-N-CO), 132.0 (CH), 127.0 (m, CF-CF-C), 
118.2 (CHCH2), 50.0 (N-CH2-CH), 23.0 (NHCO-CH3), 21.9 (NCO-CH3) 
IR (ν, cm-1, CDCl3)  3419, 2930, 1727, 1681, 1621, 1500, 1472, 1449, 1382, 1224 
HRMS (EI+)    Calcd. for C12H12F3N3O2 : 287.0882     Found : 287.0881 
 
 
N-allyl-N-(3,5,6-trifluoro-4-(1H-1,2,4-triazol-1-yl)pyridin-2-yl)acetamide (4-11) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 500mg pentafluoropyridine (2.96 mmol, 1.0 eq.), 252mg triazole (3.64mmol, 
1,2 eq.) and 0.5ml TEA (3.55mmol, 1.2 eq.) in 2.5ml EtOH (1.2 mmol/ml) stirring at room 
temperature for 16 hours. After work-up, the crude product was used directly in the next step 
without further purification. 
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Then the reaction was carried out with the crude product of last step (2.96 mmol, 1.0 eq.) and 
0.88ml allylamine (11.8 mmol, 4.0 eq.) in 6ml THF (0.5 mmol/ml). The mixture was stirring 
at room temperature overnight and then refluxed for 20 minutes to complete the reaction. 
After work-up, the crude product was used directly in the next step without further 
purification. 
 
Finally, the acetylation was carried out with the crude product of the last step which was 
dissolved by 2.0ml acetyl chloride (28.1mmol, 9.5 eq.) and was refluxed for 1 hour to 
complete the acetylation. After work-up, the crude product was purified with flash 
chromatography on silica gel with AcOEt / DCM = 10 / 90 afforded 4-11 (869mg, 99% for 3 
steps) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.59 (s, 1H, C-N-CH), 8.26 (s, 1H, C-N-N-CH), 5.83 
(qd, J = 10.68, 5.59 Hz, 1H, CH), 5.18 (t, J = 14.72 Hz, 2H, CHCH2), 4.43 (d, J = 5.55 Hz, 
2H, CH-CH2-N), 2.15 (s, 3H, CO-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 169.6 (N-CO), 153.5 (C-N-N-C), 146.3 (ddd, J = 
242.25, 14.08, 2.75 Hz, N-CF), 145.4 ( m, CF-C-N-CO), 144.1 (ddd, J = 265.85, 6.08, 2.80 
Hz, N-CF-CF), 137.1 (dd, J = 273.21, 32.83 Hz, CO-N-C-CF), 132.1 (CH), 125.6 (m, CF-
CF-C), 118.3 (CHCH2), 50.3 (N-CH2-CH), 22.0 (CH3) 
IR (ν, cm-1, CDCl3)  3692, 3606, 3138, 2931, 1682, 1623, 1603, 1531, 1522, 1471, 1420, 
1387, 1377, 1328, 1265, 1241, 1201, 1171, 1130, 993, 981 
HRMS (EI+)    Calcd. for C12H10F3N5O : 297.0837     Found : 297.0848 
 
 
N-allyl-N-(3,5,6-trifluoro-4-(1H-imidazol-1-yl)pyridin-2-yl)acetamide (4-12) 
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Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 500mg pentafluoropyridine (2.96 mmol, 1.0 eq.) and 239mg imidazole 
(3.51mmol, 1,2 eq.) in 2.5ml EtOH (1.2 mmol/ml) stirring at room temperature for 19 hours. 
After work-up, the crude product was used directly in the next step without further 
purification. 
 
Then the reaction was carried out with the crude product of last step (2.96 mmol, 1.0 eq.) and 
0.88ml allylamine (11.8 mmol, 4.0 eq.) in 6ml THF (0.5 mmol/ml). The mixture was stirring 
at room temperature overnight and then refluxed for 20 minutes to complete the reaction. 
After work-up, the crude product was purified with flash chromatography on silica gel with 
AcOEt / EP = 10 / 90 afforded the product as a white solid. 
 
Finally, the acetylation was carried out with 306mg crude product of last step. It was 
dissolved by 12ml anhydrous DMF (0.1 mmol/ml) and 58mg of NaH (60%) (1.45mmol, 1.2 
eq.) was added little by little. Then 0.41ml acetyl chloride (6.01mmol, 5 eq.) was added drop 
by drop. The mixture was refluxed for several hours until the starting material was totally 
consumed. After work-up, the crude product was purified with flash chromatography on 
silica gel with AcOEt / DCM = 35 / 65 afforded 4-12 (302mg, 84% for 3 steps) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.95 (s, 1H, N-CH-N), 7.38 (s, 1H, C-N-CH), 7.30 (s, 
1H, C-N-CH-CH ), 5.84 (qd, J = 10.77, 5.60 Hz, 1H, CH), 5.19 (t, J = 14.77 Hz, 2H, 
CHCH2), 4.43 (d, J = 5.65 Hz, 2H, CH-CH2-N), 2.15 (s, 3H, CO-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 169.6 (N-CO), 146.5 (ddd, J = 241.38, 14.46, 2.66 
Hz, N-CF), 144.0 (ddd, J = 7.94, 6.75, 2.07 Hz, N-CF-CF), 137.3 (t, J = 5.22 Hz, N-CH-N), 
136.7 (dd, J = 268.39, 32.47 Hz, CO-N-C-CF), 136.4-133.5 (m, CF-C-N-CO), 132.2 (CH), 
130.7 (N-CH-CH), 127.8-124.5 (m, CF-CF-C), 119.3 (t, J = 3.64 Hz, N-CH-CH2), 118.2 
(CHCH2), 50.4 (N-CH2-CH), 30.90 (s,1C), 22.0 (d, J = 1.14 Hz, CH3) 
IR (ν, cm-1, CDCl3)  3692, 1681, 1621, 1518, 1471, 1380, 1243, 1207, 1175, 1077 
HRMS (EI+)    Calcd. for C13H11F3N4O : 296.0885     Found : 296.0882 
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N-allyl-N-(3,5,6-trifluoro-4-(1H-indol-1-yl)pyridin-2-yl)acetamide (4-13) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 350mg indole (2.99 mmol, 1.0 eq.) and 118mg NaH (60%) (2.96 mmol, 1.0 
eq.) in 3ml anhydrous THF (1.0 mmol/ml), with 500mg pentafluoropyridine (2.96 mmol, 1.0 
eq.) in 3ml anhydrous THF (1.0 mmol/ml) for 1 hour. After work-up, the crude product was 
used directly in the next step without further purification. 
 
Then the reaction was carried out with the crude product of last step and 1.1ml allylamine 
(14 mmol, 4.7 eq.) in 3.5ml THF (0.9 mmol/ml) stirring overnight. After work-up, the crude 
product as was used directly in the next step without further purification. 
 
Finally, the acetylation was carried out with the crude product of the last step and 3ml acetyl 
chloride (42mmol, 14 eq.) refluxing for 1 hour to complete the reaction. Flash 
chromatography on silica gel with AcOEt / EP = 10 / 90 afforded 4-13 (848mg, 83% for 3 
steps) as a light yellow solid. 
 
m.p. 82-84 oC 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.70 (d, J = 7.74 Hz, 1H, N-CH), 7.36-7.27 (m, 
aromatic 4H), 6.85 (d, J = 3.4 Hz, 1H, N-CH-CH), 5.88 (dt, J = 10.8, 5.7 Hz, 1H, CH), 5.21 
(dd, J = 21.8, 13.8 Hz, 2H, CHCH2), 4.47 (d, J = 5.7 Hz, 2H, CH-CH2-N), 2.17 (s, 3H, CO-
CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 169.6 (N-CO), 146.6 (ddd, J = 241, 14, 2.6 Hz, N-
CF), 145.9 (dd, J = 263, 5.0 Hz, N-CF-CF), 138.5 (dd, J = 269, 31 Hz, CO-N-C-CF), 135.6 
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(m, CF-C-N-CO), 135.4 (CH), 132.4, 129.0, 127.4, 123.7, 122.1, 121.4 (6s, aromatic C), 
128.4 (m, CF-CF-C), 118.1 (CHCH2), 111.0 (N-CH-CH), 107.3 (N-CH), 50.3 (N-CH2-CH), 
22.1 (CH3) 
IR (ν, cm-1, CDCl3)  3692, 2930, 1678,1609, 1532,1508, 1467, 1380, 1259,1242, 1209, 1173, 
1096 
HRMS (EI+)    Calcd. for C18H14F3N3O : 345.1089     Found : 345.1084 
 
 
N-allyl-N-(3,5,6-trifluoro-4-((4-iodophenyl)amino)pyridin-2-yl)acetamide (4-14) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 946mg pentafluoropyridine (5.6 mmol, 1.9eq.) and 626mg 4-iodoaniline 
(2.9mmol, 1.0eq.) in 8ml EtOH (0.4 mmol/ml) stirring at room temperature for 120 hours. 
After work-up, the crude product was used directly in the next step without further 
purification. 
 
Then the reaction was carried out with 409mg crude product of last step (1.11 mmol, 1.0 eq.) 
and 1.34ml allylamine (17.9 mmol, 16eq.) in 2ml THF (0.5 mmol/ml). The mixture was 
refluxed for 4 days to complete the reaction. After work-up, the crude product was purified 
with flash chromatography on silica gel with DCM / EP = 60 / 40 to give the intermediate 
(1.07g, 91% for 2 steps) as brown oil. 
 
Finally, the acetylation was carried out with 1.07g crude product of last step. It was dissolved 
by 9ml DCM (0.3 mmol/ml) and 0.76ml acetyl chloride (10.7mmol, 4eq.) was added drop by 
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drop under ice-bain. The mixture was refluxed for 3 hours until the starting material was 
totally consumed. After work-up, the crude product was purified with flash chromatography 
on silica gel with AcOEt / EP = 20 / 80 to afford 4-14 (1.08g, 84% for 3 steps) as white solid. 
 
m.p. 154~157oC 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.64 (d, 2H, J = 8.6 Hz, aromatic-CH), 6.81 (d, 2H, J 
= 8.3 Hz, aromatic-CH), 6.49 (br s, 1H, NH), 5.80 (dt, 1H, J = 10.7, 5.6 Hz, CH=CH2), 5.36-
5.02 (dd,2H, J = 21.6, 10.4 Hz, CH=CH2), 4.35 (d, 2H, J = 5.9 Hz, CHCH2), 2.01 (br s, 3H, 
CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  170.0 (CO), 146.9 (dd, J = 237.3, 13.2 Hz, N-CF), 
142.7 (dd, J = 254.1, 3.9 Hz, CF-C-NAc), 138.5 (NH-C-CH), 138.0 (2 CH-C-I), 134.2 (dd, J 
= 259.3, 33.5 Hz, CF-CF-CNH), 134.1 (C-NH), 132.5 (CH=CH2), 131.9 (d, J = 11.4 Hz, C-
NAc), 123.0 (2 CH-C-NH), 118.1 (CH=CH2), 88.3 (C-I), 49.8 (NAc-CH2), 22.0 (d, J = 1.5 
Hz, CH3), 
IR (ν, cm-1, CCl4)  3418, 2959, 1688, 1657, 1621, 1585, 1476, 1371, 1306, 1264, 1235, 1117, 
1094, 1059, 1008, 979, 929 
HRMS (EI+)    Calcd. for C16H13F3IN3O : 447.0055      Found : 447.0055 
 
 
N-(4-(1H-benzo[d]imidazol-1-yl)-3,5,6-trifluoropyridin-2-yl)-N-allylacetamide (4-15) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 458mg benzimidazole (3.9 mmol, 1.1eq.) and 0.6ml TEA (4.3mmol, 1.2eq.) 
with 597mg pentafluoropyridine (3.5 mmol, 1.0eq.) in 3ml EtOH (1.0 mmol/ml) stirring 
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overnight at room temperature. After work-up, the crude product was used directly in the 
next step without further purification. 
 
Then the reaction was carried out with the crude product of last step and 1.1ml allylamine 
(14 mmol, 4.0eq.) in 2.4ml THF (1.5 mmol/ml) stirring overnight. After work-up, the crude 
product was used directly in the next step without further purification. 
 
Finally, the acetylation was carried out with the crude product of last step in 3ml acetyl 
chloride (1.2mmol/ml) stirring overnight at room temperature, and then refluxing for 1 hour 
to complete the reaction. After work-up, the crude product was purified with flash 
chromatography on silica gel with AcOEt / EP = 40 / 60 to give 4-15 (770mg, 63% for 3 
steps) as light yellow sticky oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.11 (s, 1H, NCH), 7.90-7.88 (m, 1H, CHCHCHCH), 
7.42-7.40 (m, 2H, CHCHCHCH), 7.32 (brs, 1H, CHCHCHCH), 5.87 (tdd, J = 16.02, 10.57, 
5.44 Hz, 1H, CH2CH), 5.26-5.18 (m, 2H, CH=CH2), 4.47 (d, J = 5.32 Hz, 2H, NCH2), 2.20 
(brs, 3H, N-CO-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 169.6 (N-CO), 147.9 (ddd , J = 276.05, 14.43, 2.43 
Hz, N-CF), 146.3 (dd, J = 242.42, 11.84 Hz, N-CF-CF), 143.1 (CF-C-N-C), 141.5 (NCH), 
136.7 (dd, J = 250.40, 14.52 Hz, CO-N-C-CF), 134.1-133.9 ( m, CF-C-N-CO), 132.3 (N-
CH-N-C), 132.2 (CH2CH), 127.7-127.5 (m, CF-CF-C), 125.0 (CHCHCHCH), 124.1 
(CHCHCHCH), 121.0 (CHCHCHCH), 118.0 (CHCH2), 111.0 (CHCHCHCH), 50.4 (N-CH2-
CH), 22.0 (NCO-CH3) 
IR (ν, cm-1, CDCl3)  3691, 3605, 3113, 3088, 3020, 2986, 2935, 1682, 1648, 1622, 1612, 
1515, 1477, 1468, 1452, 1417, 1380, 1324, 1304, 1291, 1257, 1239, 1204, 1178, 1154, 1076, 
1033, 1012, 980 
HRMS (EI+)    Calcd. for C17H13F3N4O : 346.1041     Found : 346.1047  
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tert-butyl (2-((ethoxycarbonothioyl)thio)-5-oxohexyl)(3,5,6-trifluoro-4-(pyrrolidin-1-yl) 
pyridin-2-yl)carbamate (4-16) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-1 (886mg, 2.48mmol, 2.0 eq.) and the corresponding xanthate Xa-i 
(223mg, 1.24mmol, 1.0 eq.) in AcOEt (1.3ml, 1.0 mmol/ml), with DLP (100mg, 0.20 eq.). 
Flash chromatography on silica gel with AcOEt / PE = 20 / 80 afforded 4-16 (455mg, 68%) 
as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.59 (q, 2H, J=7.1Hz, -CH2CH3), 4.04-3.97 (m, 1H, 
CHH-NBoc), 3.91-3.83 (m, 2H, CHH-NBoc + CH-Xa), 3.72 (br s, 4H, -CH2CH2NCH2CH2-), 
2.70-2.53 (m, 2H, CH2-COMe), 2.17-2.09 (m+s (2.13), 4H, CHH-CH-Xa + COCH3), 1.93 (t, 
4H, J=6.1Hz, -CH2CH2NCH2CH2-), 1.88-1.77 (m, 1H, CHH-CH-Xa), 1.44 (s, 9H, C(CH3)3), 
1.38 (t, 3H, J=7.1Hz, -CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.1 (C=S), 207.4 (COMe), 153.2 (COOtBu), 
147.4 (dd, J=14.4Hz, J=231.6Hz, N-CF), 141.6 (d, 1H, J=248.7Hz, CF-C-NBoc), 136.0 (ddd, 
1H, J=3.1Hz, J=6.1Hz, J=7.1Hz, N-C-NBoc), 133.9 (t, J=16.0Hz, N-C-CF), 132.8 (dd, 
J=5.5Hz, J=31.8Hz, J=250.3Hz, N-CF-CF), 81.5 (CMe3), 70.0 (OCH2CH3), 51.2 (t, J=6.1Hz, 
-CH2-N-CH2-), 49.9 (CH-Xa), 49.7 (CH2-NBoc), 40.5 (CH2-COMe), 29.9 (COCH3), 
28.1(C(CH3)3),  25.6 (-CH2-CH2-N-CH2-CH2-), 25.0 (CH2-CHXa), 13.6 (OCH2CH3) 
IR (ν, cm-1, CCl4)  2979, 2888, 1721, 1616, 1514, 1471, 1368, 1224, 1156, 1114, 1054 
HRMS (EI+)    Calcd. for C23H32F3N3O4S2 : 535.1786      Found : 535.1789 
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Ethyl 4-(ethoxycarbonothioylthio)-5-(methoxycarbonyl(3,5,6-trifluoro-4-(pyrrolidin-1-
yl)pyridin-2-yl)amino)pentanoate (4-17) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-2 (316mg, 1.00mmol, 0.5eq.) and the corresponding xanthate Xa-h 
(416mg, 2.00mmol, 1.0eq.) in AcOEt (1.0ml, 2.0mmol/ml), with DLP (240mg, 0.30 eq.). 
Flash chromatography on silica gel with AcOEt / PE = 25 / 75 afforded 4-17 (328mg, 63%) 
as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 4.58 (dq, 1H, J=2.1Hz, J=7.1 Hz, -CH2-CH3), 4.11 (q, 
1H, J=7.1 Hz, COO-CH2-CH3), 4.06-4.01 (m, 1H, CO-N-CHH), 3.95-3.85 (m, 2H, CO-N-
CHH + Xa-CH), 3.73 (br s, 7H, -CH2-N-CH2- + COOCH3), 2.56-2.38 (m, 2H, CH2-COOEt), 
2.24-2.15 (m, 1H, CHH-CH2-COOEt), 1.94-1.83 (m, 5H, CHH-CH2-COOEt + CH2-CH2-
CH2-CH2), 1.66 (br s, 6H, CH2-CH2-CH2), 1.38 (t, 3H, J=7.1 Hz, CSO-CH2-CH3), 1.24 (t, 3H, 
J=7.1Hz, COO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 212.9 (C=S), 172.6 (COOEt), 155.0 (COOMe), 
147.64 (dd, J=15.4Hz, J=231.6Hz, N-CF), 141.90 (d, J=251.3Hz, CF-C-NCO), 136.3-136.1 
(m, (CH2)2N-C), 133.08 (ddd, J=4.5Hz, J=32.6Hz, J=251.1Hz, (CH2)2N-C-CF-CF), 133.21 
(dt, 1H, J=3.7Hz, J=17.0Hz, N-C-N-CO), 70.0 (CSO-CH2-CH3), 60.5 (COO-CH2-CH3), 53.4 
(COOCH3), 51.3 (t, J=6.2Hz), CH2-N-CH2), 50.5 (CO-N-CH2), 49.4 (Xa-CH), 31.5 (CH2-
COOEt), 26.3 (Xa-CH-CH2),  25.6 (CH2-CH2-N-CH2-CH2), 14.2(COO-CH2-CH3), 13.6 
(CSO-CH2-CH3) 
IR (ν, cm-1, CDCl3)  2982, 2958, 2891, 2338, 1721, 1616, 1564, 1519, 1473, 1449, 1337, 
1354, 1222, 1140, 1114, 1051 
HRMS (EI+)    Calcd. for C21H28F3N3O5S2 :523.1422      Found : 523.1420 
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methyl 2-(ethoxycarbonothioylthio)hex-5-ynyl(3,5,6-trifluoro-4-(pyrrolidin-1-yl) 
pyridin-2-yl)carbamate (4-18) 
 
 
 
Following the general procedure E for radical addition of xanthate, the reaction was carried 
out with the protected olefin (285 mg, 0.904 mmol, 0.5 eq.) and the corresponding xanthate 
(303mg, 1.88mmol, 1.0 eq.) in AcOEt (0.9ml, 1.0 mmol/ml), with DLP (108mg, 0.15 eq.). 
Flash chromatography on silica gel with AcOEt / PE = 25 / 75 afforded 017.1 (307 mg, 71%) 
as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.60 (dq, J = 7.08, 3.04 Hz, 2H, CSO-CH2-CH3), 
4.05 (dd, J = 14.01, 8.21 Hz, 1H, CO-N-CHH), 3.98-3.84 (m, 2H, CO-N-CHH + Xa.-CH), 
3.73 (br s, 7H, N(CH2)2 + COOCH3), 2.77-2.39 (m, 2H, CN-CH2), 2.39-2.17 (m, 1H, CN-
CH2-CHH), 2.00-1.85 (m, 5H, CN-CH2-CHH + CH2-CH2- CH2-CH2), 1.39 (t, J = 7.12 Hz, 
3H, CSO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 211.6 (C=S), 155.1 (COOCH3), 147.8 (dd, J = 
232.29, 14.88 Hz, N-CF), 146.9 (dd, J = 254.76, 8.68 Hz, CF-C-NCO), 141.9 (d, J = 251.04 
Hz, (CH2)2N-C-CF-CF), 136.4-136.2 (m, (CH2)2N-C), 133.0-132.3 (m, N-C-N-CO), 118.8 
(CN), 70.5 (CSO-CH2-CH3), 53.5 (COOCH3), 51.3 (t, J = 6.18 Hz, N(CH2)2), 50.2 (OOC-N-
CH2), 48.4 (Xa.-CH), 26.9 (CN-CH2-CH2), 25.5 (CH2-(CH2)-CH2), 15.0 (CN-CH2), 13.6 
(CSO-CH2-CH3) 
IR (ν, cm-1, CCl4)  2981, 2958, 2890, 2253, 1716, 1616, 1520, 1473, 1449, 1377, 1354, 1309, 
1279, 1229, 1140, 1114, 1050 
HRMS (EI+)    Calcd. for C19H23F3N4O3S2 : 476.1164     Found : 476.1146 
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ethyl 4-((ethoxycarbonothioyl)thio)-5-((methoxycarbonyl)(3,5,6-trifluoro-4-(piperidin-
1-yl)pyridin-2-yl)amino)pentanoate (4-19) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-3 (491mg, 1.49mmol, 2.0 eq.) and the corresponding xanthate Xa-h 
(153mg, 0.74mmol, 1.0 eq.) in AcOEt (0.75ml, 1.0 mmol/ml), with DLP (59mg, 0.20 eq.). 
Flash chromatography on silica gel with AcOEt / PE = 15 / 85 afforded 4-19 (241mg, 61%) 
as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.58 (dq, 2H, J=1.3Hz, J=7.1Hz, CSO-CH2-CH3), 
4.11 (q, 2H, J=7.1Hz, COO-CH2-CH3), 4.08-4.03 (m, 1H, CO-N-CHH), 3.97-3.84 (m, 2H, 
CO-N-CHH + Xa-CH), 3.74 (s, 3H, COOCH3), 3.36 (br s, 4H, CH2-N-CH2), 2.55-2.38 (m, 
2H, CH2-COOEt), 2.23-2.15 (m, 1H, CHH-CH2-COOEt), 1.92-1.83 (m, 1H, CHH-CH2-
COOEt), 1.66 (br s, 6H, CH2-CH2-CH2), 1.38 (t, 3H, J=7.1Hz, CSO-CH2-CH3), 1.23 (t, 3H, 
J=7.1Hz, COO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  212.8 (C=S), 172.5 (COOEt), 154.9 (COOMe), 
147.0 (ddd, J=1.5Hz, J=15.1Hz, J=234.8Hz, N-CF), 145.0 (dd, J=3.3Hz, J=254.8Hz, CF-C-
NCO), 139.4-139.1 (m, (CH2)2N-C), 136.5 (ddd, J=3.0Hz, J=30.8Hz, J=256.2Hz, (CH2)2N-
C-CF), 133.2 (dt, J=3.8Hz, J=15.9Hz, N-C-N-CO), 70.0 (CSO-CH2-CH3), 60.4 (COO-CH2-
CH3), 53.4 (COOCH3), 51.5 (t, J=4.6Hz, CH2-N-CH2), 50.4 (CO-N-CH2), 49.5 (Xa-CH), 
31.4 (CH2-COOEt), 26.4 (Xa-CH-CH2),  26.3 (CH2-CH2-N-CH2-CH2), 24.0 (-N-CH2-CH2-
CH2), 14.1(COO-CH2-CH3), 13.6 (CSO-CH2-CH3) 
IR (ν, cm-1, CDCl3)    2942, 2857, 1722, 1617, 1570, 1515, 1452, 1378, 1286, 1226, 1156, 
1105, 1051, 995, 959 
HRMS (EI+)    Calcd. for C19H25F3N3O4 : 416.1797      Found : 416.1789      
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methyl (4-cyano-2-((ethoxycarbonothioyl)thio)butyl)(3,5,6-trifluoro-4-(piperidin-1-yl) 
pyridin-2-yl)carbamate (4-20) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-3 (884mg, 2.68mmol, 2.0 eq.) and the corresponding xanthate Xa-a 
(216mg, 1.34mmol, 1.0 eq.) in AcOEt (1.4ml, 1.0 mmol/ml), with DLP (80mg, 0.15 eq.). 
Flash chromatography on silica gel with AcOEt / PE = 15 / 85 afforded 4-20 (494mg, 75%) 
as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.60 (dq, 1H, J=1.6Hz, J=7.1Hz, CSO-CH2-CH3), 
4.14-4.05 (m, 1H, CO-N-CHH), 3.97-3.85 (m, 2H, CO-N-CHH + Xa-CH), 3.75 (s, 3H, 
COOCH3), 3.38 (br s, 4H, CH2-N-CH2), 2.64-2.46  (m, 2H, CH2-CN), 2.34-2.25 (m, 1H, 
CHH-CH2-CN), 1.98-1.88 (m, 1H, CHH-CH2-CN), 1.67 (br s, 6H, CH2-CH2-CH2), 1.39 (t, 
3H, J=7.1Hz, CSO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  211.6 (C=S), 155.0 (COOMe), 147.2 (dd, 
J=16.1Hz, J=235.4Hz, N-CF), 145.1 (d, J=255.7Hz, CF-C-NCO), 139.4 ((CH2)2N-C), 136.7 
(dd, J=30.9Hz, J=256.6Hz, (CH2)2N-C-CF), 132.9 (dt, J=3.6Hz, J=15.9Hz, N-C-N-CO), 
118.7 (CN), 70.5 (CSO-CH2-CH3), 53.7 (COOCH3), 51.5 (t, J=4.6Hz, CH2-N-CH2), 50.1 
(CO-N-CH2), 48.6 (Xa-CH), 27.0 (Xa-CH-CH2), 26.3 CH2-CH2-N-CH2-CH2), 24.0 (-N-CH2-
CH2-CH2), 15.0 (CH2-CN), 13.6 (CSO-CH2-CH3) 
IR (ν, cm-1, CDCl3)    2943, 2858, 1718, 1617, 1515, 1471, 1451, 1379, 1227, 1156, 1105, 
1050, 995 
HRMS (EI+)    Calcd. for C20H25F3N4O3S2 : 490.1320      Found : 490.1315      
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S-4-(ethoxycarbonyl)-1-(N-(3,5,6-trifluoro-4-(piperidin-1-yl)pyridin-2-yl) acetamido) 
butan-2-yl O-ethyl carbonodithioate (4-21) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-4 (2.01g, 6.43mmol, 2.0 eq.) and the corresponding xanthate Xa-h (664mg, 
3.20mmol, 1.0 eq.) in AcOEt (3.2ml, 1.0 mmol/ml), with DLP (254mg, 0.20 eq.). Flash 
chromatography on silica gel with AcOEt / PE = 30 / 70 afforded 4-21 (934mg, 56%) as a 
yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.57 (dq, 2H, J=1.7Hz, J=7.1Hz,  CSO-CH2-CH3) 
4.22 (dd, 1H, J=10.1Hz, J=15.6Hz, CHH-NAc), 4.10 (q, 2H, J=7.1Hz, COO-CH2-CH3), 3.78 
(d, 2H, J=8.6Hz, CHH-NAc + Xa-CH), 3.39 (br s, 4H, CH2-N-CH2), 2.56-2.36 (m, 2H, CH2-
COOEt), 2.24-2.15 (m, 1H, CHH-CH2-COOEt), 1.95-1.84 (s + m, 4H, COCH3 + CHH-CH2-
COOEt), 1.68 (br s, 4H, CH2-CH2-CH2), 1.65 (br s, 2H, CH2-CH2-CH2), 1.37 (t, 3H, J=7.1Hz, 
CSO-CH2-CH3), 1.23 (t, 3H, J=7.1Hz, COO-CH2-CH3)  
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.3 (C=S), 172.6 (COOEt), 170.3 (COMe), 
147.5 (dd, J=15.4Hz, J=236.1Hz, N-CF), 145.1 (d, J=253.1Hz, CF-C-NCO), 139.6-139.3 (m, 
N(piperidine)-C), 136.8 (dd, J=33.5Hz, J=257.5Hz, C-CF-CF), 134.5-134.1 (m, N-C-N-CO), 
70.1(CSO-CH2-CH3), 60.4 (COO-CH2-CH3), 51.6 (t, J=4.6Hz, CH2-N-CH2), 49.2 (Xa-CH), 
49.0 (CO-N-CH2), 31.6 (CH2-COOEt), 26.3 (Xa-CH-CH2 + CH2-CH2-N-CH2-CH2), 23.9 (-
N-CH2-CH2-CH2), 21.8 (COCH3), 14.2 (COO-CH2-CH3), 13.7 (CSO-CH2-CH3) 
IR (ν, cm-1, CDCl3)    2943, 2858, 1728, 1675, 1612, 1516, 1463, 1329, 1284, 1225, 1157, 
1109, 1052, 1003 
HRMS (EI+)    Calcd. for C19H25F3N3O3 : 400.1848      Found : 400.1849 
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S-4-(ethoxycarbonyl)-1-(N-(4-(cyclopropylamino)-3,5,6-trifluoropyridin-2-yl)acetamido) 
butan-2-yl O-ethyl carbonodithioate (4-22) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-5 (304mg, 1.07mmol, 1.0eq.) and the corresponding xanthate Xa-h 
(333mg, 1.60mmol, 1.5eq.) in AcOEt (1.6ml, 1.0mmol/ml), with DLP (95.5mg, 0.15 eq.). 
Flash chromatography on silica gel with Acetone / DCM = 3 / 97 afforded 4-22 (382mg, 
72%) as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.79 (br s, 1H, NH), 4.57 (dq, 2H, J=2.1Hz, J=7.1Hz, 
CS-OCH2CH3), 4.27-4.17 (m, 1H, CHH-NAc), 4.11 (q, 1H, J=7.1Hz, CO-OCH2CH3), 3.84-
3.74 (m, 2H, CHH-NAc + CH-Xa), 2.99-2.98 (m, 1H, NH-CH), 2.56-2.49 (m, 1H, CHH-
COOEt), 2.44-2.32 (m, 1H, CHH-COOEt), 2.24-2.15 (m, 1H, CHH-CH-Xa), 1.96 (s, 3H, 
COCH3), 1.96-1.84 (m, 1H, CHH-CH-Xa), 1.38 (t, 3H, J=7.1Hz, CS-OCH2-CH3), 1.23 (t, 3H, 
J=7.1Hz, CO-OCH2-CH3), 0.87 (q, 2H, J=6.7Hz, -CHH-CHH-), 0.71 (m, 2H, -CHH-CHH-) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.1 (C=S), 172.6 (COOEt), 170.3 (COMe), 
147.0 (dd, J=15.1Hz, J=234.2Hz, N-CF), 141.2 (d, J=250.0Hz, CF-C-NAc), 136.7 (dd, 
J=7.1Hz, J=14.1Hz, N-C-NAc), 133.2 (m, N-C-CF), 132.6 (dd, J=32.1Hz, J=255.5Hz, N-CF-
CF), 70.1 (CS-OCH2CH3), 60.4 (CO-OCH2CH3), 49.1(CH2-NAc), 49.0 (CH-Xa), 31.6 (CH2-
COOEt), 26.7 (NH-CH), 26.2 (CH2-CHXa), 21.8 (COCH3), 14.1 (CO-OCH2-CH3), 13.6 (CS-
OCH2-CH3), 8.7 (-CH2-CH2-) 
IR (ν, cm-1, CDCl3)    3428, 2985, 2938, 1728, 1676, 1624, 1527, 1475, 1381, 1361, 1224, 
1182, 1111, 1051 
HRMS (EI+)    Calcd. for C17H21F3N3O3 : 372.1535      Found : 372.1526      
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S-4-(ethoxycarbonyl)-1-(N-(4-(N-cyclopropyl-N-acetylamino)-3,5,6-trifluoropyridin-2-
yl)acetamido)butan-2-yl O-ethyl carbonodithioate (4-23) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-6 (398mg, 1.22mmol, 1.0eq.) and the corresponding xanthate Xa-h 
(389mg, 1.82mmol, 1.5eq.) in AcOEt (1.8ml, 1.0mmol/ml), with DLP (109mg, 0.15 eq.). 
Flash chromatography on silica gel with Acetone / DCM = 5 / 95 afforded 4-23 (545mg, 
84%) as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.57 (q, 2H, J=7.1Hz, CS-OCH2CH3), 4.39-4.27 + 
3.83-3.70 (br s, 1H, CHH-NAc), 4.28-4.17 + 4.07-3.99 (br s, 1H, CHH-NAc), 4.10 (q, 2H, 
J=7.1Hz, CO-OCH2CH3), 3.88-3.81 (m, 1H, CH-Xa), 3.20 (br s, 1H, NAc-CH), 2.55-2.44 (m, 
2H, CH2-COOEt), 2.44 (br s, 3H, CH-N-COCH3), 2.23-2.14 (m, 1H, CHH-CH-Xa), 1.99 (br 
s, 3H, CH2-N-COCH3), 1.93-1.84 (m, 1H, CHH-CH-Xa), 1.37 (t, 3H, J=7.1Hz, CS-OCH2-
CH3), 1.23 (t, 1H, J=7.1Hz, CO-OCH2-CH3), 1.01 (br s, 2H, -CHH-CHH-), 0.75 (br s, 2H, -
CHH-CHH-) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  212.8 (C=S), 172.5 (COOEt), 171.7 (CHN-COMe), 
170.2 (CH2N-COMe), 147.97 (dd, 1H, J=5.9Hz, J=260.5Hz, N-CF-CF), 146.06 (dd, 1H, 
J=14.9Hz, J=241.3Hz, N-CF), 140.44 (d, 1H, J=263.8Hz, CF-C-NAc), 134.7 (m, N-C-NAc), 
131.7 (m, AcN-C-CF), 70.2 (CS-OCH2CH3), 60.5 (CO-OCH2CH3), 49.7 (CH-Xa), 48.8 
(CH2-NAc), 31.5 (CH2-COOEt + NAc-CH), 26.5 (CH2-CHXa), 22.3 (CHN-COCH3), 21.7 
(CH2N-COCH3), 14.2 (CO-OCH2-CH3), 13.6 (CS-OCH2-CH3), 10.1(-CH2-CH2-),  9.2 (-CH2-
CH2-) 
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IR (ν, cm-1, CDCl3)    3692, 2985, 2940, 1729, 1686, 1618, 1466, 1377, 1309, 1228, 1187, 
1112, 1051 
HRMS (EI+)    Calcd. for C22H28F3N3O5S2 : 535.1422,  -Xa. 414.1641     Found :   414.1641 
 
 
4-(ethoxycarbonothioylthio)-5-(N-(3,5,6-trifluoro-4-(1H-pyrrol-1-yl)pyridin-2-yl) 
acetamido) pentanoate (4-24) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-7 (1.03 g, 3.49 mmol, 2.0 eq.) and the corresponding xanthate Xa-h 
(359mg, 1.72mmol, 1.0 eq.) in AcOEt (1.75ml, 1.0 mmol/ml), with DLP (140mg, 0.20 eq.). 
Flash chromatography on silica gel with AcOEt / PE = 25 / 75 afforded 4-24 (470mg, 53%) 
as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.13 (m, 2H, J=2.1Hz, -CH-CH), 6.46 (m, 2H,-CH-
CH), 4.56 (q, 2H, J=6.9Hz, CSO-CH2-CH3), 4.28-4.33 (m, 1H, CO-N-CHH), 4.10 (q, 2H, 
J=7.1Hz, COO-CH2-CH3), 3.93-3.83 (m, 2H, CO-N-CHH + Xa-CH), 2.56-2.39 (m, 2H, CH2-
COOEt), 2.27-2.18 (m, 1H, CHH-CH2-COOEt), 2.06 (br s, 3H, COCH3), 1.93-1.83 (m, 1H, 
CHH-CH2-COOEt), 1.36 (t, 3H, J=7.1Hz, CSO-CH2-CH3), 1.23 (t, 3H, J=7.1Hz, COO-CH2-
CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 213.2 (C=S), 172.5 (COOEt), 169.9 (COMe), 
146.90 (dd, J=14.7Hz, J=240.8Hz, N-CF), 144.72 (dd, J=4.6Hz, J=261.0Hz, CF-C-NCO), 
137.21 (dd, J=32.3Hz, J=267.9Hz, (CH2)2N-C-CF-CF), 135.6.3-135.3 (m, (CH2)2N-C), 
129.8-129.6 (m, N-C-N-CO), 70.4 (COO-CH2-CH3), 60.5 (CSO-CH2-CH3), 49.5 (CO-N-CH2 
Experimental Part 
 303 
+ 49.4 (Xa-CH), 31.3 (CH2-COOEt), 26.3 (Xa-CH-CH2),  22.00 (d, J=2.4Hz,CO-CH3), 
14.2(COO-CH2-CH3), 13.6 (CSO-CH2-CH3) 
IR (ν, cm-1, CCl4)  2927, 2855, 1728, 1682, 1619, 1519, 1468, 1379, 1222, 1194, 1103, 1052 
HRMS (EI+)    Calcd. for C21H24F3N3O5S2 :503.1160     Found : 503.1174 
 
 
4-(ethoxycarbonothioylthio)-5-(N-(3,5,6-trifluoro-4-(N-methylacetamido)pyridin-2-yl) 
acetamido)pentanoate (4-25) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-8 (223mg, 0.74 mmol, 0.7 eq.) and the corresponding xanthate Xa-h 
(231mg, 1.11mmol, 1.0 eq.) in AcOEt (0.8ml, 1.0 mmol/ml), with DLP (44mg, 0.15 eq.). 
Flash chromatography on silica gel with AcOEt / DCM = 20 / 80 afforded 4-25 (317mg, 
84%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.57 (q, J = 7.09 Hz, 2H, CSO-CH2-CH3), 4.32-4.27 
(m, 1H, CO-N-CHH), 4.09 (q, J = 7.12 Hz, 2H, COO-CH2-CH3), 4.04-3.63 (m, 2H, CO-N-
CHH + Xa-CH), 3.41-3.27 (m, 3H, N-CH3), 2.53-2.40 (m, CH2-COOEt) 2.24-2.14 (m, 1H, 
CHH-CH2-COOEt), 2.02 (br s, 6H, COCH3), 1.93-1.79 (m, 1H, CHH-CH2-COOEt), 1.39 (t, 
J = 7.10 Hz, 3H, CSO-CH2-CH3), 1.23 (t, J = 7.12 Hz, 3H, COO-CH2-CH3 ) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 213.2 (C=S), 172.5 (COOEt), 170.3-168.7 (N-
COMe + CH3N-COMe), 147.7 (d, J = 260.75 Hz, N-CF), 146.1 (dd, J = 242.98, 13.78 Hz, 
CF-C-NCO), 140.4 (d, J = 265.23 Hz, (CH2)2N-C-CF-CF ), 132.3 ((CH2)2N-C), 118.0 (N-C-
N-CO), 70.5 (CSO-CH2-CH3), 60.4 (COO-CH2-CH3), 49.7 (CO-N-CH2 + Xa-CH), 37.8  + 
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35.5 (N-CH3), 31.2 (CH2-COOEt), 26.3 (Xa-CH-CH2), 21.9 + 21.4 (NCO-CH3+ CH3-NCO-
CH3), 14.1 +13.6 (CSO-CH2-CH3 + COO-CH2-CH3 ) 
IR (ν, cm-1, CDCl3)  3691, 3607, 2985, 2940, 1728, 1682, 1618, 1489, 1464, 1422, 1375, 
1330, 1301, 1227, 1151, 1113, 1051 
HRMS (EI+)    Calcd. for C20H26F3N3O5S2 : 509.1266     Found : 509.1245 
 
 
5-(N-(4-acetamido-3,5,6-trifluoropyridin-2-yl)acetamido)-4-(ethoxycarbonothioyl 
thio)pentanoate (4-26) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-10 (268 mg, 0.93 mmol, 1.0 eq.) and the corresponding xanthate Xa-h 
(195 mg, 0.94 mmol, 1.0 eq.) in AcOEt (0.93 ml, 1.0 mmol/ml), with DLP (75 mg, 0.40 eq.). 
Flash chromatography on silica gel with AcOEt / EP = 30 / 70 afforded 4-26 (291 mg, 63%) 
as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.76 (s, 1H, NH), 4.56 (q, J = 7.10 Hz, 1H, CSO-
CH2-CH3), 4.33-4.19 (m, 1H, CO-N-CHH), 4.10 (q, J = 7.09 Hz, 2H, COO-CH2-CH3), 3.88 
(dd, J = 13.79, 5.92 Hz, 1H, CO-N-CHH), 3.82-3.73 (m, 1H, Xa-CH), 2.58-2.36 (m, 2H, 
CH2-COOEt), 2.29 (s, 3H, NH-CO-CH3), 2.24-2.11 (m, 1H, CHH-CH2-COOEt), 2.02 (s, 3H, 
COCH3), 1.92-1.78 (m, 1H, CHH-CH2-COOEt), 1.37 (t, J = 7.11 Hz, 3H, CSO-CH2-CH3), 
1.23 (t, J = 7.14 Hz, 3H, COO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 212.9 (C=S), 172.7 (COOEt), 170.4 (COMe), 167.2 
(NH-CO), 146.2 (ddd, J = 240.48, 14.37, 2.23 Hz, N-CF), 145.7 (dd, J = 259.65, 5.36 Hz, 
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CF-C-NCO), 138.5 (dd, J = 267.98, 31.49 Hz, (CH2)2N-C-CF-CF), 134.5-134.0 (m, 
(CH2)2N-C), 127.3-126.4 (m, N-C-N-CO), 70.3 (COO-CH2-CH3), 60.6 (CSO-CH2-CH3), 
49.3 (CO-N-CH2 + Xa-CH), 31.5 (CH2-COOEt), 26.2 (Xa-CH-CH2), 23.2 (NH-CO-CH3), 
21.9 (d, J = 2.45 Hz, CO-CH3), 14.1 (COO-CH2-CH3), 13.6 (CSO-CH2-CH3) 
IR (ν, cm-1, CDCl3)  3691, 3418, 2985, 2939, 1727, 1682, 1622, 1501, 1476, 1448, 1379, 
1223, 1113, 1051 
HRMS (EI+)    Calcd. for C16H19F3N3O4 : 374.1328     Found : 374.1324 
 
 
4-(ethoxycarbonothioylthio)-5-(N-(3,5,6-trifluoro-4-(N-methylmethylsulfonamido) 
pyridin-2-yl)acetamido)pentanoate (4-27) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-9 (278mg, 0.82mmol, 1.2 eq.) and the corresponding xanthate Xa-h 
(139mg, 0.67mmol, 1.0 eq.) in AcOEt (0.65ml, 1.0 mmol/ml), with DLP (40mg, 0.15eq.). 
Flash chromatography on silica gel with AcOEt / DCM = 5 / 95 afforded 4-27 (316mg, 71%) 
as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.58 (dq, J = 7.08, 2.63 Hz, 2H, CSO-CH2-CH3), 
4.28 (dd, J = 14.12, 7.32 Hz, 1H, CO-N-CHH), 4.10 (q, J = 7.15 Hz, 2H, COO-CH2-CH3), 
3.92 (dd, J = 13.46, 6.34 Hz, 1H, CO-N-CHH), 3.85-3.74 (m, 1H, Xa-CH), 3.37 (s, 3H, N-
CH3), 3.14 (s, 3H, SO2-CH3), 2.51-2.41 (m, 2H, CH2-COOEt), 2.27-2.11 (m, 1H, CHH-CH2-
COOEt), 2.03 (s, 3H, COCH3), 1.94-1.78 (m, 1H, CHH-CH2-COOEt), 1.40 (t, J = 7.11 Hz, 
3H, CSO-CH2-CH3), 1.24 (t, J = 7.12 Hz, 3H, COO-CH2-CH3) 
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13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 213.0 (C=S), 172.5 (COOEt), 170.0 (COMe), 146.2 
(dd, J = 243.01, 17.46 Hz, N-CF), 144.8 (dd, J = 263.85, 14.39 Hz, CF-C-NCO),  139.2 (dd, 
J = 263.88, 28.30 Hz, (CH2)2N-C-CF-CF), 134.7-134.10 (m, (CH2)2N-C), 128.1-127.1 ( m, 
N-C-N-CO), 70.4 (COO-CH2-CH3), 60.5 (CSO-CH2-CH3), 49.6 (CO-N-CH2 + Xa-CH), 39.0 
(SO2-CH3), 37.3 (N-CH3), 31.3 (CH2-COOEt), 26.3 (Xa-CH-CH2), 21.9 (d, J = 2.45 Hz, CO-
CH3), 14.2 (CSO-CH2-CH3), 13.7 (COO-CH2-CH3) 
IR (ν, cm-1, CDCl3)  3692, 3606, 2985, 2940, 1720, 1684, 1602, 1489, 1383, 1330, 1301, 
1227, 1151, 1097 
HRMS (EI+)    Calcd. for C16H21F3N3O5S : 424.1154     Found : 424.1167 
 
 
S-1-(N-(4-acetamido-3,5,6-trifluoropyridin-2-yl)acetamido)-4-(1,3-dioxoisoindolin-2-
yl)butan-2-yl O-ethyl carbonodithioate (4-28) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-10 (217mg, 0.76mmol, 0.7 eq.) and the corresponding xanthate Xa-c 
(319mg, 1.13mmol, 1.0 eq.) in AcOEt (0.76ml, 1.0 mmol/ml), with DLP (137mg, 0.30eq.). 
Flash chromatography on silica gel with AcOEt / EP = 50 / 50 afforded 4-28 (315mg, 73%) 
as a colourless solid. 
 
m.p. 59-61 oC 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.87-7.81 (m, 3H, NH + C-CH-CH), 7.81-7.70 (m, 
2H, C-CH-CH), 4.52 (q, J = 7.09 Hz, 2H, CSO-CH2-CH3), 4.23 (dd, J = 14.18, 7.51 Hz, 1H, 
CH3-CO-N-CHH), 3.99 (dd, J = 14.24, 6.47 Hz, 1H, CH3-CO-N-CHH), 3.88-3.73 (m, 2H, 
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CH2-NCO-C), 3.73-3.63 (m, 1H, Xa-CH), 2.31 (s, 3H, NH-CO-CH3), 2.22-2.10 (m, 1H, 
CHH-CH2- NCO-C), 2.00 (m, 4H, CHH-CH2- NCO-C + N-COCH3), 1.33 (t, J = 7.07 Hz, 
3H, CSO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 212.8 (C=S), 170.4 (COMe), 168.2 (NCOC), 167.2 
(NH-CO), 146.3 (dd, J = 241.01, 14.72 Hz, N-CF), 145.8 (dd, J = 259.62, 5.32 Hz, CF-C-
NCO), 138.7 (dd, J = 268.79, 31.68 Hz, (CH2)2N-C-CF-CF), 134.0 (C-CH-CH), 133.8-133.3 
(m, (CH2)2N-C), 132.0 (C-CH-CH), 128.2-125.2 (m, N-C-N-CO), 123.2 (C-CH-CH), 70.3 
(CSO-CH2-CH3), 48.8-48.5 (m, CO-N-CH2), 47.3 (Xa-CH), 35.6 (CH2-NCO-C), 29.9 (Xa.-
CH2-CH2), 23.3 (NH-CO-CH3), 21.9 (N-CO-CH3), 13.6 (CSO-CH2-CH3) 
IR (ν, cm-1, CDCl3)  3691, 3606, 2928, 1714, 1602, 1476, 1447, 1398, 1379, 1226, 1050 
HRMS (EI+)    Calcd. for C24H23F3N4O5S2 : 568.1062     Found : 568.1062 
 
 
S-1-(N-(4-acetamido-3,5,6-trifluoropyridin-2-yl)acetamido)-5-(4-fluorophenyl)-5-
oxopentan-2-yl O-ethyl carbonodithioate (4-29) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-10 (318mg, 1.11 mmol, 0.7 eq.) and the corresponding xanthate Xa-g (431 
mg, 1.66 mmol, 1.0 eq.) in AcOEt (1.10 ml, 1.0 mmol/ml), with DLP (99mg, 0.15 eq.). Flash 
chromatography on silica gel with AcOEt / DCM = 30 / 70 afforded 4-29 (598mg, 85%) as a 
white solid. 
 
m.p. 55-58 oC 
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1H-NMR (į, ppm) (CDCl3, 400 MHz)  8.04 (s, 1H, NH), 7.95 (dd, J = 8.26, 5.84 Hz, 2H, 
CO-C-CH), 7.11 (t, J = 8.57 Hz, 2H, F-C-CH), 4.53 (dq, J = 7.39, 7.05, 2.81 Hz, 2H, CSO-
CH2-CH3), 4.30 (dd, J = 12.16, 7.68 Hz, 1H, CH3-CO-N-CHH), 4.03-3.88 (m, 1H, Xa.-CH), 
3.88-3.76 (m, 1H, CH3-CO-N-CHH), 3.17-3.08 (m, 2H, CH2-CO-C), 2.30 (s, 4H, NH-CO-
CH3 + Xa.-CHH-CO), 2.01 (s, 4H, N-COCH3 + Xa.-CHH-CO), 1.35 (t, J = 7.12 Hz, 3H, 
CSO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 212.8 (C=S), 197.4 (Xa.-CH2-CO), 170.5 (N-
COMe), 167.4 (NH-CO), 167.0 (CO-C-CH), 164.5 (CO-C-CH), 146.2 (ddd, J = 240.88, 
14.47, 2.34 Hz, N-CF), 145.8 (dd, J = 259.59, 5.33 Hz, CF-C-NCO), 138.5 (dd, J = 268.08, 
31.68 Hz, (CH2)2N-C-CF-CF), 135.5-133.6 (m, (CH2)2N-C), 133.0 (d, J = 2.97 Hz, CH-C-F), 
130.6 (d, J = 9.33 Hz, CO-C-CH), 128.1-125.7 (m, N-C-N-CO), 115.7 (d, J = 21.87 Hz, CH-
C-F), 70.3 (CSO-CH2-CH3), 49.2 (CO-N-CH2 + Xa.-CH), 35.5 (CH2-CO-C), 25.1 (Xa.-CH2-
CH2), 23.2 (NH-CO-CH3), 21.9 (d, J = 1.95 Hz, N-CO-CH3), 13.60 (CSO-CH2-CH3) 
IR (ν, cm-1, CDCl3)  3418, 2938, 1727, 1685, 1622, 1599, 1504, 1476, 1448, 1380, 1284, 
1226, 1157, 1113, 1051 
HRMS (EI+)    Calcd. for C20H18F4N3O3 : 424.1284     Found : 424.1290 
 
 
S-6,6-dimethyl-5-oxo-1-(N-(3,5,6-trifluoro-4-(1H-1,2,4-triazol-1-yl)pyridin-2-yl) 
acetamido)heptan-2-yl O-ethyl carbonodithioate (4-30) 
 
 
 
Following the general procedure 4-30 for radical addition of xanthate, the reaction was 
carried out with 4-11 (168 mg, 0.45 mmol, 0.7 eq.) and the corresponding xanthate Xa-d 
(207 mg, 0.93 mmol, 1.0 eq.) in AcOEt (0.50 ml, 1.0 mmol/ml), with DLP (185 mg, 0.5 eq.). 
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Flash chromatography on silica gel with AcOEt / DCM = 30 / 70 afforded 4-30 (186 mg, 
82%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  8.76 (s, 1H, C-N-CH), 8.28 (s, 1H, C-N-N-CH), 4.58 
(q, J = 7.10 Hz, 2H, CSO-CH2-CH3), 4.39-4.29 (m, 1H, CO-N-CHH), 4.01-3.92 (m, 1H, 
CO-N-CHH), 3.73-3.71 (m, 1H, S-CH), 2.76-2.59 (m, 2H, CO-CH2), 2.21-2.13 (m, 4H, CO-
CH2-CHH + CO-CH3), 1.76-1.67 (m, 1H, CO-CH2-CHH), 1.37 (t, J = 7.13 Hz, 3H, CSO-
CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 214.9 (C=S), 213.1 (CO-CH2), 169.7 (COMe), 
153.6 (C-N-N-CH), 146.4 (dd, J = 241.24, 17.15 Hz, N-CF), 146.0 (C-N-CH), 144.7 (dd, J = 
252.73, 17.35 Hz, CF-C-NCO), 137.7 (dd, J = 245.15, 30.44 Hz, (CH2)2N-C-CF-CF), 135.7-
135.5 (m, (CH2)2N-C), 126.3-125.9 (m, N-C-N-CO), 70.5 (CSO-CH2-CH3),), 49.4 (Xa-CH + 
CO-N-CH2), 44.1 (CO-C), 33.1 (CH2-CO-C), 26.4 (C(CH3)3), 24.6 (S-CH-CH2),  22.1 (CO-
CH3), 13.7 (CSO-CH2-CH3) 
IR (ν, cm-1, CDCl3)  2970, 1699, 1624, 1527, 1469, 1438, 1368, 1230, 1181, 1129, 1112, 
1051, 997 
HRMS (EI+)    Calcd. for C18H21F3N5O2 : 396.1647      Found : 396.1648 
 
 
O-ethyl S-5-oxo-5-(2-oxooxazolidin-3-yl)-1-(N-(3,5,6-trifluoro-4-(1H-imidazol-1-yl) 
pyridin-2-yl)acetamido)pentan-2-yl carbonodithioate (4-31) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-12 (229 mg, 0.77 mmol, 1.1 eq.) and the corresponding xanthate Xa-f (179 
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mg, 1.72 mmol, 1.0 eq.) in AcOEt (0.80 ml, 1.0 mmol/ml), with DLP (58 mg, 0.20 eq.). 
Flash chromatography on silica gel with AcOEt / DCM = 45 / 55 afforded 4-31 (118 mg, 
56%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  8.00 (s, 1H, N-CH-N), 7.41 (s, 1H, C-N-CH-CH), 
7.30 (s, 1H, C-N-CH-CH), 4.57 (q, J = 7.07 Hz, 2H, CSO-CH2-CH3), 4.39 (t, J = 7.89 Hz, 
2H, N-CH2-CH2-O), 4.35-4.30 (m, 1H, CO-N-CHH), 4.02-3.94 (m, 3H, N-CH2-CH2-O + Xa-
CH), 3.87-3.77 (m, 1H, CO-N-CHH), 3.16-3.01 (m, 2H, N-CO-CH2), 2.32-2.23  (m, 1H, N-
CO-CH2-CHH), 2.11 (br s, 3H, COCH3), 2.27-2.18 (m, 1H, CHH-CH2-COOEt), 1.94-1.84 
(m, 1H, CHH-CH2-CO-N), 1.38 (t, J = 7.10 Hz, 3H, CSO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 213.4 (C=S), 172.2 (COOEt), 169.8 (COMe), 153.5 
(N-COO-CH2), 146.6 (d, J = 230.40 Hz, N-CF), 144.7 (d, J = 262.51 Hz, CF-C-NCO), 137.5 
(N-CH-N), 137.1 (d, J = 266.41 Hz, (CH2)2N-C-CF-CF), 135.6 (m, (CH2)2N-C), 130.8 (C-N-
CH-CH), 126.4 (m, N-C-N-CO), 119.5 (C-N-CH-CH), 70.7 (CSO-CH2-CH3), 62.2 (COO-
CH2), 49.8 (CO-N-CH2), 49.4 (Xa-CH), 42.5 (COO-CH2-CH2), 32.2 (CH2-CO-N), 25.6 (Xa-
CH-CH2),  22.1 (d, J=2.4Hz,CO-CH3), 13.7 (CSO-CH2-CH3) 
IR (ν, cm-1, CCl4)  3693, 1783, 1693, 1602, 1519, 1470, 1386, 1225, 1051 
HRMS (EI+)    Calcd. for C18H17F3N5O4 : 424.1233      Found : 424.1221 
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O-ethyl S-5-oxo-1-(N-(3,5,6-trifluoro-4-(1H-indol-1-yl)pyridin-2-yl)acetamido) hexan-2-
yl carbonodithioate (4-32) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-13 (144 mg, 0.42 mmol, 0.7 eq.) and the corresponding xanthate Xa-i (111 
mg, 0.62 mmol, 1.0 eq.) in AcOEt (0.42 ml, 1.0 mmol/ml), with DLP (87 mg, 0.35 eq.). 
Flash chromatography on silica gel with AcOEt / EP = 30 / 70 afforded 4-32 (166 mg, 75%) 
as a dark yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.75 (d, J = 7.67 Hz, 1H, N-CH), 7.43-7.23 (m, 4H, 
aromatic H), 6.89 (d, J = 3.36 Hz, 1H, N-CH-CH), 4.60 (dq, J = 7.10, 3.01 Hz, 2H, CSO-
CH2-CH3), 4.41-4.36 (m, 1H, CO-N-CHH), 4.04-4.00 (m, 1H, CO-N-CHH), 3.88 (dd, J = 
5.87, 3.35 Hz, 1H, Xa.-CH), 2.79-2.58 (m, 2H, CO-CH2), 2.18 (s, 7H, CH2CO-CH3 + N-CO-
CH3 + CO-CH2-CHH ), 1.91-1.86 (m, 1H, CO-CH2-CHH), 1.38 (t, J = 7.11 Hz, 3H, CSO-
CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 213.2 (C=S), 207.2 (CO-CH2), 169.9 (COMe), 
146.6 (dd, J = 241.91, 15.06 Hz, N-CF), 146.4 (dd, J = 263.08, 5.40 Hz, N-C-CF-CF), 138.8 
(dd, J = 269.61, 31.69 Hz, CF-C-NCO), 136.6-136.4 (m, CH-N-C), 128.8-128.6 (m, N-C-N-
CO), 135.5, 129.0, 127.6, 123.7, 121.4, 111.1 (6s, aromatic C), 122.1 (N-CH), 107.3 (N-CH-
CH), 70.5 (CSO-CH2-CH3), 53.4 (CO-N-CH2), 49.6 (Xa.-CH), 40.3 (CO-CH2), 30.0 (CH2-
CO-CH3), 24.9 (Xa.-CH-CH2), 22.1 (d, J = 2.00 Hz, N-CO-CH3), 13.6 (CSO-CH2-CH3) 
IR (ν, cm-1, CCl4)  2928, 2855, 1716, 1683,1610, 1531, 1508, 1465, 1451, 1372, 1230, 1209, 
1180, 1112, 1046 
HRMS (EI+)    Calcd. for C21H19F3N3O2 : 402.1429     Found : 402.1427 
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S-(5-cyclopropyl-5-oxo-1-(N-(3,5,6-trifluoro-4-((4-iodophenyl)amino)pyridin-2-yl) 
acetamido)pentan-2-yl) O-ethyl carbonodithioate (4-33) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with the protected olefin 4-14 (375 mg, 0.84 mmol, 0.7 eq.) and the 
corresponding xanthate Xa-l (257 mg, 1.25 mmol, 1.0 eq.) in AcOEt (0.84 ml, 1.0 mmol/ml), 
with DLP (75 mg, 0.15 eq.). Flash chromatography on silica gel with AcOEt / EP = 20 / 80 
afforded 4-33 (491 mg, 90%) as a light yellow sticky oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.65 (d, J = 8.58 Hz, 2H, ICCH), 6.86 (d, J = 8.05 Hz, 
2H, NHCCH), 6.47 (brs, 1H, NH), 4.57 (dq, J = 7.08, 2.20 Hz, 2H, CH2CH3), 4.27-4.22 (m, 
1H, N-CHH), 3.87-3.84 (m, 1H, N-CHH), 3.80-3.76 (m, 1H, S-CH), 2.82-2.64 (m, 2H, 
COCH2), 2.19-2.10 (m, 1H, COCH2CHH), 1.99 (brs, 3H, COCH3), 1.92-1.84 (m, 2H, 
COCH2CHH + COCH), 1.38 (t, J = 7.12 Hz, 3H, CH2CH3), 1.00-0.96 (m, 2H, COCH-CH2), 
0.87-0.83 (m, 2H, COCH-CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 213.3 (C=S), 209.4 (COCH), 170.1 (NCO), 146.8 
(dd, J = 236.81, 12.49 Hz, N-CF), 142.7 (d, J = 254.26 Hz, NCFCF), 138.3 (NHCCH), 
138.1 (NHCCH), 134.3 (dd, J = 260.72, 32.92 Hz, CF-C-NCO), 134.3-133.9 (NCN), 132.2-
131.9 (CFCFC), 123.3 (ICCH), 88.7 (IC), 70.3 (CSOCH2CH3), 49.5 (CONCH2), 49.1 (SCH), 
40.2 (NCH2), 25.0 (COCH2), 21.9 (COCH), 20.5 (COCH2CH2), 13.7 (CH2CH3), 10.8 
(COCHCH2CH2) 
IR (ν, cm-1, CDCl3)  3692, 3607, 3411, 1681, 1621, 1602, 1527, 1475, 1386, 1233, 1113, 
1051, 1007 
MS (NH3 ionisation) 530 (-Xa.) 
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S-(4-(1-benzyl-1H-tetrazol-5-yl)-1-(N-(3,5,6-trifluoro-4-((4-iodophenyl)amino)pyridin-2-
yl)acetamido)butan-2-yl) O-ethyl carbonodithioate (4-34) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with 4-14 (333 mg, 0.75mmol, 1.0eq.) and the corresponding xanthate Xa-i 
(220mg, 0.75mmol, 1.0eq.) in AcOEt (0.75ml, 1.0 mmol/ml), with DLP (60mg, 0.2eq.). 
Flash chromatography on silica gel with Et2O / DCM = 15 / 85 afforded 4-34 (426mg, 77%) 
as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.66 (d, 2H, J = 6.8 Hz, ICCH), 7.38-7.34 (m, 3H, 
CH-Ph), 7.24-7.16 (m, 2H, CH-Ph), 6.89 (d, 2H, J = 7.8 Hz, NHCCH), 6.56 (br s, 1H, NH), 
5.90-5.20 (m, 2H, CH2-Ph), 4.65-4.48 (m, 2H, CH2CH3), 4.39-4.19 (m, 1H, NAc-CHH), 
3.95-3.68 (m, 2H, NAc-CHH + S-CH), 3.10-2.79 (m, 2H, tetrazole C-CH2), 2.34-2.18 (m, 
1H, CH-CHH-CH2), 2.03-1.96 (m, 1H, CH-CHH-CH2), 1.96 (br s, 3H, COCH3), 1.36 (t, 3H, 
J = 6.9 Hz, CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 212.4 (C=S), 170.2 (NCO), 154.1 (C-tetrazole), 
147.0 (dd, J = 236.5, 14.1 Hz, N-CF), 142.9 (dd, J = 253.6, 4.1 Hz, NCFCF), 138.3 
(NHCCH), 138.0 (2 NHCCH), 134.3 (dd, J = 264.0, 31.5 Hz, CF-C-NCO), 133.8-133.4 
(NCN), 133.2 (C-benzene), 132.4-132.1 (CFCFC), 129.2 (2 CH-benzene), 128.9 (CH-
benzene), 127.6 (2 CH-benzene), 123.3 (ICCH), 88.7 (IC), 70.5 (CSOCH2CH3), 50.7 (CH2-
Ph), 48.5 (br s, SCH + NAcCH2), 28.0 (CH2-CH2-CH), 21.9 (CH3), 20.6 (tetrazole C-CH2), 
13.6 (CH2-CH3) 
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IR (ν, cm-1, CDCl3)  3691, 3409, 2986, 2937, 2247, 1678, 1622, 1585, 1527, 1477, 1381, 
1343, 1278, 1234, 1113, 1051, 1007 
HRMS (EI+)    Calcd. for C28H27F3IN7O2S2 : 741.0664      Found : 741.0688 
 
 
S-(1-(N-(4-(1H-benzo[d]imidazol-1-yl)-3,5,6-trifluoropyridin-2-yl)acetamido)-4-
cyanobutan-2-yl) O-ethyl carbonodithioate (4-35) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with the protected olefin 4-15 (255 mg, 0.74 mmol, 0.6 eq.) and the 
corresponding xanthate Xa-a (199 mg, 1.23 mmol, 1.0 eq.) in AcOEt (1.2 ml, 0.6 mmol/ml), 
with DLP (74 mg, 0.15 eq.). Flash chromatography on silica gel with AcOEt / EP = 30 / 70 
afforded 4-35 (335 mg, 90%) as a yellow sticky oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.14 (s, 1H, NCH), 7.92-7.90 (m, 1H, CHCHCHCH), 
7.44-7.42 (m, 2H, CHCHCHCH), 7.34-7.32 (m, 1H, CHCHCHCH), 4.58-4.55 (m, 2H, 
CH2CH3), 4.39 (dd, J = 14.06, 7.46 Hz, 1H, NCHH), 3.97 (dd, J = 14.20, 5.76 Hz, 1H, 
NCHH), 3.92-3.85 (m, 1H, SCH), 2.65-2.47 (m, 2H, NCCH2), 2.32-2.23 (m, 1H, 
NCCH2CHH), 2.12 (brs, 3H, NCOCH3), 2.01-1.91 (m, 1H, NCCH2CHH), 1.35 (t, J = 7.11 
Hz, 3H, CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 211.8 (C=S), 169.8 (N-COCH3),), 146.6 (ddd, J = 
244.08, 13.88, 2.43 Hz, N-CF), 145.8 (dd, J = 265.44, 5.97 Hz, NCFCF), 143.2 (CNCCH), 
141.6 (NCH), 138.69 (dd, J = 272.40, 31.41 Hz, CF-C-NCO), 135.6-135.3 (NCN), 132.3 
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(CHNC), 126.0-125.7 (CFCFC), 125.0 (CHCHCHCH), 124.2 (CHCHCHCH), 121.8 
(CHCHCHCH), 118.5 (CN), 110.8 (CHCHCHCH), 71.0 (CSOCH2CH3), 49.0 (SCH), 48.9 
(CONCH2), 26.9 (NCH2CH2), 22.0 (NCOCH3), 15.0 (NCCH2), 13.6 (COOCH2CH3)  
IR (ν, cm-1, CDCl3)  3691, 3607, 3109, 3062, 2989, 2963, 2938, 2872, 1687, 1622, 1612, 
1515, 1477, 1468, 1451, 1424, 1380, 1330, 1302, 1275, 1236, 1197, 1152, 1112, 1051, 1012, 
1002 
HRMS (EI+)    Calcd. for C22H20F3N5O2S2 : 507.1011 –Xa. 386.1229      Found : 386.1232 
 
 
tert-butyl 5,6-difluoro-2,3-dihydro-3-(3-oxobutyl)-4-(1H-pyrrol-1-yl)pyrrolo[2,3-b] 
pyridine-1-carboxylate (4-36’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 4-16 (108mg, 0.20mmol) and 2,6-lutidine (0.02 ml, 
0.20mmol, 1eq.) in chlorobenzene (4.0 ml, 0.05 mmol/ml), with DTBP (0.19ml, 1.0mmol, 
5.0eq.) for 3h. Flash chromatography on silica gel with AcOEt / PE = 30 / 70 afforded 4-36’ 
(14.2 mg, 18%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.92 (dd, 2H, J=1.8Hz, J=3.7Hz, –CH=CH-N-
CH=CH-), 6.42 (t, 2H, J=1.9Hz, –CH=CH-N-CH=CH-), 4.11 (t, 1H, J=10.4Hz, CHH-NBoc), 
3.75 (dd, 1H, J=3.6Hz, J=11.4Hz, CHH-NBoc), 3.62-3.54 (m, 1H, CH-CH2-NBoc), 2.19-
2.01 (m, 2H, CH2-COMe), 1.98 (s, 3H, COCH3), 1.57 (s, 9H, C(CH3)3), 1.52-1.41 (m, 2H, 
CH2-CH2-COMe) 
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13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  207.2 (COMe), 151.8 (dd, J=15.8Hz, J=236.6Hz, 
N-CF), 150.4 (COOtBu), 149.2 (dd, J=4.1Hz, J=17.0Hz N-C-NBoc), 136.5 (d, J=15.1Hz, N-
C-CF), 134.6 (dd, J=27.8Hz, J=251.7Hz, N-CF-CF), 121.2 (=CH-N-CH=), 118.8 (C-C-
NBoc), 111.5 (-CH=CH-N-CH=CH-), 82.4 (CMe3), 52.9 (CH2-NBoc), 39.1 (CH2-COMe), 
35.2 (CH-CH2-NBoc), 29.7 (COCH3), 28.2 (C(CH3)3), 27.4 (CH2-CH2-COOMe) 
IR (ν, cm-1, CCl4)  2982, 2931, 1706, 1620, 1601, 1513, 1431, 1369, 1344, 1265, 1162, 1146, 
1088 
HRMS (EI+)    Calcd. for C20H23F2N3O3 : 391.1707      Found : 391.1697 
 
 
Methyl 3-(3-ethoxy-3-oxopropyl)-5,6-difluoro-4-(pyrrolidin-1-yl)-2,3-dihydro-1H-
pyrrolo[2,3-b]pyridine-1-carboxylate (4-37) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 4-17 (97 mg, 0.19 mmol) and 2,6-lutidine (0.03 ml, 
0.19mmol, 1.2eq.) in chlorobenzene (3.8 ml, 0.05 mmol/ml), with DTBP (0.17 ml, 
0.92mmol, 5.0eq.) for 3h. Flash chromatography on silica gel with AcOEt / PE = 40 / 60 
afforded 4-37 (18.4 mg, 26 %) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 4.10 (dq, 1H, J=1.6Hz, J=7.1Hz, COO-CH2-CH3), 
3.92-3.84 (m, 5H,  CO-N-CH2 + COOCH3), 3.75-3.68 (m, 2H, CHH-N-CHH), 3.50-3.54 (m, 
2H, CHH-N-CHH), 3.36-3.31 (m, 1H, , CHH-CH2-COOEt ), 2.30 (t, 2H, J=7.6Hz, CH2-
COOEt), 2.10-2.02 (m, 2H,  CH2-CHH-CHH-CH2), 1.89-1.81  (m, 3H, CHH-CH2-COOEt + 
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CH2-CHH-CHH-CH2), 1.63-1.54 (m, 1H,  CHH-CH2-COOEt), 1.25 (t, 3H, J=7.1Hz, COO-
CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 172.8 (COOEt), 152.9 (COOMe), 152.6 (dd, 
J=16.0Hz, J=230.7Hz , N-CF), 147.6 (dd, J=2.7Hz, J=19.8Hz, N-C-N-CO), 143.1 (t, 
J=5.8Hz, (CH2)2N-C), 132.1 (dd, J=29.7Hz, J=244.1Hz, (CH2)2N-C-CF), 109.5 (d , J=3.4Hz, 
C-C-NCO), 60.6 (COO-CH2-CH3), 53.2 (COOCH3), 51.0 (d, J=3.0Hz, N-(CH2)2), 50.9 (CO-
N-CH2), 36.9 (CH), 30.3 (CH2-COOEt), 28.7 (CH-CH2), 25.8 (d, J=2.0Hz, CH2-CH2-N-CH2-
CH2), 14.2 (COO-CH2-CH3) 
IR (ν, cm-1, CCl4)  3690, 2981, 2957, 2877, 1727, 1699, 1617, 1507, 1444, 1368, 1332, 1237, 
1195, 1125, 1114, 1029 
HRMS (EI+)    Calcd. for C18H23F2N3O4 :383.1657      Found : 383.1660 
 
 
Methyl 3-(3-ethoxy-3-oxopropyl)-5,6-difluoro-4-(1H-pyrrol-1-yl)-2,3-dihydro-1H-
pyrrolo[2,3-b]pyridine-1-carboxylate.(4-37’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 4-17 (97 mg, 0.19 mmol) and 2,6-lutidine (0.03 ml, 
0.19mmol, 1.2eq.) in chlorobenzene (3.8 ml, 0.05 mmol/ml), with DTBP (0.17 ml, 
0.92mmol, 5.0eq.) for 3h. Flash chromatography on silica gel with AcOEt / PE = 30 / 70 
afforded 4-37’ (20.8 mg, 30 %) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.92 (dd, 2H, J=2.0Hz, J=4.1Hz, CH-N-CH), 6.42 (t, 
2H, J=2.1Hz, CH-CH-CH-CH), 4.18 (dd, 1H, J=9.7Hz, J=11.4Hz, CO-N-CHH), 4.11 (q, 2H, 
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J=7.1 Hz, COO-CH2-CH3), 3.90 (s, 3H, COOCH3), 3.87 (dd, 1H, J=3.9Hz, J=11.4Hz, CO-N-
CHH), 3.67 (m, 1H, CH), 2.08 (m, 2H, CH-CH2-CH2), 1.48 (td, 2H, J=4.8Hz, J=7.8Hz, CH-
CH2-CH2), 1.21 (t, 3H, J=7.2Hz, COO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 172.2 (COOEt), 151.9 (dd, J=15.0Hz, J=237.8Hz, 
N-CF), 152.2 (COOMe), 148.4 (dd, J=4.1Hz, J=17.8Hz, N-C-N), 136.8 (dd, J=4.9Hz, 
J=9.5Hz, N-C-CF), 134.9 (dd, J=28.8Hz, J=255.3Hz, N-C-CF), 121.1 (d, 1H, J=2.7Hz, CH-
N-CH), 118.7 (dd, J=3.0Hz, J=5.6Hz, C-C-N), 111.6 (CH-CH-CH-CH), 60.6 
(COOCH2CH3), 53.4 (COOCH3), 52.4 (CO-N-CH2), 35.5 (CH-CH2-N), 30.3 (CH-CH2-CH2), 
28.0 (CH-CH2-CH2), 14.1 (COO-CH2-CH3) 
IR (ν, cm-1, CDCl3)  3691, 2984, 2958, 2930, 1731, 1622, 1603, 1515, 1445, 1348, 1312, 
1265, 1237, 1189, 1032, 964 
HRMS (EI+)    Calcd. for C9H8F4N2 : 379.1344      Found : 379.1354 
 
 
Methyl 3-(2-cyanoethyl)-5,6-difluoro-4-(1H-pyrrolidine-1-yl)-2,3-dihydro-1H-pyrrolo 
[2,3-b] pyridine-1-carboxylate.(4-38) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 4-18 (293 mg, 0.62 mmol) and 2,6-lutidine (0.09 ml, 
0.74mmol, 1.2eq.) in chlorobenzene (12ml, 0.05 mmol/ml), with DTBP (0.57 ml, 3.1mmol, 
5.0eq.) for 2h. Flash chromatography on silica gel with AcOEt / PE = 40 / 60 afforded 4-38 
(58.2 mg, 29%) as light yellow solid. 
 
m.p. 160~165oC 
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1H-NMR (į, ppm) (CDCl3, 400 MHz) 3.96 (dd, J = 11.38, 8.27 Hz, 1H, CO-N-CHH), 3.87 
(s, 4H, CO-N-CHH + COOCH3), 3.71 (dq, J = 9.94, 9.73, 3.87 Hz, 2H, CH2-CH2-CH2-CH2), 
3.58 (t, J = 7.29 Hz, 2H, CH2-CH2-CH2-CH2), 3.49 (t, J = 9.00 Hz, 1H, CH), 2.38 (dd, J = 
10.63, 4.62 Hz, 2H, CN-CH2), 2.27-1.98 (m, 2H, CH2-CH2-CH2-CH2), 1.97-1.75 (m, 3H, 
CH2-CH2-CH2-CH2 + CNCH2-CHH), 1.64 ( m, 1H, CNCH2-CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 152.9 (dd, J = 231.83, 15.98 Hz, N-CF), 152.8 
(COOCH3), 147.6 (dd, J = 20.23, 2.93 Hz, N-C-N), 143.7-142.9 (m, C-N(CH2)2), 132.1 (dd, 
J = 244.91, 29.58 Hz, N-C-CF), 118.8 (CH2-CN), 108.2 (d, J = 3.39 Hz,CO-N-C-C), 51.2 (d, 
J = 6.71 Hz, COO-CH3), 50.6 (N-(CH2)2), 36.6 (CH), 29.3 (d, J = 9.09 Hz,CN-CH2-CH2), 
25.8 (d, J = 1.98 Hz, CH2-CH2-CH2-CH2), 13.9 (CN-CH2) 
IR (ν, cm-1, CDCl3)  2957, 2879, 1733, 1699, 1617, 1507, 1444, 1366, 1328, 1261, 1237, 
1125, 1114, 1029 
HRMS (EI+)    Calcd. for C16H18F2N4 : 336.1398      Found : 336.1413 
 
 
Methyl 3-(2-cyanoethyl)-5,6-difluoro-4-(1H-pyrrol-1-yl)-2,3-dihydro-1H-pyrrolo[2,3-b] 
pyridine-1-carboxylate.(4-38’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 4-18 (293 mg, 0.615 mmol) and 2,6-lutidine (0.09 ml, 
0.74 mmol) in chlorobenzene (12 ml, 0.05 mmol/ml), with DTBP (0.56 ml, 3.08 mmol) for 
1.5 h. Flash chromatography on silica gel with AcOEt / PE = 40 / 60 afforded 4-38’ (41.3 
mg, 21 %) as a yellow oil. 
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1H-NMR (į, ppm) (CDCl3, 400 MHz) 6.94 (dd, 2H, J=2.0Hz, J=4.1Hz, N-(CH2)2), 6.46 (m, 
2H, CH2-CH2-CH2-CH2), 4.27 (dd, 1H, J=9.8Hz, J=11.5Hz, CO-N-CHH), 3.91 (s, 3H, COO-
CH3), 3.87 (dd, 1H, J=4.0Hz, J=11.6Hz,  CO-N-CHH),  3.76 (m, 1H, CH),  2.16 (m, 2H, 
CH2-CN),  1.46 (m, 2H, CH2-CH2-CN) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 152.3 (dd, J=14.8Hz, J=239.0Hz, N-CF), 152.1 
(COOCH3), 148.4 (dd, J=4.1Hz, J=17.5Hz, N-C-N), 136.9 (dd, J=5.1Hz, J=9.6Hz, C-
N(CH2)2), 134.9 (dd, J=28.8Hz, J=256.1Hz, N-C-CF), 121.0 (d, J=2.6Hz,  N-(CH2)2), 118.1 
(CH2-CN),  117.33 (dd, J=2.8Hz, J=5.5Hz, CH-C), 112.2 (CH2-CH2-CH2-CH2), 53.5 (COO-
CH3), 52.1 (CO-N-CH2), 35.3 (CH), 28.4 (CH2-CH2-CN), 14.0 (CH2-CN) 
IR (ν, cm-1, CDCl3)  3690, 2958, 2253, 1737, 1708, 1621, 1604, 1515, 1482, 1444, 1349, 
1311, 1190, 1140, 1089 
HRMS (EI+)    Calcd. for C9H8F4N2 : 332.1085      Found : 332.1091 
 
 
methyl 3-(2-(ethoxycarbonyl)ethyl)-5,6-difluoro-2,3-dihydro-4-(piperidin-1-yl) 
pyrrolo[2,3-b]pyridine-1-carboxylate (4-39) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 4-19 (90 mg, 0.17 mmol) and 2,6-lutidine (0.12 ml, 
1.0mmol, 6eq.) in chlorobenzene (3.4 ml, 0.05 mmol/ml), with DTBP (0.15 ml, 0.84mmol, 
5.0eq.) for 3h. Flash chromatography on silica gel with AcOEt / PE = 30 / 70 afforded 4-39 
(21.8 mg, 33%) as yellow oil. 
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1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.12 (dq, 2H, J=2.3Hz, J=7.1Hz, COO-CH2-CH3), 
4.00 (dd, 1H, J=9.2Hz, J=11.4Hz, CO-N-CHH), 3.86 (s, 3H, COOCH3), 3.83 (dd, 1H, 
J=3.0Hz, J=11.4Hz, CO-N-CHH), 3.39-3.33 (m, 3H, Xa-CH + CHH-N-CHH), 3.17-3.12 (m, 
2H, CHH-N-CHH), 2.35-2.23 (m, 2H, CH2-COOEt), 2.10-2.01 (m, 1H, CHH-CH2-COOEt), 
1.80-1.68  (m, 3H, CHH-CH2-COOEt + CHH-CH2-CHH), 1.67-1.60 (m, 4H, CHH-CH2-
CHH), 1.25 (t, 3H, J=7.1Hz, COO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  172.7 (COOEt), 152.7 (COOMe), 152.3 (dd, 
J=15.7Hz, J=234.5Hz, , N-CF), 147.8 (dd, J=3.2Hz, J=18.7Hz, N-C-N-CO), 147.3 (dd, 
J=4.8Hz, J=6.8Hz, (CH2)2N-C), 135.7 (dd, J=27.5Hz, J=248.6Hz, (CH2)2N-C-CF), 115.5 (d, 
J=4.4Hz, C-C-NCO), 60.6 (COO-CH2-CH3), 53.2 (COOCH3), 51.6 (CO-N-CH2), 51.3 (d, 
J=4.4Hz, CH2-N-CH2), 36.3 (CH), 30.6 (CH2-COOEt), 28.7 (CH-CH2), 26.2 (CH2-CH2-N-
CH2-CH2), 24.0 (-N-CH2-CH2-CH2), 14.2 (COO-CH2-CH3) 
IR (ν, cm-1, CDCl3)    3691, 2941, 2855, 1730, 1696, 1616, 1444, 1427, 1384, 1331, 1300, 
1197, 1099, 996 
HRMS (EI+)    Calcd. for C19H25F2N3O4 : 397.1813      Found :    397.1809  
 
 
methyl 3-(2-cyanoethyl)-5,6-difluoro-2,3-dihydro-4-(piperidin-1-yl)pyrrolo[2,3-b] 
pyridine-1-carboxylate (4-40) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 4-20 (100 mg, 0.20 mmol) and 2,6-lutidine (0.14ml, 
1.2mmol, 6eq.) in chlorobenzene (4.1ml, 0.05 mmol/ml), with DTBP (0.19ml, 1.0mmol, 
Experimental Part 
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5.0eq.) for 2h. Flash chromatography on silica gel with AcOEt / PE = 50 / 50 afforded 4-40 
(19.2 mg, 27%) as white solid. 
 
m.p. 142~146oC 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.06 (dd, 1H, J=9.1Hz, J=11.4Hz, CO-N-CHH), 3.87 
(s, 3H, COOCH3), 3.83 (dd, 1H, J=2.6Hz, J=11.5Hz, CO-N-CHH), 3.47 (t, 1H, J=9.3Hz, 
CON-CH2-CH), 3.39-3.34 (m, 2H, CHH-N-CHH), 3.19-3.15 (m, 2H, CHH-N-CHH), 2.42-
2.38 (m, 2H, CH2-CN), 2.16-2.08 (m, 1H, CHH-CH2-CN), 1.82-1.71 (m, 3H, CHH-CH2-CN 
+ CHH-CH2-CHH), 1.70-1.61 (m, 4H, CHH-CH2-CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  152.5 (COOMe), 152.8 (dd, J=15.5Hz, J=221.2Hz, 
N-CF), 147.7 (d, J=15.8Hz, N-C-N-CO), 147.3 (dd, J=4.9Hz, J=6.6Hz, (CH2)2N-C ), 135.9 
(dd, J=26.8Hz, J=249.9Hz, (CH2)2N-C-CF), 118.7 (CN), 114.5 (d, J=4.4Hz, C-C-NCO), 53.3 
(COOCH3), 51.6 (d, J=4.6Hz, CH2-N-CH2), 51.3 (CO-N-CH2), 35.9 (CH), 28.7 (CH-CH2), 
26.3 (CH2-CH2-N-CH2-CH2), 23.9 (-N-CH2-CH2-CH2), 14.3 (CH2-CN) 
IR (ν, cm-1, CDCl3)    3691, 3606, 2943, 2855, 1733, 1698, 1603, 1444, 1428, 1384, 1301, 
1198, 1136, 1093, 996 
 
 
ethyl 3-(1-acetyl-5,6-difluoro-2,3-dihydro-4-(piperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-
3-yl)propanoate (4-41) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 147mg 4-21 (0.29mmol, 1.0 eq.) and 0.04ml 2,6-lutidine 
(0.35mmol, 1.2 eq.) in chlorobenzene (5.8ml, 0.05 mmol/ml), with 0.16ml DTBP (0.87mmol, 
Experimental Part 
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3.0 eq.) for 3 hours. Flash chromatography on silica gel with Acetone / DCM = 3 / 97 
afforded 4-41 (29mg, 31%) as a colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.10 (dq, 2H, J=3.3Hz, J=7.1Hz, COO-CH2-CH3), 
3.94 (dq, 2H, J=6.1Hz, J=12.3Hz, CH2-NAc), 3.38-3.34 (m, 3H, CH-CH2NAc + CHH-N-
CHH), 3.17-3.13 (m, 2H, CHH-N-CHH), 2.56 (s, 3H, COCH3), 2.30-2.26 (m, 2H, CH2-
COOEt), 2.10-2.02 (m, 1H, CHH-CH2-COOEt), 1.75-1.63 (m, 7H, CHH-CH2-COOEt + 
CH2-CH2-CH2), 1.24 (t, 3H, J=7.1Hz, COO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  172.7 (COOEt), 169.7 (COMe), 151.8 (dd, 
J=15.9Hz, J=234.3Hz, N-CF), 147.7 (d, J=3.3Hz, N-C-N-CO), 147.5 (m, N(piperidine)-C), 
135.6 (dd, J=27.4Hz, J=248.4Hz, C-CF-CF), 116.3 (d, J=4.3Hz, C-C-N-CO), 60.6 (COO-
CH2-CH3), 51.2 (d, J=4.4Hz, CH2-N-CH2), 50.6 (CO-N-CH2), 35.5 (AcN-CH2-CH), 30.5 
(CH2-COOEt), 28.7 (CH2-CH2-COOEt), 26.2 (CH2-CH2-N-CH2-CH2), 24.6 (COCH3), 23.9 
(-N-CH2-CH2-CH2), 14.2 (COO-CH2-CH3) 
IR (ν, cm-1, CDCl3)    3691, 2941, 2856, 1727, 1651, 1615, 1505, 1477, 1424, 1388, 1322, 
1250, 1216, 1158, 1104, 1031, 972 
 
 
ethyl 3-(1-acetyl-4-(cyclopropylamino)-5,6-difluoro-2,3-dihydro-1H-pyrrolo[2,3-b] 
pyridin-3-yl)propanoate (4-42) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 149mg 4-22 (0.30mmol, 1.0 eq.) and 0.07ml 2,6-lutidine 
(0.6mmol, 2.0eq.) in chlorobenzene (6.0ml, 0.05mmol/ml), with 0.28ml DTBP (1.5mmol, 
Experimental Part 
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5.0eq.) for 4.5hours. Flash chromatography on silica gel with Acetone / DCM = 2 / 98 
afforded 4-42 (13mg, 12%) as a colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.42 (br s, 1H, NH), 4.17 (q, 1H, J=7.1Hz, CO-
OCH2CH3), 3.94 (dq, 2H, J=5.5Hz, J=12.2Hz, CH2-NAc), 3.10 (t, 1H, J=9.1Hz, CH- CH2-
NAc), 3.00 (tq, 1H, J=3.2Hz, J=6.5Hz, NH-CH), 2.57 (s, 3H, COCH3), 2.48-2.32 (m, 2H, 
CH2-COOEt), 1.98-1.98 (m, 1H, CHH-CH2-COOEt), 1.54-1.48 (m, 1H, CHH-CH2-COOEt), 
1.28 (t, 3H, J=7.2Hz, CO-OCH2-CH3), 0.89-0.82 (m, 1H, -CHH-CH2-), 0.81-0.74 (m, 1H, -
CH2-CHH-), 0.72-0.63 (m, 2H, -CHH-CHH-) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  173.9 (COOEt), 169.9 (COMe), 151.7 (dd, 
J=14.6Hz, J=231.0Hz, N-CF), 146.7 (m, N-C-N-CO), 143.1 (t, J=6.3Hz, HN-C), 130.9 (dd, 
J=30.5Hz, J=244.7Hz, HN-C-CF), 109.8 (d, J=3.4Hz, C-C-NCO), 61.0 (COO-CH2-CH3), 
52.2 (CO-N-CH2), 33.8 (CH), 30.7 (CH2-COOEt), 28.6 (CH-CH2), 26.7 (d, J=5.2Hz, HN-
CH), 24.3 (COCH3), 14.2 (COO-CH2-CH3), 8.85 (d, J=3.2Hz, -CH2-CH2-), 8.54 (d, J=3.2Hz, 
-CH2-CH2-) 
IR (ν, cm-1, CDCl3)    3691, 3607, 2929, 1718, 1651, 1623, 1603, 1526, 1435, 1417, 1383, 
1352, 1219, 1182 
HRMS (EI+)    Calcd. for C17H21F2N3O3 : 353.1551      Found :     353.1545  
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ethyl 3-(1-acetyl-4-(N-cyclopropylacetamido)-5,6-difluoro-2,3-dihydro-1H-pyrrolo[2,3-
b]pyridin-3-yl)propanoate (4-43)  
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 161mg 4-23 (0.30mmol, 1.0 eq.) and 0.08ml 2,6-lutidine 
(0.68mmol, 2.3eq.) in chlorobenzene (7.0ml, 0.04mmol/ml), with 0.33ml DTBP (1.7mmol, 
5.6 eq.) for 4 hours. Flash chromatography on silica gel with AcOEt / EP = 60 / 40 afforded 
4-43 (58mg, 46%) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.13 (q, J = 7.2 Hz, 3H, CH2CH3 + NCHH), 3.77 (dd, 
J = 12, 4.6 Hz, NCHH), 3.24-3.11 (m, 1H, NCH2CH), 3.36-3.25 (m, 1H, NCH), 2.58 (s, 3H, 
NCOCH3), 2.47 (s, 3H, NCOCH3), 2.27 (t, J = 6.6Hz, 2H, COCH2), 1.83-1.69 (m, 1H, 
COCH2CHH), 1.47-1.34 (m, 1H, COCH2CHH), 1.26 (t, J = 7.13 Hz, 3H, CH2CH3), 1.18-
1.04 (m, 1H, NCHCHH), 0.99-0.80 (m, 2H, NCH(CHH)2), 0.52-0.47 ( m, 1H, NCHCHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  172.7 (COOEt), 172.5 (CHNCOCH3), 169.5 
(CH2NCOCH3), 151.9 (dd, J = 17, 14 Hz, N-C-N-CO), 148.4 (dd, J = 238, 16 Hz, N-CF), 
138.4 (dd, J = 5.9, 4.2 Hz, CHN-C), 136.7 (d, J = 253 Hz, CHN-C-CF), 124.4 (dd, J = 5.0, 
2.96 Hz, CHC), 123.04 (dd, J = 4.3, 2.1 Hz, CHC), 60.7 (COOCH2CH3), 51.6 (CONCH2), 
35.5 (NCH2CH), 32.3 (NCH), 30.7 (CH2COOEt), 28.1 (CHCH2CH2), 24.6 (CH2NCOCH3), 
22.9  (CHNCOCH3), 14.2 (COOCH2CH3), 10.9 (NCHCH2), 7.8 (NCHCH2) 
IR (ν, cm-1, CDCl3)    3322, 2984, 2963, 2931, 1727, 1671, 1618, 1484, 1424, 1380, 1328, 
1254, 1227, 1183, 1101, 1084, 1035, 973 
HRMS (EI+)    Calcd. for C19H23F2N3O4 : 395.1657      Found :    395.1661  
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ethyl 3-(1-acetyl-4-(N-cyclopropylacetamido)-5,6-difluoro-1H-pyrrolo[2,3-b]pyridin-3-
yl)propanoate (4-43’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 161mg 4-23 (0.30mmol, 1.0 eq.) and 0.08ml 2,6-lutidine 
(0.68mmol, 2.3eq.) in chlorobenzene (7.0ml, 0.04mmol/ml), with 0.33ml DTBP (1.7mmol, 
5.6 eq.) for 4 hours. Flash chromatography on silica gel with AcOEt / EP = 30 / 70 afforded 
4-43’ (21mg, 18%, rotamers 1:3) as yellow solid. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.81 (s, 0.25H, CH-aromatic), 7.72 (s, 0.75H, CH-
aromatic), 4.35-3.97 (m, 2H, CO-OCH2CH3), 3.26 (m, 1H, NAc-CH), 2.98-2.88 (m, 0.5H, 
CH2), 2.94 (s, 0.75H, COCH3), 2.91 (s, 2.25H, COCH3), 2.85-2.80 (m, 1.5H, CH2), 2.71-2.59 
(m, 2H, CH2), 2.49 (s, 2.25H, COCH3), 1.90 (s, 0.75H, COCH3), 1.32-1.20 (m, 3H, CO-
OCH2-CH3), 1.09-0.98 (m, 1H, -CHH-CH2-), 0.97-0.83 (m, 2H, -CHH-CH2- + -CH2-CHH-), 
0.63 (m, 1H, -CH2-CHH-) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  173.8 (COOEt), 172.5 (COMe), 167.9 
(COMe),149.2 (d, J = 268.8 Hz, CF), 139.1 (d, J = 252.3 Hz, CF), 138.6 (C-aromatic), 133.7 
(C-aromatic), 123.0 (d, J = 4.3 Hz, CO-N-CH), 119.8 (C-aromatic), 117.7 (C-aromatic), 60.7 
(COO-CH2-CH3), 33.0 and 32.7 (CH2), 32.4 and 32.3 (CH), 25.5 (COCH3), 23.0 and 22.5 
(COCH3), 20.5 and 20.4 (CH2), 14.2 (COO-CH2-CH3), 9.8 (-CH2-CH2-), 8.4 (-CH2-CH2-) 
IR (ν, cm-1, CCl4)    3420, 2930, 1700, 1675, 1625, 1510, 1420, 1378, 1330, 1240, 1180, 
1030 
HRMS (EI+)    Calcd. for C19H21F2N3O4 : 393.1500      Found :    393.1502   
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3-(1-acetyl-5,6-difluoro-4-(1H-pyrrol-1-yl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-yl) 
propanoate (4-44) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 147mg 4-24 (0.29mmol, 1.0 eq.) and 0.04ml 2,6-lutidine 
(0.35mmol, 1.2 eq.) in chlorobenzene (5.8ml, 0.05 mmol/ml), with 0.16ml DTBP (0.87mmol, 
5.0 eq.) for 3 hours. Flash chromatography on silica gel with Acetone / DCM = 3 / 97 
afforded 4-44 (29mg, 38%) as a colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 6.98 (dd, 2H, J=2.0Hz, J=4.1Hz, CH-N-CH), 6.48 (m, 
2H, CH-CH-CH-CH), 4.23 (dd, 1H, J=9.7Hz, J=12.3Hz, CO-N-CHH), 4.10 (dq, 2H, 
J=3.3Hz, J=7.2Hz, COO-CH2-CH3), 3.98 (dd, 1H, J=4.0Hz, J=12.3Hz, CO-N-CHH), 3.72 (m, 
1H, CH), 2.66 (s, 3H,  CO-CH3), 2.15 (m, 2H, CO-CH2-CH2), 1.53 (m, 2H, CO-CH2-CH2),  
1.26 (t, 3H, J=7.1Hz, COO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 172.2 (COOEt), 169.5 (COMe), 151.5 (dd, 
J=15.3Hz, J=238.1Hz, N-CF), 148.3 (dd, J=4.0Hz, J=16.9Hz, N-C-N), 137.2 (dd, J=5.0Hz, 
J=9.1Hz, N-C-CF),  135.0 (dd, J=28.4Hz, J=255.3Hz, N-C-CF),  121.1 (d, J=2.7Hz, CH-N-
CH), 119.7 (dd, J=2.8Hz, J=5.5Hz, C-C-N), 111.7 (CH-CH-CH-CH), 60.6 (COOCH2CH3), 
51.5 (CO-N-CH2), 34.7 (CH), 30.3 (COCH2-CH2), 28.0 (COCH2-CH2), 24.8 (CH3-CO-N), 
14.1 (COO-CH2-CH3) 
IR (ν, cm-1, CCl4)  3139, 2984, 2931, 2856, 1724, 1601, 1562, 1516, 1439, 1405, 1382, 1328, 
1289, 1240, 1190, 1086, 1038 
HRMS (EI+)    Calcd. for C18H19F2N3O3 :361.1238      Found : 361.1237 
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3-(1-acetyl-5,6-difluoro-4-(1H-pyrrol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)propanoate 
(4-44’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 147mg 4-24 (0.29mmol, 1.0 eq.) and 0.04ml 2,6-lutidine 
(0.35mmol, 1.2 eq.) in chlorobenzene (5.8ml, 0.05 mmol/ml), with 0.16ml DTBP (0.87mmol, 
5.0 eq.) for 3 hours. Flash chromatography on silica gel with Acetone / DCM = 2 / 97 
afforded 4-44’ (11mg, 14%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.79 (s, 1H, CH 3-CO-N-CH), 6.89 (dd, 2H, J=2.0Hz, 
J=3.1Hz, CH-N-CH), 6.45 (t, 2H, J=2.1Hz, CH-CH-CH-CH), 4.06 (q, 2H, J=7.1Hz, COO-
CH2-CH3), 2.96 (s, 3H,  COO-CH2-CH3), 2.65 (t, 2H, J=7.4Hz, CO-CH2-CH2), 2.16 (t, 2H, 
J=7.4Hz, CO-CH2-CH2),  1.20 (t, 3H, J=7.1Hz, COO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 172.2 (COOEt), 167.8 (COMe), 148.5 (dd, 
J=16.5Hz, J=239.4Hz, N-CF), 138.9 (dd, J=3.5Hz, J=17.1Hz, N-C-N), 138.1 (dd, J=28.7Hz, 
J=255.4Hz, N-C-CF),   132.5 (dd, J=4.8Hz, J=10.5Hz, N-C-CF),  124.2 (d, J=4.4Hz, CO-N-
CH), 123.0 (s, CH-N-CH),  118.2 (dd, J=2.1Hz, J=4.3Hz, C-C-N), 117.6 (dd, J=1.2Hz, 
J=3.2Hz, CH2-C), 110.9 (CH-CH-CH-CH), 60.5 (COOCH2CH3), 33.2 (COCH2-CH2), 25.6 
( CH3-CO-N), 21.3 ( COCH2-CH2), 14.2 (COO-CH2-CH3) 
IR (ν, cm-1, CCl4)  3139, 2984, 2931, 2856, 1724, 1601, 1562, 1516, 1439, 1405, 1382, 1328, 
1289, 1240, 1190, 1086, 1038 
HRMS (EI+)    Calcd. for C18H19F2N3O3 :361.1238      Found : 361.1237 
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3-(1-acetyl-5,6-difluoro-4-(N-methylacetamido)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-
3-yl)propanoate (4-45) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 117mg 4-25 (0.23mmol, 1.0 eq.) and 0.04ml 2,6-lutidine 
(0.34mmol, 1.4 eq.) in chlorobenzene (6.0ml, 0.04 mmol/ml), with 0.27ml DTBP (1.47mmol, 
6.0 eq.) for 3 hours. Flash chromatography on silica gel with AcOEt / DCM = 30 / 70 
afforded 4-45 (38mg, 44%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 4.29-4.15 (m, 3H, CO-N-CHH + COO-CH2-CH3), 
3.96, 3.86 (dd, J = 12.34, 5.04 Hz, dd, J = 12.08, 4.72 Hz, 1H, CO-N-CHH), 3.45, 3.42, 3.30, 
3.28 (4H, CH + CH3-N-CO-CH3), 2.65-2.63 (m, 3H, N-CH3), 2.43-2.31 (m, 3H, CO-CH2 + 
N-CO-CH3), 2.18-2.10 (m, 3H, CH-CHH-CH2 + N-CO-CH3), 1.73-1.64 (m, 1H, CH-CHH-
CH2), 1.30 (t, J = 7.08 Hz, 3H, COO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 172.5 (COOEt), 169.3 (NCOMe), 168.9 (CH3-N-
CO-CH3), 151.1 (dd, J = 253.45, 14.45 Hz,, N-CF), 147.7 (d, J = 16.20 Hz, N-C-CF), 140.9 
(d, J = 11.16 Hz, N-C-N), 137.0 (ddd, J = 255.85, 28.10, 11.62 Hz, N-C-CF), 124.7 (d, J = 
5.21 Hz, C-C-N), 60.8 (COOCH2CH3), 51.4 (CO-N-CH2), 38.3, 37.3 (CH3-N-CO-CH3), 35.3 
(CH), 30.5 (COCH2-CH2), 28.1 (COCH2-CH2), , 24.6 (N-CH3), 21.8, 21.3 (N-CO-CH3), 14.1 
(COO-CH2-CH3) 
IR (ν, cm-1, CCl4)  3693, 2930, 1730, 1673, 1691, 1476, 1429, 1380, 1343, 1325, 1255, 1191, 
1034 
HRMS (EI+)    Calcd. for C17H21F2N3O4 : 369.1500      Found : 369.1503 
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3-(1-acetyl-5,6-difluoro-4-(N-methylacetamido)-1H-pyrrolo[2,3-b]pyridin-3-yl) 
propanoate (4-45’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 117mg 4-25 (0.23mmol, 1.0 eq.) and 0.04ml 2,6-lutidine 
(0.34mmol, 1.4 eq.) in chlorobenzene (6.0ml, 0.04 mmol/ml), with 0.27ml DTBP (1.47mmol, 
6.0 eq.) for 3 hours. Flash chromatography on silica gel with AcOEt / DCM = 15 / 85 
afforded 4-45’ (12mg, 15%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.82, 7.75 (s, 1H, CH 3-CO-N-CH), 4.13 (q, 2H, 
J=7.15Hz, COO-CH2-CH3), 3.44, 3.31 (s, 3H, CH3-N-CO-CH3), 2.94 (s, 3H, N-CH3 ), 2.92 (t, 
2H, J = 7.21 Hz, , CO-CH2-CH2), 2.69 (t, 2H, J = 6.95 Hz, CO-CH2-CH2), 2.06, 2.37, 1.92 
(s, 3H, C-NCO-CH3), 1.25 (t, J = 6.92 Hz, 3H, COO-CH2-CH3)  
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 171.9 (COOEt), 169.7 (CH3N-CO-CH3), 167.6 (C-
N-COMe), 148.7 (dd, J = 241.03, 16.65 Hz, N-CF), 139.1 (dd, J = 254.60, 27.67 Hz, N-C-
CF), 139.0 (d, J = 13.42 Hz, N-C-N), 135.1 (dd, J = 11.73, 4.28 Hz, N-C-CF), 123.9 (d, J = 
4.52 Hz, CO-N-CH), 119.1 (dd, J = 4.46, 1.61 Hz, C-C-N), 117.5 (dd, J = 3.20, 1.04 Hz, 
CH-C), 60.8 (COOCH2CH3), 38.8, 36.4 (CH3-N-CO-CH3) ), 33.5, 32.9 (CO-CH2-CH2),  25.5 
( CH3-CO-N-C), 21.9, 21.6 (C-NCO-CH3), 20.7, 20.3 (CO-CH2-CH2), 14.2 (COO-CH2-CH3) 
IR (ν, cm-1, CCl4)  3151, 2984, 2938, 1726, 1674, 1598, 1562, 1439, 1404, 1379, 1341, 1284, 
1234, 1031  
HRMS (EI+)    Calcd. for C17H19F2N3O4 :367.1344      Found : 367.1348 
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3-(4-acetamido-1-acetyl-5,6-difluoro-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-yl) 
propanoate (4-46) 
 
 
 
Following the general procedure 4-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 160mg 4-26 (0.32 mmol, 1.0 eq.) and 0.04ml 2,6-lutidine 
(0.39 mmol, 1.2 eq.) in chlorobenzene (6.5 ml, 0.05 mmol/ml), with 0.30 ml DTBP (1.62 
mmol, 5.0 eq.) for 1.5 hours. Flash chromatography on silica gel with AcOEt / DCM = 25 / 
75 afforded 4-46 (58 mg, 50%) as a white solid. 
 
m.p. 134-136 oC 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.03 (s, 1H, NH), 4.21-4.04 (m, 3H, CO-N-CHH + 
COO-CH2-CH3), 3.89 (dd, J = 12.12, 3.50 Hz, 1H, CO-N-CHH), 3.48-3.34 (m, 1H, CH), 
2.58 (s, 3H, NH-CO-CH3), 2.40-2.23 (m, 5H, CO-CH2 + N-CO-CH3), 1.97-1.82 (m, 1H, CH-
CHH-CH2), 1.72-1.56 (m, 1H, CH-CHH-CH2), 1.27 (t, J = 7.13 Hz, 3H, COO-CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 173.6 (COOEt), 169.7 (NCOMe), 167.8 (NH-CO-
CH3), 150.5 (dd, J = 237.56, 15.76 Hz, N-CF), 147.8 -147.5 (N-C-CF), 134.65 (dd, J = 
251.54, 29.15 Hz, N-C-CF), 133.7-133.5 (m, N-C-N), 119.78 (d, J = 5.13 Hz, C-C-N), 60.1 
(COOCH2CH3), 52.2 (CO-N-CH2), 35.2 (CH), 30.8 (COCH2-CH2), 28.4 (COCH2-CH2), 24.6 
(CH3-CO-NH), 23.6 (N-CO-CH3), 14.1 (COO-CH2-CH3) 
IR (ν, cm-1, CCl4)  2928, 1720, 1663, 1623, 1501, 1472, 1425, 1380, 1328, 1238 
HRMS (EI+)    Calcd. for C16H19F2N3O4 : 355.1344      Found : 355.1340 
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3-(1-acetyl-5,6-difluoro-4-(N-methylacetamido)-1H-pyrrolo[2,3-b]pyridin-3-yl) 
propanoate (4-46’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 160mg 4-26 (0.32 mmol, 1.0 eq.) and 0.04ml 2,6-lutidine 
(0.39 mmol, 1.2 eq.) in chlorobenzene (6.5 ml, 0.05 mmol/ml), with 0.30 ml DTBP (1.62 
mmol, 5.0 eq.) for 1.5 hours. Flash chromatography on silica gel with AcOEt / DCM = 15 / 
85 afforded 4-46’ (23 mg, 20%) as a white solid. 
 
m.p. 169-173 oC 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 9.50 (s, 1H, NH), 7.75 (s, 1H, CH), 4.11 (q, J = 7.15 
Hz, 2H, COO-CH2-CH3), 3.03-3.00 (m, 2H, CO-CH2-CH2), 2.92 (s, 3H, NH-CO-CH3), 2.77-
2.74 (m, 2H, CO-CH2-CH2), 2.32 (s, 3H, N-CO-CH3), 1.21 (t, J = 7.13 Hz, 3H, COO-CH2-
CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 175.0 (COOEt), 168.4 (NCOMe), 168.1 (NH-CO-
CH3), 149.1 (dd, J = 237.90, 17.12 Hz, N-CF), 138.1 (dd, J = 17.51, 3.13 Hz, N-C-CF), 
137.8 (dd, J = 256.05, 29.00 Hz, N-C-CF), 129.0-128.7(m, N-C-N), 124.1 (d, J = 4.50 Hz, 
CH), 118.0 (m, C-C-N), 116.7 (d, J = 4.20 Hz,CH-C), 61.6 (COOCH2CH3), 36.5 (COCH2-
CH2), 25.6 (CH3-CO-N), 23.3 (CH3-CO-NH), 19.5 (COCH2-CH2), 14.1 (COO-CH2-CH3) 
IR (ν, cm-1, CDCl3)  3420, 3280, 2986, 1713, 1600, 1505, 1437, 1396, 1283, 1250, 1213, 
1094 
HRMS (EI+)    Calcd. for C16H17F2N3O4 : 353.1187      Found : 353.1194 
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3-(1-acetyl-5,6-difluoro-4-(N-methylmethylsulfonamido)-2,3-dihydro-1H-pyrrolo[2,3-
b]pyridin-3-yl)propanoate (4-47) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 162 mg 4-27 (0.30 mmol, 1.0 eq.) and 0.04ml 2,6-
lutidine (0.36mmol, 1.2 eq.) in chlorobenzene (6.0ml, 0.05 mmol/ml), with 0.27ml DTBP 
(1.47mmol, 5.0 eq.) for 2 hours. Flash chromatography on silica gel with AcOEt / DCM = 10 
/ 90 afforded 4-47 (52 mg, 43%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.81 (s, 1H, CH 3-CO-N-CH), 4.13 (q, 2H, J=7.2Hz, 
COO-CH2-CH3), 3.44 (s, 3H, SO2-CH3), 3.22 (m, 2H, CO-CH2-CH2), 3.11 (d, 3H, J=1.7Hz, 
N-CH3 ), 2.91 (s, 3H, CO-CH3), 2.73 (dt, 2H, J=3.5Hz, J=7.1Hz, CO-CH2-CH2), 1.25 (t, 3H, 
J=7.1Hz, COO-CH2-CH3)  
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 172.4 (COOEt), 169.3 (COMe), 150.8 (dd, J = 
239.30, 15.17 Hz, N-CF), 148.5 (dd, J = 16.65, 3.70 Hz, N-C-N), 138.4 (dd, J = 259.72, 
23.32 Hz, N-C-CF), 137.3 (m, N-C-CF), 127.7 (m, C-C-N), 60.7 (COOCH2CH3), 51.4 (CO-
N-CH2), 37.7, 37.4 (N-CH3 + SO2-CH3), 34.7 (CH), 30.8 (COCH2-CH2), 29.6 (COCH2-CH2), 
24.6 (N-CO-CH3), 14.1 (COO-CH2-CH3) 
IR (ν, cm-1, CCl4)  2984, 1729, 1664, 1621, 1594, 1480, 1430, 1379, 1354, 1326, 1252, 1195, 
1160, 1034  
HRMS (EI+)    Calcd. for C16H19F2N3O5S :405.1170      Found : 405.1156 
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3-(1-acetyl-5,6-difluoro-4-(N-methylmethylsulfonamido)-1H-pyrrolo[2,3-b]pyridin-3-
yl)propanoate (4-47’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 162 mg 4-27 (0.30 mmol, 1.0 eq.) and 0.04ml 2,6-
lutidine (0.36mmol, 1.2 eq.) in chlorobenzene (6.0ml, 0.05 mmol/ml), with 0.27ml DTBP 
(1.47mmol, 5.0 eq.) for 2 hours. Flash chromatography on silica gel with AcOEt / DCM = 3 / 
97 afforded 4-47’ (22 mg, 18%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.81 (s, 1H, CH 3-CO-N-CH), 4.13 (q, 2H, J=7.2Hz, 
COO-CH2-CH3), 3.44 (s, 3H, SO2-CH3), 3.22 (m, 2H, CO-CH2-CH2), 3.11 (d, 3H, J=1.7Hz, 
N-CH3 ), 2.91 (s, 3H, CO-CH3), 2.73 (dt, 2H, J=3.5Hz, J=7.1Hz, CO-CH2-CH2), 1.25 (t, 3H, 
J=7.1Hz, COO-CH2-CH3)  
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 172.5 (COOEt), 167.6 (COMe), 148.3 (dd, 
J=16.6Hz, J=239.6Hz, N-CF), 140.5 (dd, J=28.1Hz, J=253.8Hz, N-C-CF), 139.2 (d, 
J=16.9Hz, N-C-N), 132.1 (dd, J=3.8Hz, J=10.6Hz, N-C-CF), 124.4 (d, J=4.5Hz, CO-N-CH), 
121.6 (d, J=4.5Hz, C-C-N),  118.8 (CH-C), 60.6 (COOCH2CH3), 37.90 (dd, J=4.5Hz, 
J=17.4Hz, N-CH3 + SO2-CH3 ),33.3 (CO-CH2-CH2),  25.5 ( CH3-CO-N), 20.7 ( COCH2-
CH2), 14.2 (COO-CH2-CH3) 
IR (ν, cm-1, CCl4)  3692, 3607, 1725, 1602, 1436, 1404, 1381, 1352, 1278, 1159, 1009  
HRMS (EI+)    Calcd. for C16H19F2N3O5S :403.1013      Found : 403.1019 
 
 
Experimental Part 
 335 
N-(1-acetyl-3-(2-(1,3-dioxoisoindolin-2-yl)ethyl)-5,6-difluoro-2,3-dihydro-1H-pyrrolo 
[2,3-b]pyridin-4-yl)acetamide (4-48) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 101mg 4-28 (0.18 mmol, 1.0 eq.) and 0.02ml 2,6-lutidine 
(0.21 mmol, 1.2 eq.) in chlorobenzene (3.6 ml, 0.05 mmol/ml), with 0.16 ml DTBP (0.89 
mmol, 5.0 eq.) for 3.5 hours. Flash chromatography on silica gel with AcOEt / EP = 45 / 55 
afforded 4-48 (41 mg, 53%) as a white solid. 
 
m.p. 207-210 oC 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.84 (dd, J = 5.46, 3.05 Hz, 2H, C-CH-CH), 7.73 (dd, 
J = 5.45, 3.05 Hz, 2H, C-CH-CH), 7.49 (s, 1H, NH), 4.34 (dd, J = 12.27, 10.26 Hz, 1H, CO-
N-CHH), 3.97 (dd, J = 12.34, 5.31 Hz, 1H, CO-N-CHH), 3.79 (ddd, J = 14.16, 9.57, 6.19 Hz, 
1H, CH2-CH), 3.72-3.56 (m, 2H, CH-CH2-CH2), 2.58 (s, 3H, NH-CO-CH3), 2.19 (s, 3H, N-
CO-CH3), 2.09 (dddd, J = 14.00, 9.61, 6.98, 2.65 Hz, 1H, CO-N-CH2-CHH), 1.59 (dddd, J = 
14.12, 10.20, 6.15, 4.29 Hz, 1H, CO-N-CH2- CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 169.6 (NCOMe), 168.5 (N-CO-C), 167.5 (NH-CO-
Me), 149.7 (dd, J = 235.44, 14.82 Hz, N-CF), 148.4 (dd, J = 16.27, 3.53 Hz, N-C-CF),  
134.2 (C-CH-CH), 133.9 (dd, J = 248.76, 28.76 Hz, N-C-CF), 133.5 (dd, J = 10.22, 4.72 Hz, 
N-C-N), 132.1 (C-CH-CH), 123.2 (C-CH-CH), 119.6 (dd, J = 5.33, 2.59 Hz, C-C-N),  51.8 
(CO-N-CH2), 34.8 (CH2-CH), 34.2 (CO-N-CH2-CH2), 30.2 (CO-N-CH2-CH2), 24.9 (NH-
CO-CH3), 23.6 (N-CO-CH3) 
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IR (ν, cm-1, CCl4)  3691, 3606, 3417, 2927, 2855, 1772, 1712, 1660, 1603, 1426, 1398, 1380, 
1328, 1241 
HRMS (EI+)    Calcd. for C21H18F2N4O4 : 428.1296      Found : 428.1291 
 
 
N-(1-acetyl-3-(2-(1,3-dioxoisoindolin-2-yl)ethyl)-5,6-difluoro-1H-pyrrolo[2,3-b]pyridin-
4-yl)acetamide (4-48’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 101mg 4-28 (0.18 mmol, 1.0 eq.) and 0.02ml 2,6-lutidine 
(0.21 mmol, 1.2 eq.) in chlorobenzene (3.6 ml, 0.05 mmol/ml), with 0.16 ml DTBP (0.89 
mmol, 5.0 eq.) for 3.5 hours. Flash chromatography on silica gel with AcOEt / EP = 25 / 75 
afforded 4-48’ (11 mg, 15%) as a white solid. 
 
m.p. 245-249 oC 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.39 (s, 1H, NH), 7.90-7.86 (m, 3H, CO-C-CH + N-
CH), 7.78 (dd, J = 5.44, 3.07 Hz, 2H, C-CH-CH), 3.82-3.78 (m, 2H, CO-N-CH2), 3.07-3.02 
(m, 2H, CH-C-CH2), 2.93 (s, 3H, NH-CO-CH3), 2.41 (s, 3H, N-CO-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 169.4 (NCOMe), 168.4 (N-CO-C), 168.0 (NH-CO-
CH3), 148.1 (dd, J = 233.17, 17.36 Hz, N-CF), 137.3 (dd, J = 257.91, 23.13 Hz, N-C-CF), 
135.4-135.2(m, N-C-CF), 134.5 (N-CO-C), 131.9 (C-CH-CH), 128.0-127.9 (m, N-C-N), 
124.5 (d, J = 4.23 Hz, CH), 123.7 (C-CH-CH), 120.7-120.4 (m, C-C-N), 119.1-119.0 (CH-
C), 38.7 (CON-CH2-CH2), 25.6 (CH3-CO-N), 25.3 (C-CH2), 23.3 (CH3-CO-NH) 
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IR (ν, cm-1, CDCl3)  2933, 1773, 1714, 1503, 1437, 1395, 1383, 1274, 1094 
HRMS (EI+)    Calcd. for C19H13F2N4O3 : 384.1034      Found : 384.1023 
 
 
N-(1-acetyl-5,6-difluoro-3-(3-(4-fluorophenyl)-3-oxopropyl)-2,3-dihydro-1H-pyrrolo 
[2,3-b]pyridin-4-yl)acetamide (4-49) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 151mg 4-29 (0.28 mmol, 1.0 eq.) and 0.04ml 2,6-lutidine 
(0.33 mmol, 1.2 eq.) in chlorobenzene (5.5 ml, 0.05 mmol/ml), with 0.25 ml DTBP (1.38 
mmol, 5.0 eq.) for 1.5 hours. Flash chromatography on silica gel with AcOEt / DCM = 25 / 
75 afforded 4-49 (55 mg, 50%) as a white solid. 
 
m.p. 226-230 oC 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.27 (s, 1H, NH), 8.04-7.94 (m, 2H, CO-C(CH)2), 
7.21-7.09 (m, 2H, CF-(CH)2), 4.11 (dd, J = 12.03, 9.41 Hz, 1H, CO-N-CHH), 3.96 (dd, J = 
12.10, 3.46 Hz, 1H, CO-N-CHH), 3.43-3.31 (m, 1H, CH2-CH), 3.08-3.03 (m, CO-CH2-CH2), 
2.58 (s, 3H, NH-CO-CH3), 2.38 (s, 3H, N-CO-CH3), 2.15-2.03 (m, 1H, CO-CH2-CHH), 1.81-
1.66 (m, 1H, CO-CH2-CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 198.3 (CH2-CO), 169.9 (N-CO-CH3), 168.0 (NH-
CO-CH3), 166.20 (d, J = 256.48 Hz, CF(CH)2), 151.8 (dd, J = 238.30, 23.90 Hz, N-CF), 
145.0.1-145.8 (m, N-C-CF), 138.6 (dd, J = 252.63, 21.09 Hz, N-C-CF), 133.76 (d, J = 5.18 
Hz, CO-C), 130.81 (d, J = 9.44 Hz,CO-C(CH)2), 126.7-126.5 (m, N-C-N), 119.3-119.1 (m, 
Experimental Part 
 338
C-C-N), 116.1 (d, J = 21.97 Hz, CF(CH)2), 52.5 (N-CH2), 35.2 (CH2-CH), 34.9 (CO-CH2), 
27.7 (CO-CH2-CH2), 24.6 (NH-CO-CH3), 23.7 (N-CO-CH3) 
IR (ν, cm-1, CDCl3) 3418, 1719, 1673, 1622, 1599, 1505, 1424, 1381, 1330, 1240, 1157 
HRMS (EI+)    Calcd. for C20H18F3N3O3 : 405.1300      Found : 405.1299 
 
 
N-(1-acetyl-5,6-difluoro-3-(3-(4-fluorophenyl)-3-oxopropyl)-1H-pyrrolo[2,3-b]pyridin-
4-yl)acetamide (4-49’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 151mg 4-29 (0.28 mmol, 1.0 eq.) and 0.04ml 2,6-lutidine 
(0.33 mmol, 1.2 eq.) in chlorobenzene (5.5 ml, 0.05 mmol/ml), with 0.25 ml DTBP (1.38 
mmol, 5.0 eq.) for 1.5 hours. Flash chromatography on silica gel with AcOEt / DCM = 15 / 
85 afforded 4-49’ (13 mg, 12%) as a white solid. 
 
m.p. 235-237 oC 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 9.93 (s, 1H, NH), 8.04-7.95 (m, 2H, CO-C-CH), 7.76 
(s, 1H, CO-N-CH), 7.16-7.12 (m, 2H, F-C-CH), 3.51-3.41 (m, 2H, CO-CH2-CH2), 3.21-3.11 
(m, 2H, CO-CH2-CH2), 2.90 (s, 3H, NH-CO-CH3), 2.38 (s, 3H, N-CO-CH3)  
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 199.9 (CH2-CO), 168.3 (N-CO-CH3), 168.1 (NH-
CO-CH3), 166.3 (d, J = 257.06 Hz, CF-CH), 149.2 (dd, J = 238.18, 16.85 Hz, N-CF), 138.1-
137.9 (m, N-C-CF), 137.7 (dd, J = 256.06, 29.14 Hz, N-C-CF), 132.41 (d, J = 2.97 Hz, CO-
C), 131.1 (d, J = 9.53 Hz,CF-CH-CH), 129.2-129.0 (m, N-C-N), 123.78 (d, J = 4.44 Hz, N-
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CH), 118.7-118.6 (m, C-C-N), 116.6 (d, J = 4.14 Hz,N-CH-C), 116.0 (d, J = 21.97 Hz, CF-
CH), 41.1 (CO-CH2), 25.5 (N-CO-CH3), 23.4 (NH-CO-CH3), 18.5 (CO-CH2-CH2) 
IR (ν, cm-1, CDCl3)  3277, 1709, 1678, 1598, 1507, 1472, 1439, 1383, 1285, 1234, 1157, 
1093 
HRMS (EI+)    Calcd. for C20H16F3N3O3 : 403.1144      Found : 403.1155 
 
 
N-(4-acetamido-3,5,6-trifluoropyridin-2-yl)-N-((7-fluoro-4-oxo-1,2,3,4-tetrahydro 
naphthalen-1-yl)methyl)acetamide (4-49”) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 240mg 4-29 (0.44 mmol, 1.0 eq.) in chlorobenzene (8.8 
ml, 0.05 mmol/ml), with 0.40 ml DTBP (2.2 mmol, 5.0 eq.) for 1.5 hours. Flash 
chromatography on silica gel with AcOEt / DCM = 15 / 85 afforded 4-49” (18 mg, 10%) 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.26 (s, 1H, NH), 8.04-8.00, 7.00-6.95 (m, 3H, 
aromatic H), 4.18 (dd, J = 13.96, 10.33 Hz, 1H, CO-N-CHH), 3.90 (dd, J = 13.62, 4.34 Hz, 
1H, CO-N-CHH), 3.21 (td, J = 13.58, 4.31 Hz, 1H, CH2-CH), 2.88-2.79 (m, 1H, CO-CHH), 
2.57-2.50 (m, 1H, CO-CHH), 2.30 (s, 3H, NH-CO-CH3), 2.23-2.17 (m, 1H, CO-CH2-CHH), 
2.13-2.08 (m, 1H, CO-CH2-CHH), 2.00 (s, 3H, N-CO-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 196.5 (CH2-CO), 170.6 (N-CO-CH3), 167.5 (NH-
CO-CH3), 165.8 (d, J = 256.32 Hz, CF-CH), 147.2 (d, J = 8.88 Hz,CO-C), 146.2 (dd, J = 
239.63, 13.79 Hz, N-CF-CF), 145.5 (dd, J = 260.14, 5.41 Hz,1C, NH-C-CF-C), 138.5 (dd, J 
= 267.78, 31.46 Hz, N-C-CF), 134.7-134.3 (m, N-C-CF), 130.6 (d, J = 9.64 Hz, CF-CH-CH), 
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128.86 (d, J = 2.63 Hz, CF-CH-C), 127.5-127.0 (m, N-C-N), 115.7, 115.1 (dd, J = 21.85, 
6.66 Hz, dd, J = 21.78, 4.67 Hz, CF-CH), 50.2 (CO-N-CH2), 37.2 (CH2-CH), 34.2 (CO-CH2), 
24.2 (CO-CH2-CH2), 23.1 (NH-CO-CH3), 22.0 (NH-CO-CH3) 
IR (ν, cm-1, CDCl3)  3418, 2931, 1726, 1682, 1608, 1500, 1476, 1452, 1380, 1249, 1224, 
1157, 1106 
HRMS (EI+)    Calcd. for C20H17F4N3O3 : 423.1206     Found : 423.1214 
 
 
1-(1-acetyl-5,6-difluoro-4-(1H-1,2,4-triazol-1-yl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-
3-yl)-4,4-dimethylpentan-3-one (4-50) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 167mg 4-30 (0.33 mmol, 1.0 eq.) and 0.05 ml 2,6-
lutidine (0.40 mmol, 1.2 eq.) in chlorobenzene (6.6 ml, 0.05 mmol/ml), with 0.30 ml DTBP 
(1.65 mmol, 5.0 eq.) for 1.5 hours. Flash chromatography on silica gel with AcOEt / DCM = 
25 / 75 afforded 4-50 (74 mg, 61%) as a yellow solid. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.74 (d, J = 3.43 Hz, 1H, C-N-CH), 8.21 (s, 1H, C-N-
N-CH), 4.12 (dd, J = 11.99, 9.42 Hz, 1H, CO-N-CHH), 4.05-3.89 (m, 2H, CO-N-CHH + 
CH2-CH), 2.62 (s, 3H, CO-CH3), 2.49-2.38 (m, 2H, CO-CH2), 1.54 (dd, J = 14.24, 7.22 Hz, 
2H, CH-CH2), 1.06 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 214.0 (CO-CH2), 169.5 (CO-CH3), 152.7 (C-N-N-
CH), 150.9 (dd, J = 238.20, 15.22 Hz, N-CF), 148.9 (dd, J = 16.27, 3.93 Hz, N-C-N), 145.5 
(d, J = 12.92 Hz, C-N-CH), 133.0 (dd, J = 255.06, 30.50 Hz, N-C-CF), 132.2 (dd, J = 8.62, 
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4.74 Hz, N-C-CF), 112.0 (dd, J = 5.73, 3.30 Hz, C-C-N), 51.5 (N-CH2), 44.0 (CO-C), 35.3 
(CH2-CH), 32.7 (CO-CH2), 27.8 (CH-CH), 26.2 (C(CH3)3), 24.7 (CO-CH3) 
IR (ν, cm-1, CDCl3)  3052, 2985, 2930, 1730, 1671, 1623, 1519, 1479, 1435, 1391, 1314, 
1265, 1174, 1131, 992 
HRMS (EI+)    Calcd. for C18H21F2N5O2 :377.1663      Found : 377.1675 
 
 
1-(1-acetyl-5,6-difluoro-4-(1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-4,4-
dimethylpentan-3-one (4-50’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 167mg 4-30 (0.33 mmol, 1.0 eq.) and 0.05 ml 2,6-
lutidine (0.40 mmol, 1.2 eq.) in chlorobenzene (6.6 ml, 0.05 mmol/ml), with 0.30 ml DTBP 
(1.65 mmol, 5.0 eq.) for 1 hours. Flash chromatography on silica gel with AcOEt / DCM = 
15 / 85 afforded 4-50’ (21 mg, 18%) as a yellow solid. 
 
m.p. 108-111 oC 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.54 (d, J = 2.19 Hz, 1H, C-N-CH), 8.25 (s, 1H, C-N-
N-CH), 7.82 (s, 1H, CO-N-CH), 2.97 (s, 3H, CO-CH3), 2.69-2.46 (m, 4H, CO-CH2-CH2), 
1.06 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 213.7 (CO-CH2), 167.5 (CO-CH3), 153.1 (C-N-N-
CH), 147.9 (dd, J = 240.39, 16.43 Hz, N-CF), 145.7 (C-N-CH), 139.0 (dd, J = 16.51, 3.01 
Hz, N-C-N), 137.2 (dd, J = 257.31, 29.65 Hz, N-C-CF), 129.5-126.2 (m, N-C-CF), 125.2 (d, 
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J = 4.24 Hz, CO-N-CH), 119.1-117.8 (m, CH2-C), 117.5-117.4 (m, C-C-N), 43.9 (CO-C), 
35.9 (CO-CH2), 26.4 (C(CH3)3), 25.6 (CO-CH3), 19.9 (C-CH2) 
IR (ν, cm-1, CDCl3)  2970, 1721, 1596, 1561, 1518, 1473, 1455, 1418, 1382, 1348, 1280, 
1239, 1176, 1130, 1080, 1005 
HRMS (EI+)    Calcd. for C18H19F2N5O2 :375.1507      Found : 375.1509 
 
 
3-(3-(1-acetyl-5,6-difluoro-4-(1H-imidazol-1-yl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-
3-yl)propanoyl)oxazolidin-2-one (4-51) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 66mg 4-31 (0.12 mmol, 1.0 eq.) and 0.01 ml 2,6-lutidine 
(0.14 mmol, 1.2 eq.) in chlorobenzene (2.5 ml, 0.05 mmol/ml), with 0.11 ml DTBP (0.60 
mmol, 5.0 eq.) for 3 hours. Flash chromatography on silica gel with Acetone / DCM = 10 / 
90 afforded 4-51 (18 mg, 38%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.84, 7.34, 7.30 (3s, 3H, NCH-N + N-CH + N-CH), 
4.62-4.34 (m, 2H, COO-CH2), 4.24 (dd, J = 12.28, 9.38 Hz, 1H, CO-N-CHH), 4.09-3.93 (m, 
3H, CO-N-CHH + COO-CH2-CH2), 3.80-3.65 (m, 1H, CH2-CH), 2.88-2.70 (m, 2H, CO-
CH2), 2.67 (s, 3H, N-CO-CH3), 1.73-1.52 (m, 2H, CO-CH2-CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 171.5 (COO-CH2), 169.5 (N-CO-CH3), 153.4 (CO-
N-CO), 151.5 (dd, J = 243.96, 25.20 Hz, N-CF), 148.8-148.6 (m, N-C-CF), 136.8, 130.8, 
119.2 (3C, imidazole C), 134.7 (dd, J = 259.39, 26.12 Hz, N-C-CF), 133.8-133.6 (m, N-C-N), 
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120.3-120.1 (m, C-C-N), 62.2 (COO-CH2), 52.0 (CH3-CO-N-CH2), 42.4 (COO-CH2-CH2), 
34.3 (CH2-CH), 31.3 (CH2-CO-N-CO), 27.9 (CO-CH2-CH2), 24.8 (N-CO-CH3) 
IR (ν, cm-1, CDCl3)  2926, 1782, 1677, 1625, 1512, 1433, 1383, 1318, 1183, 1077, 1041 
HRMS (EI+)    Calcd. for C18H17F2N5O4 : 405.1249     Found : 405.1258 
 
 
3-(3-(1-acetyl-5,6-difluoro-4-(1H-imidazol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl) 
propanoyl)oxazolidin-2-one (4-51’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 66mg 4-31 (0.12 mmol, 1.0 eq.) and 0.01 ml 2,6-lutidine 
(0.14 mmol, 1.2 eq.) in chlorobenzene (2.5 ml, 0.05 mmol/ml), with 0.11 ml DTBP (0.60 
mmol, 5.0 eq.) for 3 hours. Flash chromatography on silica gel with Acetone / DCM = 10 / 
90 afforded 4-51’ (9 mg, 19%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.84, 7.80,7.34, 7.26 (4s, 4H, NCH-N + N-CH + N-
CH + CO-N-CH), 4.40 (t, J = 8.00 Hz, 2H, COO-CH2), 3.95 (t, J = 8.00 Hz, 2H, COO-CH2-
CH2), 2.97 (s, 3H, N-CO-CH3), 2.90 (t, J = 7.29 Hz, 2H, CO-CH2), 2.62 (t, J = 7.37 Hz, 2H, 
CO-CH2-CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 171.4 (COO-CH2), 168.1 (N-CO-CH3), 153.5 (CO-
N-CO), 148.5 (dd, J = 243.96, 25.20 Hz, N-CF), 142.8-142.6 (m, N-C-CF), 138.1, 130.1, 
119.3 (3C, imidazole C), 133.2 (dd, J = 259.39, 26.12 Hz, N-C-CF), 132.5-132.4 (m, N-C-N), 
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125.0 (CO-N-CH), 120.3-120.1 (m, C-C-N), 117.2 (CH2-C), 62.2 (COO-CH2), 42.4 (COO-
CH2-CH2), 34.5 (CH2-CO-N-CO), 25.6 (N-CO-CH3), 19.9 (CO-CH2-CH2) 
IR (ν, cm-1, CDCl3)  3688, 3632, 3470, 2944, 2839, 1782, 1707, 1602, 1387, 1018 
HRMS (EI+)    Calcd. for C18H15F2N5O4 : 403.1092     Found : 403.1096 
 
 
4-(1-acetyl-5,6-difluoro-4-(1H-indol-1-yl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-yl) 
butan-2-one (4-52) 
 
 
 
Following the general procedure 4-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 154mg 4-32 (0.29 mmol, 1.0 eq.) and 0.04 ml 2,6-lutidine 
(0.35 mmol, 1.2 eq.) in chlorobenzene (6.0 ml, 0.05 mmol/ml), with 0.27 ml DTBP (1.47 
mmol, 5.0 eq.) for 2 hours. Flash chromatography on silica gel with AcOEt / EP = 30 / 70 
afforded 4-52 (47 mg, 42%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.13-6.59 (m, 6H, aromatic H), 4.25 (dd, J = 21.56, 
10.77 Hz, 1H, CO-N-CHH), 3.92 (ddd, J = 23.90, 12.38, 3.85 Hz, 1H CO-N-CHH), 3.72-
3.55, 3.43-3.30 (m, 1H, CH2-CH), 2.70 (s, 3H, N-CO-CH3), 2.15-1.84 (m, 2H, CO-CH2), 
1.81, 1.67 (s, 3H, CH2-CO-CH3), 1.37-1.27 (m, 2H, CO-CH2-CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 206.7, 206.6 (CO-CH2), 169.5 (N-CO-CH3), 151.3 
(dd, J = 238.56, 13.90 Hz, N-CF), 148.6-148.3 (m, N-C-CF), 136.38 (dd, J = 261.49, 23.91 
Hz, N-C-CF), 135.6-135.6 (m, N-C-N), 135.8, 134.4, 129.1, 128.7, 127.8, 125.8, 123.8, 
123.4, 121.9, 121.7, 121.5, 110.7, 110.4, 106.9, 106.1 (8C, aromatic C), 122.5-122.2 (m, C-
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C-N), 52.2, 52.0 (CO-N-CH2), 39.4, 38.7 (CO-CH2), 35.4, 34.2 (CH2-CH), 29.2 (CH2-CO-
CH3), 27.1 (CO-CH2-CH2), 24.8 (N-CO-CH3) 
IR (ν, cm-1, CDCl3)  2934, 1716, 1666, 1621, 1523, 1504, 1472, 1429, 1382, 1346, 1334, 
1317, 1259, 1211, 1176 
HRMS (EI+)    Calcd. for C21H19F2N3O2 : 383.1445     Found : 383.1442 
 
 
4-(1-acetyl-5,6-difluoro-4-(1H-indol-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)butan-2-one (4-
52’) 
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 154mg 4-32 (0.29 mmol, 1.0 eq.) and 0.04 ml 2,6-
lutidine (0.35 mmol, 1.2 eq.) in chlorobenzene (6.0 ml, 0.05 mmol/ml), with 0.27 ml DTBP 
(1.47 mmol, 5.0 eq.) for 2 hours. Flash chromatography on silica gel with AcOEt / EP = 30 / 
70 afforded 4-52’ (21 mg, 18%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.76 (s, 1H, CO-N-CH), 7.74-6.78 (m, 6H, aromatic 
H), 3.00 (s, 3H, N-CO-CH3), 2.46-2.25 (m, 2H, CO-CH2), 2.01 (dddd, J = 23.49, 17.61, 8.59, 
6.29 Hz, 2H, CO-CH2-CH2), 1.69 (s, 3H, CH2-CO-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 206.5 (CO-CH2), 167.7 (N-CO-CH3), 148.6 (dd, J 
= 238.99, 16.13 Hz, N-CF), 140.5-140.0 (m, N-C-CF), 139.0 (dd, J = 256.11, 27.69 Hz, N-
C-CF), 137.2, 128.5, 128.4, 123.5, 121.5, 121.4, 110.1, 105.5 (8C, aromatic C), 130.3-130.1 
(m, N-C-N), 124.4 (d, J = 4.38 Hz, N-CH), 119.3-119.2 (m, C-C-N), 118.0 (N-CH-C), 42.4 
(CO-CH2), 29.2 (CH2-CO-CH3), 25.6 (N-CO-CH3), 20.0 (CO-CH2-CH2) 
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IR (ν, cm-1, CDCl3)  2928, 2855, 1718, 1594, 1562, 1505, 1472, 1459, 1438, 1403, 1380, 
1344, 1328, 1256, 1233, 1212, 1179, 1095 
HRMS (EI+)    Calcd. for C21H17F2N3O2 : 381.1289      Found : 381.1279 
 
 
3-(1-acetyl-5,6-difluoro-4-((4-iodophenyl)amino)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-
3-yl)-1-cyclopropylpropan-1-one (4-53) 
 
 
 
Following the general procedure 4-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 100mg xanthate 4-33 (0.15 mmol, 1.0 eq.) and 0.03 ml 2,6-
lutidine (0.23 mmol, 1.2 eq.) in chlorobenzene (3.5 ml, 0.05 mmol/ml), with 0.14 ml DTBP 
(0.76 mmol, 5.0 eq.) for 2h. Flash chromatography on silica gel with AcOEt / PE = 30 / 70 
afforded 4-53 (41.3 mg, 53 %) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.72 (brs, 1H, NH), 7.62 (d, J = 8.57Hz, 2H, 2 ICCH), 
6.85 (dd, J = 8.70, 2.85 Hz, 2H, 2 NCCH), 3.98 (ddd, J = 14.8, 12.1, 5.9 Hz, 2H, NCH2), 2.89 
(t, J = 8.92 Hz, 1H, NCH2CH), 2.69-2.64 (m, 2H, COCH2), 2.59 (s, 3H, CH3), 1.96-1.89 (m, 
2H, COCH + COCH2CHH), 1.51-1.43 (m, 1H, COCH2CHH), 1.06-1.05 (m, 2H, COCHCH2), 
0.96-0.93 (m, 2H, COCHCH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 211.9 (CHCO), 169.8 (NCOCH3), 151.7 (dd, J = 
233, 14 Hz, N-CF), 147.0 (dd, J = 18, 3 Hz, NHCCF), 139.9 (d, J = 1.1 Hz, NHCCH), 138.0 
(dd, J = 7.2, 6.0 Hz, N=C-N-CO), 137.7 (NHCCH), 132.1 (dd, J = 250, 30Hz, NHCCF), 
122.4 (d, J = 3.1 Hz, ICCH), 114.0 (d, J = 3.8 Hz, NHCC), 86.7 (I-C), 53.0 (CONCH2), 39.9 
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(COCH2), 34.0 (CH2CH), 27.7 (CO-CH2-CH2), 24.4 (NCOCH3), 21.0 (COCH), 11.72, 11.69 
(COCH(CH2)2) 
IR (ν, cm-1, CCl4)  3690, 3607, 3512, 3410, 3296, 3217, 3098, 3013, 2929, 2856, 1716, 1685, 
1655, 1623, 1586, 1527, 1485, 1421, 1394, 1380, 1349, 1280, 1265, 1234, 1194, 1182, 1143, 
1121, 1077, 1040, 1007, 972 
HRMS (EI+)    Calcd. for C21H20F2IN3O2 : 511.0568       Found : 511.0575 
 
 
1-(3-(2-(1-benzyl-1H-tetrazol-5-yl)ethyl)-5,6-difluoro-4-((4-iodophenyl)amino)-2,3-
dihydro-1H-pyrrolo[2,3-b]pyridin-1-yl)ethanone (4-54) 
 
 
 
Following the general procedure 4-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 325mg 4-34 (0.44mmol, 1.0eq.) and 0.06 ml 2,6-lutidine 
(0.53mmol, 1.2eq.) in chlorobenzene (8.8ml, 0.05 mmol/ml), with 0.40ml DTBP (2.17mmol, 
4.9eq.) for 3 hours. Flash chromatography on silica gel with AcOEt / EP = 30 / 70 afforded 
4-54 (68mg, 26%) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.54 (s, 1H, NH), 7.67 (d, J = 8.66 Hz, 2H, 2 ICCH), 
7.46-7.42 (m, 3H, Ph-CH), 7.23 (dd, J = 6.46, 2.97 Hz, 2H, Ph-CH), 6.98 (dd, J = 8.65, 3.42 
Hz, 1H, NHCCH), 5.54 (s, 2H, Ph-CH2), 3.97 (d, J = 5.67 Hz, 2H, NCH2CH), 3.26 (td, J = 
7.39, 6.07 Hz, 1H, CHCH2), 2.74 (dd, J = 5.07, 3.94 Hz, 1H, CHCH2CHH), 2.69-2.59 (m, 4H, 
CHCH2CHH + CH3), 2.32 (dt, J = 12.80, 2.34 Hz, 1H, CHCHHCH2), 1.83 (ddt, J = 9.01, 
5.45, 3.62 Hz, 1H, CHCHHCH2) 
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13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 169.8 (NCOCH3), 154.2 (C=N), 152.0 (dd, J = 234, 
14 Hz, N-CF), 147.0 (dd, J = 19, 2.4 Hz,NHCCF), 139.9 (NHCCH), 138.2 (dd, J = 7.0, 6.1 
Hz, N=C-N-CO), 137.7 (NHCCH), 132.3 (Ph-CH2C), 132.1 (dd, J = 251, 30 Hz, NHCCF), 
129.4 (2 Ph-CH), 129.3 (Ph-CH), 127.6 (2 Ph-CH), 122.1 (d, J = 3.2 Hz, ICCH), 113.4 (d, J 
= 3.7 Hz, NHCC), 86.5 (IC), 52.8 (NCH2CH), 51.1 (CH2Ph), 39.9 (COCH2), 33.4 (CH2CH), 
29.6 (CH2CH2CH), 24.3 (NCOCH3), 21.1 (N=CCH2) 
IR (ν, cm-1, CDCl3)  3409, 3273, 3209, 3092, 3070, 3035, 2960, 2930, 2873, 2856, 1720, 
1659, 1622, 1585, 1529, 1485, 1421, 1394, 1380, 1350, 1324, 1280, 1263, 1236, 1145, 1113, 
1096, 1075, 1060, 1006 
MS (NH3 ionisation) 602 (MH+) 
 
 
N-(4-cyanobutyl)-N-(5,6-difluoro-4-((4-iodophenyl)amino)pyridin-2-yl)acetamide.(4-54”) 
 
 
 
Following the general procedure 4-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 325mg 4-34 (0.44mmol, 1.0eq.) and 0.06 ml 2,6-lutidine 
(0.53mmol, 1.2eq.) in chlorobenzene (8.8ml, 0.05 mmol/ml), with 0.40ml DTBP (2.17mmol, 
4.9eq.) for 3 hours. Flash chromatography on silica gel with AcOEt / EP = 30 / 70 afforded 
4-54” (35mg, 17%) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.67 (d, J = 8.59 Hz, 2H, ICCH), 6.85 (d, J = 7.59 Hz, 
2H, NHCCH), 6.40 (s, 1H, NH), 3.77 (t, J = 6.46 Hz, 2H, NCH2), 2.39 (t, J = 6.55 Hz, 2H, 
NCCH2), 1.97 (s, 3H, CH3), 1.74-1.67 (m, 4H, NCH2CH2CH2) 
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13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 169.9 (NCO), 147.0 (dd, J = 251, 12 Hz, N-CF), 
142.6 (d, J = 257 Hz, NCFCF), 138.1 (NHCCH), 138.0 (NHCCH), 134.3 (dd, J = 261, 33 Hz, 
CF-C-NCO), 134.3-133.9 (NCN), 132.2-131.9 (CFCFC), 123.3 (ICCH), 119.4 (CN), 88.9 
(IC), 45.8 (CONCH2), 27.0 (CH2), 22.4 (CH2), 21.9 (CH3), 16.8 (CH2CN) 
IR (ν, cm-1, CDCl3)  3694, 3606, 3412, 2940, 2246, 1674, 1621, 1600, 1586, 1528, 1478, 
1469, 1462, 1453, 1423, 1305, 1266, 1237, 1123, 1059, 1007 
MS (NH3 ionisation) 488 (MH+) 
 
 
3-(4-(1H-benzo[d]imidazol-1-yl)-6-ethoxy-5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl) 
propanenitrile (4-55) 
 
 
 
Following the general procedure 4-III for the cyclization using DTBP, the reaction was 
carried out with the solution of 151mg xanthate 4-35 (0.30 mmol, 1.0 eq.) and 0.04 ml 2,6-
lutidine (0.35 mmol, 1.2 eq.) in chlorobenzene (6.0 ml, 0.05 mmol/ml), with 0.27 ml DTBP 
(1.48 mmol, 5.0 eq.) for 3 hours. After evaporating the solvent, the crude cyclization 
products were directly used in next step. 
 
The deprotection was carried out with the solution of the crude cyclization products and 
potassium carbonate (205 mg, 1.48 mmol, 5.0 eq.) refluxing for 5h in EtOH (6.0 ml, 0.05 
mmol/ml). After work-up, the crude deprotection products were dissolved by DMSO (4.3 ml, 
0.07 mmol/ml) and 134mg IBX (0.33 mmol, 1.1 eq.) was added, then stirring at 50oC for 6 h. 
Flash chromatography on silica gel with AcOEt / DCM = 30 / 70 afforded 4-55 (38 mg, 23% 
for 3steps) as a white solid. 
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1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.70 (s, 1H, NH), 8.11 (s, 1H, N-CH=N), 7.94 (d, J = 
8.14 Hz, 1H, C-N-C-CH), 7.41-7.31 (m, 2H, CH-CH-CH), 7.21 (d, J = 8.10 Hz, 1H, CH=N-
C-CH), 7.14 (s, 1H, NH-CH), 4.55 (q, J = 7.07 Hz, 2H, CH2-CH3), 2.35 (t, J = 6.65 Hz, 2H, 
NC-CH2-CH2), 2.02-1.86 (m, 2H, NC-CH2-CH2), 1.51 (t, J = 7.08 Hz, 3H, CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 150.6 (d, J = 13 Hz, CH2O-C), 143.0 (C-N-C), 
142.8 (C-N-C-CH), 141.6 (d, J = 3.0 Hz, N-C-NH), 139.7 (d, J = 254 Hz, EtO-C-C-F), 134.7 
(CH=N-C), 124.5 (CH-CH-CH-CH), 123.6 (d, J = 11 Hz,FC-C-N), 123.4 (CH-CH-CH-CH), 
122.0 (NH-CH), 120.8 (C-N-C-CH), 118.8 (CN), 111.1 (d, J = 3.9 Hz, NH-C-C), 110.4 
(CH=N-C-CH), 108.9 (NH-CH-C), 63.2 (CH3CH2O), 21.9 (NC-CH2), 18.4 (NC-CH2-CH2), 
14.5 (CH3) 
IR (ν, cm-1, CCl4) 3692, 3465, 2932, 1685, 1623, 1580, 1548, 1519, 1493, 1469, 1445, 1423, 
1385, 1355, 1306, 1211, 1184, 1092, 1026 
HRMS (EI+) Calcd. for C19H16FN5O :349.1339      Found : 349.1335 
 
 
N-(4-acetamido-3,5,6-trifluoropyridin-2-yl)-N-(but-3-en-1-yl)acetamide (4-56) 
 
 
 
Following the general procedure 4-I for preparing the olefinic precursors, the reaction was 
carried out with 2.5g pentafluoropyridine (14.8 mmol, 1.0 eq.) and 10ml ammonia (25%) 
(64.4 mmol, 4.3 eq.) in 12 ml EtOH (1.2 mmol/ml) refluxing for 16 hours. After work-up, 
2.09 g of crude product as white solid was used directly in the next step without further 
purification. 
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The crude product of last step was dissolved by 12 ml acetyl chloride (168.8 mmol, 13.4 eq.) 
and refluxed overnight to complete the reaction. After work-up, 2.48g of crude product as 
white solid was used directly in the next step without further purification. 
 
Then the reaction was carried out with 203mg crude product of last step (0.99 mmol, 1.0 eq.), 
310 mg but-3-en-1-amine hydrochloride(3.91 mmol, 4.0 eq.) and 0.68 ml TEA (4.89 mmol, 
4.9 eq.) in 6.0 ml THF (1.5 mmol/ml). The mixture was refluxing overnight. After work-up, 
the crude product was used directly in the next step without further purification. 
 
Finally the acetylation was carried out by dissolving the crude product of the last step with 
5.0 ml acetyl chloride (0.02 mmol/ml) and refluxing overnight. After work-up, the crude 
product was purified with flash chromatography on silica gel with AcOEt / EP = 40 / 60 
afforded 4-56 (196 mg, 67% for 2 steps) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.24 (s, 1H, NH), 5.68 (tdd, J = 17.0, 10.2, 6.8 Hz, 1H, 
CH2CH), 5.05-4.97 (m, 2H, CH=CH2), 3.79 (t, J = 7.40 Hz, 2H, NCH2), 2.31-2.27 (m, 5H, 
NH-CO-CH3 + CH=CH2), 1.99 (brs, 3H, N-CO-CH3)  
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 170.2 (NHCOCH3), 167.6 (NCOCH3), 146.2 (ddd, 
J = 2340, 14, 2.1 Hz, N-CF), 145.7 (dd, J = 260, 5.4 Hz, N-CF-CF), 138.5 (dd, J = 268, 32 
Hz, CO-N-C-CF), 134.4-134.1 (m, CF-C-N-CO), 127.0-126.7 (m, CF-CF-C), 117.1 
(CHCH2), 47.1 (CH), 32.6 (N-CH2-CH), 23.1 (NHCO-CH3), 22.0 (NCO-CH3)  
IR (ν, cm-1, CDCl3) 3690, 3606, 3521, 3418, 2970, 2932, 1733, 1645, 1629, 1510, 1486, 
1468, 1456, 1433, 1419, 1379, 1321, 1280, 1222, 1170, 1089, 1037, 1007, 975  
MS (NH3 ionisation) 302 (MH+) 
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S-(1-(N-(4-acetamido-3,5,6-trifluoropyridin-2-yl)acetamido)-7,7-dimethyl-6-oxooctan-3-
yl) O-ethyl carbonodithioate (4-57) 
 
 
 
Following the general procedure 4-II for radical addition of xanthate, the reaction was 
carried out with the protected olefin 4-56 (196 mg, 0.65 mmol, 0.5 eq.) and the 
corresponding xanthate (279 mg, 1.30 mmol, 1.0 eq.) in AcOEt (0.7 ml, 0.5 mmol/ml), with 
DLP (160 mg, 0.30 eq.). Flash chromatography on silica gel with AcOEt / DCM = 10 / 90 
afforded 4-57 (145 mg, 43%) as a light yellow oil.  
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.26 (brs, 1H, NH), 4.58 (q, J = 7.1 Hz, 2H, CH2CH3), 
3.82 (t, J = 7.3 Hz, 2H, NCH2), 3.68-3.61 (m, 1H, SCH), 2.71-2.54 (m, 2H, COCH2), 2.28 (s, 
3H, NHCOCH3), 2.03 (s, 3H, NCOCH3), 2.01-1.96 (m, 3H, NCH2CH2 + COCH2CHH), 
1.78-1.69 (m, 1H, COCH2CHH), 1.39 (t, J = 7.1 Hz, 3H, CH2CH3), 1.10 (s, 9H, C(CH3)3)  
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 215.5 (C=S), 213.8 (COCH2), 170.0 (NHCOCH3), 
167.3 (NCOCH3), 146.3 (dd, J = 241, 14 Hz, N-CF), 145.6 (dd, J = 260, 5.9 Hz, NCFCF), 
138.7 (dd, J = 268, 30 Hz, CF-C-NCO), 134.7-134.3 (NCN), 127.0-126.8 (CFCFC), 70.2 
(CSOCH2CH3), 48.9 (CONCH2), 45.6 (C(CH3)3), 44.2 (SCH), 33.4 (COCH2), 23.1 
(NHCOCH3), 21.9 (NCOCH3), 13.6 (CSOCH2CH3)  
IR (ν, cm-1, CDCl3) 3691, 3607, 3418, 2971, 1727, 1702, 1678, 1621, 1602, 1501, 1477, 
1449, 1385, 1369, 1283, 1222, 1112, 1050  
HRMS (EI+) Calcd. for C22H30F3N3O4S2: 521.1630  -Xa.: 400.1848      Found : 400.1848  
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N-(8-acetyl-5-(4,4-dimethyl-3-oxopentyl)-2,3-difluoro-5,6,7,8-tetrahydro-1,8-
naphthyridin-4-yl)acetamide (4-58)  
 
 
 
Following the general procedure 4-III for the radical cyclization using DTBP, the reaction 
was carried out with the solution of 63.4mg 4-57 (0.12mmol, 1.0 eq.) and 0.028ml 2,6-
lutidine (0.24mmol, 2eq.) in chlorobenzene (2.4ml, 0.05mmol/ml), with 0.11ml DTBP 
(0.61mmol, 5 eq.) for 3 hours. Purification with preparative TLC plate with MeOH / DCM = 
3 / 97 afforded 4-58 (7.3mg, 16%) as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 9.45 (s, 1H, NH), 4.17 (td, 1H, J = 13.7, 4.5 Hz, AcN-
CHH), 3.60 (ddd, 1H, J = 13.6, 10.5, 5.4 Hz, AcN-CHH), 2.83 (ddd, 1H, J = 19.3, 11.9, 1.9 
Hz, CO-CHH), 2.69-2.54 (m, 2H, CH + CO-CH2), 2.49 (s, 3H, CH3), 2.43 (s, 3H, CH3), 
1.86-1.77 (m, 2H, N-CH2-CH2), 1.77-1.70 (m, 1H, CHH-CH2CO), 1.61-1.50 (m, 1H, CHH-
CH2-CO), 1.22 (s, 9H, tBu) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  214.2 (COtBu), 171.4 (COMe), 168.6 (COMe), 
148.6 (dd, J = 235.5, 16.7 Hz, N-CF), 144.6 (dd, J = 250.4, 20.7 Hz, N-C-CF), 142.3 (dd, J 
= 22.3, 13.8 Hz, N-C-CF), 135.3 (dd, J = 9.3, 5.0 Hz, N-C-N), 119.0 (d, J = 5.9 Hz, C-C-N), 
44.4 (CMe3), 38.9 (CO-N-CH2), 32.8 (COCH2), 30.9 (CH), 27.5 (COCH2-CH2), 26.5 
(C(CH3)3), 26.2 (CH3), 24.5 (CON-CH2-CH2), 23.3 (CH3) 
IR (ν, cm-1, CCl4)  3686, 3607, 2928, 2855, 1731, 1674, 1620, 1601, 1485, 1427, 1373, 1324, 
1260, 1226, 1182, 1034 
HRMS (EI+)    Calcd. for C19H25F2N3O3 : 381.1864      Found : 381.1851 
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Chapter 5 
 
General procedure 5-I for radical addition of xanthates on the olefins  
 
 
A magnetically stirred solution of the corresponding olefin (0.5-2.0 eq.) and the desired 
xanthates (1.0 eq.) in AcOEt (1.0M-2.0M of xanthate) was refluxed for about 20-30min 
under nitrogen. Lauroyl peroxide (DLP) (10%mol) was then added to the refluxing solution, 
followed by additional portions (5%mol) every 90min until the starting xanthate was 
completely consumed. The reaction mixture was then cooled down to room temperature, 
concentrated under reduced pressure and purified by flash chromatography on silica gel to 
yield the desired compounds.  
 
 
General procedure 5-II for radical cyclization of the corresponding xanthates 
 
 
 
A magnetically stirred solution of the corresponding xanthate (1.0 eq.) in AcOEt (0.05M of 
xanthate) was refluxed for about 15-30min under nitrogen. Lauroyl peroxide (DLP) (20%mol) 
was then added to the refluxing solution every 60min. The reaction was monitored by TLC 
every hour until the starting xanthate was completely consumed. The reaction mixture was 
then cooled down to room temperature, concentrated under reduced pressure and purified by 
flash chromatography on silica gel to yield the desired compounds.  
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General procedure 5-III for radical addition of xanthates on the pyrimidine rings  
 
 
 
A magnetically stirred solution of the corresponding aromatic ring (0.5-2.0 eq.) and the 
desired xanthates (1.0 eq.) in AcOEt (1.0M-2.0M of xanthate) was refluxed for about 20-
30min under nitrogen. Lauroyl peroxide (DLP) (10%mol or 20%mol) was then added to the 
refluxing solution every 60min, until the xanthate was completely consumed. The reaction 
mixture was then cooled down to room temperature, concentrated under reduced pressure 
and purified by flash chromatography on silica gel to yield the desired compounds.  
 
 
 
 
tert-butyl (2,6-dichloropyrimidin-4-yl)(2-((ethoxycarbonothioyl)thio)-5-oxo-5-(2-
oxooxazolidin-3-yl)pentyl)carbamate (5-1) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of tert-butyl allyl(2,6-
dichloropyrimidin-4-yl)carbamate (1.51g, 4.96mmol, 2.0 eq.) and the xanthate Xa-f (618mg, 
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2.48mmol, 1.0 eq.) in AcOEt (2.5ml, 1.0mmol/ml), with DLP (148mg, 0.15 eq.). Flash 
chromatography on silica gel with AcOEt / EP = 25 / 75 afforded 5-1 (1.10g, 81%) as 
colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  8.05 (s, 1H, H-aromatic), 4.58 (ttd, 2H, J=3.6Hz, 
J=7.1Hz, J=10.7Hz, CH2-CH3), 4.48-4.39 (m, 1H, BocN-CHH), 4.41 (t, 2H, J=8.1Hz, N-
COO-CH2), 4.33-4.24 (m, 2H, Xa-CH + BocN-CHH), 4.01 (t, 2H, J=8.2Hz, N-COO-CH2-
CH2), 3.25-3.17 (m, 1H, CO-CHH), 3.12-3.04 (m, 1H, CO-CHH), 2.21-2.13 (m, 1H, CO-
CH2-CHH), 2.04-1.94 (m, 1H, CO-CH2-CHH), 1.59 (s, 9H, C(CH3)3), 1.36 (t, 3H, J=7.1Hz, 
CH2-CH3)  
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.3 (C=S), 172.2 (CO-NCOO), 162.3 (C-NBoc), 
162.0 (C-CH-C-NBoc), 158.7 (C-N-C-NBoc), 153.4 (tBuO-CO), 152.2 (NCOO-CH2), 110.4 
(CH-C-NBoc), 84.7 (CMe3), 70.4 (CH2-CH3), 62.1 (NCOO-CH2), 49.7 (Xa-CH), 48.2 (CH2-
NBoc), 42.5 (N-COO-CH2-CH2), 32.4 (N-CO-CH2), 28.0 (C(CH3)3), 26.9 (Xa-CH-CH2-CH2), 
13.7 (CH2-CH3) 
IR (ν, cm-1, CDCl3)  2984, 1783, 1728, 1559, 1525, 1420, 1388, 1230, 1150, 1113, 1048 
HRMS (EI+)    Calcd. for C20H26N4Cl2S2O6 : 552.0671      Found : 552.0668 
 
 
tert-butyl 2,4-dichloro-5-(3-oxo-3-(2-oxooxazolidin-3-yl)propyl)-5H-pyrrolo[2,3-
d]pyrimidine-7(6H)-carboxylate (5-2) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-1 (1.03g, 1.86mmol, 1.0 eq.) in 
Experimental Part 
 357 
AcOEt (28ml, 0.07mmol/ml), with DLP (1.18g, 1.6 eq.). Flash chromatography on silica gel 
with AcOEt / EP = 30 / 70 afforded 5-2 (76mg, 10%) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.44 (dt, 2H, J=1.4Hz, J=8.2Hz, N-COO-CH2), 4.09 
(t, 1H, J=10.6Hz, BocN-CHH), 4.01 (t, 2H, J=8.3Hz, N-COO-CH2-CH2), 3.86 (ddd, 1H, 
J=1.4Hz, J=3.8Hz, J=11.5Hz, BocN-CHH), 3.41 (m, 1H, BocN-CH2-CH), 3.01 (t, 2H, 
J=7.3Hz, CO-CH2), 2.36-2.28 (m, 1H, CO-CH2-CHH), 1.94-1.84 (m, 1H, CO-CH2-CHH), 
1.56 (d, 9H, J=1.5Hz, C(CH3)3)  
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  171.8 (CO-NCOO), 164.9 (C-NBoc), 159.9 (C-C-
C-NBoc), 155.1 (C-N-C-NBoc), 153.5 (tBuO-CO), 149.4 (NCOO-CH2), 121.2 (C-C-NBoc), 
83.8 (CMe3), 62.2 (NCOO-CH2), 52.5 (CH2-NBoc), 42.5 (N-COO-CH2-CH2), 34.7 (CH-
CH2-NBoc), 32.0 (N-CO-CH2), 28.1 (C(CH3)3), 27.1 (N-CO-CH2-CH2) 
IR (ν, cm-1, CDCl3)  2984, 2930, 1783, 1741, 1699, 1588, 1547, 1482, 1445, 1389, 1309, 
1252, 1151, 1041 
HRMS (EI+)    Calcd. for C17H20N4O5Cl2 : 430.0811      Found : 430.0824 
 
 
tert-butyl 5-chloro-7-oxo-3-(3-oxo-3-(2-oxooxazolidin-3-yl)propyl)-2,3-dihydroimidazo 
[1,2-c]pyrimidine-1(7H)-carboxylate (5-3) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-1 (1.03g, 1.86mmol, 1.0 eq.) in 
AcOEt (28ml, 0.07mmol/ml), with DLP (1.18g, 1.6 eq.). Flash chromatography on silica gel 
with AcOEt / DCM = 40 / 60 afforded 5-3 (388mg, 51%) as white solid. 
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1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.68 (br s, 1H, H-aromatic), 4.89-4.57 (m, 1H, BocN-
CH2-CH), 4.43 (t, 2H, J = 8.0 Hz, N-COO-CH2), 4.10 (dd, 1H, J = 10.8, 9.6 Hz, BocN-
CHH), 4.00 (t, 2H, J = 8.0 Hz, N-COO-CH2-CH2), 3.91 (dd, 1H, J = 11.1, 3.3 Hz, BocN-
CHH), 3.02 (t, 2H, J = 7.4 Hz, CO-CH2), 2.42 (dtd, 1H, J = 11.6, 7.3, 4.5 Hz, CO-CH2-
CHH), 2.21-2.07 (m, 1H, CO-CH2-CHH), 1.57 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 171.4 (CO-NCOO), 167.4 (C-Ar), 153.6 (tBuO-
CO), 152.9 (C-Ar), 152.3 (C-Ar), 149.2 (NCOO-CH2), 90.3 (CH-Ar), 85.6 (CMe3), 62.3 (N-
COO-CH2), 55.0 (CH-CH2-NBoc), 50.4 (CH2-NBoc), 42.5 (N-COO-CH2-CH2), 30.8 (N-CO-
CH2), 28.0 (C(CH3)3), 27.1 (N-CO-CH2-CH2) 
IR (ν, cm-1, CDCl3)  3160, 2985, 2928, 2247, 1783, 1739, 1678, 1609, 1526, 1480, 1439, 
1373, 1312, 1148, 1042, 1003   
HRMS (EI+)    Calcd. for C17H21ClN4O6 : 412.1150      Found : 412.1146       
 
 
methyl allyl(2,6-dichloropyrimidin-4-yl)carbamate (5-5) 
 
 
 
1.22g N-(but-3-en-1-yl)-2,6-dichloropyrimidin-4-amine (5.99mmol, 1.0eq.) was dissolved by 
13.0ml anhydrous THF (0.5mmol/ml), following by adding 294mg NaH (60% suspension in 
oil, 7.35mmol, 1.2eq.). Then 0.56ml methyl chloroformate (7.19 mmol, 1.2eq.) was added 
portionwise, and the mixture was strring for 1 hour. After work-up, flash chromatography on 
silica gel with DCM / EP = 60 / 40 afforded 5-5 (1.46g, 93%) as clolourless crystal. 
 
m.p. : 30-35°C 
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1H-NMR (į, ppm) (CDCl3, 400 MHz)  8.14 (s, 1H, H-aromatic), 5.87 (qd, 1H, J=5.6Hz, 
J=10.4Hz, CH2-CH=CH2), 5.21-5.16 (m, 2H, CH2-CH=CH2), 4.67 (dd, 2H, J=1.2Hz, 
J=5.6Hz, CH2-CH=CH2), 3.89 (s, 3H, CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  162.3 (CO-N-C-N), 161.7 (N-C-C-C-Cl), 159.0 
(N-C-N-C-Cl), 154.4 (CO) 132.1 (CH2-CH=CH2), 117.8 (CH2-CH=CH2), 110.0 (Cl-C-C), 
54.1 (COO-CH3), 47.8 (CH2-CH=CH2) 
IR (ν, cm-1, CDCl3)  1732, 1559, 1526, 1440, 1415, 1352, 1240, 1133 
HRMS (EI+)    Calcd. for C9H9N3O2Cl2 : 261.0072      Found : 261.0072 
 
 
methyl (4-cyano-2-((ethoxycarbonothioyl)thio)butyl)(2,6-dichloropyrimidin-4-yl) 
carbamate (5-6)  
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of methyl allyl(2,6-
dichloropyrimidin-4-yl)carbamate (874mg, 3.34mmol, 2.0 eq.) and the xanthate Xa-a 
(269mg, 1.67mmol, 1.0 eq.) in AcOEt (1.7ml, 1.0mmol/ml), with DLP (100mg, 0.15 eq.). 
Flash chromatography on silica gel with DCM 100% afforded 5-6 (516mg, 73%) as light 
yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  8.06 (s, 1H, H-aromatic), 4.61 (dq, 2H, J=3.0Hz, 
J=7.1Hz, CH2-CH3), 4.49 (dd, 1H, J=10.8Hz, J=15.8Hz, CO-N-CHH), 4.34-4.26 (m, 2H, 
CO-N-CHH + Xa-CH), 3.93 (s, 3H, CH3), 2.67-2.52 (m, 2H, CH2-CN), 2.18-1.99 (m, 2H, 
CH2-CH2-CN), 1.39 (t, 3H, J=7.1Hz, CH2-CH3) 
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13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  211.9 (C=S), 162.6 (CO-N-C-N), 161.7 (N-C-CH-
C-Cl), 158.8 (N-C-N-C-Cl), 153.9 (COOMe), 118.7 (C≡N), 110.3 (Cl-C-CH), 70.8 (CH2-
CH3), 54.4 (COO-CH3), 49.0 (Xa-CH), 47.5 (CO-N-CH2), 28.4 (Xa-CH-CH2), 15.1 (CH2-
CN), 13.7(CH2-CH3) 
IR (ν, cm-1, CDCl3)  2960, 1737, 1558, 1528, 1439, 1419, 1353, 1226, 1147, 1050 
HRMS (EI+)    Calcd. for C14H16N4O3S2Cl2 : 422.0041      Found : 422.0053 
 
 
methyl 2,4-dichloro-5-(2-cyanoethyl)-5,6-dihydropyrrolo[2,3-d]pyrimidine-7-
carboxylate (5-7) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-6 (457mg, 1.08mmol, 1.0 eq.) in 
AcOEt (16ml, 0.07mmol/ml), with DLP (516mg, 1.2 eq.). Flash chromatography on silica 
gel with Acetone / DCM = 5 / 95 afforded 5-7 (11mg, 6%) as white solid. 
 
m.p. : 182-186°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.23 (t, 1H, J=10.7Hz, CHH-N-COOMe), 3.96-3.93 
(m, 4H, CHH-N-COOMe + COOCH3), 3.59-3.52 (m, 1H, CH-CH2-N-COOMe), 2.56-2.41 
(m, 2H, CH2-CN), 2.38-2.29 (m, 1H, CHH-CH2-CN), 1.99-1.90 (m, 1H, CHH-CH2-CN) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  164.3 (MeOOC-N-C-N), 160.5 (MeOOC-N-C-C-
C), 155.6 (MeOOC-N-C-N-C), 151.3 (MeO-CO-N), 120.1 (MeOOC-N-C-C), 118.0 (C≡N), 
54.1 (N-COOCH3), 52.2 (CH2-N-COOMe), 34.5 (CH-CH2-N-COOMe), 28.2 (CH2-CH2-CN), 
14.7 (CH2-CN) 
IR (ν, cm-1, CDCl3)  2929, 2247, 1725, 1592, 1547, 1484, 1443, 1314, 1251, 1126 
HRMS (EI+)    Calcd. for C11H10N4O2Cl2 : 300.0181      Found : 300.0178 
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methyl 5-chloro-3-(2-cyanoethyl)-7-oxo-2,3-dihydroimidazo[1,2-c]pyrimidine-1(7H)-
carboxylate (5-8) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-6 (457mg, 1.08mmol, 1.0 eq.) in 
AcOEt (16ml, 0.07mmol/ml), with DLP (516mg, 1.2 eq.). Flash chromatography on silica 
gel with Acetone / DCM = 30 / 70 afforded 5-8 (86mg, 29%) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.77 (br s, 1H, H-aromatic), 4.73 (ddd, 1H, J = 11.4, 
7.5, 3.6 Hz, CH), 4.28 (t, 1H, J = 10.4 Hz, N-CHH), 4.09 (dd, 1H, J = 11.3, 3.9 Hz, N-CHH), 
3.94 (s, 3H, CH3), 2.82-2.33 (m, 3H, CH2-CN + CHH-CH2-CN), 2.19-2.14 (m, 1H, CHH-
CH2-CN) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 168.1 (C-Ar), 152.6 (C-Ar), 152.0 (C-Ar), 150.8 
(MeO-CO-N), 118.1 (C≡N), 90.6 (CH-Ar), 55.0 (CH-CH2-N), 54.6 (CH3), 50.0 (CH2-N), 
27.9 (CH2-CH2-CN), 13.5 (CH2-CN) 
IR (ν, cm-1, CDCl3)  3157, 2961, 2250, 1754, 1681, 1611, 1524, 1449, 1382, 1313, 1277, 
1209, 1163, 1053   
HRMS (EI+)    Calcd. for C11H11ClN4O3 : 282.0520      Found : 282.0508       
 
 
 
 
 
 
 
Experimental Part 
 362
N-allyl-N-(2,6-dichloropyrimidin-4-yl)methanesulfonamide (5-12) 
 
 
 
1.30g N-(but-3-en-1-yl)-2,6-dichloropyrimidin-4-amine (6.36mmol, 1.0eq.) was dissolved by 
13.0ml anhydrous THF (0.5mmol/ml), following by adding 310mg NaH (60% suspension in 
oil, 7.75mmol, 1.2eq.). Then 0.59ml methanesulfonyl chloride (7.63 mmol, 1.2eq.) was 
added portionwise, and the mixture was strring for 1 hour. After work-up, flash 
chromatography on silica gel with DCM / EP = 80 / 20 afforded 5-12 (1.64g, 91%) as white 
solid. 
 
m.p. : 61-65°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.29 (s, 1H, H-aromatic), 5.92 (qd, 1H, J=5.6Hz, 
J=10.3Hz, CH2-CH=CH2), 5.35 (dd, 1H, J=13.8Hz, J=19.1Hz, CH2-CH=CH2), 4.63 (dd, 1H, 
J=1.2Hz, J=5.6Hz, CH2-CH=CH2), 3.29 (s, 3H, CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  162.6 (Ms-N-C-N), 161.2 (N-C-CH-C-Cl), 159.6 
(N-C-N-C-Cl), 130.9 (CH2-CH=CH2), 119.8 (CH2-CH=CH2), 106.8 (Cl-C-CH), 49.4 (CH2-
CH=CH2), 42.3 (C-SO2) 
IR (ν, cm-1, CDCl3)  3141, 2257, 1555, 1528, 1428, 1402, 1369, 1321, 1288, 1257, 1170, 
1133 
HRMS (EI+)    Calcd. for C8H9N3Cl2SO2 : 280.9793      Found : 280.9807 
 
 
 
 
 
 
Experimental Part 
 363 
N-allyl-2,6-dichloro-N-methylpyrimidin-4-amine (5-13) 
 
 
 
1.51g N-(but-3-en-1-yl)-2,6-dichloropyrimidin-4-amine (7.40mmol, 1.0eq.) was dissolved by 
15.0ml anhydrous THF (0.5mmol/ml), following by adding 355mg NaH (60% suspension in 
oil, 8.88mmol, 1.2eq.). Then 0.55ml iodomethane (8.88 mmol, 1.2eq.) was added 
portionwise, and the mixture was strring for 4 hours. After work-up, flash chromatography 
on silica gel with DCM / EP = 60 / 40 afforded 5-13 (1.34g, 83%) as colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.32 (s, 1H, H-aromatic), 5.77 (ddd, 1H, J=5.3Hz, 
J=10.4Hz, J=22.3Hz, CH2-CH=CH2), 5.20 (dd, 1H, J=13.6Hz, J=34.1Hz, CH2-CH=CH2), 
4.12 (br d, 1H, J=115.3Hz, CH2-CH=CH2), 3.07 (br d, 1H, J=61.1Hz, CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  163.4 (Me-N-C-N), 160.0 (N-C-CH-C-Cl), 159.6 
(N-C-N-C-Cl), 131.9 (CH2-CH=CH2), 117.8 (CH2-CH=CH2), 99.7 (Cl-C-C), 52.1 (CH2-
CH=CH2), 35.5 (CH3) 
IR (ν, cm-1, CCl4)  2932, 1644, 1575, 1530, 1497, 1421, 1302, 1195, 1127, 1014, 969 
HRMS (EI+)    Calcd. for C8H8N3Cl2 : 217.0174      Found : 217.0179 
 
 
 
 
 
 
 
 
 
Experimental Part 
 364
S-1-(N-(2,6-dichloropyrimidin-4-yl)-N-methanesulfonylamino)-4-cyanobutan-2-yl O-
ethyl carbonodithioate (5-14) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of N-allyl-N-(2,6-
dichloropyrimidin-4-yl)methanesulfonamide (821mg, 2.91mmol, 2.0 eq.) and the xanthate 
Xa-a (235mg, 1.45mmol, 1.0 eq.) in AcOEt (1.5ml, 1.0mmol/ml), with DLP (87mg, 0.15 
eq.). Flash chromatography on silica gel with AcOEt / EP = 35 / 65 afforded 5-14 (476mg, 
74%) as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.53 (s, 1H, H-aromatic), 4.64 (dq, 2H, J=1.0Hz, 
J=7.1Hz, CH2-CH3), 4.35 (ddd, 2H, J=7.4Hz, J=14.7Hz, J=21.2Hz, Ms-N-CH2), 4.21 (m, 1H, 
Xa-CH), 3.24 (s, 3H, CH3), 2.60 (m, 2H,), 2.25-2.17 (m, 1H, CHH-CH2-CN), 2.08-1.98 (m, 
1H, CHH-CH2-CN), 1.41 (t, 3H, J=7.1Hz, CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  211.2 (C=S), 163.0 (Ms-N-C-N), 160.7 (N-C-CH-
C-Cl), 159.7 (N-C-N-C-Cl), 118.6 (C≡N), 108.0 (Cl-C-CH), 71.1 (CH2-CH3), 48.8 (Ms-N-
CH2), 48.6 (Xa-CH) 41.0 (C-SO2), 27.9 (Xa-CH-CH2), 15.0 (CH2-CN), 13.7 (CH2-CH3) 
IR (ν, cm-1, CCl4)  2931, 1555, 1529, 1375, 1317, 1229, 1172, 1050 
HRMS (EI+)    Calcd. for C13H16O3S3Cl2N4 : 441.9762      Found : 441.9778 
 
 
 
 
 
Experimental Part 
 365 
S-1-(N-(2,6-dichloropyrimidin-4-yl)-N-methylamino)-4-cyanobutan-2-yl O-ethyl 
carbonodithioate (5-15) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of N-allyl-2,6-dichloro-
N-methylpyrimidin-4-amine (1.34g, 6.14mmol, 2.0 eq.) and the xanthate Xa-a (506mg, 
3.14mmol, 1.0 eq.) in AcOEt (3.2ml, 1.0mmol/ml), with DLP (188mg, 0.15 eq.). Flash 
chromatography on silica gel with AcOEt / EP = 25 / 75 afforded 5-15 (1.10g, 92%) as light 
yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.39 (s, 1H, H-aromatic), 4.66 (dq, 2H, J=3.4Hz, 
J=7.1Hz, CH2-CH3), 4.27 (s, 1H, Me-N-CHH), 4.13 (s, 1H, Xa-CH), 3.64 (s, 1H, Me-N-
CHH), 3.13 (s, 3H, CH3), 2.71-2.51 (m, 2H, CH2-CN), 2.08-1.96 (m, 2H, CH2-CH2-CN), 
1.43 (dt, 1H, J=3.4Hz, J=7.1Hz, CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  211.9 (C=S), 163.7 (Me-N-C-N), 160.6 (N-C-CH-
C-Cl), 159.5 (N-C-N-C-Cl), 118.7 (C≡N), 99.8 (Cl-C-CH), 70.9 (CH2-CH3), 51.9 (Me-N-
CH2), 48.3 (Xa-CH), 36.8 (N-CH3), 27.4 (Xa-CH-CH2), 15.1 (CH2-CN), 13.7 (CH2-CH3) 
IR (ν, cm-1, CDCl3)  2939, 2244, 1574, 1531, 1498, 1425, 1382, 1298, 1227, 1126, 1051, 
1014 
HRMS (EI+)    Calcd. for C13H16N4OS2Cl2 : 378.01427      Found : 378.01370 
 
 
 
 
Experimental Part 
 366
tert-butyl 2,4-dichloro-5-(2-cyanoethyl)-5,6-dihydropyrrolo[2,3-d]pyrimidine-7-
carboxylate (5-16) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-10 (935mg, 2.01mmol, 1.0 eq.) 
in AcOEt (30ml, 0.07mmol/ml), with DLP (1.28g, 1.6 eq.). Flash chromatography on silica 
gel with AcOEt / EP = 25 / 75 afforded 5-16 (65mg, 9%) as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.18 (dd, 1H, J=9.8Hz, J=11.7Hz, CHH-NBoc), 3.86 
(dd, 1H, J=4.0Hz, J=11.7Hz, CHH-NBoc), 3.51 (tt, 1H, J=3.8Hz, J=9.5Hz, CH-CH2-NBoc), 
2.55-2.40 (m, 2H, CH2-CN), 2.36-2.28 (m, 1H, CHH-CH2-CN), 1.99-1.90 (m, 1H, CHH-
CH2-CN), 1.57 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  164.8 (BocN-C-N), 160.5 (BocN-C-C-C), 155.2 
(BocN-C-N-C), 149.2 (tBuO-CO-N), 119.8 (BocN-C-C), 118.1 (C≡N), 84.2 (CMe3), 52.1 
(CH2-NBoc), 34.4 (CH-CH2-NBoc), 28.2 (CH2-CH2-CN), 28.0 (C(CH3)3), 14.6 (CH2-CN) 
IR (ν, cm-1, CDCl3)  2929, 2856, 1712, 1588, 1546, 1484, 1444, 1311, 1251, 1151 
HRMS (EI+)    Calcd. for C14H16N4O2Cl2 : 342.0650      Found : 342.0641 
 
 
 
 
 
 
 
Experimental Part 
 367 
tert-butyl 3-(2-cyanoethyl)-5,7-dioxo-2,3,6,7-tetrahydroimidazo[1,2-c]pyrimidine-1(5H)-
carboxylate (5-18’) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-10 (935mg, 2.01mmol, 1.0 eq.) 
in AcOEt (30ml, 0.07mmol/ml), with DLP (1.28g, 1.6 eq.). Flash chromatography on silica 
gel with Acetone / EP = 30 / 70 afforded 5-17247 (216mg, 33%) as light yellow oil, and with 
Acetone / EP = 40 / 60 gave 5-18’ (115mg, 18%) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  9.44 (s, 1H, NH), 5.95 (s, 1H, CO-CH), 4.57 (tdd, 1H, 
J = 8.6, 7.4, 3.7 Hz, CH-CH2-NBoc), 4.10 (dd, 1H, J = 11.2, 9.0 Hz, CHH-NBoc), 3.88 (dd, 
1H, J = 11.3, 3.3 Hz, CHH-NBoc), 2.58-2.44 (m, 2H, CH2-CN), 2.42-2.30 (m, 1H, CHH-
CH2-CN), 2.19-2.10 (m, 1H, CHH-CH2-CN), 1.55 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 165.1 (C-NBoc), 149.6 (CO), 149.5 (CO), 148.5 
(CO), 118.2 (C≡N), 85.3 (CMe3), 83.3 (CH-Ar), 52.6 (CH-CH2-NBoc), 49.9 (CH2-NBoc), 
28.6 (CH2-CH2-CN), 28.0 (C(CH3)3), 13.4 (CH2-CN) 
IR (ν, cm-1, CDCl3)  3400, 2984, 2934, 1719, 1678, 1638, 1534, 1456, 1372, 1321, 1148, 
1016 
MS (NH3 ionisation) 307 (MH+) 
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 N-cyclized product 5-17 has been characterized in the reported work of: Laot, Y.; Petit, L.; Zard, S. Z. Chem. 
Commun. 2010, 46, 5784-5786. 
Experimental Part 
 368
3-(2,4-dichloro-6,7-dihydro-7-methanesulfonyl-5H-pyrrolo[2,3-d]pyrimidin-5-yl) 
propanenitrile (5-21) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-12 (436mg, 0.98mmol, 1.0 eq.) 
in AcOEt (15ml, 0.07mmol/ml), with DLP (549mg, 1.4 eq.). Flash chromatography on silica 
gel with AcOEt / EP = 30 / 70 afforded 5-21 (113mg, 36%) as white solid. 
 
m.p. : 182-186°C 
1H-NMR (į, ppm) (DεSO, 400 εHz)  4.22 (dt, 1H, J=2.0Hz, J=10.1Hz, CHH-NMs), 3.99 
(ddd, 1H, J=2.1Hz, J=3.9Hz, J=10.2Hz, CHH-NMs), 3.59-3.54 (m, 1H, CH-CH2-NMs), 3.37 
(d, 3H, J=2.2Hz, SO2-CH3), 2.66 (t, 2H, J=7.7Hz, CH2-CN), 2.15-1.92 (m, 2H, CH2-CH2-CN) 
13C-NMR (į, ppm) (DεSO, 100.6 εHz)  164.8 (εsN-C-N), 157.6 (MsN-C-C-C), 153.8 
(MsN-C-N-C), 121.4 (MsN-C-C), 120.2 (C≡N), 53.0 (CH2-NMs), 39.1 (SO2-CH3), 34.6 
(CH-CH2-NMs), 26.8 (CH2-CH2-CN), 13.4 (CH2-CN) 
IR (ν, cm-1, Nujol)  2925, 1588, 1548, 1456, 1377, 1166, 1038 
HRMS (EI+)    Calcd. for C10H10N4O2SCl2 : 319.9902      Found : 319.9897 
 
 
 
 
 
 
 
Experimental Part 
 369 
3-(2,4-dichloro-6,7-dihydro-7-methyl-5H-pyrrolo[2,3-d]pyrimidin-5-yl)propanenitrile 
(5-22) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-15 (594mg, 1.56mmol, 1.0 eq.) 
in AcOEt (24ml, 0.07mmol/ml), with DLP (624mg, 1.0 eq.). Flash chromatography on silica 
gel with AcOEt / EP = 40 / 60 afforded 5-22 (220mg, 54%) as a white solid. 
 
m.p. : 84-87°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  3.85 (t, 1H, J=9.7Hz, CHH-NMe), 3.56-3.46 (m, 2H, 
CH-CH2-NMe + CHH-NMe), 3.01 (s, 3H, N-CH3), 2.51-2.23 (m, 3H, CH2-CN + CHH-CH2-
CN), 2.03-1.94 (m, 1H, CHH-CH2-CN) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  168.0 (MeN-C-N), 160.2 (MeN-C-C-C), 151.4 
(MeN-C-N-C), 118.5 (MeN-C-C), 116.6 (C≡N), 56.4 (CH2-NMe), 35.6 (CH-CH2-NMe), 
31.2 (N-CH3), 28.1 (CH2-CH2-CN), 14.5 (CH2-CN) 
IR (ν, cm-1, CDCl3)  2929, 2256, 1607, 1533, 1415, 1341, 1286, 1011 
HRMS (EI+)    Calcd. for C10H10N4Cl2 : 256.0283      Found : 256.0274 
 
 
 
 
 
 
 
Experimental Part 
 370
S-1-(2,6-dichloropyrimidin-4-ylamino)-4-(1,3-dioxoisoindolin-2-yl)butan-2-yl O-ethyl 
carbonodithioate (5-24) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of N-allyl-2,6-
dichloropyrimidin-4-amine (274mg, 1.34mmol, 2.0 eq.) and the xanthate Xa-c (190mg, 
0.67mmol, 1.0 eq.) in AcOEt (0.7ml, 1.0mmol/ml), with DLP (53mg, 0.20 eq.). Flash 
chromatography on silica gel with AcOEt / EP = 20 / 80 afforded 5-24 (210mg, 64%) as a 
light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.91-7.79 (m, 2H, 2 H-phthalimide), 7.76-7.70 (m, 
2H, 2 H-phthalimide), 6.38 (br s, 1H, CH-Ar), 5.80 (br s, 1H, NH), 4.61 (q, J = 7.1 Hz, 2H, 
OCH2CH3), 4.04-3.92 (m, 1H, CH), 3.88 (t + br s, J = 6.9 Hz, 4H, CH2-phthalimide + 
CH2NH), 2.24-2.11 (m, 1H, CHCHH), 2.11-1.99 (m, 1H, CHCHH), 1.38 (t, J = 7.1 Hz, 3H, 
OCH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  212.9 (C=S), 168.3 (2 CO-phthalimide), 164.1 (C-
Ar), 159.9 (C-Ar), 158.7 (C-Ar), 134.2 (2 CH-phthalimide), 131. 9 (2 C-phthalimide), 123.4 
(2 CH-phthalimide), 102.7 (CH-Ar), 70.7 (OCH2CH3), 47.8 (CH), 44.4 (CH2NH), 35.4 (CH2-
Nphthalimide),  30.5(CH2-CH2-Nphthalimide), 13.7 (OCH2CH3) 
IR (ν, cm-1, CCl4)  2926, 1775, 1720, 1581, 1495, 1436, 1395, 1373, 1269, 1227, 1121, 971 
HRMS (EI+)    Calcd. for C16H13Cl2N4O2 : 363.0416      Found : 363.0413 
 
 
 
Experimental Part 
 371 
2-((4-(allylamino)-2,6-dichloropyrimidin-5-yl)methyl)isoindoline-1,3-dione (5-24’) 
 
 
 
In the same procedure for preparing 5-24, a second product was isolated by flash 
chromatography with AcOEt / EP = 30 / 70 afforded 5-24’ (8.3mg, 4%) as a white solid. 
 
m.p. : 195-199°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.87 (dd, J = 4.9, 3.3 Hz, 2H, 2 H-phthalimide), 7.77 
(dd, J = 5.1, 3.1 Hz, 2H, 2 H-phthalimide), 7.01 (br s, 1H, NH), 5.96-5.85 (m, 1H, CH2=CH), 
5.25 (d, 1H, J=17.1Hz, CHH=CH), 5.19 (d, 1H, J=10.3Hz, CHH=CH), 4.87 (s, 2H, CH2-
Nphthalimide), 4.10 (dd, J = 5.2, 5.2 Hz, 2H, CH2-NH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 168.6 (2 CO-phthalimide), 162.4 (C-Ar), 160.1 (C-
Ar), 159.2 (C-Ar), 134.7 (2 CH-phthalimide), 133.0 (CH2=CH), 131.5 (2 C-phthalimide), 
123.8 (2 CH-phthalimide), 117.4 (CH2=CH), 107.2 (CH-Ar), 44.4 (CH2NH), 34.5 (CH2-
Nphthalimide) 
IR (ν, cm-1, CCl4)  3333, 2927, 2855, 1776, 1716, 1563, 1489, 1469, 1414, 1393, 1370, 1345, 
1322, 1273, 1133, 1077, 929 
HRMS (EI+)    Calcd. for C16H12Cl2N4O2 : 362.0337      Found : 362.0337 
 
 
 
 
 
 
 
Experimental Part 
 372
S-1-(5-(Phthalimidyl-methyl)-2,6-dichloropyrimidin-4-ylamino)-4-(1,3-dioxoisoindolin-
2-yl)butan-2-yl O-ethyl carbonodithioate (5-24”) 
 
 
 
In the same procedure for preparing 5-24, a third product was isolated by flash 
chromatography on silica gel with AcOEt / EP = 50 / 50 afforded 5-24” (7.1mg, 2%) as a 
yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.94-7.82 (m, 4H, 4 H-phthalimide), 7.82-7.72 (m, 
4H, 4 H-phthalimide), 7.27 (t, J = 5.4 Hz, 1H, NH), 4.90 (s, 2H, CH2-Ar), 4.55 (q, J = 7.1 
Hz, 2H, CH2CH3), 4.16-4.01 (m, 1H, CH), 3.98-3.83 (m, 4H, CH2-Nphthalimide + CH2-NH), 
2.29-2.16 (m, 1H, CHCHH), 2.11-1.99 (m, 1H, CHCHH), 1.36 (t, J = 7.1 Hz, 3H, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  212.4 (C=S), 168.7 (2 CO-phthalimide), 168.2 (2 
CO-phthalimide), 162.8 (C-Ar), 160.3 (C-Ar), 159.0 (C-Ar), 134.6 (2 CH-phthalimide), 
134.0 (2 CH-phthalimide), 132.0 (2 C-phthalimide), 131.6 (2 C-phthalimide), 123.8 (2 CH-
phthalimide), 123.3 (2 CH-phthalimide), 107.5 (CH2C-Ar), 70.2 (CH2CH3), 47.0 (CH), 44.8 
(CH2-NH), 35.6 (CH2-Nphthalimide), 34.4 (CH2-Ar), 30.2 (CHCH2), 13.6 (CH3) 
IR (ν, cm-1, CCl4)  3333, 2982, 2936, 1775, 1715, 1580, 1563, 1497, 1393, 1359, 1323, 1273, 
1224, 1112, 1051 
HRMS (EI+)    Calcd. for C25H18Cl2N5O4 : 522.0736      Found : 522.0725 
 
 
 
 
 
Experimental Part 
 373 
S-1-(2,6-dichloropyrimidin-4-ylamino)-4-cyanobutan-2-yl O-ethyl carbonodithioate (5-
25) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of N-allyl-2,6-
dichloropyrimidin-4-amine (285mg, 1.40mmol, 2.0 eq.) and the xanthate Xa-a (114mg, 
0.71mmol, 1.0 eq.) in AcOEt (0.7ml, 1.0mmol/ml), with DLP (42mg, 0.15 eq.). Flash 
chromatography on silica gel with AcOEt / EP = 30 / 70 afforded 5-25 (237mg, 91%) as a 
colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.36 (s, 1H, H-Ar), 5.53 (br s, 1H, NH), 4.67 (q, J = 
7.1 Hz, 2H, CH2-CH3), 4.11-4.05 (m, 1H, CH), 3.76 (br s, 2H, NH-CH2), 2.83-2.46 (m, 2H, 
CH2-CN), 2.23-2.14 (m, 1H, CHH-CH2-CN), 2.04-1.94 (m, 1H, CHH-CH2-CN), 1.44 (t, J = 
7.1 Hz, 3H, CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  211.9 (C=S), 164.1 (C-Ar), 160.1 (C-Ar), 159.2 
(C-Ar), 118.6 (CN), 102.6 (CH-Ar), 71.1 (CH2-CH3), 49.8 (CH), 44.3 (NH-CH2), 27.6 (Xa-
CH-CH2), 15.1 (CH2-CN), 13.7 (CH2-CH3) 
IR (ν, cm-1, CCl4)  2926, 1578, 1495, 1266, 1233, 1196, 1124, 1052, 970 
HRMS (EI+)    Calcd. for C12H14Cl2N4OS2 : 363.9986      Found : 363.9989 
 
 
 
 
 
 
 
Experimental Part 
 374
2-(2-(2,4-dichloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)isoindoline-1,3-
dione (5-26) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-24 (173mg, 0.36mmol, 1.0 eq.) 
in AcOEt (7.0ml, 0.05mmol/ml), with DLP (142mg, 1.0 eq.). Flash chromatography on silica 
gel with AcOEt / EP = 50 / 50 afforded 5-26 (14mg, 11%) as a white powder. 
 
m.p. : 248-251°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.97-7.79 (m, 2H, H-phthalimide), 7.77-7.71 (m, 2H, 
H-phthalimide), 5.65 (br s, 1H, NH), 3.98 (dd, J = 9.9, 9.9 Hz, 1H, NH-CHH), 3.87-3.74 (m, 
2H, CH2-Nphthalimide), 3.70 (dd, J = 10.2, 4.6 Hz, 1H, NH-CHH), 3.50-3.42 (m, 1H, CH), 
2.48-2.29 (m, 1H, CH-CHH), 2.01-1.91 ( m, 1H, CH-CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  169.8 (C-Ar), 168.3 (2CO-phthalimide), 159.3 (C-
Ar), 152.3 (C-Ar), 134.3 (2CH-phthalimide), 131.9 (2C-phthalimide), 123.5 (2CH-phtha-
limide), 117.2 (C-Ar), 49.3 (NH-CH2), 35.8 (CH), 34.9 (CH2-Nphthalimide), 30.9 (CH2-CH) 
IR (ν, cm-1, CCl4) 3643, 2927, 2854, 1773, 1717, 1581, 1468, 1395, 1363, 1264, 1121, 1022 
HRMS (EI+)    Calcd. for C16H12Cl2N4O2 : 362.0337      Found : 362.0329 
 
 
 
 
 
 
 
 
Experimental Part 
 375 
2-(4-(2,6-dichloropyrimidin-4-ylamino)butyl)isoindoline-1,3-dione (5-26’) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-24 (173mg, 0.356mmol, 1.0 eq.) 
in AcOEt (7.0ml, 0.05mmol/ml), with DLP (142mg, 1.0 eq.). Flash chromatography on silica 
gel with AcOEt / EP = 30 / 70 afforded 5-26’ (36mg, 28%) as a white powder. 
 
m.p. : 152-155°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.96-7.85 (m, 2H, 2 CH-phthalimide), 7.80-7.74 (m, 
2H, 2 CH-phthalimide), 6.34 (s, 1H, CH-Ar), 6.09-5.37 (br d, 1H, NH), 3.78 (t, J = 6.9 Hz, 
2H, CH2-Nphthalimide), 3.65-3.25 (br d, 2H, NH-CH2), 1.89-1.77 (m, 2H, CHH + CHH), 
1.77-1.65 (m, 2H, CHH + CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 168.5 (2 CO-phthalimide), 164.1 (C-Ar), 159.9 (C-
Ar), 158.6 (C-Ar), 134.1 (2 CH-phthalimide), 131.9 (2 C-phthalimide), 123.3 (2 CH-
phthalimide), 100.5 (CH-Ar), 41.3 (NH-CH2), 37.2 (CH2-Nphthalimide), 26.0 (2 CH2) 
IR (ν, cm-1, CCl4)  2928, 1770, 1712, 1581, 1498, 1434, 1394, 1353, 1267, 1215, 1121, 1048, 
989, 963 
HRMS (EI+)    Calcd. for C16H14Cl2N4O2 : 364.0494      Found : 364.0502 
 
 
 
 
 
 
 
Experimental Part 
 376
3-(2,4-dichloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-5-yl)propanenitrile (5-27) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-25 (127mg, 0.35mmol, 1.0 eq.) 
in AcOEt (7.0ml, 0.05mmol/ml), with DLP (139mg, 1.0 eq.). Flash chromatography on silica 
gel with AcOEt / EP = 70 / 30 afforded 5-27 (11mg, 13%) as a white powder. 
 
m.p. : 175-179°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.92 (br s, 1H, NH), 3.97 (dd, J = 9.3, 9.3 Hz, 1H, 
NH-CHH), 3.68-3.51 (m, 2H, CH + NH-CHH), 2.53-2.42 (m, 2H, CH2-CN), 2.35-2.25 (m, 
1H, CH-CHH), 2.08-1.97 (m, 1H, CH-CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 169.8 (C-Ar), 159.7 (C-Ar), 152.7 (C-Ar), 118.5 
(CN), 116.4 (C-Ar), 49.2 (NH-CH2), 37.0 (CH), 28.1 (CH2-CH), 14.6 (CN-CH2) 
IR (ν, cm-1, CCl4)  3645, 2926, 2854, 1602, 1464, 1264, 1021 
HRMS (EI+)    Calcd. for C9H8Cl2N4 : 242.0126      Found : 242.0132 
 
 
5-(2,6-dichloropyrimidin-4-ylamino)pentanenitrile (5-27’) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-25 (127mg, 0.35mmol, 1.0 eq.) 
Experimental Part 
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in AcOEt (7.0ml, 0.05mmol/ml), with DLP (139mg, 1.0 eq.). Flash chromatography on silica 
gel with AcOEt / EP = 30 / 70 afforded 5-27’ (34mg, 40%) as a white powder. 
 
m.p. : 102-105°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.29 (s, 1H, CH-Ar), 6.04-5.13 (br s, 1H, NH), 3.82-
2.97 (br s, 2H, NH-CH2), 2.44 (t, J = 6.6 Hz, 2H, CH2-CN), 1.82-1.71 ( m, 4H, CH2 + CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 164.2 (C-Ar), 160.0 (C-Ar), 157.1 (C-Ar), 119.2 
(CN), 102.4 (CH-Ar), 40.4 (NH-CH2), 28.2 (CH2), 22.6 (CH2), 16.9 (CN-CH2) 
IR (ν, cm-1, CCl4)    3253, 2926, 2854, 1718, 1579, 1496, 1454, 1373, 1264, 1216, 1132, 
1108, 988 
HRMS (EI+)    Calcd. for C9H10Cl2N4 : 244.0283      Found : 244.0282 
 
 
N-(but-3-enyl)-2,6-dichloropyrimidin-4-amine (5-28) 
 
 
 
1.40g trichloropyrimidine (7.61mmol, 1.2 eq.) was dissolved by 6.5ml EtOH and 1.8ml TEA 
(12.6mmol, 2eq.) was added. Then 669mg butenylamine hydrochloride (6.22mmol, 1eq.) in 
6ml EtOH was added drop by drop during 30min. After 4 hours the reaction was terminated. 
After work-up, flash chromatography on silica gel with AcOEt / DCM = 1/ 99 afforded 5-28 
(913mg, 67%248) as colorless oil. 
 
1H-NMR (į, ppm) (MeOD, 400 MHz)  6.53 (NH), 6.41 (s, 1H, H-aromatic), 5.88-5.76 (m, 
CH2-CH=CH2), 5.12-5.04 (m, 2H, CH2-CH=CH2), 3.45 (t, 2H, J=6.5Hz, NH-CH2), 2.34-2.29 
(m, CH2-CH=CH2) 
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 The modest yield is due to the competing substitution at the 2-position (33%) of 2,4,6-trichloropyrimidine.  
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13C-NMR (į, ppm) (εeOD, 100.6 εHz) 165.9 (NH-C-N), 161.2 (NH-C-CH-C-Cl), 158.8 
(NH-C-N-C-Cl), 136.5 (CH2-CH=CH2), 117.3 (CH2-CH=CH2), 103.6 (Cl-C-CH), 41.4 (NH-
CH2), 34.4 (CH2-CH=CH2) 
IR (ν, cm-1, CDCl3)    3417, 2938, 1583, 1541, 1497, 1383, 1339, 1270, 1201, 1121, 995, 970   
HRMS (EI+)    Calcd. for C8H9Cl2N3 : 217.0174      Found : 217.0165       
 
 
 
N-(but-3-en-1-yl)-4,6-dichloropyrimidin-2-amine (5-28’) 
 
 
 
1.40g trichloropyrimidine (7.61mmol, 1.2 eq.) was dissolved by 6.5ml EtOH and 1.8ml TEA 
(12.6mmol, 2eq.) was added. Then 669mg butenylamine hydrochloride (6.22mmol, 1eq.) in 
6ml EtOH was added drop by drop during 30min. After 4 hours the reaction was terminated. 
After work-up, flash chromatography on silica gel with AcOEt / DCM = 3 / 97 afforded 5-
28’ (459mg, 33%) as white crystal. 
 
m.p. : 65~68°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.59 (s, 1H, H-aromatic), 5.84-5.73 (m, CH2-
CH=CH2), 5.40 (NH), 5.16-5.10 (m, 2H, CH2-CH=CH2), 3.52-3.48 (m, 2H, NH-CH2), 2.38-
2.29 (m, CH2-CH=CH2) 
13C-NMR (į, ppm) (εeOD, 100.6 εHz)  161.6 (2 C-Cl), 134.8 (CH2-CH=CH2), 117.7 
(CH2-CH=CH2), 109.0 (Cl-C-CH), 40.7 (NH-CH2), 33.4 (CH2-CH=CH2) 
 
 
 
 
Experimental Part 
 379 
2,6-dichloro-N-(pent-4-enyl)pyrimidin-4-amine (5-29) 
 
 
 
2.25g trichloropyrimidine (12.3mmol, 1.0 eq.) was dissolved by 62ml EtOH and 1.8ml TEA 
(13.2mmol, 1.1 eq.) was added. Then a solution of pentenylamine hydrochloride249 (43ml, 
0.30mol/ml, 12.9mmol, 1.1eq.) was added drop by drop during 30min. After 5 hours the 
reaction was terminated. After work-up, flash chromatography on silica gel with DCM / EP = 
60 / 40 afforded 5-29 (1.73g, 61%) as a light yellow oil.  
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.26 (s, 1H, H-Ar), 5.84-5.72 (m, 1H, CH2-CH=CH2), 
5.65 (br s, 1H, NH), 5.06 (d, 1H, J=16.9Hz, CH2-CH=CHH), 5.03 (d, 1H, J=8.8Hz, CH2-
CH=CHH), 3.43 (br s, 1H, NH-CHH), 3.24 (br s, 1H, NH-CHH), 2.14 (dt, J = 6.9 Hz, 2H, 
CH2-CH=CH2), 1.72 (tt, J = 7.2 Hz, 2H, NH-CH2-CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 164.2 (C-Ar), 160.7 (C-Ar), 159.9 (C-Ar), 136.9 
(CH2-CH=CH2), 116.0 (CH2-CH=CH2), 98.5 (CH-Ar), 41.2 (NH-CH2), 30.8 (CH2-CH=CH2), 
28.0 (NH-CH2-CH2) 
IR (ν, cm-1, CCl4)  3424, 3263, 2935, 1575, 1495, 1438, 1361, 1269, 1194, 1121, 974, 919 
HRMS (EI+)    Calcd. for C9H11Cl2N3 : 231.0330     Found : 231.0326 
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Experimental Part 
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S-1-(2,6-dichloropyrimidin-4-ylamino)-5-(1,3-dioxoisoindolin-2-yl)pentan-3-yl O-ethyl 
carbonodithioate (5-30) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-28 (95mg, 
0.44mmol, 0.67 eq.) and the xanthate Xa-c (184mg, 0.66mmol, 1.0 eq.) in AcOEt (0.5ml, 
1.3mmol/ml), with DLP (42mg, 0.20 eq.). Flash chromatography on silica gel with AcOEt / 
EP = 30 / 70 afforded 5-30 (128mg, 59%) as a colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.89-7.85 (m, 2H, H-phthalimide), 7.78-7.74 (m, 2H, 
H- phthalimide), 6.51-6.29 (br s, 1H, H-Ar), 5.84 (br s, 1H, NH), 4.58-4.43 (m, 2H, CH2CH3), 
3.88-3.78 (m, 2H, CH2- phthalimide), 3.67 (br s, 1H, CH), 3.60 (br s, H, CHH-NH), 3.41 (br 
s, H, CHH-NH), 2.37-2.13 (m, 2H, 2 CH-CHH), 2.06-1.95 (m, 1H, CHH-CH2-phthalimide), 
1.92-1.80 (m, 1H, CHH-CH2NH), 1.33 (t, J = 7.1 Hz, 3H, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  214.3 (CS), 168.8 (2 CO-phth), 164.2 (C-Ar), 
160.1 (C-Ar), 158.4 (C-Ar), 134.3  (2 CH-phth), 131.9 (2 C-phth), 123.4 (2 CH-phth), 103.0 
(CH-Ar), 70.5 (CH2CH3), 45.5 (CH2NH), 38.3 (CH), 35.3 (CH2-phth), 35.0 (CH2-CH2phth), 
31.6 (CH2-CH2NH), 13.7 (CH2CH3) 
IR (ν, cm-1, CCl4)   3370, 2941, 1774, 1712, 1583, 1496, 1470, 1442, 1397, 1357, 1269, 1223, 
1118, 1052, 1004, 970, 908 
HRMS (EI+)    Calcd. for C17H15Cl2N4O2 : 377.0572      Found : 377.0560       
 
 
 
 
Experimental Part 
 381 
S-1-(2,6-dichloropyrimidin-4-ylamino)-5-cyanopentan-3-yl O-ethyl carbonodithioate (5-
31) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-28 (116mg, 
0.53mmol, 0.67 eq.) and the xanthate Xa-a (129mg, 0.80mmol, 1.0 eq.) in AcOEt (0.7ml, 
1.1mmol/ml), with DLP (48mg, 0.15 eq.). Flash chromatography on silica gel with AcOEt / 
EP = 30 / 70 afforded 5-31 (161mg, 80%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.30 (s, 1H, H-Ar), 6.05-5.33 (br s, 1H, NH), 4.84-
4.62 (m, 2H, CH2CH3), 4.06-3.90 (m, 1H, CH), 3.75 (br s, 1H, CHHNH), 3.47 (br s, 1H, 
CHHNH), 2.73-2.45 (m, 2H, CH2CN), 2.34-1.86 (m, 4H, 2 CH2), 1.44 (t, J = 7.1 Hz, 3H, 
CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.6 (CS), 164.0 (C-Ar), 160.1 (C-Ar), 158.2 (C-
Ar), 118.8 (CN), 102.9 (CH-Ar), 71.1 (CH2CH3), 48.0 (CH), 38.6 (CH2NH), 33.8 (CH2), 
30.7 (CH2), 15.0 (CH2CN), 13.8 (CH2CH3) 
IR (ν, cm-1, CCl4)    2928, 1581, 1544, 1497, 1441, 1365, 1271, 1225, 1122, 1054, 971 
HRMS (EI+)    Calcd. for C13H16Cl2N4OS2 : 378.0143      Found : 378.0125       
 
 
 
 
 
 
 
Experimental Part 
 382
S-1-(2,6-dichloropyrimidin-4-ylamino)-7,7-dimethyl-6-oxooctan-3-yl O-ethyl 
carbonodithioate (5-32) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-28 (111mg, 
0.51mmol, 0.5 eq.) and the xanthate Xa-d (241mg, 1.09mmol, 1.0 eq.) in AcOEt (0.6ml, 
1.8mmol/ml), with DLP (44mg, 0.20 eq.). Flash chromatography on silica gel with AcOEt / 
EP = 20 / 80 afforded 5-32 (197mg, 82%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.31 (s, 1H, H-Ar), 5.96 (br s, 1H, NH), 4.62 (q, J = 
7.1 Hz, 2H, CH2CH3), 3.80-3.68 (m, 1H, CH), 3.63 (br s, 1H, NH-CHH), 3.42 (br s, 1H, NH-
CHH), 2.83-2.67 (m, 1H, CO-CHH), 2.67-2.55 (m, 1H, CO-CHH), 2.22-2.05 (m, 1H, 
COCH2-CHH), 2.03-1.93 (m, 1H, NHCH2-CH2), 1.84-1.66 (m, 1H, COCH2-CHH), 1.40 (t, J 
= 7.1 Hz, 3H, CH2CH3), 1.13 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  215.8 (CO), 214.5 (CS), 164.1 (C-Ar), 160.1 (C-
Ar), 158.7 (C-Ar), 102.9 (CH-Ar), 70.5 (CH2CH3), 48.7 (CH), 44.2 (CMe3) 39.2 (NH-CH2), 
34.7 (NHCH2-CH2), 33.6 (CO-CH2), 27.3 (COCH2-CH2), 26.5 (C(CH3)3), 13.7 (CH2CH3) 
IR (ν, cm-1, CCl4)   3366, 2969, 2872, 1741, 1707, 1591, 1499, 1477, 1442, 1368, 1273, 1219, 
1121, 1053, 970, 908 
HRMS (EI+)    Calcd. for C17H25Cl2N3O2S2 : 437.0765     Found : 437.0765    
 
 
 
 
Experimental Part 
 383 
 
S-4-(2,6-dichloropyrimidin-4-ylamino)-1-(tetrahydro-2-oxofuran-3-yl)butan-2-yl O-
ethyl carbonodithioate (5-33) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-28 (119mg, 
0.55mmol, 0.5 eq.) and the xanthate Xa-e (225mg, 1.09mmol, 1.0 eq.) in AcOEt (0.6ml, 
1.8mmol/ml), with DLP (44mg, 0.20 eq.). Flash chromatography on silica gel with AcOEt / 
EP = 35 / 65 afforded 5-33 (181mg, 74%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.32 (s, 0.5H, H-Ar), 6.30 (s, 0.5H, H-Ar), 5.90 (br s, 
0.5H, NH), 5.71 (br s, 0.5H, NH), 4.79-4.54 (m, 2H, CH2CH3), 4.43-4.32 (m, 1H, COO-
CHH), 4.26-4.14 (m, 1H, COO-CHH), 4.12-4.01(m, 0.5H, Xa-CH),  3.98-3.85 (m, 0.5H, Xa-
CH), 3.70-3.31 (m, 2H, CH2NH), 2.92-2.65 (m, 1H, COCH), 2.53-2.39 (m, 1H, COOCH2-
CHH), 2.37-2.15 (m, 1H, XaCH-CHH), 2.14-1.90 (m, 3H, COOCH2-CHH + NHCH2-CH2), 
1.90-1.75 (m, 1H, XaCH-CHH), 1.44 and 1.41 (2 t, J = 7.1 Hz, 3H, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.01 (CS), 178.7 (CO), 164.1 (C-Ar), 160.1 (C-
Ar), 158.9 (C-Ar), 102.9 (CH-Ar), 71.0 and 70.6 (CH2CH3), 66.6 (COOCH2), 47.6  and 47.1 
(Xa-CH), 38.6 (CH2NH), 37.5 and 37.4 (COCH), 35.1 and 34.8 (COCH-CH2), 33.8 (CH2-
CH2NH), 29.5 and 29.4 (COOCH2-CH2), 13.8 and 13.7 (CH2CH3) 
IR (ν, cm-1, CCl4)    3372, 2926, 1782, 1582, 1558, 1498, 1441, 1374, 1265, 1217, 1149, 
1121, 1048, 1030 
HRMS (EI+)    Calcd. for C12H14Cl2N3O2 : 302.0463      Found : 302.0468       
 
Experimental Part 
 384
2-(2-(2,4-dichloro-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-5-yl)ethyl)isoindoline-1,3-
dione (5-34) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-30 (120mg, 0.24mmol, 1.0 eq.) 
in AcOEt (5.0ml, 0.05mmol/ml), with DLP (114mg, 1.2 eq.). Flash chromatography on silica 
gel with AcOEt / DCM = 10 / 90 afforded 5-34 (40mg, 44%) as a white powder. 
 
m.p. : 183-187°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.91-7.80 (m, 2H, H-phth), 7.78-7.71 (m, 2H, H-
phthalimide), 6.30 (s, 1H, NH), 3.91-3.74 (m, 2H, NH-CH2), 3.60-3.44 (m, 2H, CH2-N 
phthalimide), 3.07 (dd, J = 5.8, 4.5 Hz, 1H, CH), 2.29 (br s, 0.5H, phthalimideNCH2-CHH), 
2.26 (br s, 0.5H, phthalimideNCH2-CHH), 2.12-2.01 (m, 1H, NHCH2-CHH), 1.86-1.76 (m, 
1H, phthalimideNCH2-CHH), 1.75-1.63 (m, 1H, NHCH2-CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  168.3 (CO), 161.3 (C-Ar), 157.2 (C-Ar), 157.1 (C-
Ar), 134.2 (CH-phthalimide), 131.9 (C-phthalimide), 123.4 (CH-phthalimide), 111.6 (C-Ar), 
36.7 (CH2-Nphthalimide), 35.1 (NH-CH2), 31.2 (NHCH2-CH2), 29.5 (CH), 22.2 (CH2-CH2N 
phthalimide) 
IR (ν, cm-1, CCl4)  3439, 3247, 2944, 1775, 1718, 1602, 1578, 1550, 1395, 1377, 1339, 1279, 
1226, 1160, 908   
HRMS (EI+)    Calcd. for C17H14Cl2N4O2 : 376.0494     Found : 376.0488       
 
 
 
 
 
Experimental Part 
 385 
3-(2,4-dichloro-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-5-yl)propanenitrile (5-35) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-31 (71mg, 0.19mmol, 1.0 eq.) in 
AcOEt (5.2ml, 0.04mmol/ml), with DLP (103mg, 1.0 eq.). Flash chromatography on silica 
gel with AcOEt / DCM = 10 / 90 afforded 5-35 (34mg, 71%) as a white solid. 
 
m.p. : 177-181°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.27 (s, 1H, NH), 3.60-3.53 (m, 1H, CHH-NH), 3.43 
(dt, 1H, J=3.7Hz, J=13.1Hz, CHH-NH), 3.25-3.22 (m, 1H, CH), 2.57-2.44 (m, 2H, CH2-CN), 
2.08-1.97 (m, 2H, CHH-CH2-NH + CHH-CH2-CN), 1.91-1.82 (m, 1H, CHH-CH2-NH), 1.82-
1.72 (m, 1H, CHH-CH2-CN) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 161.3 (C-Ar), 157.5 (C-Ar), 157.3 (C-Ar), 118.7 
(CN), 110.6 (C-Ar), 36.6 (CH2-NH), 31.2 (CH), 28.4 (CH2-CH2CN), 22.5 (CH2-CH2NH), 
15.0 (CH2-CN) 
IR (ν, cm-1, Nujol)    3261, 1595, 1551, 1375, 1341, 1287, 1220, 1201, 1113, 1054, 863, 781   
HRMS (EI+)    Calcd. for C10H10Cl2N4 : 256.0283      Found : 256.0284       
 
 
 
 
 
 
 
 
 
Experimental Part 
 386
1-(2,4-dichloro-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-5-yl)-4,4-dimethylpentan-3-
one (5-36) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-32 (106mg, 0.24mmol, 1.0 eq.) 
in AcOEt (4.8ml, 0.05mmol/ml), with DLP (116mg, 1.2 eq.). Flash chromatography on silica 
gel with AcOEt / DCM = 20 / 80 afforded 5-36 (41mg, 54%) as a white solid.  
 
In comparative study, the reaction was carried out with the solution of 5-32 (42mg, 
0.10mmol, 1.0 eq.) in DMC (1.9ml, 0.05mmol/ml), with DLP (46mg, 1.2 eq.). Flash 
chromatography on silica gel with AcOEt / DCM = 20 / 80 afforded 5-36 (17mg, 55%) as a 
white solid.  
 
m.p. : 180-184°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.84 (br s, 1H, NH), 3.53-3.50 (m, 2H, NHCH2), 
3.11-3.06 (m, 1H, CH), 2.63 (t, J = 7.5 Hz, 2H, COCH2), 1.94 (br s, 0.4H, NHCH2CHH), 
1.91 (br s, 0.6H, NHCH2CHH), 1.86-1.65 (m, 3H, NHCH2CHH + COCH2CH2), 1.15 (s, 9H, 
(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 215.1 (CO), 161.4 (C-Ar), 157.0 (C-Ar), 156.8 (C-
Ar), 112.1 (C-Ar), 44.2 (CMe3), 36.8 (NH-CH2), 33.9 (CO-CH2), 31.5 (CH), 27.2 (CH2-
CH2CO), 26.5 (3(CH3)), 23.2 (CH2-CH2NH) 
IR (ν, cm-1, CCl4)  3438, 3248, 3108, 2968, 2870, 1708, 1603, 1579, 1477, 1403, 1376, 1338, 
1284, 1223, 1193, 1158, 1118, 1052, 997, 918   
HRMS (EI+)    Calcd. for C14H19Cl2N3O : 315.0905     Found : 315.0905       
 
 
Experimental Part 
 387 
3-((2,4-dichloro-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-5-yl)methyl)-dihydrofuran-
2(3H)-one (5-37) 
 
 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-33 (110mg, 0.26mmol, 1.0 eq.) 
in AcOEt (5.2ml, 0.05mmol/ml), with DLP (104mg, 1.0 eq.). Flash chromatography on silica 
gel with AcOEt / DCM = 20 / 80 afforded 5-37 (46mg, 59%) as a white solid. 
 
m.p. : 195-198°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.81 (s, 0.6H, NH), 6.71 (s, 0.4H, NH), 4.46-4.37 (m, 
1H, COOCHH), 4.32-4.19 (m, 1H, COOCHH), 3.65-3.36 (m, 2.6H, NHCH2 + CH-CAr), 
3.22-3.07 (m, 0.4H, CH-CAr), 2.75-2.47 (m, 2H, COCH + COOCH2CHH), 2.22-1.93 (m, 3H, 
COOCH2CHH + NHCH2CHH + COCHCHH), 1.92-1.73 (m, 1H, NHCH2CHH), 1.63 (m, 1H, 
COCHCHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  178.7 (CO), 178.5 (CO), 161.5 (C-Ar), 161.4 (C-
Ar), 157.2 (2 C-Ar), 157.1 (C-Ar), 157.0 (C-Ar), 111.4 (C-Ar), 111.2 (C-Ar), 66.5 
(COOCH2), 66.4 (COOCH2), 37.0 (COCH), 36.9 (COCH), 36.7 (CH2-NH), 36.6 (CH2-NH), 
34.1 (COCHCH2), 33.5 (COCHCH2), 30.5 (CH-CAr), 29.6 (CH-CAr), 29.4 (COOCH2CH2), 
28.9 (COOCH2CH2), 23.8 (CH2-CH2NH), 21.9 (CH2-CH2NH) 
IR (ν, cm-1, CCl4)  3427, 3249, 2947, 1769, 1583, 1546, 1382, 1338, 1277, 1225, 1192, 1160, 
1027 
HRMS (EI+)    Calcd. for C12H13Cl2N3O2 : 301.0385      Found : 301.0370 
 
 
 
 
Experimental Part 
 388
S-6-(2,6-dichloropyrimidin-4-ylamino)-1-(1,3-dioxoisoindolin-2-yl)hexan-3-yl O-ethyl 
carbonodithioate (5-38) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-29 (254mg, 
1.10mmol, 0.7 eq.) and the xanthate Xa-c (421mg, 1.50mmol, 1.0 eq.) in AcOEt (1.1ml, 
1.4mmol/ml), with DLP (132mg, 0.30 eq.). Flash chromatography on silica gel with AcOEt / 
EP = 30 / 70 afforded 5-38 (317mg, 56%) as a colourless oil250. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.93-7.80 (m, 2H, 2 H-phthalimide), 7.77-7.69 (m, 
2H, 2 H-phthlimide), 6.34 (br s, 1H, H-Ar), 5.94 (br s, 1H, NH), 4.55 (q, J = 7.1 Hz, 1H, 
OCH2CH3), 3.91-3.73 (m, 2H, CH2-phthalimide), 3.68 (br s, 1H, CH), 3.59-3.18 (br s, 2H, 
CH2-NH), 2.34-2.10 (m, 1H, CHH-CH2phthalimide), 2.08-1.93 (m, 2H, CH-CHH + CHH-
CH2phthalimide), 1.91-1.79 (m, 1H, CHH-CH2NH), 1.77-1.61 (m, 2H, CH-CHH + CHH-
CH2NH), 1.34 (t, J = 7.1Hz, 3H, OCH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.9 (C=S), 168.6 (2 CO-phthalimide), 164.2 (C-
Ar), 160.0 (C-Ar), 158.6 (C-Ar), 134.1 (2 CH-phthalimide), 132.0 (2 C-phthalimide), 123.3 
(2 CH-phthalimide), 100.7 (CH-Ar), 70.1 (OCH2CH3), 47.7 (CH), 40.4 (CH2NH), 35.4 (CH2-
Nphthalimide), 34.5 (CH2-CH2-Nphthalimide), 29.3 (CH-CH2), 25.7 (CH2-CH2NH), 13.7 
(OCH2CH3) 
IR (ν, cm-1, CCl4)    3386, 2941, 1773, 1709, 1581, 1499, 1437, 1397, 1358, 1274, 1222, 
1113, 1052 
HRMS (EI+)    Calcd. for C18H17Cl2N4O2 : 391.0729      Found : 391.0737 
                                                 
250
 Similar side-product from intermolecular addition was also observed, as in the case 5-24. 
Experimental Part 
 389 
S-6-(2,6-dichloropyrimidin-4-ylamino)-1-cyanohexan-3-yl O-ethyl carbonodithioate (5-
39) 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-29 (105mg, 
0.45mmol, 0.5 eq.) and the xanthate Xa-a (146mg, 0.90mmol, 1.0 eq.) in AcOEt (0.45ml, 
2.0mmol/ml), with DLP (72mg, 0.20 eq.). Flash chromatography on silica gel with AcOEt / 
EP = 20 / 80 afforded 5-39 (153mg, 86%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.27 (s, 1H, H-Ar), 5.76 (br s, 0.5H, NH), 5.35 (br s, 
0.5H, NH), 4.66 (q, J = 7.1 Hz, 2H, OCH2CH3), 4.01-3.72 (m, 1H, CH), 3.40 (br s, 2H, CH2-
NH), 2.53 (t, J = 7.4 Hz, 2H, CH2-CN), 2.17-2.07 (m, 1H, CHH-CH2CN), 2.04-1.94 (m, 1H, 
CHH-CH2CN), 1.89-1.68 (m, 4H, CH-CH2 + CH2-CH2NH), 1.44 (t, J = 7.1Hz, 3H, 
OCH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 212.9 (C=S), 164.2 (C-Ar), 160.0 (C-Ar), 158.7 (C-
Ar), 119.1 (CN), 102.5 (CH-Ar), 70.6 (OCH2CH3), 49.7 (CH), 41.1 (CH2NH), 31.3 (CH2), 
30.6 (CH2-CH2CN), 26.2 (CH2), 15.0 (CH2-CN), 13.7 (OCH2CH3) 
IR (ν, cm-1, CCl4)  3423, 2926, 2856, 1579, 1495, 1443, 1270, 1225, 1121, 1050, 970 
HRMS (EI+)    Calcd. for C11H13Cl2N4 : 271.0517      Found : 271.0519 
 
 
 
 
 
 
Experimental Part 
 390
S-1-(ethoxycarbonyl)-6-(2,6-dichloropyrimidin-4-ylamino)hexan-3-yl O-ethyl 
carbonodithioate (5-40) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-29 (193mg, 
0.66mmol, 1.0 eq.) and the xanthate Xa-h (160mg, 0.66mmol, 1.0 eq.) in AcOEt (0.66ml, 
1.0mmol/ml), with DLP (66mg, 0.25 eq.). Flash chromatography on silica gel with AcOEt / 
EP = 20 / 80 afforded 5-40 (235mg, 81%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.28 (s, 1H, H-Ar), 5.52 (br s, 1H, NH), 4.64 (q, J = 
7.1 Hz, 2H, CSOCH2CH3), 4.14 (q, J = 7.1 Hz, 2H, COOCH2CH3), 3.85-3.77 (m, 1H, CH), 
3.47 and 3.29 (2 br s,, 2H, CH2NH), 2.47 (t, J = 7.4 Hz, 2H, CH2COOEt), 2.14-2.04 (m, 1H, 
CHH-CH2COOEt), 1.94-1.82 (m, 1H, CHH-CH2COOEt), 1.83-1.72 (m, 4H, CHCH2 + 
CH2CH2NH), 1.42 (t, J = 7.1 Hz, 3H, CSOCH2CH3), 1.26 (t, J = 7.2 Hz, 3H, COOCH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  214.2 (CS), 173.0 (COOEt), 164.2 (C-Ar), 159.8 
(C-Ar), 159.2 (C-Ar), 100.7 (CH-Ar), 70.3 (CSOCH2CH3), 60.7 (COOCH2CH3), 50.2 (CH), 
41.2 (CH2NH), 31.8 (CHCH2), 31.5 (CH2COOEt), 29.3 (CH2-CH2COOEt), 26.0 
(CH2CH2NH), 14.2 (COOCH2CH3), 13.8 (CSOCH2CH3) 
IR (ν, cm-1, CCl4)  3372, 2981, 2938, 1736, 1580, 1497, 1444, 1374, 1343, 1268, 1222, 1120, 
1051, 969 
HRMS (EI+)    Calcd. for C13H18Cl2N3O2 : 318.0776      Found : 318.0800 
 
 
Experimental Part 
 391 
S-7-(2,6-dichloropyrimidin-4-ylamino)-2-acetamido-1,1,1-trifluoroheptan-4-yl O-ethyl 
carbonodithioate (5-41) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-29 (135mg, 
0.58mmol, 0.67 eq.) and the xanthate Xa-j (240mg, 0.87mmol, 1.0 eq.) in AcOEt (0.60ml, 
1.5mmol/ml), with DLP (87mg, 0.25 eq.). Flash chromatography on silica gel with AcOEt / 
EP = 20 / 80 afforded 5-41a (117mg, 40%) as a colourless oil.  
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.65-6.18 (s + br s, 2H, H-Ar + NH), 5.84 (br s, 1H, 
NHAc), 4.81-4.72 (m, 1H, CH-CF3), 4.65 (q, J = 7.1 Hz, 2H, CSOCH2CH3), 3.73 (br s, 1H, 
CHHNH), 3.64-3.54 (m, 1H, CHS), 3.06 (br s, 1H, CHHNH), 2.20 (s, 3H, CH3), 2.15-1.97 
(m, 3H, CH2-CH2NH + CHH-CH), 1.97-1.82 (m, 1H, CHH-CH),  1.74-1.51 (m, 2H, 2 CHH-
CH), 1.44 (t, J = 7.1 Hz, 3H, CSOCH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 214.2 (CS), 171.8 (CO), 164.2 (C-Ar), 159.8 (C-
Ar), 158.0 (C-Ar), 124.5 (q, J = 281 Hz, CF3), 103.0 (Ar-C-H), 70.4 (CH2CH3), 48.4 (q, J = 
31 Hz, CH-CF3), 45.6 (CHS), 39.0 (CH2NH), 35.0 (CH2-CHCF3), 27.4 (CH2-CHS), 25.2 
(CH2-CH2NH), 23.0 (CH3), 13.6 (CH2CH3) 
IR (ν, cm-1, CCl4)  3350, 2928, 1709, 1683, 1583, 1518,   1439, 1371, 1344, 1276, 1223, 
1192, 1140, 1119, 1052, 987 
HRMS (EI+)    Calcd. for C13H16Cl2F3N4O : 371.0653      Found : 371.0648 
 
Flash chromatography on silica gel with AcOEt / EP = 40 / 60 5-41b (132mg, 48%) as a light 
yellow oil. 
Experimental Part 
 392
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.31 (s, 1H, H-Ar), 5.93 (br s, 1H, NHAc), 5.76 (br s, 
1H, NH), 4.91-4.79 (m, 1H, CH-CF3), 4.63 (q, J = 7.1 Hz, 2H, CSOCH2CH3), 4.05-3.85 (m, 
1H, CH), 3.59 and 3.35 (2 br s, 2H, CH2NH), 2.26-1.87 (m + s, 5H, CH2-CHCF3 + CH3), 
1.85-1.68 (m, 4H, CH2-CH2NH + CH2-CHS), 1.41 (t, J = 7.1 Hz, 3H, CSOCH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 213.5 (CS), 169.9 (CO), 164.1 (C-Ar), 159.9 (C-
Ar), 156.0 (C-Ar), 124.9 (q, J = 282 Hz, CF3), 100.6 (Ar-CH), 70.7 (CH2CH3), 48.5 (q, J = 
31 Hz, CH-CF3), 46.9 (CH), 40.9 (CH2NH), 32.5 (CH2-CHCF3), 31.7 (CH2-CH2NH), 25.9 
(CH2-CHS), 23.3 (CH3), 13.8 (CH2CH3) 
IR (ν, cm-1, CCl4)  2926, 1705, 1587, 1511, 1370, 1263, 1232, 1191, 1133, 1050, 980 
HRMS (EI+)    Calcd. for C13H16Cl2F3N4O : 371.0653      Found : 371.0646 
 
 
2-(2-(2,4-dichloro-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]azepin-5-yl)ethyl)isoindoline-
1,3-dione (5-42) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-38 (288mg, 0.56mmol, 1.0 eq.) 
in AcOEt (11ml, 0.05mmol/ml), with DLP (447mg, 2.0 eq.). Flash chromatography on silica 
gel with AcOEt / DCM = 5 / 95 afforded 5-42 (95mg, 44%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.90-7.79 (m, 2H, 2 H-phthalimide), 7.76-7.70 (m, 
2H, 2 H-phthalimide), 5.59 (br s, 1H, NH), 3.88-3.65 (m, 2H, CH2-Nphthalimide), 3.54-3.45 
(m, 1H, NHCHH), 3.44-3.36 (m, 1H, CH), 3.26-3.15 (m, 1H, NHCHH), 2.26-2.06 (m, 2H, 2 
CH-CHH), 2.00-1.79 (m, 4H, NHCH2CH2 + 2 CH-CHH) 
Experimental Part 
 393 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  168.2 (2 CO-phthalimide), 167.6 (C-Ar), 161.1 (C-
Ar), 156.0 (C-Ar), 134.1 (2 CH-phthalimide), 132.0 (2 C-phthalimide), 123.3 (2 CH-
phthalimide), 117.5 (Ar-C-CH), 44.6 (NH-CH2), 35.8 (CH2-Nphthalimide), 34.6 (CH), 31.3 
(CH2-CH2-Nphthalimide), 26.0 (CH-CH2), 22.8 (NHCH2-CH2) 
IR (ν, cm-1, CCl4)  3642, 3352, 2940, 2832, 1774, 1717, 1563, 1446, 1395, 1342, 1216, 1024 
HRMS (EI+)    Calcd. for C18H16Cl2N4O2 : 390.0650      Found : 390.0649 
 
 
3-(2,4-dichloro-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]azepin-5-yl)propanenitrile (5-43) 
 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-39 (57mg, 0.14mmol, 1.0 eq.) in 
AcOEt (2.9ml, 0.05mmol/ml), with DLP (58mg, 1.0 eq.). Flash chromatography on silica gel 
with AcOEt / EP = 20 / 80 afforded 5-43 (18mg, 45%) as a white crystal. 
 
In comparative study, the reaction was carried out with the solution of 5-39 (56mg, 
0.14mmol, 1.0 eq.) in PhCl (2.9ml, 0.05mmol/ml), with DTBP (0.26ml, 10.0eq.) which was 
added in two times and the reaction took 7 hours. Seperation using preparative TLC plate 
with AcOEt / EP = 20 / 80 afforded 5-43 (7.3mg, 19%) as a white crystal. 
 
m.p. : 125-128°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.62 (br s, 1H, NH), 3.61-3.53 (m, 1H, CH), 3.53-
3.46 (m, 1H, NHCHH), 3.24-3.04 (m, 1H, NHCHH), 2.47-2.24 (m, 2H, CH2CN), 2.19-1.98 
(m, 2H, 2 CH-CHH), 1.96-1.77 (m, 4H, 2 CH-CHH + NHCH2CH2) 
Experimental Part 
 394
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 167.6 (Ar-C), 161.4 (Ar-C), 156.3 (Ar-C), 118.8 
(CN), 116.5 (Ar-C-CH), 45.0 (NH-CH2), 36.3 (CH), 28.2 (CH-CH2), 27.0 (CH-CH2),  22.8  
(NHCH2-CH2), 15.5 (CH2CN) 
IR (ν, cm-1, CCl4) 3418, 3384, 3267, 2929, 2856, 1821, 1546, 1456, 1386, 1345, 1302, 1219, 
1142, 997 
HRMS (EI+)    Calcd. for C11H12Cl2N4 : 270.0439      Found : 270.0446      
 
 
ethyl 3-(2,4-dichloro-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]azepin-5-yl)propanoate (5-
44) 
 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-40 (235mg, 0.54mmol, 1.0 eq.) 
in AcOEt (11ml, 0.05mmol/ml), with DLP (264mg, 1.2 eq.). Flash chromatography on silica 
gel with AcOEt / DCM = 5 / 95 afforded 5-44 (92mg, 54%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.55 (br s, 1H, NH), 4.12 (q, J = 7.1 Hz, 2H, 
OCH2CH3), 3.69-3.26 (m, 2H, NHCHH + CH), 3.26-3.01 (m, 1H, NHCHH), 2.46-2.17 (m, 
2H, CH2COOEt), 2.14-1.97 (m, 2H, 2 CHH-CH), 1.94-1.71 (m, 4H, 2 CHH-CH + 
NHCH2CH2), 1.25 (t, J = 7.1 Hz, 3H, OCH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 172.9 (CO), 167.6 (Ar-C), 161.3 (Ar-C), 156.0 (Ar-
C), 117.8 (Ar-C-CH), 60.6 (OCH2CH3), 45.3 (NH-CH2), 36.6 (CH), 32.3 (CH2COOEt), 27.6 
(2 CH-CH2), 22.9 (NHCH2-CH2), 14.2 (CH3) 
IR (ν, cm-1, CCl4)  3419, 3386, 2936, 2857, 1736, 1576, 1456, 1385, 1376, 1344, 1308, 1264, 
1217, 1159, 1136, 1023, 996 
HRMS (EI+)    Calcd. for C13H17Cl2N3O2 : 317.0698      Found : 317.0695 
Experimental Part 
 395 
N-(3-(2,4-dichloro-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]azepin-5-yl)-1,1,1-trifluoro-
propan-2-yl)acetamide (5-45) 
 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-41b (128mg, 0.25mmol, 1.0 eq.) 
in AcOEt (5ml, 0.05mmol/ml), with DLP (100mg, 1.0 eq.). Flash chromatography on silica 
gel with AcOEt / EP = 30 / 70 afforded 5-45a (26mg, 27%) as a white crystal. 
 
m.p. : 222~226°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.71 (br s, NH, 1H), 5.59 (d, J = 10.1 Hz, 1H, NH-
Ac), 4.95-4.72 (m, 1H, CH-CF3), 3.54-3.44 (m, 1H, CHHNH), 3.48-3.39 (m, 1H, CH-C-Ar), 
3.28-3.19 (m, 1H, CHHNH), 2.28-2.08 (m + s, 5H, 2 CH-CHH + CH3), 2.06-1.93 (m, 1H, 
CHH-CH2NH), 1.82-1.66 ( m, 3H, CHH-CH2NH + 2 CH-CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  170.3 (C=O), 167.8 (Ar-C), 160.7 (Ar-C), 156.3 
(Ar-C), 124.9 (q, J = 281 Hz, CF3), 116.9 (Ar-C-CH), 48.0 (q, J = 31Hz, CH-CF3), 44.5 
(NH-CH2), 32.6 (CH), 30.8 (CH-CH2), 24.8 (CH-CH2), 23.1 (CH3), 22.4 (CH2-CH2NH) 
IR (ν, cm-1, CCl4)  3259, 2928, 2855, 1708, 1662, 1570, 1458, 1343, 1306, 1273, 1222, 1129, 
995 
HRMS (EI+)    Calcd. for C13H15Cl2F3N4O : 370.0575      Found : 370.0589 
 
 
Flash chromatography on silica gel with AcOEt / EP = 70 / 30 afforded 5-45b (15mg, 16%) 
as a white solid. 
 
m.p. : 204-208°C 
Experimental Part 
 396
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.58 (d, J = 9.6 Hz, 1H, NH-Ac), 5.51 (br s, NH, 1H), 
4.59-4.47 (m, 1H, CH-CF3), 3.74-3.57 (m, 1H, CH-C-Ar), 3.55-3.41 (m, 1H, CHHNH), 3.19-
3.10 (m, 1H, CHHNH), 2.32-2.23 (m, 1H, CF3CH-CHH), 2.13-1.99 (m + s, 4H, CH-CHH + 
CH3), 1.97-1.80 (m, 3H, CH2-CH2NH + CH-CHH), 1.80-1.70 (m, 1H, CF3CH-CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  169.5 (C=O), 167.6 (Ar-C), 161.3 (Ar-C), 156.4 
(Ar-C), 125.1 (q, J = 282 Hz, CF3), 116.74 (Ar-C-CH), 48.8 (q, J = 30Hz, CH-CF3), 45.2 
(NH-CH2), 33.9 (CH), 31.4 (CF3CH-CH2), 27.3 (CH-CH2), 23.2 (CH3), 23.0 (CH2-CH2NH) 
IR (ν, cm-1, CCl4)  2926, 2854, 1704, 1575, 1506, 1458, 1373, 1264, 1217, 1191, 1134 
HRMS (EI+)    Calcd. for C13H15Cl2F3N4O : 370.0575      Found : 370.0584 
 
 
N-(but-3-en-1-yl)-N-(2,6-dichloropyrimidin-4-yl)acetamide (5-46) 
 
 
 
344mg N-(but-3-en-1-yl)-2,6-dichloropyrimidin-4-amine (1.58mmol, 1.0eq.) was dissolved 
by 5.0ml acetyl chloride (0.3mmol/ml), and the mixture was refluxing for 110 hours. After 
work-up, flash chromatography on silica gel with DCM / EP = 80 / 20 afforded 5-46 (384mg, 
94%) as colorless oil. 
 
1H-NMR (į, ppm) (εeOD, 400 εHz)  7.97 (s, 1H, H-aromatic), 5.80 (tdd, 1H, J = 17.2, 
10.2, 7.0Hz, CH2-CH=CH2), 5.19-5.04 (m, 2H, CH2-CH=CH2), 4.13-3.98 (m, 2H, NAc-CH2), 
2.51-2.36 (m + s, 5H, CH2-CH=CH2 + CH3) 
13C-NMR (į, ppm) (εeOD, 100.6 εHz) 172.0 (CO), 162.5 (NAc-C-N), 161.9 (NH-C-CH-
C-Cl), 159.1 (NH-C-N-C-Cl), 133.7 (CH2-CH=CH2), 118.0 (CH2-CH=CH2), 111.7 (Cl-C-
CH), 46.4 (NAc-CH2), 32.9 (CH2-CH=CH2), 25.3 (CH3) 
 
 
Experimental Part 
 397 
N-(2,6-dichloropyrimidin-4-yl)-N-(pent-4-en-1-yl)acetamide (5-47) 
 
 
 
400mg 5-29 (1.58mmol, 1.0eq.) was dissolved by 5.7ml acetyl chloride (0.3mmol/ml), and 
the mixture was refluxing for 120 hours. After work-up, flash chromatography on silica gel 
with DCM afforded 5-47 (340mg, 72%) as colorless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.98 (s, 1H, H-aromatic), 5.82 (tdd, 1H, J = 16.9, 
10.2, 6.6 Hz, CH2-CH=CH2), 5.07 (qdd, 2H, J = 13.0, 10.2, 1.4 Hz, CH2-CH=CH2), 3.98-
3.94 (m, 2H, NAc-CH2), 2.41 (s, 3H, CH3), 2.14 (q, 2H, J = 7.1 Hz, CH2-CH=CH2), 1.77 (td, 
2H, J = 15.2, 7.4 Hz, NAc-CH2-CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 172.1 (CO), 162.5 (NAc-C-N), 161.9 (NH-C-CH-
C-Cl), 159.1 (NH-C-N-C-Cl), 136.8 (CH2-CH=CH2), 115.9 (CH2-CH=CH2), 111.5 (Cl-C-
CH), 46.6 (NAc-CH2), 30.8 (CH2-CH=CH2), 27.5 (NAc-CH2-CH2), 25.2 (CH3) 
 
 
S-(1-cyano-5-(N-(2,6-dichloropyrimidin-4-yl)acetamido)pentan-3-yl) O-ethyl 
carbonodithioate (5-48) 
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Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-46 (161mg, 
0.62mmol, 1.0 eq.) and the xanthate of acetonitrile Xa-a (152mg, 0.93mmol, 1.5 eq.) in 
AcOEt (0.62ml, 1.0mmol/ml), with DLP (56mg, 0.15 eq.). Flash chromatography on silica 
gel with AcOEt / EP = 20 / 80 afforded 5-48 (219mg, 84%) as a light yellow oil, along with 
the bicycle compound 5-50 (12mg, 6%) as white solid. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.97 (s, 1H, H-aromatic), 4.67 (q, 2H, J=7.1Hz, 
CH2CH3), 4.11 (t, 2H, J = 7.8 Hz, CH2-NAc), 3.85 (ddd, 1H, J = 13.5, 8.1, 5.6Hz, Xa-CH), 
2.68-2.51 (m, 2H, CH2-CN), 2.43 (s, 3H, COCH3), 2.25-2.06 (m, 4H, CH2-CH2-CN + CH2-
CH2-NAc), 1.45 (t, 3H, J = 7.1 Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  212.3 (C=S) , 171.8 (CO), 162.8 (NAc-C-N), 
161.7 (NAc-C-CH-C-Cl), 159.2 (NAc-C-N-C-Cl) 118.7 (CN), 111.6 (Cl-C-CH), 70.8 
(CH2CH3), 47.6 (CH-Xa), 44.8 (NAc-CH2), 32.8 (CH2-CH2-NAc), 29.9 (CH2-CH2-CN), 25.1 
(CH3), 15.1 (CH2-CN), 13.8 (CH2CH3) 
IR (ν, cm-1, CCl4)  3691, 3155, 2986, 2254, 1817, 1794, 1699, 1602, 1556, 1525, 1470, 1409, 
1383, 1331, 1248, 1219, 1140, 1097, 1051 
HRMS (EI+)    Calcd. for C15H18Cl2N4O2S2 : 420.0248      Found : 420.0254 
 
 
S-(1-(N-(2,6-dichloropyrimidin-4-yl)acetamido)-7-oxooctan-4-yl) O-ethyl 
carbonodithioate (5-49) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-47 (92mg, 
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0.33mmol, 1.0eq.) and the xanthate Xa-i (119mg, 0.67mmol, 2.0eq.) in AcOEt (0.33ml, 
2.0mmol/ml), with DLP (28mg, 0.1eq.). Flash chromatography on silica gel with AcOEt / 
DCM = 10 / 90 afforded 5-49 (133mg, 82%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.97 (s, 1H, H-aromatic), 4.64 (dq, 2H, J=7.1, 1.1 Hz, 
CH2CH3), 4.19-3.85 (m, 2H, CH2-NAc), 3.83-3.70 (m, 1H, Xa-CH), 2.78-2.53 (m, 2H, CH2-
COMe), 2.42 (s, 3H, NCOCH3), 2.14 (s, 3H, COCH3), 2.13-2.05 (m, 1H, CHH-CH2-COMe), 
1.87-1.72 (m, 5H, CHH-CH2-COMe + CH2-CH2-NAc + CH2-CH2-CH2-NAc), 1.42 (t, 3H, J 
= 7.1 Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  214.3 (C=S), 207.5 (CH2CO), 172.0 (NCO), 162.6 
(NAc-C-N), 161.9 (NAc-C-CH-C-Cl), 159.1 (NAc-C-N-C-Cl), 111.6 (Cl-C-CH), 70.2 
(CH2CH3), 50.5 (CH-Xa), 46.7 (NAc-CH2), 40.5 (CH2-COMe), 32.0 (CH2), 30.1 (COCH3), 
27.8 (CH2-CH2-COMe), 25.9 (CH2), 25.2 (NCOCH3), 13.8 (CH2CH3) 
 
 
3-(8-acetyl-2,4-dichloro-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-5-yl)propane-nitrile 
(5-50) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-48 (93mg, 0.22mmol, 1.0 eq.) in 
AcOEt (4.4ml, 0.05mmol/ml), with DLP (106mg, 1.2eq.). Flash chromatography on silica 
gel with AcOEt / EP = 30 / 70 afforded 5-50 (44mg, 67%) as a white crystal. 
 
m.p. : 129-132°C 
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1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.35 (bd, 1H, J=14.1Hz, CHH-NAc), 3.45 (dt, 1H, 
J=4.0Hz, J=13.7Hz, CHH-NAc), 3.35-3.30 (m, 1H, CH), 2.68 (s, 3H, CH3), 2.52 (m, 2H, 
CH2-CN), 2.13 (dd, 1H, J=2.9Hz, J=14.4Hz, CHH-CH2-NAc), 2.04 (m, 1H, CHH-CH2-CN), 
1.93-1.84 (m, 1H, CHH-CH2-NAc), 1.82-1.73 (m, 1H, CHH-CH2-CN) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  172.1 (COCH3), 160.4 (C-NAc), 159.4 (C-C-Cl), 
156.8 (N-C-Cl), 118.3 (CN), 117.4 (C-CCl), 39.5 (CH2-NAc), 32.4 (CH), 28.2 (CH3), 27.5 
(CH2-CH2CN), 23.7 (CH2-CH2NAc), 15.2 (CH2-CN) 
IR (ν, cm-1, CDCl3)  3691, 3155, 2984, 2254, 1817, 1794, 1694, 1602, 1561, 1522, 1472, 
1432, 1379, 1341, 1299, 1263, 1217, 1165, 1132, 1096, 1041   
HRMS (EI+)    Calcd. for C12H12Cl2N4O : 298.0388     Found : 298.0390       
 
 
4-(9-acetyl-2,4-dichloro-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]azepin-5-yl)butan-2-one 
(5-51) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-49 (127mg, 0.26mmol, 1.0eq.) 
in AcOEt (7ml, 0.04mmol/ml), with DLP (137mg, 1.3eq.). Flash chromatography on silica 
gel with Acetone / DCM = 10 / 90 afforded 5-51 (33mg, 38%) as colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.73 (br s, 1H, CHH-NAc), 3.76-3.38 (m, 1H, CH), 
2.88-2.51 (m, 1H, CHH-NAc), 2.44 (td, 1H, J = 14.6, 7.0 Hz, CHH-COMe), 2.28 (td, 1H, J 
= 17.8, 7.0 Hz, CHH-COMe), 2.13 (s, 3H, NCO-CH3), 2.10 (s, 3H, CH2CO-CH3), 2.03-1.58 
(m, 6H, 3 CH2) 
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13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  206.8 (CH2CO), 169.2 (NCO), 164.9 (NAc-C-N), 
163.6 (NAc-C-CH-C-Cl), 156.8 (NAc-C-N-C-Cl), 129.8 (Cl-C-C-CH), 45.7 (CH2-NAc), 
41.0 (CH2-COMe), 37.1 (CH), 30.0 (COCH3), 28.3 (CH2), 24.4 (CH2), 23.3 (NCOCH3), 22.9 
(CH2) 
 
 
N-(but-3-enyl)-6-fluoropyridin-2-amine (5-52) 
 
 
 
2.0ml prepared butenylamine hydrochloride solution in EtOH (2mmol estimated, 2eq.) and 
119mg 2,6-difluoropyridine (1.03mmol, 1.0eq.) was dissolved by 1.9ml DMF, and then 
0.35ml TEA (2.51mmol, 2.4eq.) was added. The mixture was heated to 95°C for 18 hours. 
After work-up, flash chromatography on silica gel with AcOEt / EP = 10 / 90 afforded 5-52 
(26mg, 15%251) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.46 (dd, J = 16.4, 7.9 Hz, 1H, H-aromatic), 6.18 (dd, 
J = 8.0, 2.4 Hz, 1H, H-aromatic), 6.13 (dd, J = 7.7, 2.2 Hz, 1H, H-aromatic), 5.81 (tdd, J = 
17.1, 10.2, 6.8 Hz, 1H, CH2-CH=CH2), 5.21-5.04 (m, 2H, CH2-CH=CH2), 4.57 (br s, 1H, 
NH), 3.33 (dd, J = 10.0, 6.3 Hz, 2H, NH-CH2), 2.45-2.30 (m, 2H, CH2-CH=CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  163.2 (d, J = 236 Hz, C-F), 157.9 (d, J = 17 Hz, 
NH-C), 141.7 (d, J = 9 Hz, C-Ar), 135.3 (CH2-CH=CH2), 117.4 (CH2-CH=CH2), 102.5 (d, J 
= 4 Hz, C-Ar), 95.6 (d, J = 37 Hz, C-Ar), 41.1 (NH-CH2), 33.5 (CH2-CH=CH2) 
IR (ν, cm-1, CDCl3)  3692, 3431, 3082, 2928, 2253, 1622, 1576, 1504, 1456, 1421, 1369, 
1335, 1235, 1152, 996   
HRMS (EI+)    Calcd. for C9H11FN2 : 166.0906      Found : 166.0905       
                                                 
251
 Similar procedure in refluxing THF only affords 7% of 5-52. Improvement could be achieved by operating 
the reaction with 2,6-difluoropyridine, amine and DIPEA in a sealed tube at 110°C. See the synthesis of 5-53. 
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6-fluoro-N-(pent-4-enyl)pyridin-2-amine (5-53) 
 
 
 
236mg 2,6-difluoropyridine (2.05mmol, 1.0eq.) was mixed with 257mg 5-pentenylamine 
hydrochloride (2.11mmol, 1.0eq.), and 0.65ml diisopropylethylamine (3.93mmol, 1.9eq.) 
was added. The mixture was heated to 110°C in a sealed tube for 40 hours to complete the 
reaction. After work-up, flash chromatography on silica gel with Et2O / hexane = 10 / 90 
afforded 5-53 (338mg, 92%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.46 (ddd, J = 8.1, 8.1, 8.1 Hz, 1H, CH-CH-CH), 
6.17 (dd, J = 8.0, 2.4 Hz, 1H, CH-CH-CNH), 6.12 (dd, J = 7.7, 2.3 Hz, 1H, CF-CH-CH), 
5.82 (tdd, J = 16.9, 10.2, 6.7 Hz, 1H, CH2-CH=CH2), 5.05 (dd, J = 17.1, 1.6 Hz, 1H, CH2-
CH=CHH), 5.00 (dd, J = 10.1, 1.0 Hz, 1H, CH2-CH=CHH), 4.55 (br s, 1H, NH), 3.27 (td, J 
= 6.6, 6.6 Hz, 2H, NH-CH2), 2.16 (td, J = 14.2, 7.1 Hz, 2H, CH2-CH=CH2), 1.71 (tt, J =7.3, 
7.3 Hz, 2H, CH2-CH2-CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  163.3 (d, J = 236 Hz, C-F), 158.0 (d, J = 17 Hz, 
NH-C), 141.7 (d, J = 9 Hz, CH-CH-CH), 137.7 (CH2-CH=CH2), 115.3 (CH2-CH=CH2), 
102.2 (d, J = 4 Hz, CH-CH-CNH), 95.5 (d, J = 37 Hz, CF-CH-CH), 41.6 (NH-CH2), 31.1 
(CH2-CH=CH2), 28.5 (CH2-CH2-CH2) 
IR (ν, cm-1, CCl4)  3448, 3288, 3081, 2930, 2860, 1622, 1578, 1503, 1456, 1422, 1372, 1335, 
1268, 1240, 1150, 990, 915   
HRMS (EI+)    Calcd. for C10H13FN2 : 180.1063      Found : 180.1062       
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S-4-(ethoxycarbonyl)-1-(6-fluoropyridin-2-ylamino)butan-2-yl O-ethyl carbonodithioate 
(5-54) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of N-allyl-6-
fluoropyridin-2-amine 252  (67mg, 0.44mmol, 0.63 eq.) and the xanthate Xa-h (146mg, 
0.70mmol, 1.0 eq.) in AcOEt (0.7ml, 1.0 mmol/ml), with DLP (42mg, 0.15 eq.). Flash 
chromatography on silica gel with AcOEt / EP = 10 / 90 afforded 5-54 (75mg, 47%) as a 
colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.45 (dd, J = 16.2, 8.1 Hz, 1H, CH-CH-CH), 6.25 (dd, 
J = 8.0, 2.2 Hz, 1H, CH-CNH), 6.14 (dd, J = 7.7, 2.3 Hz, 1H, CH-CF), 4.90 (br s, 1H, NH), 
4.73-4.53 (m, 2H, CH2), 4.13 (q, J = 7.1 Hz, 2H, CH2), 4.07-3.97 (m, 1H, CH), 3.68 (m, 1H, 
NH-CHH), 3.62-3.49 (m, 1H, NH-CHH), 2.70-2.41 (m, 2H, CH2-COOEt), 2.28-2.10 (m, 1H, 
CHH-CH2-COOEt), 2.00-1.84 (m, 1H, CHH-CH2-COOEt), 1.39 (t, J = 7.1 Hz, 3H, CH3), 
1.25 (t, J = 7.1 Hz, 3H, CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.4 (C=S), 172.7 (CO), 163.2 (d, J = 237 Hz, C-
F), 157.5 (d, J = 17 Hz, NH-C), 141.6 (d, J = 9. Hz, CH-CH-CH), 103.5 (d, J = 4 Hz, CH-
CNH), 96.0 (d, J = 37 Hz, CH-CF), 70.3 (CH2), 60.6 (CH2), 50.5 (CH), 45.2 (NH-CH2), 31.6 
(CH2-COOEt), 26.7 (CH2-CH2-COOEt), 14.2 (CH3), 13.7 (CH3) 
IR (ν, cm-1, CDCl3)  3691, 3441, 2985, 2939, 2255, 1728, 1619, 1578, 1505, 1463, 1422, 
1377, 1334, 1227, 1152, 1112, 1051 
HRMS (EI+)    Calcd. for C15H21FN2O3S2 : 360.0978      Found : 360.0977       
 
                                                 
252El Qacemi, M., L. Ricard, et al. Chem. Comm., 2006, (42): pp 4422-4424. 
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S-1-(ethoxycarbonyl)-5-(6-fluoropyridin-2-ylamino)pentan-3-yl O-ethyl 
carbonodithioate (5-55) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-52 (26mg, 
0.16mmol, 0.5 eq.) and the xanthate Xa-h (75mg, 0.36mmol, 1.0 eq.) in AcOEt (0.2ml, 1.8 
mmol/ml), with DLP (22mg, 0.30 eq.). Flash chromatography on silica gel with AcOEt / EP 
= 10 / 90 afforded 5-55 (38mg, 67%) as a yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.45 (dd, J = 16.2, 8.0 Hz, 1H, CH-CH-CH), 6.20 (dd, 
J = 8.0, 2.3 Hz, 1H, CH-CNH), 6.12 (dd, J = 7.7, 2.3 Hz, 1H, CH-CF), 4.81 (br s, 1H, NH), 
4.63 (q, J = 7.1 Hz, 2H, CH2), 4.13 (q, J = 7.1 Hz, 2H, CH2), 3.89 (ddd, J = 14.1, 9.2, 5.2 Hz, 
1H, CH), 3.52 (qd, J = 12.9, 6.4 Hz, 1H, NH-CHH), 3.40 (dt, J = 13.5, 13.2, 6.8 Hz, 1H, 
NH-CHH), 2.58-2.36 (m, 2H, COOEt-CH2), 2.13 (dddd, J = 14.0, 12.7, 8.6, 5.1 Hz, 1H, 
CHH-CH2COOEt), 2.03 (td, J = 19.8, 6.4 Hz, 1H, NHCH2-CHH), 1.98-1.87 (m, 2H, CHH-
CH2COOEt + NHCH2-CHH), 1.41 (t, J = 7.1 Hz, 3H, CH3), 1.24 (t, J = 7.2 Hz, 3H, CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  214.3 (C=S), 172.9 (CO), 163.3 (d, J = 236 Hz, C-
F), 157.8 (d, J = 17 Hz, NH-C), 141.5 (d, J = 9 Hz, CH-CH-CH), 103.1 (d, J = 4 Hz, CH-
CNH), 95.5 (d, J = 37 Hz, CH-CF), 70.3 (CH2), 60.6 (CH2), 48.7 (CH), 39.3 (NH-CH2), 34.3 
(NHCH2-CH2), 31.6 (CH2-COOEt), 29.5 (CH2-CH2COOEt), 14.2 (CH3), 13.7 (CH3) 
IR (ν, cm-1, CDCl3)  3691, 3429, 2985, 2939, 2258, 1727, 1622, 1577, 1508, 1456, 1421, 
1375, 1338, 1291, 1223, 1152, 1112, 1048 
HRMS (EI+)    Calcd. for C16H23FN2O3S2 : 374.1134      Found : 374.1131       
 
 
Experimental Part 
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S-1-(ethoxycarbonyl)-6-(6-fluoropyridin-2-ylamino)hexan-3-yl O-ethyl 
carbonodithioate (5-56) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-53 (15mg, 
0.082mmol, 0.3 eq.) and the xanthate Xa-h (52mg, 0.24mmol, 1.0 eq.) in AcOEt (0.24ml, 1.0 
mmol/ml), with DLP (20mg, 0.20 eq.). Flash chromatography on silica gel with AcOEt / EP 
= 10 / 90 afforded 5-56 (23mg, 71%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.45 (ddd, J = 8.1, 8.1, 8.1 Hz, 1H, CH-CH-CH), 
6.17 (dd, J = 8.0, 2.3 Hz, 1H, CH-CH-CNH), 6.12 (dd, J = 7.7, 2.2 Hz, 1H, CF-CH-CH), 
4.64 (q, J = 7.1 Hz, 2H, CH2), 4.60-4.50 (br s, 1H, NH), 4.13 (q, J = 7.2 Hz, 2H, CH2), 3.88-
3.73 (m, 1H, CH), 3.30 (m, 2H, NH-CH2), 2.60-2.32 (m, 2H, COOEt-CH2), 2.09 (m, 1H, 
CHH-CH2COOEt), 1.90 (m, 1H, CHH-CH2COOEt), 1.82-1.68 (m, 4H, NHCH2-CH2-CH2-
CH), 1.42 (t, J = 7.1 Hz, 3H, CH3), 1.25 (t, J = 7.1 Hz, 3H, CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  214.2 (CS), 172.9 (CO), 163.3 (d, J = 236Hz, CF), 
157.9 (d, J = 17Hz, NH-C), 141.6 (d, J = 9Hz, CH-CH-CH), 102.5 (d, J = 4Hz, CHCNH), 
95.5 (d, J = 37Hz, CH-CF), 70.1 (CH2), 60.6 (CH2), 50.5 (CH), 41.6 (NHCH2), 31.9 
(NHCH2CH2), 31.6 (CH2-COOEt), 29.4 (CH2-CH2COOEt), 26.6 (CH2CH), 14.2 (CH3), 13.8 
(CH3) 
IR (ν, cm-1, CDCl3)  3691, 3607, 2985, 2939, 1727, 1602, 1577, 1508, 1456, 1420, 1375, 
1337, 1223, 1153, 1112, 1049 
HRMS (EI+)    Calcd. for C17H25FN2O3S2 : 388.1291      Found : 388.1289       
 
 
Experimental Part 
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Deuterated S-1-(ethoxycarbonyl)-6-(6-fluoropyridin-2-ylamino) hexan-3-yl O-ethyl 
carbonodithioate (5-56’) 
 
 
 
63mg of 5-56 (0.13mmol, 1.0eq.) was dissolved by 0.64ml DCM following by adding 0.08ml 
deuterated trifluoroacetic acid (1.03mmol, 8.0eq.). Under the protection of nitrogen, the 
mixture was kept stirring at room temperature for 30min to complete the Boc deprotection. 
Solvent and the rest TFA-d were removed to maximum by evaporation at 60°C under 
reduced pressure. Then 0.7ml D2O, 0.7ml Et2O with 2 drops of TEA were used to wash the 
crude product. After evaporating the solvent, the residue was kept in vacuo for 1 hour to 
maximum remove the rest solvent and base. Since the 1H-NMR indicated no significant 
impurity existed, the crude product was used directly into the next step without further 
purification in order to avoid the active proton exchange. 
 
 
ethyl 3-(7-fluoro-1,2,3,4-tetrahydro-1,8-naphthyridin-4-yl)propanoate (5-58) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-55 (36mg, 0.10mmol, 1.0 eq.) in 
AcOEt (1.9ml, 0.05mmol/ml), with DLP (39mg, 1.0 eq.). Flash chromatography on silica gel 
with AcOEt / EP = 10 / 90 afforded 5-58 (10mg, 41%) as a light yellow oil. 
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1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.25 (t, J = 8.0 Hz, 1H, CH-CH-C), 6.06 (dd, J = 7.8, 
2.3 Hz, 1H, CH-CF), 4.99 (br s, 1H, NH), 4.14 (q, J = 7.1 Hz, 2H, CH2-CH3), 3.54-3.33 (m, 
2H, NH-CH2), 2.93-2.63 (m, 1H, CH), 2.49-2.25 (m, 2H, COOEt-CH2 ), 2.03-1.84 (m, 2H, 2 
CH-CHH), 1.85-1.72 (m, 2H, 2 CH-CHH), 1.26 (t, J = 7.1 Hz, 3H, CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  173.3 (CO), 161.9 (d, J = 235 Hz, C-F), 154.0 (d, 
J = 17 Hz, NH-C), 140.3 (d, J = 9 Hz, CH-CH-C), 114.6 (d, J = 4 Hz, C-CNH), 95.0 (d, J = 
37 Hz, CH-CF), 60.5 (CH2-CH3), 37.7 (NH-CH2), 34.2 (CH), 31.5 (CH2-COOEt), 30.3 (CH-
CH2), 25.3 (CH-CH2), 14.2 (CH2-CH3) 
IR (ν, cm-1, CDCl3)  3691, 3443, 2938, 2863, 2255, 1727, 1618, 1523, 1464, 1376, 1356, 
1287, 1230, 1193, 1159, 1115, 1033 
HRMS (EI+)    Calcd. for C13H17FN2O2 : 252.1274      Found : 252.1278       
 
 
ethyl 6-(6-fluoropyridin-2-ylamino)hexanoate (5-58’) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-55 (36mg, 0.10mmol, 1.0 eq.) in 
AcOEt (1.9ml, 0.05mmol/ml), with DLP (39mg, 1.0 eq.). Flash chromatography on silica gel 
with AcOEt / EP = 20 / 80 afforded 5-58’ (12mg, 48%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.46 (dd, J = 8.0, 8.0 Hz, 1H, CH-CH-CH), 6.17 (dd, 
J = 8.0, 2.3 Hz, 1H, CH-CNH), 6.11 (dd, J = 7.8, 2.3 Hz, 1H, CH-CF), 4.57 (br s, 1H, NH), 
4.13 (q, J = 7.1 Hz, 2H, CH2-CH3), 3.25 (t, J = 7.1 Hz, 2H, NH-CH2), 2.31 (t, J = 7.4 Hz, 
2H, CH2-COOEt), 1.65 (m, 4H, 2 CH2), 1.52-1.33 (m, 2H, C2H4-CH2- C2H4), 1.25 (t, J = 7.1 
Hz, 3H, CH2-CH3) 
Experimental Part 
 408
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  173.6 (CO), 163.2 (d, J = 236 Hz, C-F), 158.0 (d, 
J = 17 Hz, NH-C), 141.7 (d, J = 9 Hz, CH-CH-CH), 102.2 (d, J = 4 Hz, CH-CNH), 95.4 (d, 
J = 37 Hz, CH-CF), 60.3 (CH2-CH3), 41.9 (NH-CH2), 34.2 (CH2-COOEt), 29.0 (CH2), 26.4 
(CH2), 24.6 (CH2), 14.2 (CH2-CH3) 
IR (ν, cm-1, CDCl3)  3691, 3432, 2937, 2863, 2254, 1726, 1623, 1576, 1508, 1457, 1420, 
1375, 1338, 1226, 1189, 1153, 1032 
HRMS (EI+)    Calcd. for C13H19FN2O2 : 254.1431      Found : 254.1436       
 
 
ethyl 7-(6-fluoropyridin-2-ylamino)heptanoate (5-59’) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-56 (22mg, 0.055mmol, 1.0 eq.) 
in AcOEt (1.1ml, 0.05mmol/ml), with DLP (22mg, 1.0 eq.). Flash chromatography on silica 
gel with AcOEt / EP = 10 / 90 afforded 5-59’ (7.8mg, 53%) as a colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.46 (dd, J = 8.1, 8.1 Hz, 1H, CH-CH-CH), 6.17 (dd, 
J = 8.0, 2.4 Hz, 1H, CH-CNH), 6.11 (dd, J = 7.7, 2.2 Hz, 1H, CH-CF), 4.52 (br s, 1H, NH), 
4.12 (q, J = 7.1 Hz, 2H, CH2-CH3), 3.23 (dt, J = 13.1, 6.6 Hz, 2H, NH-CH2), 2.29 (t, J = 7.5 
Hz, 2H, CH2-COOEt), 1.77-1.60 (m, 4H, NHCH2-CH2 + CH2- CH2COOEt), 1.52-1.37 (m, 
4H, CH2-CH2-CH2- CH2), 1.25 (t, J = 7.1 Hz, 3H, CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  173.7 (CO), 163.3 (d, J = 236 Hz, C-F), 158.1 (d, 
J = 17 Hz, NH-C), 141.7 (d, J = 9 Hz, CH-CH-CH), 102.2 (d, J = 4 Hz, CH-CNH), 95.4 (d, 
J = 37 Hz, CH-CF), 60.2 (CH2-CH3), 42.1 (NH-CH2), 34.2 (CH2-COOEt), 29.2 (CH2), 28.8 
(CH2), 26.6 (CH2), 24.8 (CH2), 14.3 (CH2-CH3) 
Experimental Part 
 409 
IR (ν, cm-1, CCl4)  3448, 2933, 2858, 1736, 1621, 1578, 1505, 1456, 1421, 1373, 1336, 1240, 
1227, 1181, 1151, 1097, 1034 
HRMS (EI+)    Calcd. for C14H21FN2O2 : 268.1587      Found : 268.1588       
 
 
Deuterated ethyl 7-(6-fluoropyridin-2-ylamino)heptanoate (5-59”) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-56’ (46mg, 0.12mmol, 1.0 eq.) 
in AcOEt (2.3ml, 0.05mmol/ml), with DLP (47mg, 1.0 eq.). Flash chromatography on silica 
gel with Et2O/n-pentane = 20/80 afforded a mixture of 5-59’ and 5-59”253 (12mg, 44%) as a 
light yellow oil.  
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.45 (dd, J = 8.0, 8.0 Hz, 1H, CH-CH-CH), 6.16 (dd, 
J = 8.0, 1.8 Hz, 1H, CH-CNH), 6.11 (dd, J = 7.7, 1.6 Hz, 1H, CH-CF), 4.56 (br s, 1H, NH), 
4.12 (q, J = 7.1 Hz, 2H, CH2-CH3), 3.23 (t, J = 7.1 Hz, 2H, NH-CH2), 2.29 (t, J = 7.5 Hz, 
2H, CH2-COOEt), 1.67-1.57 (m, 4H, NHCH2-CH2 + CH2- CH2COOEt), 1.44-1.38 (m, 4H, 
CH2-CH2-CH2- CH2), 1.25 (t, J = 7.1 Hz, 3H, CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  173.7 (CO), 163.2 (d, J = 236 Hz, C-F), 158.1 (d, 
J = 17 Hz, NH-C), 141.7 (d, J = 9 Hz, CH-CH-CH), 102.2 (d, J = 3 Hz, CH-CNH), 95.4 (d, 
J = 37 Hz, CH-CF), 60.2 (CH2-CH3), 42.1 (NH-CH2), 34.2 (CH2-COOEt), 29.2 (CH2), 28.8 
(CH2), 26.6 (CH2), 24.8 (CH2), 14.2 (CH2-CH3) 
                                                 
253
 Both of 5-59’ and 5-59" are detected by Mass Spectra, with an estimation of 20-25% 5-59” in the mixture. 
NMR and IR tests are made for this mixture since they are not separable.  
Experimental Part 
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IR (ν, cm-1, CCl4)  3449, 2933, 2859, 1736, 1621, 1578, 1503, 1456, 1421, 1373, 1336, 1227, 
1181, 1151, 1096, 1034 
HRMS (EI+)    Calcd. for C14H21FN2O2 : 268.1587      Found : 268.1590      (5-59’) 
HRMS (EI+)    Calcd. for C14H20FN2O2D : 269.1650      Found : 269.1653      (5-59”) 
 
 
tert-butyl 6-fluoropyridin-2-ylpent-4-enylcarbamate (5-60) 
 
 
 
208mg 6-fluoro-N-(pent-4-enyl)pyridin-2-amine 5-53 (1.16mmol, 1.0eq.) was dissolved by 
3.0ml anhydrous DMF (0.4 mmol / ml), following by adding 65mg NaH (60% suspension in 
oil). The mixture was heated to 50°C for 2 hours until no bubble formed. Then 340mg di-
tert-butyl dicarbonate (1.56mmol, 1.3eq.) was added portionwise. One hour later the reaction 
was finished. After work-up, flash chromatography on silica gel with Et2O / hexane = 5 / 95 
afforded 5-60 (265mg, 82%) as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.69 (dd, J = 8.1, 8.1 Hz, 1H CH-CH-CH), 7.60 (dd, 
J = 8.0, 1.9 Hz, 1H, CH-CH-CNH), 6.59 (dd, J = 7.8, 2.6 Hz, 1H, CF-CH-CH), 5.82 (tdd, J 
= 16.9, 10.2, 6.6 Hz, 1H, CH2-CH=CH2), 5.01 (dd, J = 17.1, 1.7 Hz, 1H, CH2-CH=CHH), 
4.96 (d, J = 10.2 Hz, 1H, CH2-CH=CHH), 3.92 (d, J = 7.5 Hz, 1H, NBoc-CHH), 3.90 (d, J = 
7.5 Hz, 1H, NBoc-CHH), 2.08 (td, J = 14.2, 7.3 Hz, 2H, CH2-CH=CH2), 1.73 (tt, J =7.5, 7.5 
Hz, 2H, CH2-CH2-CH2), 1.52 (s, 9H, (CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  161.7 (d, J = 238 Hz, C-F), 153.8 (CO), 153.0 (d, 
J = 14 Hz, NH-C), 141.4 (d, J = 8. Hz, CH-CH-CH), 138.0 (CH2-CH=CH2), 115.5 (d, J = 5 
Hz, CH-CH-CNH), 114.8 (CH2-CH=CH2), 103.3 (d, J = 36 Hz, CF-CH-CH), 81.5 (C(CH3)3), 
46.2 (NBoc-CH2), 31.1 (CH2-CH=CH2), 28.3 ((CH3)3), 27.9 (CH2-CH2-CH2) 
Experimental Part 
 411 
IR (ν, cm-1, CCl4)  2979, 2931, 1715, 1607, 1582, 1555, 1439, 1388, 1368, 1325, 1298, 1276, 
1242, 1207, 1154, 992, 913 
HRMS (EI+)    Calcd. for C15H21FN2O2 : 280.1587     Found : 280.1587 
 
 
ethyl 7-((tert-butoxycarbonyl)(6-fluoropyridin-2-yl)amino)-4-((ethoxycarbonothioyl) 
thio)heptanoate (5-62) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-60 (145mg, 
0.52mmol, 0.5 eq.) and the xanthate Xa-h (216mg, 1.03mmol, 1.0 eq.) in AcOEt (1.0ml, 1.0 
mmol/ml), with DLP (42mg, 0.10eq.). Flash chromatography on silica gel with AcOEt / EP = 
10 / 90 afforded 5-62 (113mg, 45%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.69 (dd, J = 8.1, 8.1 Hz, 1H, CH-CH-CH), 7.60 (dd, 
J = 8.0, 2.0 Hz, 1H, CH-CH-CNH), 6.59 (dd, J = 7.8, 3.0 Hz, 1H, CF-CH-CH), 4.62 (q, J = 
7.1 Hz, 2H, CH2), 4.12 (q, J = 7.1 Hz, 2H, CH2), 3.91 (t, J = 7.0 Hz, 2H, NBoc-CH2), 3.83-
3.71 (m, 1H, CH), 2.53-2.35 (m, 2H, COOEt-CH2), 2.15-2.01 (m, 1H, CHH-CH2COOEt), 
1.96-1.83 (m, 1H, CHH-CH2COOEt), 1.84-1.65 (m, 4H, NHCH2-CH2-CH2-CH), 1.52 (s, 9H, 
(CH3)3), 1.40 (t, J = 7.1 Hz, 3H, CH3), 1.24 (t, J = 7.1 Hz, 3H, CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  214.1 (C=S), 172.9 (COOEt), 161.6 (d, J = 238 Hz, 
C-F), 153.7 (COOtBu), 152.8 (d, J = 14 Hz, NH-C), 141.5 (d, J = 7 Hz, CH-CH-CH), 115.4 
(d, J = 5 Hz, CH-CNH), 103.4 (d, J = 36 Hz, CH-CF), 81.7 (CMe3), 69.9 (CH2), 60.5 (CH2), 
Experimental Part 
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50.5 (CH), 46.1 (NBoc-CH2), 31.6 (NBocCH2CH2), 31.6 (CH2-COOEt), 29.3 (CH2-
CH2COOEt), 28.3 (3(CH3)), 26.0 (CH2CH), 14.2 (CH3), 13.8 (CH3) 
IR (ν, cm-1, CCl4)  2981, 2933, 1737, 1716, 1606, 1582, 1439, 1390, 1369, 1296, 1276, 1215, 
1151, 1112, 1053, 992, 928, 910 
HRMS (EI+)    Calcd. for C22H33FN2O5S2 : 488.1815     Found : 488.1816 
 
 
 
ethyl 4-((ethoxycarbonothioyl)thio)-7-(N-(6-fluoropyridin-2-yl)acetamido)heptanoate 
(5-63) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-61 (83mg, 
0.37mmol, 0.5eq.) and the xanthate Xa-h (156mg, 0.75mmol, 1.0eq.) in AcOEt (0.8ml, 1.0 
mmol/ml), with DLP (60mg, 0.20eq.). Flash chromatography on silica gel with AcOEt / EP = 
30 / 70 afforded 5-63 (76mg, 48%) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.84 (dd, 1H, J = 16.0, 8.1 Hz, CH-CH-CH), 7.16 (d, 
1H, J = 6.4 Hz, CH-CH-CNAc), 6.85 (dd, 1H, J = 8.0, 2.8 Hz, CF-CH-CH), 4.62 (q, 2H, J = 
7.1 Hz, CH2), 4.12 (q, 2H, J = 7.1 Hz, CH2), 3.95-3.79 (m, 2H, NAc-CH2), 3.78-3.70 (m, 1H, 
CH), 2.43 (ddd, 2H, J = 8.3, 6.8, 2.6 Hz, COOEt-CH2), 2.08 (s, 3H, COCH3), 2.08-2.00 (m, 
1H, CHH-CH2COOEt), 1.95-1.80 (m, 1H, CHH-CH2COOEt), 1.77-1.63 (m, 4H, NHCH2-
CH2-CH2-CH), 1.41 (t, 3H, J = 7.1 Hz, CH3), 1.24 (t, 3H, J = 7.1 Hz, CH3) 
Experimental Part 
 413 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  214.1 (C=S), 173.0 (COOEt), 171.6 (d, J = 238.7 
Hz, C-F), 170.3 (COCH3), 153.5 (d, J = 15.0 Hz, NH-C), 142.7 (d, J = 7.9 Hz, CH-CH-CH), 
118.1 (d, J = 4.6 Hz, CH-CNH), 103.2 (d, J = 39 Hz, CH-CF), 70.0 (CH2), 60.6 (CH2), 50.5 
(CH), 47.3 (CH2), 31.6 (2 CH2), 29.5 (CH2), 25.7 (CH2), 23.4 (COCH3), 14.3 (CH2CH3), 13.8 
(CH2CH3) 
 
 
 
2-((2,4-dichloro-6-(methylamino)pyrimidin-5-yl)methyl)isoindoline-1,3-dione (5-66) 
 
 
 
Following the general procedure 5-III for the radical addition of xanthates on the pyrimidine 
rings, the reaction was carried out with the solution of 2,6-dichloro-N-methylpyrimidin-4-
amine (51mg, 0.28mmol, 0.9eq.) and the xanthate Xa-c (90mg, 0.32mmol, 1.0eq.) in AcOEt 
(0.6ml, 0.5mmol/ml), with DLP (140mg, 1.1eq.). Flash chromatography on silica gel with 
AcOEt / DCM = 5 / 95 recovered 24mg 2,6-dichloro-N-methylpyrimidin-4-amine and 
afforded 5-66 (37mg, 39% and 74% as modified yield) as white needle crystal. 
 
m.p. : 221-225°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.95-7.82 (m, 2H, 2 H-phthalimide), 7.80-7.73 (m, 
2H, 2 H-phthalimide), 6.99 (d, 1H, J = 3.2 Hz, NH), 4.85 (s, 2H, CH2), 3.02 (d, 3H, J = 4.7 
Hz, CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  168.7 (2 CO-phthalimide), 163.2 (C-Ar), 159.8 (C-
Ar), 159.2 (C-Ar), 134.7 (2 CH-phthalimide), 131.5 (2 C-phthalimide), 123.8 (2 CH-
phthalimide), 107.2 (Ar-C-CH2), 34.5 (CH2), 28.9 (CH3) 
 
 
Experimental Part 
 414
ethyl 2-(2,4-dichloro-6-(methylamino)pyrimidin-5-yl)acetate (5-67) 
 
 
 
Following the general procedure 5-III for the radical addition of xanthates on the pyrimidine 
rings, the reaction was carried out with the solution of 2,6-dichloro-N-methylpyrimidin-4-
amine (10mg, 0.056mmol, 0.4eq.) and the xanthate Xa-h (32mg, 0.154mmol, 1.0eq.) in 
AcOEt (0.4ml, 0.4mmol/ml), with DLP (47.4mg, 0.8eq.). Flash chromatography on silica gel 
with AcOEt / EP = 10 / 90 recovered 2.9mg 2,6-dichloro-N-methylpyrimidin-4-amine and 
afforded 5-67 (8.4mg, 57% and 80% as modified yield) as colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.99 (br s, 1H, NH), 4.18 (q, 2H, J = 7.1 Hz, 
CH2CH3), 3.61 (s, 2H, CH2), 3.06 (d, 3H, J = 4.8 Hz, NHCH3), 1.28 (t, 3H, J = 7.1 Hz, 
CH2CH3) 
 
 
ethyl 2-(4,6-dichloro-2-(methylamino)pyrimidin-5-yl)acetate (5-68) 
 
 
 
Following the general procedure 5-III for the radical addition of xanthates on the pyrimidine 
rings, the reaction was carried out with the solution of 4,6-dichloro-N-methylpyrimidin-2-
amine (12mg, 0.068mmol, 0.3eq.) and the xanthate Xa-h (56mg, 0.27mmol, 1.0eq.) in 
AcOEt (0.54ml, 0.5mmol/ml), with DLP (76mg, 0.7eq.). Flash chromatography on silica gel 
with AcOEt / EP = 15 / 85 afforded 5-68 (7.4mg, 41%) as white solid. 
Experimental Part 
 415 
In comparative study, the reaction was carried out with the solution of 4,6-dichloro-N-
methylpyrimidin-2-amine (194mg, 1.09mmol, 2.0eq.) and the xanthate Xa-h (114mg, 
0.54mmol, 1.0eq.) in DCE (2.1ml, 0.3mmol/ml), with DLP (260mg, 1.2eq.). Flash 
chromatography on silica gel with AcOEt / EP = 15 / 85 afforded 5-68 (36mg, 13%) as white 
solid. 
 
m.p. : 124-128°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.48 (br s, 1H, NH), 4.20 (dq, 2H, J = 7.1, 2.8 Hz, 
CH2CH3), 3.77 (s, 2H, CH2), 3.00 (d, 3H, J = 5.1 Hz, NHCH3), 1.27 (t, 3H, J = 7.1 Hz, 
CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  169.3 (CO), 162.2 (NH-C-Ar),160.5 (2 Cl-C-Ar), 
112.7 (CH2-C-Ar), 61.4 (CH2CH3), 35.0 (CO-CH2), 28.5 (NH-CH3), 14.2 (CH2CH3) 
 
 
4-allyl-1-tosylpiperidin-4-amine (5-69-0) 
 
 
 
To 239mg 1-tosylpiperidin-4-one (0.94mmol 1.0 eq.) was added 5.2 mL a solution of 
ammonia in methanol (2M in MeOH, 10.4mmol, 11 eq.). The resulting solution was stirred 
for 15 min at rt. 0.2 ml allylboronic acid pinacolester (1.07mmol, 1.1 eq.) was then added 
dropwise. The reaction mixture was subseq.uently stirred for 17 hours at rt. All volatiles were 
removed in vacuo and the residue re-dissolved in Et2O. The desired amine was then extracted 
with 1N HCl. The acidic aqueous extract was washed with Et2O. The aqueous extract was 
next made alkaline by addition of solid NaOH. The alkaline aqueous layer was then extracted 
with dichloromethane. The combined organic extracts were dried (MgSO4), filtered and 
Experimental Part 
 416
concentrated in vacuo to afford a crude product of the desired amine. Flash chromatography 
on silica gel with AcOEt / DCM = 20 / 80 afforded the olefinic precursor for 5-69-0 (212mg, 
77%) as a white powder. 
 
m.p. : 113-117°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.65 (d, J = 8.2 Hz, 2H, H-aromatic), 7.31 (d, J = 8.3 
Hz, 2H, H-aromatic), 5.76 (tdd, J = 17.4, 10.1, 7.5 Hz, 1H, CH2-CH=CH2), 5.10 (ddd, J = 
18.3, 13.6, 1.4 Hz, 2H, CH2-CH=CH2), 3.41 (td, J = 8.0, 3.8 Hz, 2H, 2 CHH-NTs), 2.78 (dt, 
J = 11.5, 2.8 Hz, 2H, 2 CHH-NTs), 2.43 (s, 3H, CH3), 2.06 (d, J = 7.5 Hz, 2H, CH2-
CH=CH2), 1.78-1.61 (m, 2H, 2 NHC-CHH), 1.41 (d, J = 13.4 Hz, 2H, 2 NHC-CHH), 0.98  
(br s, 2H, NH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  143.3 (C-Ar), 133.5 (C-Ar), 132.7 (CH2-CH=CH2), 
129.6 (2 CH-Ar), 127.6 (2 CH-Ar), 119.4 (CH2-CH=CH2), 48.9 (CH2-CH=CH2), 48.6 (NH2-
C), 42.2 (2 CH2-NTs), 36.8 (2 NHC-CH2), 21.5 (CH3) 
IR (ν, cm-1, CCl4)  2927, 2855, 1639, 1599, 1464, 1443, 1361, 1347, 1305, 1248, 1166, 1094, 
1051, 921 
HRMS (EI+)    Calcd. for C15H22N2O2S : 294.1402      Found : 294.1407       
 
 
N-(4-allyl-1-tosylpiperidin-4-yl)-2,6-dichloropyrimidin-4-amine (5-69) 
 
 
 
Experimental Part 
 417 
158mg trichloropyrimidine (0.86mmol, 1.2eq.) was dissolved by 1.8ml THF and then 212mg 
of the above precursor (0.72mmol, 1.0eq.) was added. The mixture was refluxed for 18 hours 
to finish the reaction. After work-up, flash chromatography on silica gel with AcOEt / EP = 
40 / 60 afforded 5-69 (93mg, 29%) as colorless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.63 (d, J = 8.2 Hz, 2H, H-aromatic), 7.33 (d, J = 7.9 
Hz, 2H, H-aromatic), 6.23 (s, 1H, , H-aromatic), 5.60 (qd, J = 10.1, 7.4 Hz, 1H, CH2-
CH=CH2), 5.02 (dd, J = 39.6, 13.6 Hz, 2H, CH2-CH=CH2), 4.62 (br s, 1H, NH), 3.46 (d, J = 
11.5 Hz, 2H, 2 CHH-NTs), 2.63 (m, 4H, 2 CHH-NTs + CH2-CH=CH2), 2.44 (s, 3H, CH3), 
2.26 (d, J = 12.8 Hz, 2H, 2 NHC-CHH), 1.85 (m, 2H, 2 NHC-CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  163.5 (C-pyrimidine), 159.6 (C-pyrimidine), 159.3 
(C-pyrimidine), 143.8 (C-Ar), 133.1 (C-Ar), 131.5 (CH2-CH=CH2), 129.8 (2 CH-Ar), 127.6 
(2 CH-Ar), 119.9 (CH2-CH=CH2), 103.1 (CH-pyrimidine), 55.0 (NH-C), 41.8 (2 CH2-NTs), 
40.5 (CH2-CH=CH2), 34.0 (2 NHC-CH2), 21.6 (CH3) 
IR (ν, cm-1, CCl4)  3433, 3366, 2928, 2855, 1574, 1488, 1448, 1362, 1327, 1269, 1171, 1121, 
1092, 1053, 1034, 995, 923   
HRMS (EI+)    Calcd. for C19H22Cl2N4O2S : 440.0841      Found : 440.0812       
 
 
S-1-(4-(2,6-dichloropyrimidin-4-ylamino)-1-tosylpiperidin-4-yl)-4-(1-benzyl-1H-
tetrazol-5-yl)butan-2-yl O-ethyl carbonodithioate (5-70) 
 
 
 
Experimental Part 
 418
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-69 (62mg, 
0.14mmol, 0.8 eq.) and the xanthate Xa-m (53mg, 0.18mmol, 1.0 eq.) in AcOEt (0.14ml, 1.3 
mmol/ml), with DLP (11mg, 0.15 eq.). Flash chromatography on silica gel with AcOEt / EP 
= 30 / 70 afforded 5-70 (63mg, 62%) as a colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.63 (d, J = 8.2 Hz, 2H, H-aromatic), 7.34 (m, 5H, 
H-aromatic), 7.15 (dd, J = 6.6, 2.9 Hz, 2H, H-aromatic), 6.24 (d, J = 1.8 Hz, 1H, H-
pirimidine), 5.48 (d, J = 15.4 Hz, 1H, CHH-Ph), 5.40 (br s, 1H, NH), 5.32 (d, J = 15.4 Hz, 
1H, CHH-Ph), 4.52 (dq, J = 7.1, 1.3 Hz, 2H, CH2-CH3), 3.82 (dt, J = 9.5, 9.3, 5.8 Hz, 1H, 
CH), 3.63-3.48 (m, 2H, 2 CHH-NTs), 2.78 (m, 2H, tetrazole C-CHH + NHC-CHH), 2.67-
2.15 (m +s, 10H, tetrazole C-CHH + 2 CHH-NTs + CH3 + NHC-CHH + CH-CH2-C + CH-
CHH-CH2), 1.86 (tt, J = 15.0, 5.1 Hz, 1H, CH-CHH-CH2), 1.80-1.68 (m, 2H, 2 NHC-CHH), 
1.36 (t, J = 7.1 Hz, 3H, CH2-CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  214.3 (C=S), 164.0 (C-pyrimidine), 159.4 (C-
pyrimidine), 158.9 (C-pyrimidine), 154.3 (C-tetrazole), 143.7 (C-toluene), 133.1 (C-toluene), 
132.7 (C-benzene), 129.9 (2 CH-toluene), 129.3 (2 CH-benzene), 129.1 (CH-benzene), 127.6 
(2 CH-toluene + 2 CH-benzene), 104.0 (CH-pyrimidine),  70.8 (CH2-CH3), 55.3 (C-NH), 
50.9 (CH2-Ph), 45.9 (CH), 42.0 (NHC-CH2-CH), 41.8 (2 CH2-NTs), 34.8 (NHC-CH2), 34.5 
(NHC-CH2), 32.0 (CH2-CH2-CH), 21.6 (CH3), 20.9 (tetrazole C-CH2), 13.8 (CH2-CH3) 
IR (ν, cm-1, CCl4)  2927, 2855, 1573, 1489, 1453, 1360, 1270, 1221, 1173, 1120, 1054, 909 
HRMS (EI+)    Calcd. for C28H31Cl2N8O2S : 613.1668      Found : 613.1658       
 
 
 
 
 
 
 
 
Experimental Part 
 419 
5'-(2-(1-benzyl-1H-tetrazol-5-yl)ethyl)-2',4'-dichloro-1-tosyl-6',8'-dihydro-5'H-
spiro[piperidine-4,7'-pyrido[2,3-d]pyrimidine] (5-71) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-70 (35mg, 0.048mmol, 1.0 eq.) 
in AcOEt (1.6ml, 0.03mmol/ml), with DLP (19mg, 1.0 eq.). Flash chromatography on silica 
gel with AcOEt / EP = 40 / 60 afforded 5-71 (22mg, 77%) as a white powder. 
 
m.p. : 222-224°C 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.63 (d, J = 8.1 Hz, 2H, H-aromatic), 7.44-7.33 (m, 
5H, H-aromatic), 7.16 (m, 2H, H-aromatic), 5.59-5.45 (m, 3H, CH2-Ph + NH), 3.48 (m, 2H, 
2 CHH-NTs), 3.14-2.97 (m, 1H, CH), 2.85-2.67 (m, 2H, tetrazole C-CH2), 2.60-2.45 (m + s, 
5H, 2 CHH-NTs + CH3), 2.16 (m, 1H, CH-CHH-CH2), 1.95 (dt, J = 14.4, 8.6 Hz, 1H, CH-
CHH-CH2), 1.88-1.66 (m, 5H, 2 NHC-CH2 + CH-CHH-C), 1.58 (d, J = 13.6 Hz, 1H, CH-
CHH-C) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  160.7 (C-pyrimidine), 158.2 (C-pyrimidine), 157.4 
(C-pyrimidine), 153.8 (C-tetrazole), 144.4 (C-toluene), 133.1 (C-toluene), 132.3 (C-benzene), 
130.1 (2 CH-toluene), 129.5 (2 CH-benzene), 129.3 (CH-benzene), 127.6 (2 CH-aromatic), 
127.3 (2 CH-aromatic), 111.3 (C-pyrimidine), 51.0 (CH2-Ph), 50.3 (C-NH), 41.8 (CH2-NTs), 
41.7 (CH2-NTs), 37.3 (CH-CH2-C), 37.1 (NHC-CH2), 37.0 (NHC-CH2), 30.7 (CH), 30.6 
(CH2-CH2-CH), 21.6 (CH3), 21.3 (tetrazole C-CH2) 
Experimental Part 
 420
IR (ν, cm-1, Nujol)  3281, 1573, 1556, 1519, 1420, 1400, 1343, 1328, 1274, 1162, 1119, 
1094, 1054, 1040, 936, 924 
HRMS (EI+)    Calcd. for C28H30Cl2N8O2S : 612.1589      Found : 612.1595       
 
 
S-(2-((2,6-dichloropyrimidin-4-yl)(methyl)amino)-2-oxoethyl) O-ethyl carbonodithioate 
(5-72) 
 
 
 
5.0g trichloropyrimidine (27.3mmol, 1.0eq.) was dissolved by 70ml THF (0.4mmol/ml) and 
then 4.38ml methylamine 40% aqueous solution (42.6mmol, 1.6eq.) was added drop by drop 
with ice-bain. The mixture was then warmed to room temperature and stirring for 2 hours to 
finish the reaction. After work-up, flash chromatography on silica gel with DCM / EP = 70 / 
30 afforded 2,6-dichloro-N-methylpyrimidin-4-amine (2.95g, 61%) as white solid. 
 
722mg 2,6-dichloro-N-methylpyrimidin-4-amine (4.1mmol, 1.0eq.) was dissolved by 10ml 
toluene (0.4mmol/ml) and then1.6ml chloroacetyl chloride (20.1mmol, 4.9eq.) was added 
drop by drop, followed by refluxing the mixture under the protection of nitrogen for 8 hours. 
After work-up, the crude product was used directly in next step, without further purification. 
 
The crude product of last step was dissolved by 40ml acetone (0.1mmol/ml) and then 2.1g 
xanthate salt (13.1mmol, 3.2eq.) was added portionwise. About 30min later, the reaction 
finished and purification after work-up on silica gel with DCM / EP = 90 / 10 afforded 5-72 
(1.71g, 42% for two steps) as yellow solid. 
 
Experimental Part 
 421 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 7.82 (s, 1H, CH), 4.65 (q, J = 7.12 Hz, 2H, CH2CH3), 
4.14 (s, 2H, SCH2), 3.60 (s, 3H, NCH3), 1.43 (t, J = 7.11 Hz, 3H, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 213.2 (C=S), 168.9 (C=O), 162.8 (C-Ar), 162.2 (C-
Ar), 159.0 (C-Ar), 110.7 (CH-Ar), 71.1 (OCH2), 42.2 (SCH2), 34.0 (NCH3), 13.8 (CH2CH3) 
IR (ν, cm-1, CDCl3) 3693, 3606, 3157, 2987, 2961, 1702, 1601, 1556, 1528, 1469, 1444, 
1400, 1371, 1357, 1333, 1240, 1207, 1178, 1151, 1114, 1088, 1048, 1002, 982 
HRMS (EI+)    Calcd. for C10H11Cl2N3O2S2 : 338.9670     Found : 338.9662 
 
 
5-((2,6-dichloropyrimidin-4-yl)(methyl)amino)-2-((ethoxycarbonothioyl)thio)-5-
oxopentyl acetate (5-73) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-72 (248mg, 
0.73mmol, 1.0eq.) and allyl acetate (0.16ml, 1.46mmol, 2.0eq.) in AcOEt (0.73ml, 1.0 
mmol/ml), with DLP (87mg, 0.3eq.). Flash chromatography on silica gel with AcOEt / EP = 
15 / 85 afforded 5-73 (129mg, 40%) as a light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.06 (s, 1H, CH), 4.65 (q, J = 7.12 Hz, 2H, CH2CH3), 
4.32 (ddd, J = 17.56, 11.42, 5.50 Hz, 2H, COOCH2), 4.09 (dt, J = 10.47, 4.71 Hz, 1H, SCH), 
3.49 (s, 3H, NCH3), 2.97-2.83 (m, 2H, COCH2), 2.35-2.26 (m, 1H, COCH2CHH), 2.09 (s, 3H, 
COCH3), 2.04-1.94 (m, 1H, COCH2CHH), 1.42 (t, J = 7.12 Hz, 3H, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 212.9 (C=S), 173.8 (COO), 170.6 (CON), 162.5 
(C-Ar), 162.2 (C-Ar), 158.9 (C-Ar), 111.4 (CH-Ar), 70.6 (CH2CH3), 65.8 (COOCH2), 49.0 
(SCH), 34.0 (COCH2), 33.7 (NCH3), 25.9 (COCH2CH2), 20.8 (CH3COO), 13.7 (CH2CH3) 
Experimental Part 
 422
IR (ν, cm-1, CDCl3) 3515, 3457, 3435, 3153, 2985, 2940, 1741, 1708, 1591, 1556, 1525, 
1443, 1400, 1374, 1334, 1230, 1150, 1112, 1050, 982 
HRMS (EI+) Calcd. for C12H14Cl2N3O3: 318.0412    Found: 318.0419 
 
 
(2,4-dichloro-9-methyl-8-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]azepin-5-yl)methyl 
acetate (5-74) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-73 (123mg, 0.28mmol, 1.0eq.) 
in AcOEt (6ml, 0.05mmol/ml), with DLP (134mg, 1.2eq.). Flash chromatography on silica 
gel with AcOEt / EP = 20 / 80 afforded 5-74 (44mg, 49%) as white solid. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 4.30-4.25 (m, 1H, COOCHH), 4.16-4.11 (m, 1H, 
COOCHH), 4.04-3.98 (m, 1H, CH), 3.43 (s, 3H, NCH3), 2.57-2.51 (m, 1H, COCHH), 2.49-
2.39 (m, 2H, COCH2CH2), 2.24-2.15 m, 1H, COCHH), 1.94 (s, 3H, COCH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 172.2 (COO), 170.3 (CON), 165.0 (2 C-Ar), 158.1 
(C-Ar), 122.6 (C-Ar), 70.6 (CH2CH3), 64.0 (COOCH2), 36.4 (CH), 33.5 (COCH2), 33.4 
(NCH3), 29.0 (COCH2CH2), 20.5 (CH3COO) 
IR (ν, cm-1, CDCl3) 3693, 3519, 2928, 2856, 1803, 1744, 1695, 1601, 1541, 1526, 1457, 
1394, 1373, 1353, 1320, 1299, 1254, 1230, 1136, 1042, 1020, 970 
HRMS (EI+)    Calcd. for C12H13Cl2N3O3 : 317.0334     Found : 317.0338 
 
 
Experimental Part 
 423 
tert-butyl (5-((2,6-dichloropyrimidin-4-yl)(methyl)amino)-2-((ethoxycarbonothioyl) 
thio)-5-oxopentyl)carbamate (5-75) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-72 (300mg, 
0.88mmol, 1.0eq.) and Boc protected allylamine (276mg, 1.76mmol, 2.0eq.) in AcOEt 
(0.88ml, 1.0mmol/ml), with DLP (18mg, 0.05eq.). Flash chromatography on silica gel with 
AcOEt / EP = 15 / 85 afforded 5-75 (235mg, 54%) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.08 (s, 1H, CH), 4.88 (brs, 1H, NH), 4.64 (q, J = 
7.11 Hz, 2H, CH2CH3), 3.93 (dt, J = 11.33, 5.78 Hz, 1H, SCH), 3.54-3.49 (m, 1H, NHCHH), 
3.49 (s, 3H, NCH3), 3.45-3.38 (m, 1H, NHCHH), 2.85 (t, J = 7.11 Hz, 2H,  COCH2), 2.27-
2.18 (m, 1H, COCH2CHH), 2.01-1.93 (m, 1H, COCH2CHH), 1.43 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 213.3 (C=S), 173.8 (CON), 162.4 (C-Ar), 162.2 
(C-Ar), 158.9 (C-Ar), 155.9 (COOtBu), 111.5 (CH-Ar), 79.7 (C(CH3)3), 70.4 (CH2CH3), 
51.2 (SCH), 43.7 (NHCH2), 34.0 (COCH2), 33.7 (NCH3), 28.3 (C(CH3)3), 26.4 (COCH2CH2), 
13.7 (CH2CH3) 
IR (ν, cm-1, CDCl3) 3078, 2927, 2855, 1639, 1599, 1495, 1464, 1443, 1361, 1305, 1248, 
1166, 1119, 1094, 1051, 999, 921 
 
 
 
 
Experimental Part 
 424
S-(5-((2,6-dichloropyrimidin-4-yl)(methyl)amino)-5-oxo-1-(trimethylsilyl)pentan-2-yl) 
O-ethyl carbonodithioate (5-76) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-72 (147mg, 
0.43mmol, 1.0eq.) and allyl trimethylsilane (98mg, 0.86mmol, 2.0eq.) in AcOEt (0.43ml, 
1.0mmol/ml), with DLP (110mg, 0.6eq.). Flash chromatography on silica gel with AcOEt / 
EP = 10 / 90 afforded 5-76 (53mg, 26%) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.09 (s, 1H, CH), 4.88 (brs, 1H, NH), 4.63 (dq, J = 
7.10, 2.77 Hz, 2H, CH2CH3), 3.97 (ddd, J = 12.10, 8.58, 4.02 Hz, 1H, SCH), 3.48 (s, 3H, 
NCH3), 2.87-2.71 (m, 2H, COCH2), 2.32-2.24 (m, 1H, COCH2CHH), 1.99-1.89 (m, 1H, 
COCH2CHH), 1.41 (t, J = 7.12 Hz, 3H, CH2CH3), 1.12 (ddd, J = 23.05, 14.86, 7.64 Hz, 2H, 
SiCH2) 
 
 
2,4-dichloro-7-methyl-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one (5-77) 
 
 
 
Experimental Part 
 425 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-72 (81mg, 0.24mmol, 1.0eq.) in 
AcOEt (6ml, 0.04mmol/ml), with DLP (160mg, 1.4eq.). Flash chromatography on silica gel 
with AcOEt / EP = 25 / 75 afforded 5-77 (33mg, 64%) as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 3.58 (s, 2H, CH2), 3.28 (s, 3H, NCH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 172.4 (CO), 167.5 (C-Ar), 159.5 (C-Ar), 153.0 (C-
Ar), 113.2 (C-Ar), 32.8 (CH2), 26.2 (CH3) 
IR (ν, cm-1, CDCl3) 3690, 3606, 3502, 2928, 2856, 1754, 1606, 1562, 1498, 1466, 1406, 
1390, 1372, 1342, 1294, 1231, 1222, 1119, 1078 
HRMS (EI+)    Calcd. for C12H12F3N3O2 : 216.9810     Found : 216.9804 
 
 
S-(2-((2,6-dichloropyrimidin-4-yl)amino)-2-oxoethyl) O-ethyl carbonodithioate (5-78) 
 
 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.49 (brs, 1H, NH), 7.11 (s, 1H, CH), 4.67 (q, J = 
7.12 Hz, 2H, CH2CH3), 4.35 (s, 2H, SCH2), 1.44 (t, J = 7.10 Hz, 3H, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 212.7 (C=S), 166.2 (NHCO), 162.5 (2 C-Ar), 156.3 
(C-Ar), 116.1 (CH-Ar), 71.2 (CH2CH3), 40.9 (SCH2), 13.7 (CH2CH3) 
IR (ν, cm-1, CDCl3) 3696, 3381, 3121, 2988, 1726, 1601, 1549, 1491, 1442, 1405, 1382, 
1367, 1321, 1293, 1235, 1178, 1150, 1108, 1049, 1019, 1003 
HRMS (EI+)    Calcd. for C9H9Cl2N3O2S2 : 324.9513     Found : 324.9506 
 
 
Experimental Part 
 426
5-((2,6-dichloropyrimidin-4-yl)amino)-2-((ethoxycarbonothioyl)thio)-5-oxopentyl 
acetate (5-79) 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-78 (129mg, 
0.40mmol, 1.0eq.) and allyl trimethylsilane (79mg, 0.79mmol, 2.0eq.) in AcOEt (0.8ml, 
0.5mmol/ml), with DLP (110mg, 0.6eq.). Flash chromatography on silica gel with AcOEt / 
EP = 10 / 90 afforded 5-79 (117mg, 69%) as yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz) 8.36 (NH), 8.16 (s, 1H, CH), 4.63 (q, J = 7.11 Hz, 2H, 
CH2CH3), 4.30 (ddd, J = 17.62, 11.47, 5.49 Hz, 2H, COOCH2), 4.05 (dt, J = 10.64, 10.32, 
4.84 Hz, 1H, SCH), 2.71-2.53 (m, 2H, COCH2), 2.32-2.23 (m, 1H, COCH2CHH), 2.09 (s, 3H, 
COCH3), 2.03-1.95 (m, 1H, COCH2CHH), 1.41 (t, J = 7.12 Hz, 3H, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 212.6 (C=S), 171.1 (COO), 170.8 (CON), 163.5 
(C-Ar), 159.3 (C-Ar), 159.1 (C-Ar), 107.8 (CH-Ar), 70.7 (CH2CH3), 65.5 (COOCH2), 48.9 
(SCH), 34.4 (COCH2), 25.7 (COCH2CH2), 20.8 (CH3COO), 13.7 (CH2CH3) 
IR (ν, cm-1, CDCl3) 3398, 2986, 1737, 1571, 1548, 1491, 1383, 1365, 1340, 1230, 1215, 
1144, 1113, 1050 
HRMS (EI+)    Calcd. for C14H17Cl2N3O4S2 : 425.0038     Found : 425.0030 
 
 
 
 
 
 
 
Experimental Part 
 427 
3-(2-(benzylamino)-4-chloro-7-(methylsulfonyl)-6,7-dihydro-5H-pyrrolo[2,3-
d]pyrimidin-5-yl)propanenitrile (5-81) 
 
 
 
26mg of 5-21 (0.08mmol, 1eq.) was dissolved with 0.8ml EtOH, followed by adding 0.04ml 
benzylamine (0.4mmol, 5eq.) and 0.03ml DIPEA (0.16mmol, 2eq.). The mixture was stirring 
at room temperature for 3 hours. The desired product 5-81 as white precipitation (30mg, 95%) 
was isolated by centrifuge. 
 
m.p. : 209~212°C 
1H-NMR (į, ppm) (Acetone-d6, 400 MHz)  7.49-7.15 (m, 5H, Ph), 4.60 (d, 2H, J = 5.9 Hz, 
NH-CH2), 4.15 (t, 1H, J=10.1Hz, CHH-NMs), 3.91 (dd, 1H, J = 10.3, 3.6 Hz, CHH-NMs), 
3.53-3.41 (m, 1H, CH-CH2-NMs), 3.32 and 3.11 (br s, 1H, SO2-CH3), 2.75 (br s, 1H, NH), 
2.64 (t, 1H, J = 7.5Hz, CH2-CN), 2.27-2.19 (m, 1H, CHH-CH2-CN), 2.02-1.95 (m, 1H, 
CHH-CH2-CN) 
13C-NMR (į, ppm) (Acetone-d6, 100.6 MHz)  166.1 (Ar-C), 164.1 (Ar-C), 156.8 (Ar-C), 
141.7 (Ar-C), 130.2 (3 Ph-C), 129.5 (2 Ph-C), 128.7 (Ph-C), 121.2 (C≡N), 54.4 (CH2-NMs), 
46.8 (NH-CH2), 40.7 (SO2-CH3), 37.1 (CH-CH2-NMs), 30.5 (CH2-CH2-CN), 15.6 (CH2-CN) 
IR (ν, cm-1, CCl4)  3284, 2925, 2854, 1619, 1592, 1463, 1377, 1341, 1160, 1152, 1036 
HRMS (EI+)    Calcd. for C17H18ClN5O2S : 391.0870      Found : 391.0867 
 
 
 
 
 
Experimental Part 
 428
3-(2-(benzo[d]thiazol-2-ylthio)-4-chloro-7-(methylsulfonyl)-6,7-dihydro-5H-pyrrolo[2,3-
d]pyrimidin-5-yl)propanenitrile (5-82) 
 
 
 
24mg of 5-21 (0.074mmol, 1eq.) was dissolved with 0.8ml EtOH, followed by adding 15mg 
2-mercaptobenzothiazole (0.089mmol, 1.2eq.) and 0.06ml DIPEA (0.36mmol, 5eq.). The 
mixture was stirring at 80°C for 5 hours. The desired product 5-82 as white precipitation 
(32mg, 96%) was isolated by centrifuge. 
 
m.p. : 193~197°C 
1H-NMR (į, ppm) (DMSO, 400 MHz)  8.19 (d, 1H, J = 7.9 Hz, H-aromatic), 8.03 (d, 1H, J 
= 8.0 Hz, H-aromatic), 7.54 (td, 2H, J = 23.7, 7.5 Hz, 2 H-aromatic), 4.24 (t, 1H, J = 9.8 Hz, 
CHH-NMs), 4.02 (dd, 1H, J = 10.3, 3.8 Hz, CHH-NMs), 3.68-3.52 (m, 1H, CH-CH2-NMs), 
3.39 (s, 3H, SO2-CH3), 2.69 (t, 2H, J = 7.4 Hz, CH2-CN), 2.24-2.06 (m, 1H, CHH-CH2-CN), 
2.00 (m, 1H, CHH-CH2-CN) 
13C-NMR (į, ppm) (DεSO, 100.6 εHz)  163.3 (MsN-C-N), 157.8 (C-aromatic), 157.7 (C-
aromatic), 157.2 (C-aromatic), 151.3 (C-aromatic), 136.0 (C-aromatic), 126.7 (CH-aromatic), 
125.8 (CH-aromatic), 122.4 (CH-aromatic), 121.9 (CH-aromatic), 121.1 (MsN-C-C), 120.1 
(C≡N), 53.2 (CH2-NMs), 39.0 (SO2-CH3),34.5 (CH-CH2-NMs), 27.1 (CH2-CH2-CN), 13.5 
(CH2-CN) 
IR (ν, cm-1, CCl4)  2926, 2854, 1555, 1460, 1412, 1377, 1349, 1282, 1161, 1038, 960 
 
 
 
 
 
Experimental Part 
 429 
3-(4-chloro-2-(cyclopropylamino)-7-(methylsulfonyl)-6,7-dihydro-5H-pyrrolo[2,3-
d]pyrimidin-5-yl)propanenitrile (5-83) 
 
 
 
22mg of 5-21 (0.068mmol, 1eq.) was dissolved with 0.7ml EtOH, followed by adding 0.01ml 
cyclopropylamine (0.14mmol, 2eq.) and 0.06ml DIPEA (0.34mmol, 5eq.). The mixture was 
stirring at 80°C for 2 hours and the suspension changed to clear solution. The desired product 
5-83 as white solid (21mg, 91%) was isolated by centrifuge. 
 
m.p. : 146~149°C 
1H-NMR (į, ppm) (DεSO, 400 εHz)  7.84 (s, 1H, NH), 4.06 (t, 1H, J = 9.6 Hz, CHH-
NMs), 3.81 (dd, 1H, J = 9.9, 3.6 Hz, CHH-NMs), 3.36 (br s, 4H, SO2-CH3 + CH-CH2-NMs), 
2.78-2.64 (m, 1H, NH-CH), 2.64-2.56 (m, 2H, CH2-CN), 2.14-1.94 (m, 1H, CHH-CH2-CN), 
1.91-1.76 (m, 1H, CHH-CH2-CN), 0.75-0.55 (m, 2H, -CHH-CHH-), 0.47 (br s, 2H, CHH-
CHH-) 
IR (ν, cm-1, CCl4)  3260, 2926, 2854, 1610, 1586, 1526, 1461, 1407, 1342, 1165, 1056 
HRMS (EI+)    Calcd. for C13H16ClN5O2S : 341.0713     Found : 341.0724 
 
 
3-(2,4-dichloro-8-(methylsulfonyl)-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-5-
yl)propanenitrile (5-84) 
 
 
Experimental Part 
 430
11mg of 5-35 (0.041mmol, 1.0eq.) was dissolved with 0.4ml anhydrous THF (0.1mmol/ml), 
followed by adding 6mg NaH (0.15mmol, 3.5eq.) and then 0.004ml methanesulfonyl 
chloride (0.049mmol, 1.2eq.). The mixture was stirring at room temperature for 1 hour. After 
work-up, the crude product was purified by flash chromatography on silica gel with Acetone 
/ DCM = 1 / 99 to give 5-84 (12mg, 89%) as colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  4.31 (dt, 1H, J = 13.2 Hz, CHH-NMs), 3.60 (dd, 1H, 
J = 13.3, 3.3 Hz, CHH-NMs), 3.56 (s, 3H, SO2-CH3), 3.35-3.25 (m, 1H, CH-CH2-NMs), 
2.65-2.43 (m, 2H, CH2-CN), 2.20 (ddd, 1H, J = 14.5, 5.2, 2.7 Hz, CHH-CH2-NMs), 2.09 (dtd, 
1H, J = 12.0, 7.6, 4.5 Hz, CHH-CH2-CN), 1.95 (tt, 1H, J = 14.0, 4.7 Hz, CHH-CH2-NMs), 
1.82-1.70 (m, 1H, CHH-CH2-CN) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  160.3 (C-Ar), 158.6 (C-Ar), 157.0 (C-Ar), 118.2 
(C≡N), 116.0 (C-Ar), 43.6 (SO2-CH3), 40.3 (CH2-NMs), 31.7 (CH-CH2-NMs), 27.7 (CH2-
CH2-CN), 23.6 (CH2-CH2-NMs), 15.1 (CH2-CN) 
IR (ν, cm-1, CCl4)  3691, 3607, 1711, 1602, 1559, 1529, 1426, 1360, 1224, 1166, 1122, 1023, 
967 
 
 
3-(4-chloro-2-(cyclopropylamino)-8-(methylsulfonyl)-5,6,7,8-tetrahydropyrido[2,3-
d]pyrimidin-5-yl)propanenitrile (5-85) 
 
 
 
10mg of 5-84 (0.029mmol, 1.0eq.) was dissolved with 0.3ml EtOH, followed by adding 
0.004ml cyclopropylamine (0.057mmol, 2.0eq.) and 0.024ml DIPEA (0.14mmol, 5.0eq.). 
The mixture was stirring at 80°C for 2 hours and 10mg of the desired product 5-85 (98%) 
was isolated. 
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1H-NMR (į, ppm) (CDCl3, 400 MHz)  5.33 (s, 1H, NH), 4.24 (dt, 1H, J = 13.1 Hz, CHH-
NMs), 3.59 (s, 3H, SO2-CH3), 3.53 (dd, 1H, J = 13.0, 3.3 Hz, CHH-NMs), 3.30-3.02 (m, 1H, 
CH-CH2-NMs), 2.74 (dtt, 1H, J = 6.7, 3.6 Hz, NH-CH), 2.56-2.39 (m, 2H, CH2-CN), 2.15-
2.00 (m, 2H, CHH-CH2-CN + CHH-CH2-NMs), 1.93 (tt, 1H, J = 13.9, 4.7 Hz, CHH-CH2-
NMs), 1.73 (tdd, 1H, J = 14.0, 9.2, 6.9 Hz, CHH-CH2-CN), 0.85-0.73 (m, 2H, -CHH-CHH-), 
0.62-0.52 (m, 2H, -CHH-CHH-) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  160.1 (C-Ar), 159.9 (C-Ar), 157.7 (C-Ar), 118.8 
(C≡N), 106.3 (C-Ar), 43.5 (SO2-CH3), 40.3 (CH2-NMs), 31.5 (CH-CH2-NMs), 28.6 (CH2-
CH2-CN), 24.7 (CH2-CH2-NMs), 24.0 (NH-CH), 15.2 (CH2-CN), 7.5 (-CH2-CH2-), 7.4 (-
CH2-CH2-) 
 
 
N-(but-3-en-1-yl)-N-(2,6-dichloropyrimidin-4-yl)methanesulfonamide (5-86) 
 
 
 
A solution of 158mg 5-28 (0.73mmol, 1eq.) was dissolved with 1.5ml anhydrous THF 
(0.5mmol/ml) and cooled by an ice-bain. To the colourless solution was added 36mg NaH 
(0.9mmol, 1.2eq.) portionwise and the mixture turned to light yellow. Then 0.06ml 
methanesulfonyl chloride (0.80mmol, 1.1eq.) was added to the mixture drop by drop, and the 
yellow solution changed to colourless immediately. The mixture was stirring at room 
temperature for 1 hour. After work-up, the crude product was purified by flash 
chromatography on silica gel with AcOEt / EP = 10 / 90 to give 5-86 (198mg, 92%) as a 
white crystal. 
 
m.p. : 79~82°C 
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1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.35 (s, 1H, H-aromatic), 5.81 (ddd, 1H, J = 10.1, 9.0, 
2.7 Hz, CH2-CH=CH2), 5.13 (dd, 2H, J = 14.5, 4.8 Hz, CH2-CH=CH2), 4.09 (t, 2H, J = 7.3 
Hz, NMs-CH2), 3.25 (s, 1H, CH3), 2.48 (dt, 2H, J = 7.1 Hz, CH2-CH=CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  162.7 (NMs-C-N), 161.2 (NH-C-CH-C-Cl), 159.8 
(NH-C-N-C-Cl), 133.7 (CH2-CH=CH2), 118.3 (CH2-CH=CH2), 107.1 (Cl-C-CH), 46.7 
(NMs-CH2), 41.5 (CH3), 33.1 (CH2-CH=CH2) 
IR (ν, cm-1, CCl4)  3692, 3155, 2985, 1817, 1794, 1557, 1525, 1471, 1381, 1170, 1096 
HRMS (EI+)    Calcd. for C9H11Cl2N3O2S : 294.9949      Found : 294.9934 
 
 
tert-butyl (6-(N-(2,6-dichloropyrimidin-4-yl)methylsulfonamido)-4-((ethoxycarbono 
thioyl)thio)-1,1,1-trifluorohexan-2-yl)carbamate8-(methylsulfonyl)-5,6,7,8-tetrahydro 
pyrido[2,3-d]pyrimidin-5-yl)propanenitrile (5-87) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-86 (91mg, 
0.31mmol, 1.0eq.) and the xanthate Xa-b (197mg, 0.62mmol, 2.0eq.) in AcOEt (0.7ml, 
1.0mmol/ml), with DLP (111mg, 0.45 eq.). Flash chromatography on silica gel with AcOEt / 
EP = 20 / 80 afforded 5-87 (52mg and 77mg, 68%, dr = 1:1.5) as colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.47 (s, 1H, H-Ar), 4.81 (d, 1H, J = 10.0 Hz, NH), 
4.66 (q, 2H, J = 7.1 Hz, CSOCH2CH3), 4.48-4.32 (m, 1H, CH-CF3), 4.24 (ddd, 1H, J = 14.9, 
10.2, 4.6 Hz, CHHNMs), 3.97 (ddd, 1H, J = 15.5, 10.1, 5.7 Hz, CHHNMs), 3.75 (dd, 1H, J 
= 11.6, 7.7 Hz, CHS), 3.31 (s, 3H, SO2-CH3), 2.29 (ddd, 1H, J = 14.1, 9.6, 5.2 Hz, CHH-
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CH2-NMs), 2.18-1.96 (m, 3H, CHH-CH2-NMs + CH2-CHCF3), 1.47 (s, 9H, C(CH3)3), 1.44 (t, 
3H, J = 7.1 Hz, CSOCH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 213.1 (CS), 162.9 (C-Ar), 161.2 (C-Ar), 159.7 (C-
Ar), 155.3 (CO), 124.8 (q, J = 281 Hz, CF3), 106.8 (Ar-CH), 81.1 (C(CH3)3), 70.5 (CH2CH3), 
50.3 (q, J = 30 Hz, CH-CF3), 45.1 (CH2NMs), 44.4 (CHS), 41.9 (SO2-CH3), 34.4 (CH2-
CHCF3), 30.8 (CH2-CH2NMs), 28.3 (C(CH3)3), 13.8 (CH2CH3) 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.45 (s, 1H, H-Ar), 4.85 (d, 1H, J = 9.9 Hz, NH), 
4.60 (qd, 1H, J = 7.1, 4.0 Hz, CSOCH2CH3), 4.56-4.47 (m, 1H, CH-CF3), 4.15 (t, 2H, J = 
7.0 Hz, CH2NMs), 4.02-3.85 (m, 1H, CHS), 3.27 (s, 3H, SO2-CH3), 2.35-2.19 (m, 1H, CHH-
CH2-NMs), 2.14-1.99 (m, 3H, CHH-CH2-NMs + CH2-CHCF3), 1.43 (s, 9H, C(CH3)3), 1.40 (t, 
3H, J = 7.1 Hz, CSOCH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz) 212.8 (CS), 162.8 (C-Ar), 160.9 (C-Ar), 159.8 (C-
Ar), 154.6 (CO), 125.1 (q, J = 281 Hz, CF3), 107.6 (Ar-CH), 80.7 (C(CH3)3), 70.5 (CH2CH3), 
50.2 (q, J = 30 Hz, CH-CF3), 44.7 (CH2NMs), 44.6 (CHS), 41.3 (SO2-CH3), 34.2 (CH2-
CHCF3), 31.3 (CH2-CH2NMs), 28.3 (C(CH3)3), 13.7 (CH2CH3) 
IR (ν, cm-1, CCl4)  3691, 3155, 2984, 2254, 1817, 1794, 1724, 1643, 1602, 1557, 1526, 1471, 
1381, 1293, 1217, 1169, 1096 
HRMS (EI+)    Calcd. for C19H27Cl2F3N4O5S3 : 614.0473      Found : 614.0455 
 
 
2-chloro-4-(methylsulfonyl)-8-(trifluoromethyl)-5,6,6a,7,8,9-hexahydro-4H-
pyrimido[4,5,6-ij][2,7]naphthyridine (5-89) 
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Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was firstly carried out with the solution of the first fraction of 5-87 
(61mg, 0.10mmol, 1.0eq.) in AcOEt (2ml, 0.05mmol/ml), with DLP (47mg, 1.2eq.). Flash 
chromatography on silica gel with Acetone / DCM = 1 / 99 afforded the cyclization product 
as a white powder (32mg, 67%, dr = 1:1.04). Then the cyclization was carried out with the 
solution of the second fraction of 5-87 (91mg, 0.15mmol, 1.0eq.) in AcOEt (3ml, 
0.05mmol/ml), with DLP (83mg, 1.4eq.). Flash chromatography on silica gel with Acetone / 
DCM = 1 / 99 afforded the cyclization product as a white powder (49mg, 67%, dr = 1:1.17). 
Since both of the two cyclization products were mixture of two stereoisomers and their 
purities were not completely being satisfied for full characterization, we combined them to 
one fraction 5-88 and used it directly in the preliminary test to prepare the tricyclic 
compound.  
 
19mg 5-88 (0.038mmol, 1.0eq.) was dissolved by 0.34ml (0.1mmol/ml) of a prepared 
solution which contained 0.30ml of DCM and 0.035ml of TFA (0.46mmol, 12eq.). The 
mixture was stirring at room temperature for 80min and all starting compound was 
completely deprotected indicated by TLC. Then the solvent was removed under reduced 
pressure and the residue was dissolved by 0.76ml EtOH (0.05mmol/ml) followed by adding 
0.034ml DBU (0.23mmol, 6.0eq.) and stirring at 60°C for 40min. Finally the crude product 
was purified by preparative TLC plate with Acetone / DCM = 1 / 99 to give 5-89 (6.8mg, 
50%, dr = 1:1.5) as a white solid. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.14 (d, 0.4H, J = 4.0 Hz, NH), 5.56 (s, 0.6H, NH), 
4.59-4.34 (m, 1H, CHHNMs), 4.21-4.01 (m, 1H, CH-CF3), 3.53 (s, 3H, SO2-CH3), 3.52-3.43 
(m, 1H, CHHNMs), 2.83 (tt, 1H, J = 12.0, 4.6 Hz, CH), 2.45-2.25 (m, 2H, CHH-CH2-NMs + 
CHH-CHCF3), 1.56 (m, 2H, CHH-CH2-NMs + CHH-CHCF3) 
13C-NMR (į, ppm) (DMSO, 100.6 MHz)  159.4 (C-Ar, 158.9 (C-Ar), 157.4 (C-Ar), 157.0 
(C-Ar), 155.6 (C-Ar), 155.5 (C-Ar), 94.8 (C-Ar), 94.5 (C-Ar), 53.1 (q, J = 30 Hz, CH-CF3), 
44.2 (CH2), 44.1 (CH3), 43.8 (CH3), 43.7 (CH2), 28.5 (CH), 27.5 (CH2), 26.3 (CH2), 26.0 
(CH2), 24.7 (CH2) 
MS (NH3 ionisation) 357 (MH+) 
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2-chloro-5,6,6a,7,8,9-hexahydro-4H-pyrimido[6,5,4-ij][2,7]naphthyridine (5-91) 
 
 
 
11mg 5-34 (0.028mmol, 1.0 eq.) was dissolved by 0.15ml (0.2mmol/ml) of a prepared 
solution which contained 0.0027ml hydrazine (0.056mmol, 2.0 eq.) in EtOH, and then the 
mixture was stirring at room temperature for 3 hours and all the starting compound was 
completely deprotected indicated by TLC. Then the solvent was removed under reduced 
pressure and the residue was dissolved by 0.6ml EtOH (0.05mmol/ml) followed by adding 
0.025ml DBU (0.168mmol, 6.0 eq.) and stirring at 70℃ for 1 hour, during when white 
precipitation formed. Finally the precipitation was seperated by centrifuge and washed by 
cold EtOH to afford 5-91 (5.4mg, 91%) as a white crystal. 
 
m.p. : 320-325°C decomposed 
1H-NMR (į, ppm) (DMSO, 400 MHz)  7.00 (br s, J = 3.61 Hz, 2H, 2NH), 3.32-3.28 (m, 2H, 
2NHCHH), 3.18 (dt, J = 12.3, 2.7 Hz, 2H, 2NHCHH), 2.60-2.50 (m, 1H, CH), 1.99 (d, J = 
12.0 Hz, 2H, 2CHCHH), 1.20 (dt, J = 12.1, 4.4 Hz, 2H, 2CHCHH) 
13C-NMR (į, ppm) (DMSO, 100.6 MHz)  158.4 (C-Ar), 156.6 (C-Ar), 87.1 (C-Ar), 39.6 
(2NHCH2), 29.2 (CH), 26.8 (2CHCH2) 
IR (ν, cm-1, Nujol)  3222, 3088, 1584, 1334, 1287, 1170, 1109, 1091, 1016, 944, 905   
HRMS (EI+)    Calcd. for C9H11ClN4 : 210.0672     Found : 210.0675       
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5-chloro-1,2,3,7,8,9,10,10a-octahydro-3,4,6,7-tetraazacyclohepta[de]naphthalene (5-92) 
 
 
 
30mg 5-42 (0.077mmol, 1.0 eq.) was dissolved by 0.39ml (0.2mmol/ml) of a prepared 
solution which contained 0.0077ml hydrazine (0.153mmol, 2.0 eq.) in EtOH, and then the 
mixture was stirring at room temperature for 2.5 hours and all the starting compound was 
completely deprotected indicated by TLC. Then the solvent was removed under reduced 
pressure and the residue was dissolved by 1.6ml EtOH (0.05mmol/ml) followed by adding 
0.07ml DBU (0.46mmol, 6.0 eq.) and stirring at 75°C for 1 hour. When cooling down the 
flask, white precipitation formed. Finally the precipitation was seperated by centrifuge and 
washed by cold EtOH to afford 5-92 (13mg, 75%) as a white crystal. 
 
m.p. : 266-270°C 
1H-NMR (į, ppm) (DMSO + TFA, 400 MHz)  7.06 (s, 1H, NH), 6.54 (d, J = 4.1 Hz, 1H, 
NH), 3.67 (dd, J = 11.8 Hz 1H, CH), 3.21-3.18 (m, 2H, CH2NH), 3.12-3.08 (m, 2H, CH2NH), 
1.97-1.62 (m, 5H, 2 CH2 + CHH), 1.39 ( m, 1H, CHH) 
13C-NMR (į, ppm) (DMSO, 100.6 MHz)  164.6 (C-Ar), 161.2 (C-Ar), 155.9 (C-Ar), 93.1 
(C-Ar), 41.5 (NHCH2), 38.4 (NHCH2), 32.6 (CH2), 30.3 (CH), 29.8 (CH2), 27.4 (CH2) 
IR (ν, cm-1, Nujol) 3238, 3090, 1578, 1532, 1404, 1342, 1293, 1279, 1169, 1123, 1080, 984, 
928, 781 
HRMS (EI+)    Calcd. for C10H13ClN4 : 224.0829      Found : 224.0839 
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2-(2-(5-chloro-1-(methylsulfonyl)-7-oxo-1,2,3,7-tetrahydroimidazo[1,2-a]pyrimidin-3-
yl)ethyl)isoindoline-1,3-dione (5-99) 
 
 
 
149mg of deacetylated 5-96 (0.43mmol, 1.0eq.) was dissolved with 4.3ml anhydrous THF 
(0.1mmol/ml), followed by adding 19mg NaH (0.48mmol, 1.1eq.) and then 0.04ml 
methanesulfonyl chloride (0.52mmol, 1.2eq.). The mixture was stirring at room temperature 
for 1 hour. After work-up, the crude product was purified by flash chromatography on silica 
gel with MeOH / DCM = 1 / 99 to give 5-99 (143mg, 79%) as white solid. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.95-7.79 (m, 2H, 2 H-phthalimide), 7.78-7.69 (m, 
2H, 2 H-phthalimide), 5.97 (s, 1H, H-aromatic), 4.66 (ddd, 1H, J = 12.7, 8.9, 3.7 Hz, CH-
CH2-NMs), 4.28 (t, 1H, J = 9.8 Hz, CHH-NMs), 4.15 (dd, 1H, J = 10.4, 4.2 Hz, CHH-NMs), 
3.91 (td, 1H, J = 14.3, 5.7 Hz, CHH-phth), 3.83-3.73 (m, 1H, CHH-phth), 3.50 (s, 3H, SO2-
CH3), 2.57-2.36 (m, 1H, CHH-CH2-phth), 2.22 (tdd, 1H, J = 14.4, 9.1, 5.5 Hz, CHH-CH2-
phth) 
MS (NH3 ionisation) 423 (M+) 
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2-(2-(5-(cyclopropylamino)-1-(methylsulfonyl)-7-oxo-1,2,3,7-tetrahydroimidazo[1,2-
a]pyrimidin-3-yl)ethyl)isoindoline-1,3-dione (5-100) 
 
 
 
Preliminary test for the nucleophilic substitution was carried out with 11mg 5-99 
(0.026mmol, 1.0 eq.), which was dissolved by 0.5ml DMF (0.05mmol/ml). Then 0.05ml 
cyclopropylamine (0.72mmol, 27 eq.) was added to the solution and the mixture was stirring 
at 90°C for 3 hours, although not all the starting material was completely consumed 
according to TLC. The solvent was removed under reduced pressure and the residue was 
purified by preparative TLC plate with MeOH / DCM = 4 / 96 to afford 5-100 (5.2mg, 60%) 
as a white solid, together with recovering 2.7mg reactant 5-99. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.97-7.77 (m, 2H, 2 H-phthalimide), 7.77-7.68 (m, 
2H, 2 H-phthalimide), 5.19 (s, 1H, H-aromatic), 5.04 (br s, 1H, NH), 4.72-4.44 (m, 1H, CH-
CH2-NMs), 4.16 (t, 1H, J = 9.6 Hz, CHH-NMs), 4.06 (dd, 1H, J = 10.2, 3.7 Hz, CHH-NMs), 
3.89 (td, 1H, J = 14.3, 5.9 Hz, CHH-phth), 3.78 (ddd, 1H, J = 14.3, 8.6, 5.6 Hz, CHH-phth), 
3.38 (s, 3H, SO2-CH3), 2.57-2.41 (m, 1H, CHH-CH2-phth), 2.41-2.32 (m, 1H, NH-CH), 2.24-
2.09 (m, 1H, CHH-CH2-phth), 0.80-0.71 (m, 2H, -CHH-CHH-), 0.58-0.52 (m, 2H, -CHH-
CHH-) 
MS (NH3 ionisation) 444 (MH+) 
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N-(but-3-enyl)-N-(4,6-dichloropyrimidin-2-yl)acetamide (5-101) 
 
 
 
25ml flask was charged of 141mg 5-28’ (0.65mmol, 1.0eq.) and 1.5ml acetyl chloride 
(0.43mmol/ml), and the mixture was kept stirring under the protection of nitrogen for 49 
hours. After work-up, the crude product was purified by flash chromatography on silica gel 
with DCM / EP = 80 / 20 to give 5-101 (165mg, 98%) as colourless oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.10 (s, 1H, H-aromatic), 5.83 (dt, 1H, J=6.5Hz, 
J=17.1Hz, CH2-CH=CH2), 5.08 (d, 1H, J=17.1Hz, CH2-CH=CHH), 5.03 (d, 1H, J=10.2Hz, 
CH2-CH=CHH), 4.19 (t, 2H, J=7.3Hz, CH2-NAc), 2.59 (s, 1H, CH3), 2.43 (q, 2H, J=7.1Hz, 
CH2-CH=CH2) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  172.3 (COCH3), 161.6 (2 C-Cl), 160.1 (N-C-NAc), 
135.1 (CH2-CH=CH2), 116.8 (CH2-CH=CH2), 115.1 (Cl-C-CH), 45.2 (NAc-CH2), 32.6 
(CH2-CH=CH2), 26.9 (CH3) 
IR (ν, cm-1, CDCl3)  2980, 2338, 1687, 1558, 1529, 1451, 1423, 1391, 1370, 1245, 1223, 
1124, 1092, 980   
HRMS (EI+)    Calcd. for C10H11Cl2N3O : 259.0279     Found : 259.0280 
 
 
tert-butyl but-3-en-1-yl(4,6-dichloropyrimidin-2-yl)carbamate (5-102) 
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1H-NMR (į, ppm) (CDCl3, 400 MHz)  6.99 (s, 1H, H-aromatic), 5.80 (tdd, 1H, J=7.0Hz, 
J=10.2Hz, J=17.1Hz, CH2-CH=CH2), 5.04 (ddd, 2H, J=1.3Hz, J=13.7Hz, J=11.1Hz, CH2-
CH=CH2), 3.98 (t, 2H, J=7.4Hz, NH-CH2), 2.43 (dd, 2H, J=7.2Hz, J=14.4Hz, CH2-CH=CH2), 
1.53 (s, 9H, C(CH3)3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  161.4 (2 C-Cl), 160.2 (NBoc-C-N), 152.8 (C=O), 
134.9 (CH2-CH=CH2), 116.9 (CH2-CH=CH2), 114.8 (Cl-C-CH), 82.6 (C(CH3)3), 47.0 (NH-
CH2), 33.1 (CH2-CH=CH2), 28.0 (C(CH3)3) 
 
 
S-1-(N-(4,6-dichloropyrimidin-2-yl)-N-acethylamino)-5-cyanopentan-3-yl O-ethyl 
carbonodithioate (5-103) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-101 (159mg, 
0.61mmol, 1.0 eq.) and the xanthate Xa-a (102mg, 0.63mmol, 1.0 eq.) in AcOEt (0.6ml, 
1.0mmol/ml), with DLP (37mg, 0.15 eq.). Flash chromatography on silica gel with AcOEt / 
EP = 20 / 80 afforded 5-103 (189mg, 80%) as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.17 (s, 1H, H-aromatic), 4.64 (q, 2H, J=7.1Hz, 
CH2CH3), 4.26-4.11 (m, 2H, CH2-NAc), 3.79 (dt, 1H, J=6.9Hz, J=12.0Hz, Xa-CH), 2.58 (s, 
1H, CH3), 2.57-2.52 (m, 2H, CH2-CN), 2.33-2.24 (m, 1H, CHH-CH2-CN), 2.13-1.98 (m, 3H, 
CHH-CH2-CN + CH2-CH2-NAc), 1.43 (t, 3H, J=7.1Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  212.8 (C=S), 172.3 (COCH3), 161.9 (2 C-Cl), 
159.8 (N-C-NAc), 118.9 (CN), 115.3 (Cl-C-CH), 70.3 (CH2CH3), 47.6 (CH-Xa), 43.5 (NAc-
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CH2), 32.2 (CH2-CH2-NAc), 29.9 (CH2-CH2-CN), 27.0 (CH3), 14.9 (CH2-CN), 13.7 
(CH2CH3) 
IR (ν, cm-1, CDCl3)  2962, 1688, 1558, 1530, 1450, 1423, 1392, 1369, 1241, 1112, 1049, 995   
HRMS (EI+)    Calcd. for C15H18Cl2N4O2S2 : 420.0248     Found : 420.0244 
 
 
tert-butyl (5-cyano-3-((ethoxycarbonothioyl)thio)pentyl)(4,6-dichloropyrimidin-2-
yl)carbamate (5-104) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-102 (218mg, 
0.69mmol, 1.0 eq.) and the xanthate Xa-a (165mg, 1.03mmol, 1.5 eq.) in AcOEt (0.7ml, 
1.0mmol/ml), with DLP (41mg, 0.1 eq.). Flash chromatography on silica gel with DCM / EP 
= 80 / 20 afforded 5-104 (318mg, 97%) as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.02 (s, 1H, H-aromatic), 4.64 (q, 2H, J=7.1Hz, 
CH2CH3), 4.04 (dd, 2H, J = 8.5, 6.1 Hz, CH2-NBoc), 3.82 (dt, 1H, J = 12.2, 6.8 Hz, Xa-CH), 
2.71-2.41 (m, 2H, CH2-CN), 2.33-2.18 (m, 1H, CHH-CH2-CN), 2.06 (m, 3H, CHH-CH2-CN 
+ CH2-CH2-NBoc), 1.54 (s, 9H, C(CH3)3), 1.43 (t, 3H, J=7.1Hz, CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  212.6 (C=S), 161.6 (2 C-Cl), 159.9 (N-C-NAc), 
152.6 (CO), 119.0 (CN), 115.1 (Cl-C-CH), 83.2 (CMe3), 70.3 (CH2CH3), 47.5 (CH-Xa), 45.0 
(N-CH2), 32.4 (CH2-CH2-NBoc), 30.0 (CH2-CH2-CN), 28.1 ((CH3)3), 14.9 (CH2-CN), 13.8 
(CH2CH3) 
 
Experimental Part 
 442
N-(5-cyanopentyl)-N-(4,6-dichloropyrimidin-2-yl)acetamide (5-105’) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-103 (98mg, 0.233mmol, 1.0eq.) 
in AcOEt (4.7ml, 0.05mmol/ml), with DLP (186mg, 2.0eq.). Flash chromatography on silica 
gel with AcOEt / EP = 10 / 90 afforded the prematurely reduced material 5-105’ (10mg, 14%) 
as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.07 (s, 1H, H-aromatic), 4.06 (dd, 2H, J=7.0Hz, 
J=14.3Hz, CH2-NAc), 2.55 (s, 3H, CH3), 2.36 (t, 2H, J=7.2Hz, CH2-CN), 1.77-1.60 (m, 4H, 
CH2-CH2-NAc + CH2-CH2-CN), 1.54-1.45 (CH2-CH2-CH2-CN) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  172.3 (COCH3), 161.7 (2 C-Cl), 160.0 (N-C-NAc), 
119.6 (CN), 115.2 (Cl-C-CH), 45.3 (NAc-CH2), 26.9 (CH2-CH2-Nac + CH3), 25.7 (CH2-
CH2-CH2-CN), 24.8 (CH2-CH2-CN), 17.0 (CH2-CN) 
IR (ν, cm-1, CDCl3)  3119, 2943, 2868, 1687, 1558, 1530, 1450, 1423, 1392, 1370, 1242, 
1125, 1090, 1015, 975   
HRMS (EI+)    Calcd. for C12H14Cl2N4O : 300.0545      Found : 300.0544       
 
 
 
 
 
 
 
 
Experimental Part 
 443 
N-(4-allyl-1-tosylpiperidin-4-yl)-4,6-dichloropyrimidin-2-amine (5-107) 
 
 
 
158mg trichloropyrimidine (0.86mmol, 1.2eq.) was dissolved by 1.8ml THF and then 212mg 
of the above precursor (0.72mmol, 1.0eq.) was added. The mixture was refluxed for 18 hours 
to finish the reaction. After work-up, flash chromatography on silica gel with AcOEt / EP = 
20 / 80 afforded 5-107 (74mg, 23%) as white solid. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.62 (d, J = 8.3 Hz, 2H, 2 H-Ts), 7.32 (d, J = 8.0 Hz, 
2H, 2 H-Ts), 6.61 (s, 1H, H-aromatic), 5.63 (tdd, J = 17.5, 10.2, 7.4 Hz, 1H, CH2-CH=CH2), 
5.00 (ddd, J = 18.9, 13.6, 2.0 Hz, 2H, CH2-CH=CH2), 4.85 (br s, 1H, NH), 3.54 (td, J = 11.8, 
3.1 Hz, 2H, 2 CHH-NTs), 2.62 (d, J = 7.4 Hz, 2H, CH2-CH=CH2), 2.54 (dt, J = 12.1, 2.4 Hz, 
2H, 2 CHH-NTs), 2.44 (s, 3H, CH3), 2.30 (d, J = 13.7 Hz, 2H, 2 NHC-CHH), 1.77 (m, 2H, 2 
NHC-CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  161.4 (N-C-pyrimidine), 160.6 (2 C-Cl), 143.7 (C-
Ts), 133.0 (C-Ts), 132.1 (CH2-CH=CH2), 129.8 (2 CH-Ts), 127.6 (2 CH-Ts), 119.3 (CH2-
CH=CH2), 109.6 (CH-pyrimidine), 53.9 (NH-C), 41.8 (2 CH2-NTs), 40.9 (CH2-CH=CH2), 
33.8 (2 NHC-CH2), 21.6 (CH3) 
 
 
 
 
 
 
Experimental Part 
 444
S-(4-cyano-1-(4-((4,6-dichloropyrimidin-2-yl)amino)-1-tosylpiperidin-4-yl)butan-2-yl) 
O-ethyl carbonodithioate (5-108) 
 
 
 
Following the general procedure 5-I for the radical addition of xanthates on the 
corresponding olefins, the reaction was carried out with the solution of 5-107 (39mg, 
0.089mmol, 0.5eq.) and the xanthate Xa-a (29mg, 0.178mmol, 1.0eq.) in AcOEt (0.4ml, 
0.5mmol/ml), with DLP (11mg, 0.15eq.). Flash chromatography on silica gel with Acetone / 
DCM = 2 / 98 afforded 5-108 (49mg, 91%) as light yellow oil. 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.61 (d, 2H, J = 8.2 Hz, 2 H-Ts), 7.32 (d, 2H, J = 7.9 
Hz, 2 H-Ts), 6.65 (s, 1H, , H-aromatic), 4.95 (s, 1H, NH), 4.67-4.54 (m, 2H, CH2CH3), 3.87 
(dt, 1H, J = 9.2, 8.9, 2.1 Hz, Xa-CH), 3.65-3.53 (m, 2H, 2 CHH-NTs), 2.57-2.36 (m, 4H, 2 
CHH-NTs + 2 NHC-CHH), 2.43 (s, 3H, CH3), 2.40 (t, 2H, J =7.6 Hz CH2-CN), 2.33 (dd, 1H, 
J = 15.4, 9.6 Hz, CHH-CHXa), 2.18 (dd, 1H, J = 15.4, 2.3 Hz, CHH-CHXa), 2.04-1.92 (m, 
2H, CH2-CH2-CN), 1.77 (dt, 2H, J = 13.8, 13.6, 4.2 Hz, 2 NHC-CHH), 1.40 (t, 3H, J=7.1Hz, 
CH2CH3) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  213.0 (C=S), 161.5 (N-C-pyrimidine), 160.5 (2 C-
Cl), 143.8 (C-Ts), 132.9 (C-Ts), 129.9 (2 CH-Ts), 127.6 (2 CH-Ts), 118.7 (CN), 110.1 (CH-
pyrimidine), 70.9 (CH2CH3), 53.7 (NH-C-CH2), 45.2 (CH-Xa), 41.7 (CH2-NTs), 41.5 (CH2-
NTs), 40.1 (CH2-CH-Xa), 34.6 (2 NHC-CH2), 34.3 (2 NHC-CH2), 33.2 (CH2-CH2-CN), 21.5 
(CH3), 14.7 (CH2-CN), 13.8 (CH2CH3) 
 
 
 
Experimental Part 
 445 
3-(6'-chloro-8'-oxo-1-tosyl-1',3',4',8'-tetrahydrospiro[piperidine-4,2'-pyrimido[1,2-
a]pyrimidin]-4'-yl)propanenitrile (5-109) 
 
 
 
Following the general procedure 5-II for the radical cyclization of the corresponding 
xanthates, the reaction was carried out with the solution of 5-108 (49mg, 0.08mmol, 1.0 eq.) 
in AcOEt (1.4ml, 0.06mmol/ml), with DLP (32mg, 1.0eq.). Purification with preparative 
TLC plate with AcOEt / DCM = 20 / 80 afforded 5-109 (9.5mg, 26%) as light yellow oil, 
together with reduced product 5-109’ (2.8mg, 7%). 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.64 (d, 2H, J = 8.3 Hz, 2 H-Ts), 7.38 (d, 2H, J = 8.1 
Hz, 2 H-Ts), 5.88 (s, 1H, , H-aromatic), 5.63 (br s, 1H, NH), 4.85 (tt, 1H, J = 6.4, 3.1 Hz, 
CH), 3.51-3.31 (m, 2H, 2 CHH-NTs), 2.76 (m, 2H, 2 CHH-NTs), 2.61-2.34 (m, 2H, CH2-
CN), 2.49 (s, 3H, CH3), 2.23-2.12 (m, 2H, CHH-CH2-CN + CHH-CH-C), 2.05-1.83 (m, 4H, 
CHH-CH2-CN + 2 NHC-CHH + CHH-CH-C), 1.70-1.67 (m, 2H, 2 NHC-CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  161.1 (CO), 158.5 (NH-C-pyrimidine), 151.3 (C-
Cl), 144.4 (C-Ts), 132.2 (C-Ts), 130.1 (2 CH-Ts), 127.6 (2 CH-Ts), 118.6 (CN), 101.3 (CH-
pyrimidine), 50.3 (NH-C-CH2), 47.5 (CH), 41.9 (CH2-NTs), 41.7 (CH2-NTs), 38.8 (2 NHC-
CH2), 37.8 (2 NHC-CH2), 36.2 (CH2), 29.8 (CH2), 21.6 (CH3), 15.3 CH2-CN () 
HRMS (EI+)    Calcd. for C21H24ClN5O3S : 461.1288     Found : 461.1283 
 
 
 
 
 
 
 
Experimental Part 
 446
4-chloro-5-(4-((4,6-dichloropyrimidin-2-yl)amino)-1-tosylpiperidin-4-yl)pentanenitrile 
(5-110) 
 
 
 
In the procedure for obtaining 5-109 and 5-109’, a third product 5-110 was also seperated 
with AcOEt / EP = 30 / 70 as light yellow oil (12.6mg, 30%). 
 
1H-NMR (į, ppm) (CDCl3, 400 MHz)  7.62 (d, 2H, J = 8.3 Hz, 2 H-Ts), 7.33 (d, 2H, J = 8.0 
Hz, 2 H-Ts), 6.66 (s, 1H, ,H-aromatic), 5.01 (s, 1H, NH), 3.94 (td, 1H, J = 9.5, 7.0 Hz, Cl-
CH), 3.58 (ddd, 2H, J = 12.4, 8.5, 4.4 Hz, 2 CHH-NTs), 2.58 (dd, 1H, J = 15.5, 2.0 Hz, 
CHH-CHCl),  2.57-2.40 (m, 4H, 2 CHH-NTs + 2 NHC-CHH), 2.51 (t, 2H, J = 7.3 Hz, CH2-
CN), 2.46 (s, 3H, CH3), 2.22 (dd, 1H, J = 15.6, 9.6 Hz, CHH-CHCl), 1.98 (dd, 2H, J = 13.9, 
7.0 Hz, CH2-CH2-CN), 1.93-1.75 (m, 2H, 2 NHC-CHH) 
13C-NMR (į, ppm) (CDCl3, 100.6 MHz)  161.6 (N-C-pyrimidine), 160.2 (2 C-Cl), 143.8 (C-
Ar), 133.0 (C-Ar), 129.9 (2 CH-Ar), 127.6 (2 CH-Ar), 118.4 (CN), 110.1 (CH-pyrimidine), 
55.6 (CH-Cl), 53.6 (NH-C-CH2), 44.5(CH2-CH-Cl), 41.8 (CH2-NTs), 41.4 (CH2-NTs), 33.8 
(2 NHC-CH2), 33.5 (2 NHC-CH2), 35.3 (CH2-CH2-CN), 21.6 (CH3), 14.6 (CH2-CN) 
MS (NH3 ionisation) 517, 519, 521 (M+), 518, 520, 522 (MH+) 
 
 

  
